<SEC-DOCUMENT>0001513162-18-000006.txt : 20180109
<SEC-HEADER>0001513162-18-000006.hdr.sgml : 20180109
<ACCEPTANCE-DATETIME>20180109080117
ACCESSION NUMBER:		0001513162-18-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		60
CONFORMED PERIOD OF REPORT:	20171031
FILED AS OF DATE:		20180109
DATE AS OF CHANGE:		20180109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ITUS Corp
		CENTRAL INDEX KEY:			0000715446
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				112622630
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37492
		FILM NUMBER:		18517873

	BUSINESS ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118
		BUSINESS PHONE:		310-484-5200

	MAIL ADDRESS:	
		STREET 1:		3150 ALMADEN EXPRESSWAY, SUITE 250
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPYTELE INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<HTML>
<head><title>Form 10K</title> </head> <body vlink=blue link=blue lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:4pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <div align=center> <table width=933 bordercolor=transparent style="WIDTH:700pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=653 colspan=3 style="BORDER-TOP:windowtext 2.25pt double; BORDER-RIGHT:0px; WIDTH:489.45pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:10pt>UNITED STATES </font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:10pt>SECURITIES AND EXCHANGE COMMISSION</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:10pt>WASHINGTON, D.C. 20549</font></b></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <h1 style='FONT-SIZE:14pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:6pt 0in 3pt; TEXT-AUTOSPACE:' align=center>FORM 10-K</h1></td></tr> <tr style=HEIGHT:1.4pt> <td width=653 colspan=3 style="HEIGHT:1.4pt; WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'><font style=FONT-SIZE:10pt>[x]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2017</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:10pt>or</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'><font style=FONT-SIZE:10pt>[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>Commission file number:&nbsp; 0-11254</p></td></tr> <tr style=HEIGHT:19.5pt> <td width=653 colspan=3 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:19.5pt; BORDER-RIGHT:0px; WIDTH:489.45pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:18pt>ITUS CORPORATION</font></b></p></td></tr> <tr style=HEIGHT:17.1pt> <td width=653 colspan=3 style="HEIGHT:17.1pt; WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:9pt>(Exact Name of Registrant as Specified in its Charter)</font></p></td></tr> <tr> <td width=319 style="WIDTH:239.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><b>Delaware</b></p></td> <td width=17 style="WIDTH:12.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=316 style="WIDTH:237.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><b>11-2622630</b></p></td></tr> <tr style=HEIGHT:14pt> <td width=319 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:14pt; BORDER-RIGHT:0px; WIDTH:239.25pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:9pt>&nbsp;(State or Other Jurisdiction of Incorporation or Organization)</font></p></td> <td width=17 style="HEIGHT:14pt; WIDTH:12.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=316 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:14pt; BORDER-RIGHT:0px; WIDTH:237.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:9pt>(I.R.S. Employer Identification No.)</font></p></td></tr> <tr> <td width=653 colspan=3 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:489.45pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 0pt; TEXT-AUTOSPACE:' align=center><b>3150 Almaden Expressway, Suite 250</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>San Jose, CA 95118</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=center><b><font style=LINE-HEIGHT:90% lang=ES>(408) 708-9808</font></b></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:9pt>(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#146;s Principal Executive Offices)</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:11pt>Securities registered pursuant to Section 12(b) of the Act:</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:11pt>Common Stock, $.01 par value</font></b></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:11pt>Securities registered pursuant to Section 12(g) of the Act:</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:11pt>None</font></b></p></td></tr> <tr style=HEIGHT:0.65pt> <td width=653 colspan=3 style="HEIGHT:0.65pt; WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&nbsp; Yes [_]&nbsp; No [x]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes [_]&nbsp; No [x]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp; Yes&nbsp; [x]&nbsp;&nbsp; No&nbsp; [_]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&nbsp; Yes [x]&nbsp; No [_]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&#167;229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant&#146;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.&nbsp; [&nbsp; ]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule 12b-2 of the Exchange Act.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Large accelerated filer [__]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accelerated filer&nbsp; [__]</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-accelerated filer&nbsp; [__] (Do not check if a smaller reporting company)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Smaller reporting company&nbsp; [x]</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Emerging growth company [__]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [__]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&nbsp; Yes [_]&nbsp; No [x]</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:9pt>Aggregate market value of the voting stock (which consists solely of shares of common stock) held by non-affiliates of the registrant as of April 28, 2017 (the last business day of the registrant&#146;s most recently completed second fiscal quarter), computed by reference to the closing sale price of the registrant&#146;s common stock on the NASDAQ on such date ($1.95): $22,498,909</font></p></td></tr> <tr> <td width=653 colspan=3 style="WIDTH:489.45pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext">On </font><font style="FONT-SIZE:9pt; TEXT-DECORATION:none; COLOR:windowtext">January </font><font style=FONT-SIZE:9pt>4, 2018<font size=+0><font style="TEXT-DECORATION:none; COLOR:windowtext">,</font></font><font style=COLOR:black> the registrant had outstanding 16,609,399 shares of common stock, par value $.01 per share, which is the registrant&#146;s only class of common stock.</font></font></p></td></tr> <tr> <td width=653 colspan=3 style="BORDER-TOP:windowtext 2.25pt double; BORDER-RIGHT:0px; WIDTH:489.45pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; COLOR:black; LINE-HEIGHT:90%">DOCUMENTS INCORPORATED BY REFERENCE:&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; LINE-HEIGHT:90%; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; COLOR:black; LINE-HEIGHT:90%">NONE&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td></tr></table></div></div> <div style=page:WordSection2> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><a name=(TOC)>TABLE OF CONTENTS</a></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=933 bordercolor=transparent style="WIDTH:700pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=COLOR:black>Page</font></b></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% colspan=3 nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" align=center valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black><a href=#P1>PART I</a></font></b></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> </tr><tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Busns>Item 1.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Busns>Business</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#RF>Item 1A.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#RF>Risk Factors</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>11</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#USC>Item 1B.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#USC>Unresolved Staff Comments.</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>24</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Properties>Item 2.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Properties>Properties</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>24</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#LP>Item 3.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#LP>Legal Proceedings</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>24</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#MSD>Item 4.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#MSD>Mine Safety Disclosures</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>24</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=10% colspan=3 nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" align=center valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black><a href=#P2>PART II</a></font></b></p></td> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#MRCE>Item 5.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#MRCE>Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>24</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#SFD>Item 6.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#SFD>Selected Financial Data</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>25</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#MDNA>Item 7.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#MDNA>Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>25</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#QQD>Item 7A.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#QQD>Quantitative and Qualitative Disclosures about Market Risk </a></font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>30</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#FSSD>Item 8.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#FSSD>Financial Statements and Supplementary Data</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>30</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#CDWAAFD>Item 9.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#CDWAAFD>Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>30</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#CP>Item 9A.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#CP>Controls and Procedures</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>31</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#OI>Item 9B.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#OI>Other Information</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>32</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=10% colspan=3 nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" align=center valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black><a href=#P3>PART III</a></font></b></p></td> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#DEOCG>Item 10.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#DEOCG>Directors, Executive Officers and Corporate Governance</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>32</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#EC>Item 11.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#EC>Executive Compensation</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>38</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#SOCBOMRSM>Item 12.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#SOCBOMRSM>Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>46</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#CRRTDI>Item 13.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#CRRTDI>Certain Relationships and Related Transactions, and Director Independence</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>48</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#PAFS>Item 14.</a> </font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#PAFS>Principal Accounting Fees and Services</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>48</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=10% colspan=3 nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" align=center valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><font style=COLOR:black><a href=#P4>PART IV</a></font></b></p></td> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Exhibits>Item 15.</a></font></p></td> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Exhibits>Exhibits, Financial Statement Schedules</a> </font></p></td> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>49</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=10% nowrap style="HEIGHT:15.75pt; WIDTH:10%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=81% nowrap style="HEIGHT:15.75pt; WIDTH:81%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% nowrap style="HEIGHT:15.75pt; WIDTH:9%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:left; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=left>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style="TEXT-TRANSFORM:uppercase; FONT-WEIGHT:normal">1<font style="FONT-SIZE:9pt; FONT-WEIGHT:normal"> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></font> <p /> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)>Table of Contents</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in' align=center><u>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in' align=center><u>STATEMENTS</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><i>Information included in this Annual Report on Form 10-K (this &#147;Report&#148;) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;).&nbsp; Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results.&nbsp; We generally use the words &#147;believes,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;likely,&#148; &#147;will&#148; and similar expressions to identify forward-looking statements.&nbsp; Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.&nbsp; These risks, uncertainties and factors include, but are not limited to, those factors set forth in this Report under &#147;Item 1A. &#150; Risk Factors&#148; below.&nbsp; Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.&nbsp; You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Report.</i></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in' align=center><u>CERTAIN TERMS USED IN THIS REPORT</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>References in this Report to &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; the &#147;Company&#148; or &#147;ITUS&#148; means ITUS Corporation unless otherwise indicated.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=TEXT-TRANSFORM:uppercase><a name=P1>PART I</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:left; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=left>Item 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=Busns>Business</a>.</u>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Overview</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We were incorporated on November 5, 1982 under the laws of the State of Delaware. &nbsp;From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &nbsp;Commencing in October 2012 the primary operations of the Company involved the development, acquisition, licensing, and enforcement of patented technologies that were either owned or controlled by the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&#147;Anixa&#148;), to develop a platform for non-invasive blood tests for the early detection of cancer.&nbsp; That platform is called Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp; In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&#147;Wistar&#148;), the nation&#146;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. &nbsp;In August of 2016 and again in August of 2017, ITUS announced the renewal and expansion of our relationship with Wistar. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>From October of 2015 through January of 2017, ITUS announced that we had demonstrated the efficacy of our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>early cancer detection platform with 15 different types of cancer, including:&nbsp; breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar and prostate.&nbsp; Breast, lung, colon and prostate cancers represent the four largest categories of cancer worldwide.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In November of 2017, the Company announced the formation of a new subsidiary, Certainty Therapeutics, Inc. (&#147;Certainty&#148;), to develop immuno-therapy drugs against cancer.&nbsp; Certainty entered into a license agreement with Wistar pursuant to which Certainty was granted an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by Wistar relating to Wistar&#146;s chimeric endocrine receptor targeted therapy technology (such technology being akin to chimeric antigen receptor T-cell (&#147;CAR-T&#148;) technology). &nbsp;We plan to initially focus on the development of a treatment for ovarian cancer, but we also may pursue future applications of the technology for the development of treatments for additional solid tumors. &nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 20, 2017, we announced that Certainty entered into a collaboration agreement with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&#147;Moffitt&#148;) to advance toward human clinical testing the CAR-T technology licensed by Certainty from Wistar aimed initially at treating ovarian cancer.&nbsp; Certainty intends to work with researchers at Moffitt to complete studies necessary to submit an Investigational New Drug (&#147;IND&#148;) application with the U.S. Food and Drug Administration (&#147;FDA&#148;).</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the next several quarters, we expect Cchek&#153; and Certainty&#146;s ovarian cancer treatment to be the primary focus of the Company. &nbsp;As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&nbsp; We do not expect these activities to be a significant part of the Company&#146;s ongoing operations nor do we expect these activities to require material financial resources or attention of senior management.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the past several quarters, our revenue was derived from technology licensing and the sale of patented technologies, including revenue from the settlement of litigation. &nbsp;In addition to Anixa and Certainty, the Company may make investments in and form new companies to develop additional emerging technologies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><i><u><font style=COLOR:black>Cchek&#153;</font></u></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence, and quantity of certain immune cells that exist in and around a tumor and that can be found in the blood stream. &nbsp;These types of cells and the tumor micro-environment have been the focus of recent ground breaking published and reported research in immuno-oncology, enabling the development of revolutionary immunotherapies used for treating certain cancer types. &nbsp;We have developed proprietary techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. &nbsp;Specifically, we seek to identify a subset of myeloid cells that we believe are diagnostic.&nbsp; These cells, often referred to as Myeloid Derived Suppressor Cells (&#147;MDSCs&#148;), are identified by specific surface proteins enabling characterization.&nbsp; We generally refer to MDSCs and other cells of the immune system which we believe can be diagnostic in nature as biomarkers.&nbsp; Through our proprietary protocols, we have had early success and have demonstrated accuracy in detecting these biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients. &nbsp;We utilize Artificial Intelligence (&#147;AI&#148;), specifically a Neural Network (&#147;NN&#148;) to analyze our data and to determine the presence of a tumor.&nbsp; We believe that a NN is better able to identify subtle changes in immune response than other analytical approaches.&nbsp; The distinguishing feature of a NN is that it can be trained to answer the key biological questions of interest, in our case whether or not the patient is tumor-bearing, and as it is trained with more data, its ability to answer these questions may improve.&nbsp; Our goal is to establish Cchek&#153; as a non-invasive, inexpensive, cancer diagnostic blood test that can reduce or eliminate the need for traditionally expensive, invasive, painful, and often inaccurate cancer diagnostic procedures which are currently in use. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In each instance where ITUS has demonstrated the efficacy of its cancer detection platform, fresh (utilized within 48 hours) blood samples from biopsy verified cancer patients have been tested at Wistar using a variety of experimental methodologies and protocols.&nbsp; Such un-blinded, non-uniform testing is common during the initial development stage of new technologies and diagnostic tests.&nbsp; Blood samples from patients with differing severities of cancers (with some cancers such as Breast Cancer stage 1 to stage 4) have been tested, including samples from both pre-treatment and post-treatment patients.&nbsp; In addition, Wistar has also tested blood from healthy donors.&nbsp; A critical aspect of any cancer diagnostic is the ability to accurately distinguish patients with cancer from healthy patients.&nbsp; Based upon our encouraging early results, our scientists are working with Wistar to refine protocols and methodologies for identifying and classifying the immunologic biomarkers that are the foundation for our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>early cancer detection platform.&nbsp; Although our scientists, working in collaboration with Wistar, will continue to improve our processes and methodologies to achieve maximum performance, we expect our testing to become more uniform over time, and to eventually test patient samples in a double blinded manner.&nbsp; While studies comparing biopsy verified cancer patients have been compared to healthy donors, we have not yet extensively evaluated benign conditions such as non-malignant neoplasias, systemic inflammatory conditions, infections, and other potential conditions that impact or may impact the immune system.&nbsp; Such testing will be necessary for regulatory approval.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Based upon and following the results of the more extensive clinical study, we will determine what further studies are necessary and whether and when to begin the process of seeking regulatory approval for a confirmatory diagnostic test based upon our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>technology.&nbsp; One manner of seeking regulatory approval is to have a lab certified to run our cancer tests pursuant to t</font>he Clinical Laboratory Improvement Act of 1967 and <font style=COLOR:black>the Clinical Laboratory Improvement Act of 1988 (collectively, &#147;CLIA&#148;). &nbsp;Among other things, CLIA requires clinical laboratories that perform diagnostic testing to be certified by the state in which the lab is located, as well as the Center for Medicare and Medicaid Services. &nbsp;If we seek regulatory approval pursuant to CLIA, only those laboratories that are certified under CLIA to run our diagnostic test would be able to process test samples. &nbsp;CLIA certification may or may not require additional studies. &nbsp;We could seek to establish our own CLIA certified laboratory to run the diagnostic tests, or we could potentially contract with an existing CLIA certified lab, and seek to have that laboratory certified to run our diagnostic test.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>4</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Another manner of obtaining regulatory approval would be to seek to have Cchek&#153; approved by the FDA pursuant to what are commonly referred to as either the 510(K) process, or the Premarket Application (&#147;PMA&#148;) process. &nbsp;The appropriate pathway for FDA approval would depend upon a variety of factors, including the intended use of the test, and the risks associated with such use. &nbsp;FDA approval can take several years and would entail additional clinical studies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We currently anticipate following the FDA approval pathway, however, our decision as to whether and when to seek CLIA certification or FDA approval of a diagnostic test or tests utilizing our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>technology will be dependent on a variety of factors, including the results from more extensive clinical studies, the capital requirements of each approval process, the landscape for competitive diagnostic testing, and the time and resources required by each approval process. &nbsp;It is possible that we may seek to have one or more&nbsp;diagnostic tests approved via CLIA certification, and other diagnostic test or tests approved by the FDA, or that we may seek simultaneous FDA approval and CLIA certification of a particular diagnostic test or tests.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>While we believe our Cchek&#153; platform could eventually form the basis of a pan-cancer (all cancer) test, for our first commercial focus we will seek to launch a confirmatory test for one type of cancer.&nbsp; We feel such an approach will enable faster clinical and regulatory approval.&nbsp; The decision on which tumor type we will focus will depend on multiple factors including market opportunities, input from potential strategic partners and technical performance.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Preliminary Biomarker Results</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On December 7, 2016 we announced the preliminary results from our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>cancer patient efficacy study. &nbsp;Using our most recent protocols and methods for measuring a patients&#146; immunological response to a malignancy, the Company achieved Sensitivity of 92% and Specificity of 92% for 88 patient samples, including 54 samples from patients with multiple types and severities of cancer, and 34 healthy patients.&nbsp; During the initial phase of the study, which involved multiple experimental protocols and techniques for measuring immunological responses, the Company reviewed and analyzed data from a total of 315 patient samples, including 228 patients with varying stages of cancer, as well as blood samples from 87 healthy donors. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Patient samples representing 14 different types of cancer including breast cancer, lung cancer, colon cancer, melanoma, ovarian cancer, liver cancer, thyroid cancer, pancreatic cancer, appendiceal cancer, uterine cancer, osteosarcoma (cancer of the bone), leiomyosarcoma (cancer of the soft tissue), liposarcoma (cancer of the connective tissue), and vulvar cancer were included in the study. &nbsp;The study included samples from patients with early and late stage, biopsy-verified, drug-na&#239;ve (before therapy) tumors, as well as biopsy-verified, refractory (unresponsive to attempted chemotherapy) tumors.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>5</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Sensitivity and specificity are scientific measurements commonly used to determine the accuracy of a diagnostic test, where sensitivity measures how good a test is at identifying people with a particular disease, and specificity measures how good a test is at identifying people without the disease. &nbsp;Although published results vary widely,&nbsp; established diagnostic tests such as Low Dose Computed Tomography (LDCT), which is used by other companies to screen for lung cancer, has sensitivity of approximately 93% and specificity of approximately 73%, the Prostate Specific Antigen (&#147;PSA&#148;) test, which is used by other companies to screen for prostate cancer, has sensitivity of approximately 21% and specificity of approximately 91%, and Mammography, used by other companies to screen for breast cancer and considered to be the &#147;gold standard&#148; for breast cancer screening, has reported sensitivity as low as approximately 68% and specificity as low as approximately 75%. &nbsp;As these results indicate, current diagnostic testing is hampered by low sensitivity, low specificity or both, meaning that the tests miss a substantial portion of the cancers they are supposed to detect, or miss-diagnose a large number of healthy patients as having cancer. &nbsp;There is currently no inexpensive, non-invasive, diagnostic test that excels in both sensitivity and specificity. &nbsp;Our preliminary results, while extremely promising, will have to be confirmed in blinded clinical studies of sufficient size before we can seek marketing approval for Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black> from the FDA.&nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Initial samples in our study were tested utilizing immunostaining and fluorescent microscopic imaging. &nbsp;While results were promising, subjectivity in interpreting the imaging results together with labor intensive and time consuming sample processing hampered the commercial viability of this approach. &nbsp;Subsequently, patient samples were analyzed using flow cytometry, enabling more efficient processing and analysis.&nbsp; In addition, ITUS implemented its proprietary NN software application for analysis, which currently relies on up to 13 quantitative parameters to analyze test results.&nbsp; This approach, which is highly data intensive and requires substantial computer processing power to develop, results in a test which can be performed using a desktop computer.&nbsp; An initial version of our NN, which was trained to distinguish between the immunological responses from cancer patients and healthy patients, was responsible for the sensitivity and specificity results reported above.&nbsp; The Company expects to continue to improve its protocols, continue to upgrade its NN-software by increasing the number of patient samples used to train the software and expanding the range of markers, increasing the data resolution, and enhancing the architecture of the software, which may enable better results.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Related to our collaborative research agreement, the Company and/or Wistar currently have or have had collaborations with doctors from University of Pennsylvania Abramson Cancer Center, The Helen F. Graham Cancer Center and Research Institute at Christiana Hospital in Wilmington, Delaware, Virtua Healthcare System in southern New Jersey, Delaware Valley Urology Center, the largest urology practice in the South Jersey and greater Philadelphia Region, and MD Anderson Cancer Center at Cooper Hospital in southern New Jersey. &nbsp;In most cases, patients from participating doctors at these healthcare institutions who are beginning or in some cases, continuing cancer treatment are asked to consent to have an additional tube of blood drawn for the purpose of participating in the Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>patient efficacy trials.&nbsp; Because the number of cancer patients treated by these hospitals varies over time, and the decision whether to participate in the Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>patient studies is ultimately at the discretion of the patient, it is difficult to predict the number of patient samples that we will receive in any given week, or during any given month.&nbsp; In the past year, we did not obtain the quantity of patient samples that we had initially anticipated which slowed our development.&nbsp; However, as of December 2017 we are seeing an increase in the number of patient samples received and we expect this increase in patient sample volume to be sustained.&nbsp; ITUS is currently in discussions with additional doctors and healthcare providers about providing blood samples for our patient efficacy trials, and the Company has capacity available to process an additional quantity of samples.&nbsp; With the addition of these new sources of patient samples, the Company expects to process enough samples and generate enough data to consider regulatory discussions in the next 6 to 12 month period. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>6</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>The Market</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>There are four primary markets for a cancer diagnostic test: screening, confirmatory testing, treatment monitoring, and recurrence testing.&nbsp; </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:black'>Screening occurs when asymptomatic people are tested for indications of cancer. Examples of existing screening tests include the mammogram for breast cancer, PSA for prostate cancer, and colonoscopy for colon cancer. &nbsp;All screening tests have their strengths and weaknesses, and for many cancers there are currently no recommended screening tests available. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:black'>Confirmatory testing is used to confirm the results of a screening test. &nbsp;In certain instances, existing confirmatory testing can be invasive, painful, expensive, and have relatively high risks of complications. &nbsp;For example, a positive mammogram is often followed up with additional imaging, which can lead to a biopsy during which a needle is inserted into the breast to sample suspicious tissue or lesions. &nbsp;For lung cancer, existing confirmatory diagnostics include bronchoscopies, during which a flexible tube is inserted through the nose or mouth and into the lung, and needle biopsies, during which a long needle is inserted between the ribs and into the lung. &nbsp;One potential side effect of a lung biopsy is a pneumothorax (commonly referred to as a &#147;collapsed lung&#148;), which has been reported to occur in approximately fifteen percent (15%) of needle biopsies of the lung. &nbsp;A pneumothorax can lead to other complications and sometimes requires extended hospitalization.&nbsp; In addition to the potential side effects, biopsies of any sort can be extremely painful for the patient.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:black'>Treatment monitoring includes follow-on testing to monitor the effectiveness of a specific regimen of treatment. &nbsp;For example, diagnostic monitoring testing may be used to monitor the effectiveness of a particular type of chemotherapy, to determine how the cancer is responding and whether such treatment should be continued. &nbsp;Often, imaging techniques are not able to identify whether a treatment is working, so a biopsy is useful, however it is painful and impractical to perform multiple biopsies on a patient.&nbsp; Therefore, a &#147;liquid biopsy&#148; enabling therapy monitoring via a blood test can be useful.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:black'>Finally, recurrence diagnostic testing is used for cancer survivors to test for cancer recurrence. &nbsp;According to statistics published by the American Cancer Society, in 2017, there are approximately fifteen million cancer survivors in the U.S., sixty-seven (67%) of which were diagnosed with cancer five or more years ago. &nbsp;Most cancer survivors live in fear of recurrence, and limitations of existing diagnostics, including repeated exposure to radiation from imaging tests, and invasiveness and costs and pain from tests such as traditional biopsies, prevent cancer survivors from being tested as often as they would like.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>ITUS&#146;s long term vision is to have one or more tests based upon the Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>platform to serve each of the markets identified above. &nbsp;We anticipate the initial market focus of Cchek will be in the confirmatory, or pre-biopsy, testing.&nbsp; We estimate that there is a U.S. market of roughly 12 million biopsies annually and a high rate of negative biopsy results.&nbsp; Accordingly, we believe that positioning Cchek as a pre-biopsy test will reduce the number of unnecessary biopsies, thus improving patient outcomes and reducing healthcare costs.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>7</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style="BACKGROUND:white; COLOR:black">Competition</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><font style="BACKGROUND:white; COLOR:black">Background</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Continuing scientific advances and discoveries, the ability to more quickly process and analyze large amounts of scientific data, and decreases in the cost of sophisticated equipment and technologies, have resulted in the potential for significant advances in cancer treatment, and in particular, cancer diagnostics. &nbsp;Cancer statistics gathered over the past several decades provide overwhelming evidence that the earlier that cancers are detected, the greater the survival rates. &nbsp;Up until now, doctors have primarily relied upon technologies such as imaging (x-rays, mammograms, CT Scans, MRI&#146;s, PET Scans, Ultrasounds) and biopsies and other invasive procedures for cancer detection and cancer diagnoses. &nbsp;In many cases, these diagnostic procedures were performed after patients exhibited one or more symptoms of cancer, at which point the cancer may likely no longer be at an early stage. &nbsp;Existing diagnostic technologies such as imaging have gotten better, and invasive diagnostic procedures such as colonoscopies have become more accurate and less risky, and we expect these types of traditional diagnostic tools to continue to predominate the cancer diagnostic market for the foreseeable future.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We believe that with advancing medical knowledge, improvements in equipment and technologies, and reduction in costs of new technologies, new types of cancer diagnostics will be created and new types of cancer diagnostic testing that will outperform many of the traditional diagnostic tests, eliminate many of the negative consequences of existing diagnostic testing, and ultimately predominate the cancer diagnostic market. &nbsp;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We have identified a class and subclasses of biomarkers that we believe are measurable in the blood of patients with malignancies, and are perfecting a process and methodology for detecting those biomarkers. &nbsp;The goal is to create a platform, Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, that can be used to launch a series of simple and affordable blood tests that can be used to detect and monitor many of the most deadly forms of cancer, including lung cancer, breast cancer, ovarian cancer, colon cancer, pancreatic cancer, prostate cancer, and others. &nbsp;It is unlikely that the Company will initially simultaneously launch tests for each of the cancers identified above, and that specific and individual cancer tests for each of the four markets identified above (screening, confirmatory testing, treatment monitoring, recurrence) will be launched over time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Statistics from The American Cancer Society, in 2017 indicate that one out of every two males, and one out of every three females that are born today, will develop some form of cancer during their lifetimes. &nbsp;With approximately 200 million adults in the United States alone, we believe that the market for new, non-invasive cancer diagnostic technologies and testing will be enormous, and that there will be sufficient demand to support many different technologies and tests.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>8</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><font style=COLOR:black>Cancer Diagnostic Technologies</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>If successful, we believe Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>will have several advantages over existing diagnostic technologies. &nbsp;For example, repeated exposure to radiation from x-ray technologies, such as mammograms, has become an increasing concern for the medical community, causing authorities to re-evaluate the recommended frequency of such x-ray based tests. &nbsp;Traditional biopsies are often impossible for some tumor based cancers depending on the location of the tumor, and are invasive, expensive, and painful enough to warrant only limited use for other cancers even when the tumor can be accessed. &nbsp;In addition, such biopsies are limited in their inability to detect the heterogeneity of many cancerous tumors, and the ongoing mutations that are often evident as the tumor progresses. &nbsp;False positives in existing testing such as the PSA test, result in otherwise healthy patients being misdiagnosed, and subject to unnecessary follow-on treatments and medical procedures. &nbsp;Patient inconvenience, risk of side effects from anesthesia, and risk of other complications result in low patient compliance with otherwise effective cancer screening tests such as the colonoscopy. &nbsp;These are just a few examples of the challenges with traditional diagnostic tests that we seek to eliminate with Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>. &nbsp;This will be the foundation for the competitive advantages that we expect to have over existing diagnostic testing.&nbsp; We expect Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>will be utilized as a component of multiple diagnostic technologies and patient background information to diagnose and manage the patient&#146;s condition.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Many public and private companies have announced plans and ongoing research efforts to launch non-invasive cancer diagnostic tests and tools that can be used for non-invasive cancer testing. &nbsp;These companies include well established, and successful biotech companies, start-ups, and companies of all sizes. &nbsp;Almost every bodily fluid, including blood, plasma, urine, saliva, and excrement, are being studied for biomarkers or indicators of one or more types of cancer. The term that has been used to describe the category of this type of non-invasive cancer diagnostic testing is &#147;liquid biopsy&#148;. &nbsp;In general, most of these companies are focused on identifying and analyzing one of three types of biomarkers: circulating tumor cells (&#147;CTC&#146;s&#148;), circulating tumor DNA (&#147;ctDNA&#148;), and Exosomes. &nbsp;Each of these types of biomarkers has their advantages and disadvantages, and we expect that tests incorporating these and other biomarkers will make their way into the cancer diagnostic marketplace.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>ITUS believes that its Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>diagnostic platform has the potential for at least three distinct advantages over the types of biomarker tests referred to above. &nbsp;First, it appears that the biomarkers that we are using may be present in multiple types of and varying severities of cancers. &nbsp;As a result, we anticipate that Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>will become a platform from which multiple tests could be launched for multiple types of cancers. &nbsp;Second, it appears that the biomarkers utilized by Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>may be present in both advanced, and early stages of cancers. &nbsp;Third, we expect Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>to be significantly less expensive than the technologies commonly used for tests based on CTC&#146;s, ctDNA, and Exosomes.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>9</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><b><i><u><font style=COLOR:black>CAR-T therapeutics</font></u></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Certainty was formed to develop immuno-therapy drugs against cancer, and in November 2017, we entered into a license with Wistar whereby we obtained rights to certain intellectual property surrounding Wistar&#146;s chimeric endocrine receptor targeted therapy technology.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>CAR-T therapeutics have demonstrated positive results in B-cell cancers, but very little progress has been made on solid tumors.&nbsp; Our CAR-T technology is initially focused on ovarian cancer and is based on engineering killer T-cells with the Follicle Stimulating Hormone (&#147;FSH&#148;) to target ovarian cells that express the FSH-Receptor.&nbsp; The FSH-Receptor has been shown to be a very exclusive protein found on a large percentage of ovarian cancer cells, but not on other healthy tissue in adult females.&nbsp; Data on this technology, including the animal studies showing efficacy, was published in January 2017 in the journal, Clinical Cancer Research.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We are working with researchers at Moffitt to complete studies necessary to submit an IND application with the FDA.&nbsp; We then anticipate taking this therapy into human clinical testing for patients suffering from ovarian cancer.&nbsp; Moffitt is one of the top cancer centers in the country with pre-clinical and clinical expertise with CAR-T technology.&nbsp; Moffitt has conducted many of the highest profile CAR-T trials in the world.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>While there are many uncertainties in drug development, and most drugs fail to reach commercialization, we hope to achieve a profitable outcome by eventually licensing our technology to a large pharmaceutical company that has the resources and infrastructure in place to manufacture, market and sell our technology as a cancer treatment. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Employees</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>As of October 31, 2017, on a consolidated basis, we had seven full-time employees.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Other</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our principal executive offices are located at 3150 Almaden Expressway, San Jose, California 95118, our telephone number is (408)&nbsp;708-9808 and our Internet website address is www.ITUScorp.com. &nbsp;We make available free of charge on or through our Internet website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the Securities and Exchange Commission (the&nbsp;&#147;SEC&#148;). &nbsp;Alternatively, you may also access our reports at the SEC&#146;s website at www.sec.gov. &nbsp;You may also read and copy any document we file with the SEC at the SEC&#146;s public reference room located at 100 F Street, NE, Washington, DC 20549, on official business days during the hours of 10:00 a.m. and 3:00 p.m. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference room.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>10</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 1A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=RF>Risk Factors.</a></u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our business involves a high degree of risk and uncertainty, including the following risks and uncertainties:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><u>Risks Related to Our Financial Condition and Operations </u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We have a history of losses and may incur additional losses in the future</font></i><font style=COLOR:black>.</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On a cumulative basis we have sustained substantial losses and negative cash flows from operations since our inception.&nbsp; As of October 31, 2017, our accumulated deficit was approximately $156,174,000.&nbsp; As of October 31, 2017, we had approximately $6,839,000 in cash and cash equivalents and short-term investments, and working capital of approximately $6,124,000.&nbsp; We incurred losses of approximately $5,009,000 in fiscal year 2017.&nbsp; We expect to incur material research and development expenses and to continue incurring significant legal and general and administrative expenses in connection with our operations.&nbsp; As a result, we anticipate that we will incur losses in the future.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We will need additional funding in the future which may not be available on acceptable terms, or at all, and, if available, may result in dilution to our stockholders</font></i></b><b><i><font style=COLOR:black>.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Based on currently available information as of January 9, 2018, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next 12 months.&nbsp; However, our projections of future cash needs and cash flows may differ from actual results.&nbsp; If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, we will be required to obtain more working capital.&nbsp; We may seek to obtain working capital through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&nbsp; We cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp; If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders. &nbsp;Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. &nbsp;We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all. &nbsp;If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Failure to effectively manage our potential growth could place strains on our managerial, operational and financial resources and could adversely affect our business and operating results</font></i><font style=COLOR:black>.</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our business strategy and potential growth may place a strain on managerial, operational and financial resources and systems.&nbsp; Although we may not grow as we expect, if we fail to manage our growth effectively or to develop and expand our managerial, operational and financial resources and systems, our business and financial results will be materially harmed.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>11</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><u>Risks Related to our Biotechnology Research &amp; Development Activities</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Our cancer diagnostic and cancer therapeutics businesses are pre-revenue, and subject to the risks of an early stage biotechnology company. </font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Since the Company&#146;s primary focus for the foreseeable future will likely be our cancer diagnostics and therapeutics businesses, shareholders should understand that we are primarily an early stage biotechnology company with no history of revenue-generating operations, and our only assets consist of our proprietary and licensed technologies and the know-how of our officers. &nbsp;Therefore we are subject to all the risks and uncertainties inherent in a new business, in particular new businesses engaged in the early detection of certain cancers and CAR-T cancer therapeutics. C</font>chek<font style=FONT-FAMILY:Symbol>&#212;</font> and our CAR-T ovarian cancer therapeutics are in their early stages of development, and we<font style=COLOR:black> still must establish and implement many important functions necessary to commercialize the technologies. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Accordingly, you should consider the Company&#146;s prospects in light of the costs, uncertainties, delays and difficulties frequently encountered by companies in their pre-revenue generating stages, particularly those in the biotechnology field. &nbsp;Shareholders should carefully consider the risks and uncertainties that a business with no operating history will face. In particular, shareholders should consider that there is a significant risk that we will not be able to:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>demonstrate the effectiveness of Cchek</font><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>successfully complete studies necessary to submit an Investigational New Drug Application to the FDA for our ovarian cancer therapeutic;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>implement or execute our current business plan, or that our current business plan is sound;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>raise sufficient funds in the capital markets or otherwise to fully effectuate our business plan;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>maintain our management team, including the members of our scientific advisory board;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>determine that the processes and technologies that we have developed or will develop are commercially viable; and/or</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>attract, enter into or maintain contracts with potential commercial partners such as licensors of technology and suppliers.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:24.5pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Any of the foregoing risks may adversely affect the Company and result in the failure of our business.&nbsp; In addition, we expect to encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. &nbsp;At some point, we will need to transition from a company with a research and development focus to a company capable of supporting clinical trials and commercial activities. &nbsp;We may not be able to reach such achievements, which would have a material adverse effect on our Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>12</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We may have difficulty in raising capital for our cancer diagnostics and therapeutics businesses and may consume resources faster than expected.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:24.5pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We currently do not generate any revenue from Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>or our ovarian cancer therapeutic nor do we generate any other recurring revenues and as of October 31, 2017, the Company only had $6,839,000 in cash, cash equivalents and short-term investments. &nbsp;Therefore, we have a limited source of cash to meet our future capital requirements, which may include the expensive process of obtaining FDA approvals for our ovarian cancer therapeutic and for Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>for each type of cancer for which we desire to launch a diagnostic test. &nbsp;We do not expect to generate revenues for the foreseeable future, and we may not be able to raise funds in the future, which would leave us without resources to continue our operations and force us to resort to the Company raising additional capital in the form of equity or debt financings, which may not be available to us. &nbsp;We may have difficulty raising needed capital in the near or longer term as a result of, among other factors, the very early stage of our diagnostic business and our lack of revenues as well as the inherent business risks associated with an early stage, biotechnology company and present and future market conditions. &nbsp;Also, we may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding sooner than anticipated. &nbsp;Our inability to raise funds could lead to decreases in the price of our common stock and the failure of our cancer diagnostic business which would have a material adverse effect on the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>If we are unable to obtain and maintain intellectual property protection, our competitive position will be harmed.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our ability to compete and to achieve sustained profitability will be impacted by our ability to protect our <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>cancer diagnostic technologies, our CAR-T cancer therapeutics technologies and other </font>proprietary discoveries and technologies. &nbsp;We expect to rely on a combination of patent protection, copyrights, trademarks, trade secrets, know-how, and regulatory approvals to protect <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, our CAR-T cancer therapeutics and any of our other technologies.&nbsp; </font>Our intellectual property strategy is intended to help develop and maintain our competitive position. &nbsp;While we have been granted one patent and received a notice of allowance for an additional patent related to <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, there is no assurance that we will be able to obtain further patent protection for <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, our CAR-T cancer therapeutics and any other technologies</font>, nor can we be certain that the steps we will have taken will prevent the misappropriation and unauthorized use of our technologies. &nbsp;If we are not able to obtain and maintain patent protection our competitive position may be harmed.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font lang=EN>Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business. </font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font lang=EN>Our commercial success depends upon our ability to develop, manufacture, market and sell our </font><font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>cancer diagnostic technologies and other </font>proprietary discoveries and technologies<font lang=EN> without infringing, misappropriating or otherwise violating the proprietary rights or intellectual property of third parties. &nbsp;We may become party to, or be threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our </font><font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>cancer diagnostic technologies and other </font>proprietary discoveries and technologies<font lang=EN>. &nbsp;Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future. &nbsp;If we are found to infringe a third-party's intellectual property rights, we could be required to obtain a license from such third-party to continue developing our </font><font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>cancer diagnostic technologies and other</font> proprietary discoveries and technologies<font lang=EN>. &nbsp;However, we may not be able to obtain any required license on commercially reasonable terms or at all. &nbsp;Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. &nbsp;We could be forced, including by court order, to cease developing the infringing technology or product. &nbsp;In addition, we could be found liable for monetary damages. &nbsp;Claims that we have misappropriated the confidential information or trade secrets of third parties can have a similar negative impact on our business.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>13</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><u>Risks Related to Cchek</u></b><b><u><font style=FONT-FAMILY:Symbol>&#212;</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>While our <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>&nbsp; diagnostic technology has shown favorable results from initial testing, we cannot guarantee that these results will be replicated in future testing nor can we guarantee the success of the technology at all. </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We have initially used <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>to test the blood of small groups of individuals consisting of cancer patients and healthy patients and have reported sensitivity and specificity of over 90%. &nbsp;While these preliminary results far exceed existing diagnostic testing, there is no guarantee that these results will be replicable when we test a larger group of patients or at all. &nbsp;If we are unable to consistently attain results that are necessary for commercialization of Cchek<font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, our diagnostic technology will not have any monetary value and we will be unable to generate any revenue from this technology.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Even if we are able to attain results necessary for the commercialization of <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, our ability to commercialize the technology in the future will depend on our ability to provide evidence of clinical utility.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our ability to successfully commercialize <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> will depend on numerous factors, including whether health care providers believe that <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> provides sufficient incremental clinical utility; whether the medical community accepts that <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>has</font> sufficient sensitivity (there are no or very few false positives), specificity (detects the cancer the test is supposed to detect) and predictive value to be meaningful in patient care and treatment decisions; whether the cost of the test is reasonably priced and commercially viable; and whether health insurers, government health programs and other third-party payers will cover and pay for <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> and the amount that they will reimburse for such tests. &nbsp;These factors may present obstacles to commercial acceptance of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>. </font>&nbsp;To the extent these obstacles arise, we will need to devote substantial time and resources to overcome these obstacles, and we might not be successful. &nbsp;Failure to achieve widespread market acceptance of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> would materially harm our business, financial condition and results of operations. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We are unable to give any assurance that we will be successful in providing sufficient evidence of clinical utility or any assurance that we will have adequate managerial, technical or financial resources to support the studies necessary to provide sufficient evidence of clinical utility of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> or to adequately differentiate our test from other diagnostic products in the manner, timeframe or cost parameters we anticipate, if at all. &nbsp;If we are unable to provide evidence of clinical utility and differentiate <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, we will not be able to generate the revenues and market growth that we seek. &nbsp;Our failure to generate revenue from the sale of our products would materially adversely impact our business, financial condition, results of operations and prospects.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>14</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Diagnostic test development involves a lengthy and complex process, and we may be unable to commercialize <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> on a timely basis, or at all. </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We have begun to devote considerable resources to research and development for <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, however there can be no assurance that <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>will be capable of reliably predicting the occurrence or recurrence of any cancers with the sensitivity and specificity necessary to be clinically and commercially useful, or, even if such technology is clinically and commercially useful, that it will result in commercially successful products. &nbsp;In addition, before we can fully develop <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>and commercialize any new products, we will need to:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>conduct substantial research and development;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>conduct validation studies;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>expend significant funds;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>enter into agreements and maintain relationships with third party vendors to provide third party blood samples;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>obtain regulatory approval (either CLIA, FDA or both); and</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>establish or contract with the owner of a CLIA certified laboratory to process test samples.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Accordingly, our product development process involves a high degree of risk and may take several years, especially if the Company seeks FDA approval for each of its diagnostic tests. &nbsp;If <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> should fail at the research or development stage, not produce sufficient clinical validation data to support the effectiveness of the product or not gain regulatory approval or if we should run out of cash to devote towards the commercialization of the technology or fail to establish agreements with necessary third party vendors, we will not be able to commercialize <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>and we will not generate any revenue from the technology.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>If we fail to obtain, or if there are delays in obtaining, required regulatory approvals, we will not be able to commercialize our <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font></i></b><b><i>technology, and our ability to generate revenue and the viability of our Company will be materially impaired.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Commercialization of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> will require that we obtain either CLIA certification, FDA approval or both. &nbsp;If we are unable to obtain regulatory approval for <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, we will be unable to commercialize and generate revenue from the technology which would have a material adverse effect on our business, financial condition and results of operations. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Until we obtain FDA approval for <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, and unless we establish a CLIA certified laboratory, we will be dependent on laboratory contractors for testing of patient samples that are essential to the development and validation of <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>To pursue the development and validation of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, we will require access to test results obtained from patient blood samples. &nbsp;We have currently contracted with Wistar to provide these services. &nbsp;Unless and until <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> receives FDA approval, or we establish our own CLIA certified laboratory, we will continue to be dependent on contractors or collaborators such as Wistar for testing of patient blood samples to develop and validate&nbsp; <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>15</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>We will be dependent on third parties for the patient samples that are essential to the development and validation of <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>To pursue our development and validation of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, we are likely to need access, over time, to patient blood samples and such patients will need to consent to the use of their blood. &nbsp;As a result, we have made arrangements with Wistar and neighboring hospitals and medical practices to give us access to patient samples for the development and validation of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp; </font>In the event that we are unable to obtain patient samples, or access to patient samples becomes more limited due to changes in privacy laws governing the use and disclosure of medical information or due to changes in the laws restricting our ability to obtain patient samples and associated information, our ability to pursue the development of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> may be slowed or halted, which could have a material adverse effect on our business, financial condition and results of operations.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Our business could be harmed from the loss or suspension of a license or imposition of a fine or penalties under, or future changes in, or changing interpretations of, the law or regulations of the Clinical Laboratory Improvement Act of 1967, the Clinical Laboratory Improvement Amendments of 1988, or the FDA or other federal, state or local agencies.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We will need to seek regulatory approval in order to market <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp; </font>The clinical laboratory testing industry is subject to extensive federal and state regulation, and many of these statutes and regulations have not been interpreted by the courts. &nbsp;The Clinical Laboratory Improvement Act of 1967, the Clinical Laboratory Improvement Amendments of 1988 are federal regulatory standards that apply to virtually all clinical laboratories (regardless of the location, size or type of laboratory), including those operated by physicians in their offices, by requiring that they be certified under federal law. CLIA does not pre-empt state law, which in some cases may be more stringent than federal law and require additional personnel qualifications, quality control, record maintenance and proficiency testing. &nbsp;The sanction for failure to comply with CLIA and state requirements may be suspension, revocation or limitation of a laboratory&#146;s CLIA certificate, which is necessary to conduct business, as well as significant fines and/or criminal penalties. &nbsp;Several states have similar laws and we may be subject to similar penalties. &nbsp;The FDA regulates diagnostic products and periodically inspects and reviews their manufacturing processes and product performance.&nbsp; We may choose to seek FDA approval for one or more <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black> tests, as opposed to seeking CLIA certification.</font> &nbsp;We cannot assure that applicable statutes and regulations will not be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that would adversely affect our business. &nbsp;Potential sanctions for violation of these statutes and regulations include significant fines and the suspension or loss of various licenses, certificates and authorizations, which could have a material adverse effect on our business. &nbsp;In addition, compliance with future legislation could impose additional requirements on us, which may be costly, including FDA regulation of laboratory developed tests.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>16</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Health insurers and other third-party payers may decide not to reimburse our <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> diagnostic testing or may provide inadequate reimbursement, which could jeopardize our commercial prospects and require customers to pay for the tests out of pocket.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In the United States, the regulatory process that allows diagnostic tests to be marketed is independent of any coverage determinations made by third-party payers. &nbsp;For new diagnostic tests, private and government payers decide whether to cover the test, the reimbursement amount for a covered test and the specific conditions for reimbursement. &nbsp;Physicians may order diagnostic tests that are not reimbursed by third-party payers, but coverage determinations and reimbursement levels and conditions are critical to the commercial success of a diagnostic product. &nbsp;Each third-party payer makes its own decision about which tests it will cover and how much it will pay, although many payers will follow the lead of Medicare. &nbsp;As a result, the coverage determination process will be a time-consuming and costly process that requires us to provide scientific, clinical and economic support for the use of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> diagnostic testing to each payer separately, with no assurance that approval will be obtained. &nbsp;If third-party payers decide not to cover <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> or if they offer inadequate payment amounts, our ability to generate revenue from <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> could be limited since patients who want to take the diagnostic tests would have to pay for it out of pocket. &nbsp;Even if one or more third-party payers decide to reimburse for <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black> diagnostic testing</font>, a third-party payer may stop or lower payment at any time, which could reduce revenue. &nbsp;We cannot predict whether third-party payers will cover <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>diagnostic testing</font> or offer adequate reimbursement. &nbsp;We also cannot predict the timing of such decisions. In addition, physicians or patients may decide not to order <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font> tests if third-party payments are inadequate, especially if ordering the test could result in financial liability for the patient.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Whether or not health insurers and other third-party payers decide to reimburse <font style=COLOR:black>Cchek</font></i></b><b><i><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, the technology may cost patients more than we anticipate.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We believe that our <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>diagnostic testing </font>will significantly reduce the cost to patients of screening and confirmatory testing for certain types of cancer. &nbsp;If, however, the cost to utilize Cchek<font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>is more expensive than we anticipate, many patients and third-party payers may elect not to utilize the technology which would significantly impact our ability to generate revenue on the technology.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>We operate in a competitive market and expect to face intense competition, often from companies with greater resources and experience than us.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The clinical diagnostics industry is highly competitive and subject to rapid change. &nbsp;We are aware of many different types of diagnostic tests available to detect cancer that are currently in use or being developed and many more types of diagnostic tests may be developed in the future. &nbsp;If we are able to successfully commercialize <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font>, all of these tests will compete with our product. &nbsp;If <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>is more expensive than and/or does not have sufficient specificity, sensitivity or predictive value to compete with tests that are currently on the market, or if any other diagnostic tests that are under development, once successfully developed and commercialized, have greater specificity, sensitivity or predictive value and/or are cheaper than our technology, we may be unable to compete successfully with such products which would have a material adverse effect on our business, financial condition and results of operations.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>17</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Furthermore, as the industry continues to expand and evolve, an increasing number of competitors and potential competitors may enter the market. &nbsp;Many of these competitors and potential competitors have substantially greater financial, technological, managerial and research and development resources and experience than we do. &nbsp;Some of these competitors and potential competitors have more experience than we do in the development of diagnostic products, including validation procedures and regulatory matters. &nbsp;In addition, <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>will compete with product offerings from large and well established companies that have greater marketing and sales experience and capabilities than we do. &nbsp;If we are unable to compete successfully, we may be unable to sustain and grow our revenue.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>We are dependent upon a few key personnel and the loss of their services could adversely affect us.</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our future success of developing <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font>will depend on the efforts of the inventor of the technology, our President and Chief Executive Officer Dr. Amit Kumar. &nbsp;We do not maintain &#147;key person&#148; life insurance on Dr. Kumar. &nbsp;The loss of the services of Dr. Kumar could have a material adverse effect on our business and operating results. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><u><font style=COLOR:black>Risks Related to our CAR-T therapeutics </font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>While our <font style=COLOR:black>CAR-T</font> technology has shown favorable results from in-vitro and in-vivo testing by others, we cannot guarantee that these results will be replicated in future testing nor can we guarantee the success of the technology at all. </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>While early studies done by others have shown promising results in small numbers of mice in multiple different models, there is no guarantee that these results will be replicable when we test a larger number of animals under the Good Laboratory Practice (&#147;GLP&#148;) conditions necessary for inclusion in an IND application.&nbsp; Further, no toxicity studies have as yet been performed, and there can be no assurance that the results of these toxicity studies will be favorable. &nbsp;If we are unable to obtain results consistent with earlier studies and if our toxicity studies are not positive, we will not be able to file an IND application nor commence human clinical trials and our CAR-T technology may not have any monetary value and we may be unable to generate any revenue from this technology.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>While <font style=COLOR:black>CAR-T</font> technology has shown positive results in B-cell cancers by others, its safety and efficacy has not been seen in solid tumors and we cannot guarantee our CAR-T technology will be safe or effective in ovarian cancer. </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>CAR-T therapies function through the binding of a genetically engineered killer T-cell to a cancer cell.&nbsp; However, these engineered T-cells destroy the cell they are bound to whether it is a cancer cell or a healthy cell.&nbsp; Therefore, the engineered T-cells must be designed to only bind to cancer cells to minimize toxicity.&nbsp; Our CAR-T technology relies on the natural affinity of FSH to FSH-Receptor.&nbsp; Research by others has shown that the FSH-Receptor protein is found on ovarian cancer cells and no other healthy tissue, and therefore, we engineer our T-cells with FSH.&nbsp; However, as the research in this field is still new, we cannot guarantee that there is no FSH-Receptor on any other healthy tissue in the human body.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>18</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>We are dependent on third parties to perform the necessary studies to file an IND application with the FDA. </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>While we have contracted with Moffitt to perform the necessary studies to file an IND to begin human clinical testing of our ovarian cancer therapeutic, unless or until we have an in-house scientific team to perform these pre-clinical studies, we will remain reliant on third parties for these services.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><u><font style=COLOR:black>Risks Related to Legacy Patent Licensing Activities</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>In connection with our legacy patent licensing activities, we may not be able to license our patent portfolios which may have an adverse impact on our future operations.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We may generate revenues and related cash flows from the licensing and enforcement of patents that we currently own and from the rights to license and enforce additional patents we have obtained from third parties.&nbsp; However, we can give no assurances that we will be able to identify opportunities to exploit such patents or that such opportunities, even if identified, will generate sufficient revenues to sustain future operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We, in certain circumstances, rely on representations, warranties and opinions made by third parties that, if determined to be false or inaccurate, may expose us to certain material liabilities.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>From time to time, we may rely upon the opinions of purported experts.&nbsp; In certain instances, we may not have the opportunity to independently investigate and verify the facts upon which such opinions are made.&nbsp; By relying on these opinions, we may be exposed to liabilities in connection with the licensing and enforcement of certain patents and patent rights which could have a material adverse effect on our operating results and financial condition.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>In connection with patent licensing activities conducted by certain of our subsidiaries, a court that has ruled unfavorably against us may also impose sanctions or award attorney&#146;s fees, exposing us and our operating subsidiaries to certain material liabilities.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In connection with any of our patent licensing activities, it is possible that a court that has ruled against us may also impose sanctions or award attorney&#146;s fees to defendants, exposing us or our operating subsidiaries to material liabilities, which could materially harm our operating results and our financial condition.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Our patented technologies have an uncertain market value.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Many of our patents and technologies are in the early stages of adoption in the commercial and consumer markets.&nbsp; Demand for some of these technologies is untested and is subject to fluctuation based upon the rate at which our licensees will adopt our patents and technologies in their products and services.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>19</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><u>Risks Related to Our Common Stock </u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>The issuance or sale of shares in the future to raise money or for strategic purposes could reduce the market price of our common stock.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In the future, we may issue securities to raise cash for operations, to pay down then existing indebtedness, as consideration for the acquisition of assets, as consideration for receipt of goods or services, to pay for the development of our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black> platform, to pay for the development of our CAR-T cancer therapeutics and for acquisitions of companies.&nbsp; We have and in the future may issue securities convertible into our common stock. Any of these events may dilute stockholders' ownership interests in our company and have an adverse impact on the price of our common stock.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In addition, sales of a substantial amount of our common stock in the public market, or the perception that these sales may occur, could reduce the market price of our common stock.&nbsp; This could also impair our ability to raise additional capital through the sale of our securities.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Any actual or anticipated sales of shares by our stockholders may cause the trading price of our common stock to decline.&nbsp; The sale of a substantial number of shares of our common stock by our stockholders, or anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>20</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Delaware law and our charter documents contain provisions that could discourage or prevent a potential takeover of our company that might otherwise result in our stockholders receiving a premium over the market price of their shares.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Provisions of Delaware General Corporation Law (&#147;DGCL&#148;) and our certificate of incorporation, as amended (the &#147;Certificate of Incorporation&#148;) and by-laws (&#147;By-Laws&#148;) could make the acquisition of our company by means of a tender offer, proxy contest or otherwise, and the removal of incumbent officers and directors, more difficult.&nbsp; These provisions include:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Section 203 of the DGCL, which prohibits a merger with a 15%-or-greater stockholder, such as a party that has completed a successful tender offer, until three years after that party became a 15%-or-greater stockholder; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>The authorization in our Certificate of Incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent or discourage a takeover; and </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Provisions in our By-Laws regarding stockholders' rights to call a special meeting of stockholders limit such rights to stockholders holding together at least a majority of shares of the Company entitled to vote at the meeting, which could make it more difficult for stockholders to wage a proxy contest for control of our Board of Directors or to vote to repeal any of the anti-takeover provisions contained in our Certificate of Incorporation and By-Laws.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Together, these provisions may make the removal of management more difficult and may discourage transactions that could otherwise involve payment of a premium over prevailing market prices for our common stock.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We may fail to meet market expectations because of fluctuations in quarterly operating results, which could cause the price of our common stock to decline.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our reported revenues and operating results have fluctuated in the past and may continue to fluctuate significantly from quarter to quarter in the future, specifically as we continue to devote more of our resources towards our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black> diagnostic technology and our CAR-T cancer therapeutics.&nbsp; It is possible that in future periods, we will have no revenue or, in any event, revenues could fall below the expectations of securities analysts or investors, which could cause the market price of our common stock to decline.&nbsp; The following are among the factors that could cause our operating results to fluctuate significantly from period to period:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>clinical trial results relating to our diagnostic technology;&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>pre-clinical testing results relating to our CAR-T cancer therapeutics;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>progress with regulatory authorities towards the certification/approval of our diagnostic technology or our CAR-T cancer therapeutics; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>costs related to acquisitions, alliances and licenses.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>21<font style="FONT-SIZE:9pt; LINE-HEIGHT:115%"><strong></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p></strong> <p left? text-align: roman?,?serif?; new style="FONT-SIZE:12pt; FONT-FAMILY:" always; page-break-before: times align=left><font style=LINE-HEIGHT:115% color=#0066cc><a href=#(TOC)>Table of Contents</a></font></p></font></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Biotechnology company stock prices are especially volatile, and this volatility may depress the price of our common stock.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The stock market has experienced significant price and volume fluctuations, and the market prices of biotechnology companies have been highly volatile.&nbsp; We believe that various factors may cause the market price of our common stock to fluctuate, perhaps substantially, including, among others, the following:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>announcements of developments in the cancer diagnostic testing industry or in the field of CAR-T therapeutics;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 2in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>developments in relationships with third party vendors and laboratories;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>announcements of developments in our remaining patent enforcement actions;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>developments or disputes concerning our patents and other intellectual property;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>our or our competitors' technological innovations;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>variations in our quarterly operating results;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>our failure to meet or exceed securities analysts' expectations of our financial results;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>a change in financial estimates or securities analysts' recommendations;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>changes in management's or securities analysts' estimates of our financial performance;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, joint ventures, capital commitments, new technologies, or patents; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>the timing of or our failure to complete significant transactions.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In addition, we believe that fluctuations in our stock price during applicable periods can also be impacted by changes in governmental regulations in the diagnostic testing and drug development industries and/or court rulings and/or other developments in our remaining patent licensing and enforcement actions.&nbsp; For example, if government regulators no longer allow for the use of diagnostic technology that has not been granted FDA approval (e.g. denying products that have only received CLIA certification), the time and cost to bring our technology to market will increase which will likely have an adverse impact on our stock price. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In the past, companies that have experienced volatility in the market price of their stock have been the objects of securities class action litigation.&nbsp; If our common stock was the object of securities class action litigation, it could result in substantial costs and a diversion of management's attention and resources, which could materially harm our business and financial results.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>22</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Our common stock is currently listed on NASDAQ Capital Market, however if our common stock is delisted for any reason, it will become subject to the SEC&#146;s penny stock rules which may make our shares more difficult to sell.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>If our common stock is delisted from NASDAQ Capital Market, our common stock will then fit the definition of a penny stock and therefore would be subject to the rules adopted by the SEC regulating broker-dealer practices in connection with transactions in penny stocks.&nbsp; The SEC rules may have the effect of reducing trading activity in our common stock making it more difficult for investors to sell their shares.&nbsp; The SEC&#146;s rules require a broker or dealer proposing to effect a transaction in a penny stock to deliver the customer a risk disclosure document that provides certain information prescribed by the SEC, including, but not limited to, the nature and level of risks in the penny stock market.&nbsp; The broker or dealer must also disclose the aggregate amount of any compensation received or receivable by him in connection with such transaction prior to consummating the transaction.&nbsp; In addition, the SEC&#146;s rules also require a broker or dealer to make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser&#146;s written agreement to the transaction before completion of the transaction.&nbsp; The existence of the SEC&#146;s rules may result in a lower trading volume of our common stock and lower trading prices.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We currently have a limited number of unissued shares of common stock authorized for issuance pursuant to our Certificate of Incorporation which will limit our ability to issue shares in a financing transaction, as compensation to our officers, directors, employees or consultants or as consideration in a strategic transaction.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our Certificate of Incorporation authorizes our Board of Directors to issue up to 24,000,000 shares of common stock. As of the date hereof, there are 16,609,399 shares of common stock issued and outstanding with only 2,278,355 shares available for future issuance. Unless and until we receive stockholder approval to increase the number of shares of common stock that are authorized for issuance (or take another corporate action to increase the number of shares that may be issued under the Certificate of Incorporation), we will be limited in our ability to issue shares of common stock in a financing transaction, as compensation to our officers, directors, employees or consultants or as consideration in a strategic transaction. Such limitation will adversely impact our business. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>We do not anticipate declaring any cash dividends on our common stock which may adversely impact the market price of our stock.</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We have never declared or paid cash dividends on our common stock and do not plan to pay any cash dividends in the near future.&nbsp; Our current policy is to retain all funds and any earnings for use in the operation and expansion of our business.&nbsp; If we do not pay dividends, our stock may be less valuable to you because a return on your investment will only occur if our stock price appreciates.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>23</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 1B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=USC>Unresolved Staff Comments.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=Properties>Properties.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We lease approximately 2,000 square feet of office space at 3150 Almaden Expressway, San Jose, California (our principal executive offices) from an unrelated party pursuant to a lease that expires September 30, 2019.&nbsp; Our base rent is approximately $4,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.&nbsp; We also lease approximately 3,000 square feet of office space at 12100 Wilshire Boulevard, Los Angeles, California (our former executive offices) from an unrelated party pursuant to a lease that expires May 31, 2019.&nbsp; We vacated this space during the fourth quarter of fiscal year 2017 and are currently marketing the space for sublease.&nbsp; Our base rent is approximately $11,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.</font></p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</h4> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name=LP><u>Legal Proceedings</u>.</a></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &nbsp;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Item 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=MSD>Mine Safety Disclosures.</a></u></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:ideograph-numeric; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>Not applicable.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="TEXT-TRANSFORM:uppercase; COLOR:black"><a name=P2>PART II</a></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-1in'><font style=COLOR:black>Item 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=MRCE>Market for the Registrant&#146;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Market Information </font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our common stock trades on the NASDAQ Capital Market under the symbol &#147;ITUS&#148;.&nbsp; The high and low sales prices as reported by the NASDAQ Capital Market for each quarterly fiscal period during our fiscal years ended October 31, 2017 and 2016 is as follows:&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.4pt" cellpadding=0 cellspacing=0> <tr> <td width=216 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2.25in; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Fiscal Period</font></p></td> <td width=180 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:135pt; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>High</font></p></td> <td width=180 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Low</font></p></td></tr> <tr> <td width=216 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.25in; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;4th quarter 2017</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;3rd quarter 2017</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2nd quarter 2017</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;1st quarter 2017</font></p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:135pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 10pt 0pt 0pt; TEXT-AUTOSPACE:' align=center>$ 5.25</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2.05</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>5.50</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>6.60</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 10pt 0pt 0pt; TEXT-AUTOSPACE:' align=center>$ 0.60</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>0.71</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>1.85</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>4.20</p></td></tr> <tr> <td width=216 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;4th quarter 2016</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;3rd quarter 2016</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2nd quarter 2016</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>&nbsp;1st quarter 2016</font></p></td> <td width=180 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 10pt 0pt 0pt; TEXT-AUTOSPACE:' align=center>$ 6.82</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>3.70</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>3.31</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>4.85</p></td> <td width=180 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 10pt 0pt 0pt; TEXT-AUTOSPACE:' align=center>$ 2.85</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2.55</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>1.88</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2.01</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>24</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Holders</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>As of January 4, 2018, the approximate number of record holders of our common stock was 315 and the closing price of our common stock was $2.40 per share.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Securities Authorized for Issuance Under Equity Compensation Plans</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="TEXT-DECORATION:none; COLOR:black">See &#147;Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.&#148;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Dividend Policy</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>No cash dividends have been paid on our common stock since our inception.&nbsp; We have no present intention to pay any cash dividends in the foreseeable future. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Recent Sales of Unregistered Securities</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">During the three months ended October 31, 2017, the Company issued an aggregate of 6,000 shares of our common stock to a company in payment of investor relations services. &nbsp;The common stock was issued in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act as they were issued to accredited investors, without a view to distribution, and were not issued through any general solicitation or advertisement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'><font style=COLOR:black>Item 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=SFD>Selected Financial Data.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not required for a smaller reporting company.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'><font style=COLOR:black>Item 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name=MDNA><u>Management&#146;s Discussion and Analysis of Financial Condition and&nbsp;</u><u>Results of Operations.</u></a></font></h4> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>General</u></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In reviewing Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations, you should refer to our Consolidated Financial Statements and the notes related thereto.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black>Results of Operations</font></u></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in -9pt 0pt 0in; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Fiscal Year ended October 31, 2017 compared with Fiscal Year ended October 31, 2016</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Revenue </font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In fiscal year 2017, we recorded revenue of approximately $363,000 from one license agreement.&nbsp; In fiscal year 2016, we recorded revenue of $300,000 from two license agreements.&nbsp; The license agreements each provided for a one-time, non-recurring, lump sum payment in exchange for non-exclusive retroactive and future licenses, and/or covenants not to sue.&nbsp; Accordingly, the earnings process from this license was complete and 100% of the revenue was recognized upon execution of the license agreement. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>25</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Inventor Royalties and Contingent Legal Fees</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Inventor royalties and contingent legal fees decreased by approximately $20,000 in fiscal year 2017, to approximately $91,000, from approximately $111,000 in fiscal year 2016.&nbsp; We did not incur any royalties in fiscal year 2017, resulting in the decrease in inventor royalties and contingent legal fees.&nbsp; Inventor royalties and contingent legal fees are expensed in the period that the related revenues are recognized.&nbsp; The economic terms of patent agreements and contingent legal fee arrangements vary across the patent portfolios owned or controlled by the Company.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Litigation and Licensing Expenses</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Litigation and licensing expenses decreased by approximately $93,000 to approximately $13,000 in fiscal year 2017, from approximately $106,000 in fiscal year 2016 as a result of decreased litigation and licensing activities.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Amortization of Patents</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Amortization of patents was approximately $325,000 in fiscal years 2017 and 2016. &nbsp;We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&nbsp; During fiscal year 2017, we did not capitalize any patents or patent rights.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Research and Development Expenses</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Research and development expenses increased by approximately $41,000 to approximately $1,598,000 in fiscal year 2017, from approximately $1,556,000 in fiscal 2016.&nbsp; The increase in research and development expenses was primarily due to an increase in costs in connection with the development of <font style=COLOR:black>Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>, including increased</font> costs related to our collaboration with Wistar of approximately $98,000 as a result of greater involvement by Wistar under the renewed collaboration agreement, an increase in patent development costs of approximately $30,000, an approximate $46,000 of expense associated with the sale of no longer necessary lab equipment and increased costs related to obtaining blood samples of approximately $45,000, offset by a decrease in employee compensation and related costs of approximately $108,000 and reduced development costs associated with our legacy thin-film display technology of approximately $58,000.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Marketing, General and Administrative Expenses</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Marketing, general and administrative expenses increased by approximately $1,701,000 to approximately $4,411,000 in fiscal year 2017, from approximately $2,710,000 in fiscal 2016.&nbsp; The increase in marketing, general and administrative expenses was principally due to an increase in board compensation expense of approximately $454,000 resulting from the grant of shares of Company common stock to our independent directors, an increase in employee compensation and related costs, other than stock option expense, of approximately $326,000 resulting primarily from the severance arrangement with our former chief executive officer, an increase in employee stock option expense of approximately $321,000 resulting primarily from the re-pricing of stock options held by current employees and directors, an increase in legal and accounting fees of approximately $237,000 resulting primarily from an increase in corporate transactions including the redemption of our Series A preferred stock, filing of registration statements and management turnover, an increase in investor and public relations expenses of approximately $189,000 resulting primarily from increased investor outreach programs and an increase in rent expense of approximately $166,000 resulting from the relocation of our principal executive offices.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center>26</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Gain on Extinguishment of Patent Acquisition Obligation</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The gain on extinguishment of patent acquisition obligation of approximately $1,548,000 in fiscal year 2017 resulted from the difference in the carrying value of the patent acquisition obligation and the fair value of the shares of common stock issued to satisfy the obligation on the date of extinguishment.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Interest Expense</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Interest expense decreased by approximately $20,000 to approximately $500,000 in fiscal year 2017, from approximately $520,000 in fiscal 2016.&nbsp; The decrease in interest expense was due to the early extinguishment of the patent acquisition obligation which reduced interest expense from fiscal year 2016 by approximately $292,000, offset by the approximately $272,000 of interest associated with the secured debenture entered into during fiscal year 2017.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Interest Income</i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Interest income increased to approximately $19,000 in fiscal year 2017 compared to approximately $13,000 in fiscal year 2016, due to an increase in funds available for short-term investments.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><b><i>Deemed Dividend to Preferred Stockholder </i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The deemed dividend to preferred stockholder of approximately $2,008,000 in fiscal year 2017 resulted from the redemption of our Series A preferred stock. &nbsp;The difference between the fair value of the consideration given to the holder of our Series A preferred stock and the carrying value of the Series A preferred stock represented a return to the preferred stockholder and was treated in a similar manner as that of dividends paid on preferred stock.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Liquidity and Capital Resources</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Our primary sources of liquidity are cash, cash equivalents and short term investments.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>As of the date of filing of our last annual report on Form 10-K, there was substantial doubt about our ability to continue as a going concern due to the limited amount of cash, cash equivalents and short-term investments we held as compared to our projected cash needs for the ensuing twelve months.&nbsp; We evaluated our cash position and future plans for the Company and embarked on a plan to ensure we had sufficient resources to execute our plans.&nbsp; Accordingly, over the past twelve months, we raised nearly $12 million through multiple financing arrangements, including a shareholder rights offering, a registered direct offering, and an at-the-market equity offering, and satisfied debt obligations through payments of cash and common stock.&nbsp; With no significant debt and approximately $6.8 million in cash, cash equivalents and short-term investments as of October 31, 2017, we believe that we have alleviated substantial doubt about our ability to continue as a going concern.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>27</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Based on currently available information as of January 9, 2018, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next 12 months.&nbsp; However, our projections of future cash needs and cash flows may differ from actual results.&nbsp; If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies that are synergistic with or complimentary to our technologies, we may be required to obtain more working capital.&nbsp; We may seek to obtain working capital during our fiscal year ended 2018 or thereafter through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&nbsp; We cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp; If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders. &nbsp;Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. &nbsp;We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all. &nbsp;If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">During the year ended October 31, 2017, cash used in operating activities was approximately $3,797,000. &nbsp;Cash used in investing activities was approximately $2,735,000, resulting from the purchase of certificates of deposit totaling $5,501,000 which was offset by the proceeds on maturities of certificates of deposit totaling $2,751,000 and the sale of property and equipment of approximately $45,000 offset by the purchase of property and equipment of approximately $30,000. &nbsp;Cash provided by financing activities was approximately $7,383,000, resulting from the sale of common stock in a shareholder rights offering, an at-the-market offering and a registered direct offering of approximately $4,203,000, $3,461,000 and $3,212,000, respectively, offset by payments made on a secured debenture of approximately $3,000,000 and redemption of convertible preferred stock of approximately $500,000.&nbsp; As a result, our cash, cash equivalents, and short-term investments at October 31, 2017 increased approximately $3,601,000 to approximately $6,839,000 from approximately $3,238,000 at the end of fiscal year 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="BACKGROUND:white; COLOR:black">28</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In November 2017, the Company entered into an At-the-Market Issuance Sales Agreement (the </font><font style=COLOR:black>&#147;</font><font style=COLOR:black>Agreement</font><font style=COLOR:black>&#148;</font><font style=COLOR:black>) with B. Riley FBR, Inc. (</font><font style=COLOR:black>&#147;</font><font style=COLOR:black>B. Riley FBR</font><font style=COLOR:black>&#148;</font><font style=COLOR:black>) to create an at-the-market equity program under which it may sell up to 3,000,000 shares of its common stock from time to time through B. Riley FBR, as sales agent. &nbsp;In December 2017, the Company terminated the Agreement.&nbsp; The Company did not sell any shares under the Agreement and has no further obligations under the Agreement.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Off-Balance Sheet Arrangements</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We have no variable interest entities or other significant off-balance sheet obligation arrangements.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Critical Accounting Policies </font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>The Company&#146;s consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America.&nbsp; In preparing these financial statements, we make assumptions, judgments and estimates that can have a significant impact on amounts reported in our consolidated financial statements. &nbsp;We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. &nbsp;Actual results could differ materially from these estimates under different assumptions or conditions. &nbsp;On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We believe that, of the significant accounting policies discussed in Note 2 to our consolidated financial statements, the following accounting policies require our most difficult, subjective or complex judgments:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=COLOR:black>Revenue Recognition; and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 10pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style=COLOR:black>Stock-Based Compensation</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><font style=COLOR:black>Revenue Recognition</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style=COLOR:black>Patent Licensing</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&nbsp; These arrangements typically include some combination of the following:&nbsp; (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&nbsp; In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&nbsp; Pursuant to the terms of these agreements, we have no further obligations.&nbsp; As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>29</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><font style=COLOR:black>Stock-Based Compensation</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We account for stock options granted to employees and directors using the accounting guidance in ASC 718. &nbsp;We recognize compensation expense for stock option awards over the requisite or implied service period of the grant. &nbsp;We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $1,223,000 and $874,000 during the years ended October 31, 2017 and 2016, respectively.&nbsp; We account for stock options granted to consultants using the accounting guidance under ASC 505-50. &nbsp;We recognized stock-based compensation expense for stock options granted to non-employee consultants during the years ended October 31, 2017 and 2016, of approximately $3,000 and $-0-, respectively.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>As of October 31, 2017, there was unrecognized compensation cost related to non-vested share-based compensation arrangements for stock options granted to employees and directors of approximately $1,091,000, which will be recognized in future periods upon vesting of the stock options. &nbsp;As of October 31, 2017, there was unrecognized consulting expense related to non-vested stock options granted to consultants, related to service based options of approximately $44,000, which will be recognized in future periods upon vesting of the stock options.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Determining the appropriate fair value model and calculating the fair value of stock-based awards requires judgment, including estimating stock price volatility, forfeiture rates and expected term. &nbsp;If factors change and we employ different assumptions in the application of ASC 718 and ASC 505-50 in future periods, the compensation expense that we record may differ significantly from what we have recorded in the current period. &nbsp;See Note 2 to the consolidated financial statements for additional information.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Effect of Recent Accounting Pronouncements</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We discuss the effect of recently issued pronouncements in Note 2 to the consolidated financial statements.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 7A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=QQD>Quantitative and Qualitative Disclosures About Market Risk.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not required for a smaller reporting company.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a name=FSSD>Financial Statements and Supplementary Data.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>See accompanying &#147;Index to Consolidated Financial Statements.&#148;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-1in'><font style=COLOR:black>Item 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=CDWAAFD>Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>None.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>30</font></p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; FONT-WEIGHT:normal"> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</h4> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 9A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=CP>Controls and Procedures</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Disclosure Controls and Procedures</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.&nbsp; Under the supervision and with the participation of our management, including our President and Chief Executive Officer and our Chief Operating Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 and 15d-15 of the Exchange Act.&nbsp; Based upon that evaluation, our President and Chief Executive Officer and our Chief Operating Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of fiscal year 2017.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style=COLOR:black>Management&#146;s Report on Internal Control Over Financial Reporting</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act.&nbsp; Our management, including the principal executive officer and principal financial officer, does not expect that our internal controls over financial reporting will prevent all errors and all fraud.&nbsp; A control system, no matter how well designed and operated, cannot provide full assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.&nbsp; Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Under the supervision and with the participation of our management, including the principal executive officer and principal financial officer, we conducted an evaluation as to the effectiveness of our internal control over financial reporting as of October 31, 2017.&nbsp; In making this assessment, our management used the criteria for effective internal control set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the <i>2013</i> <i>Internal Control &#150; Integrated Framework</i>.&nbsp; Based on this assessment, our management concluded that our internal control over financial reporting was effective as of October 31, 2017.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>This Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.&nbsp; Management&#146;s report was not subject to attestation by the Company&#146;s independent registered public accounting firm pursuant to a permanent exemption of the Commission that permits the Company to provide only management&#146;s report in this Annual Report on Form 10-K.&nbsp; Accordingly, our management&#146;s assessment of the effectiveness of our internal control over financial reporting as of October 31, 2017 has not been audited by our auditors, Haskell &amp; White LLP.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black>Changes in Internal Control Over Financial Reporting</font></u></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>There were no changes in our internal control over financial reporting during the fourth quarter of fiscal year 2017 that has materially affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial reporting.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>31</font></p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; FONT-WEIGHT:normal"> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</h4> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 9B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=OI>Other Information.</a></u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black><a name=P3>PART III</a></font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b>Item 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=DEOCG>Directors, Executive Officers and Corporate Governance</a></u></b><u><a name=DEOCG>.</a></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Our Directors and Executive Officers</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The following table sets forth certain information with respect to all of our directors and executive officers:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td width=155 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:116.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Name</font></p></td> <td width=319 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:239.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Position with the Company and <br>Principal Occupation</font></p></td> <td width=36 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:27pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Age</font></p></td> <td width=102 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Director and/or Executive Officer Since</font></p></td></tr> <tr> <td width=155 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:116.2pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. Amit Kumar</font></p></td> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:239.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Chairman of the Board, President and Chief Executive Officer</font></p></td> <td width=36 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>53</font></p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2012</font></p></td></tr> <tr> <td width=155 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:116.2pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Bruce F. Johnson</font></p></td> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:239.3pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=36 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>75</font></p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2017</font></p></td></tr> <tr> <td width=155 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:116.2pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. John Monahan</font></p></td> <td width=319 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:239.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=36 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:27pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>71</font></p></td> <td width=102 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2016</font></p></td></tr> <tr> <td width=155 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:116.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Lewis H. Titterton, Jr.</font></p></td> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:239.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=36 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>73</font></p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2017</font></p></td></tr> <tr> <td width=155 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:116.2pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Richard H. Williams</font></p></td> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:239.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director</font></p></td> <td width=36 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>81</font></p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2017</font></p></td></tr> <tr> <td width=155 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:116.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Michael J. Catelani</font></p></td> <td width=319 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:239.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Chief Operating Officer and Chief Financial Officer</font></p></td> <td width=36 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>51</font></p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>2016</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><font style="BACKGROUND:white; COLOR:black">We believe that our Board represents a desirable mix of backgrounds, skills, and experiences. &nbsp;The principal occupation and business experience during the last five years for our executive officers and directors and some of the specific experiences, qualifications, attributes or skills that led to the conclusion that each person should serve as one of our directors in light of our business and structure is as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="BACKGROUND:white; COLOR:black">32</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style="BACKGROUND:white; COLOR:black">Dr. Amit Kumar, 53, Chairman of the Board, President and Chief Executive Officer.&nbsp; </font></i></b>Dr. Kumar has served as our President and Chief Executive Officer since July 2017, as a director of the Company since November 2012 and as Chairman of the Board since August 2016.&nbsp; From June 2015 until August 2016, Dr. Kumar served as Vice Chairman of the Board.&nbsp; Dr. Kumar served as a strategic advisor to the Company since September 2012.&nbsp; Dr. Kumar has been Executive Chairman of the board of directors of Anixa Diagnostics Corporation, a wholly-owned subsidiary of the Company since June 2015.&nbsp; Upon his appointment as Executive Chairman of Anixa, Dr. Kumar resigned from his position as the CEO of Geo Fossil Fuels LLC, an energy company, which he had held since December 2010.&nbsp; From September 2001 to June 2010, Dr. Kumar was President and CEO of CombiMatrix Corporation, a NASDAQ listed biotechnology company and also served as director from September 2000 to June 2012.&nbsp; Dr. Kumar was Vice President of Life Sciences of Acacia Research Corporation, a publicly traded investment company, from July 2000 to August 2007 and also served as a director from January 2003 to August 2007.&nbsp; Dr. Kumar has served as Chairman of the board of directors of Ascent Solar Technologies, Inc., a publicly-held solar energy company, since June 2007, and as a director of Aeolus Pharmaceuticals, Inc. since June 2004.&nbsp; Dr. Kumar is Chairman of BioCeryx, Inc., a private diagnostic company, and Actym Therapeutics, a private biotechnology company.&nbsp; Dr. Kumar holds an A.B. in Chemistry from Occidental College and Ph.D. from Caltech and completed his post-doctoral training at Harvard University.&nbsp; Dr. Kumar has experience in technology driven startups, both at the board of directors and operating levels, in a broad variety of areas including finance, acquisitions, research and development, and marketing, and, as described above, has served as a director and/or officer of various publicly traded companies.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Bruce F. Johnson, 75, Director.&nbsp; </font></i></b><font style=COLOR:black>Mr. Johnson has served on our Board since September 2017 and he previously served on our Board from August 2012 until August 2016.&nbsp; Mr. Johnson has been a commodity trader on the Chicago Mercantile Exchange for over 40 years.&nbsp; He served as a member of the board of directors of CME Group Inc. from 1998 to May 2015.&nbsp; From 1969 to 2003, he served as President, Director and part-owner of Packers Trading Company, a former futures commissions merchant/clearing firm at the CME.&nbsp; He also serves on the board of directors of the Chicago Crime Commission.&nbsp; Mr. Johnson holds a B.S. in Marketing from Bradley University and a J.D. from John Marshall Law School.&nbsp; Mr. Johnson has been involved with the Company as an investor for over 14 years, and has over 30 years&#146; experience in the capital markets as a result of his investment background.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Dr. John Monahan, 71, Director.&nbsp; </font></i></b><font style=COLOR:black>Dr. Monahan has served on our Board since August 2016.&nbsp; He is an experienced executive and has served on a number of biotechnology company boards over the years.&nbsp; He is currently a Scientific Advisory Consultant for Synthetic Biologics, Inc. (NYSE MKT: SYN) and from 2010 through 2015 he was the Sr. Executive Vice President of Research &amp; Development at Synthetic Biologics, Inc.&nbsp; He is also a director of Heat Biologics, Inc. (Nasdaq: HTBX), a position that he has held since 2011, and was a director of Tacere Therapeutics, Inc., a wholly-owned subsidiary of Benitec Biopharma Limited (Nasdaq: BNTC) from 2006 to 2015.&nbsp; In addition to his work with public companies, Dr. Monahan is also currently a member of the Scientific Advisory Board of Agilis Biotherapeutics, Inc., a position that he has held since 2014, and is a board member of several other biotechnology companies.&nbsp; In addition, in 1992 he founded Avigen, Inc., a biotech company that pioneered the development of gene medicines based on adeno-associated virus vectors, now an industry standard.&nbsp; Over a 12-year period as its CEO, Dr. Monahan took Avigen public through an initial public offering raising over $235M and led the company through several Investigational New Drug (IND) applications.&nbsp; Prior to Avigen, Dr. Monahan served as Vice President - Research and Development at Somatix B.V., and Director of Molecular &amp; Cell Biology at Triton Biosciences, Inc.&nbsp; He was also previously Research Group Chief, Department of Molecular Genetics at Hoffmann-LaRoche Inc., and Adjunct Assistant Professor, Department of Cell Biology at New York University.&nbsp; Dr. Monahan earned a Ph.D. in Biochemistry from McMaster University, Hamilton, Canada, and a B.S. in Science from University College, Dublin, Ireland.&nbsp; Dr. Monahan has over 50 publications in scientific literature and has made hundreds of presentations and public TV appearances, to scientific groups, investors and the general public over the years.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>33</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Lewis H. Titterton, Jr., 73, Director.&nbsp; </font></i></b><font style=COLOR:black>Mr. Titterton has served as a director since July 2017.&nbsp; He previously served as a director from August 2010 through August 2016, as the Chairman of the Board from July 2012 through August 2016, and interim Chief Executive Officer from August 2012 until September 2012. &nbsp;Mr. Titterton is currently Chairman of the Board of NYMED, Inc., a diversified health services company. &nbsp;His background is in high technology with an emphasis on health care and he has been with NYMED, Inc. since 1989. &nbsp;Mr. Titterton founded MedE America, Inc. in 1986 and was Chief Executive Officer of Management and Planning Services, Inc. from 1978 to 1986. &nbsp;Mr. Titterton also served as one of our Directors from July 1999 to January 2003. He holds a M.B.A. from the State University of New York at Albany, and a B.A. degree from Cornell University. &nbsp;Mr. Titterton has been involved with our Company as a director or investor for over twenty years. &nbsp;Mr. Titterton also has substantial experience with advising on the strategic development of technology companies and over forty years of experience in various aspects of the technology industry.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Richard H. Williams, 81, Director.&nbsp; </font></i></b><font style=COLOR:black>Mr. Williams has served on our Board since September 2017.&nbsp; Mr. Williams, an experienced businessman and entrepreneur, has served as a consultant to emerging growth companies since 1980.&nbsp; Mr. Williams currently serves as a special advisor to the Chairman and CEO of ParkerVision, Inc., a NASDAQ listed wireless technology company, in the areas of business development, acquisitions, and investment banking.&nbsp; Mr. Williams was Chairman and Chief Executive Officer of Sky Titan, Inc, a developer of air cargo aircraft from 2011 to 2013.&nbsp; Mr. Williams was a director of Iris International, Inc., a NASDAQ listed medical diagnostics company from 2003 to 2009, serving as Chairman of the Board from 2004 to 2007.&nbsp; Under his guidance, Iris became the world&#146;s largest automated urinalysis company with revenues of over $100 million.&nbsp; In 1994, Mr. Williams became a director and helped structure, finance and take public InTime Systems International, a software company selling human resource payroll products to Fortune 1000 companies.&nbsp; In 1988, Mr. Williams was appointed Chairman and Chief Executive Officer of Restor Industries, a telecommunications service company that he acquired with a group of investors.&nbsp; After several acquisitions, Restor went public and later divested.&nbsp; Previously, he was Chairman or Chief Executive Officer of several private companies, including an oil and gas exploration company and a telecommunications engineering service company.&nbsp; From 1970 to 1980, he was Vice President of a $100 million consumer product division of Pfizer Inc.&nbsp; Mr. Williams holds a B.S. in Business and Finance from New York University.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="BACKGROUND:white; COLOR:black">34</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><b><i><font style=COLOR:black>Michael J. Catelani, 51, Chief Operating Officer and Chief Financial Officer.&nbsp; </font></i></b>Mr. Catelani has served as our Chief Operating Officer since July 2017 and as Chief Financial Officer since November 2016.&nbsp; Mr. Catelani is a seasoned executive with over 25 years of experience in finance and operations.&nbsp; From October 2012 to July 2017, Mr. Catelani served as a contract Chief Financial Officer to a number of established privately held businesses in the biotechnology field. Previously, in July 2006, Mr. Catelani co-founded Tacere Therapeutics, Inc., a privately held biotechnology company, and served as its Chairman, President and Chief Financial Officer until its sale in October 2012.&nbsp; Prior to Tacere, Mr. Catelani served on the Board of Directors and was the Chief Financial Officer of Benitec Biopharma Limited, an Australian Stock Exchange-listed biotechnology company.&nbsp; Prior to Benitec, Mr. Catelani served as Vice President and Chief Financial Officer at Axon Instruments, a U.S. corporation publicly traded on the Australian Stock Exchange that was a leading designer and manufacturer of instrumentation and software systems for biotechnology and diagnostics research.&nbsp; Prior to Axon, Mr. Catelani served as the Vice President of Finance for Media Arts Group, Inc., an NYSE-listed company.&nbsp; Mr. Catelani has also worked with several early stage start-up companies in a variety of industries, including biotechnology, retail, waste water recovery, and distributed power generation, in both advisory and management roles.&nbsp; Mr. Catelani began his professional career at Ernst &amp; Young and is a CPA.&nbsp; He holds a B.S. degree in business administration, with a concentration in accountancy, from Sacramento State University and a M.B.A. from the University of California, Davis.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">Except for Drs. Kumar and Monahan, none of our current directors or executive officers has served as a director of another public company within the past five years. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="BACKGROUND:white; COLOR:black">&nbsp;</font><b>(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Our Significant Employees</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="TEXT-DECORATION:none; COLOR:black">We have no significant employees other than our executive management team.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b>(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Family Relationships</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>There are no family relationships between or among the directors, executive officers or persons nominated or chosen by the Company to become directors or executive officers.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b>(e) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Involvement of Certain Legal Proceedings </b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">To the best of our knowledge, during the past ten years, none of the following occurred with respect to a present or former director or executive officer of the Company: &nbsp;(1) any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time; (2) any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses); (3) being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities; (4) being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodities Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated; (5) being subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree or finding relating to an alleged violation of the federal or state securities, commodities, banking or insurance laws or regulations or any settlement thereof or involvement in mail or wire fraud in connection with any business entity not subsequently reversed, suspended or vacated and (6) being subject of, or a party to, any disciplinary sanctions or orders imposed by a stock, commodities or derivatives exchange or other self-regulatory organization.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="BACKGROUND:white; COLOR:black">35</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Section 16(a) Beneficial Ownership Reporting Compliance</font></h5> <p style='FONT-SIZE:9pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:12pt; COLOR:black">Section 16(a) of the Exchange Act requires our directors, executive officers and ten percent stockholders to file initial reports of ownership and reports of changes in ownership of our common stock with the Commission.&nbsp; Directors, executive officers and ten percent stockholders are also required to furnish us with copies of all Section 16(a) forms that they file.&nbsp; Based upon a review of these filings, we believe that all required Section 16(a) reports were made on a timely basis during fiscal year 2017.</font></p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Code of Ethics </font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>We have adopted a formal code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions. &nbsp;We will provide a copy of our code of ethics to any person without charge, upon request. &nbsp;For a copy of our code of ethics write to Secretary, ITUS Corporation, 3150 Almaden Expressway, Suite 250, San Jose, California 95118.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Nomination Procedures </font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On July 9, 2015, the Board established a nominating and corporate governance committee (the &#147;Nominating Committee&#148;). &nbsp;The Nominating Committee has a charter which will be reviewed on an annual basis by members of the committee and will be at all times composed of exclusively independent directors. &nbsp;The principal duties and responsibilities of the Nominating Committee are to identify qualified individuals to become board members, recommend to the Board individuals to be designated as nominees for election as directors at the annual meetings of stockholders, and develop and recommend to the Board the Company&#146;s corporate governance guidelines. &nbsp;In selecting directors, the Nominating Committee will consider candidates that possess qualifications and expertise that will enhance the composition of the Board, including the considerations set forth below. &nbsp;The considerations set forth below are not meant as minimum qualifications, but rather as guidelines in weighing all of a candidate&#146;s qualifications and expertise.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Candidates should be individuals of personal integrity and ethical character.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Candidates should have background, achievements, and experience that will enhance our Board. &nbsp;This may come from experience in areas important to our business, substantial accomplishments or prior or current associations with institutions noted for their excellence. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Candidates should have demonstrated leadership ability, the intelligence and ability to make independent analytical inquiries and the ability to exercise sound business judgment.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Candidates should be free from conflicts that would impair their ability to discharge the fiduciary duties owed as a director to ITUS and its stockholders, and we will consider directors&#146; independence from our management and stockholders.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Candidates should have, and be prepared to devote, adequate time and energy to the Board and its committees to ensure the diligent performance of their duties, including by attending meetings of the Board and its committees.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Due consideration will be given to the Board&#146;s overall balance of diversity of perspectives, backgrounds and experiences, as well as age, gender and ethnicity.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=COLOR:black>Consideration will also be given to relevant legal and regulatory requirements.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>36</font></p> <div style="BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We are of the view that the continuing service of qualified incumbents promotes stability and continuity in the board room, contributing to the Board&#146;s ability to work as a collective body, while giving us the benefit of the familiarity and insight into our affairs that our directors accumulate during their tenure. &nbsp;Accordingly, the process of the Nominating Committee for identifying nominees for directors will reflect our practice of generally re-nominating incumbent directors who continue to satisfy the Board&#146;s criteria for membership on the Board, whom the Nominating Committee believes continue to make important contributions and who consent to continue their service on the Board. &nbsp;If the Nominating Committee determines that an incumbent director consenting to re-nomination continues to be qualified and has satisfactorily performed his or her duties as director during the preceding term, and that there exist no reasons, including considerations relating to the composition and functional needs of the Board as a whole, why in the Nominating Committee&#146;s view the incumbent should not be re-nominated, the Nominating Committee will, absent special circumstances, generally propose the incumbent director for re-election. &nbsp;Although we do not have a formal policy regarding the consideration of diversity in identifying and evaluating potential director candidates, the Nominating Committee will take into account the personal characteristics (gender, ethnicity and age), skills and experience, qualifications and background of current and prospective directors&#146; diversity as one factor in identifying and evaluating potential director candidates, so that the Board, as a whole, will possess what the nominating and corporate governance committee believes are appropriate skills, talent, expertise and backgrounds necessary to oversee our Company&#146;s business.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>If the incumbent directors are not nominated for re-election or if there is otherwise a vacancy on the Board, the Nominating Committee may solicit recommendations for nominees from persons that the Nominating Committee believes are likely to be familiar with qualified candidates, including from members of the Board and management. &nbsp;While the Nominating Committee may also engage a professional search firm to assist in identifying qualified candidates, the Nominating Committee did not engage any third party to identify or evaluate or assist in identifying or evaluating the Director Nominees. &nbsp;We do not have a policy with regard to the consideration of director candidates recommended by stockholders. &nbsp;Due to the size of our Company and Board, the Nominating Committee does not believe that such a policy is necessary.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Depending on its level of familiarity with the candidates, the Nominating Committee may choose to interview certain candidates that it believes may possess qualifications and expertise required for membership on the Board. &nbsp;It may also gather such other information it deems appropriate to develop a well-rounded view of the candidate. &nbsp;Based on reports from those interviews or from Board members with personal knowledge and experience with a candidate, and on all other available information and relevant considerations, the Nominating Committee will select and nominate candidates who, in its view, are most suited for membership on the Board.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The members of the nominating committee are Dr. John Monahan (Chairman), Richard H. Williams and Bruce F. Johnson.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>37</font></p> <div style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Audit Committee and Audit Committee Financial Expert</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On July 9, 2015, the Board established a separately-designated standing audit committee (the &#147;Audit Committee&#148;) established in accordance with Section&nbsp;3(a)(58)(A) of the Exchange Act, and Nasdaq Listing Rules.&nbsp; The Audit Committee has a charter which will be reviewed on an annual basis by members of the committee and will be at all times composed of exclusively independent directors who are &#147;financially literate,&#148; meaning they are able to read and understand fundamental financial statements, including the Company&#146;s balance sheet, income statement and cash flow statement. In addition, the committee will have at least one member who qualifies as an &#147;audit committee financial expert&#148; as defined in rules and regulations of the SEC.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The principal duties and responsibilities of the Company&#146;s Audit Committee are to appoint the Company&#146;s independent auditors, oversee the quality and integrity of the Company&#146;s financial reporting and the audit of the Company&#146;s financial statements by its independent auditors and in fulfilling its obligations, the Company&#146;s Audit Committee will review with the Company&#146;s management and independent auditors the scope and result of the annual audit, the auditors&#146; independence and the Company&#146;s accounting policies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The Audit Committee will be required to report regularly to the Board to discuss any issues that arise with respect to the quality or integrity of the Company&#146;s financial statements, its compliance with legal or regulatory requirements and the performance and independence of the Company&#146;s independent auditors.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The members of the Audit Committee are Lewis H. Titterton, Jr. (Chairman), Richard H. Williams and Bruce F. Johnson. Our Board has determined that Mr. Titterton qualifies as an Audit Committee financial expert as defined by SEC rules, based on his education, experience and background. &nbsp;Please see Mr. Titterton&#146;s biographical information above for a description of his relevant experience.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name=EC><u>Executive Compensation</u>.</a></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>The following table sets forth certain information for the fiscal years ended October 31, 2017 and 2016, with respect to compensation awarded to, earned by or paid to our Chairman of the Board, our President and Chief Executive Officer and our Chief Operating Officer and Chief Financial Officer (the &#147;Named Executive Officers&#148;). &nbsp;No other executive officer received total compensation in excess of $100,000 during fiscal year 2017.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>38</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.7pt" cellpadding=0 cellspacing=0> <tr> <td width=624 colspan=7 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:467.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>SUMMARY COMPENSATION TABLE</font></p></td></tr> <tr style=HEIGHT:39.55pt> <td width=168 style="BORDER-TOP:0px; HEIGHT:39.55pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.75in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Name and</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Principal Position</font></p></td> <td width=48 style="BORDER-TOP:0px; HEIGHT:39.55pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:35.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Year</font></p></td> <td width=83 style="BORDER-TOP:0px; HEIGHT:39.55pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Salary</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>($)</font></p></td> <td width=78 style="BORDER-TOP:0px; HEIGHT:39.55pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Bonus</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>($)</font></p></td> <td width=84 style="BORDER-TOP:0px; HEIGHT:39.55pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Option Awards</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>($) (2)</font></p></td> <td width=78 style="BORDER-TOP:0px; HEIGHT:39.55pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>All Other</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Compensation</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>($) (3)</font></p></td> <td width=85 style="BORDER-TOP:0px; HEIGHT:39.55pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Total</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Compensation</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>($)</font></p></td></tr> <tr> <td width=168 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.75in; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. Amit Kumar (1)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Chairman of the Board, President and Chief Executive Officer</p></td> <td width=48 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:35.7pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2017</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2016</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=83 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.2pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 300,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 300,000</p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;$ 200,000</p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 141,938</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 566,896</p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ &nbsp;&nbsp;12,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ &nbsp;&nbsp;12,000</p></td> <td width=85 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63.8pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp; 453,938</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;$ 1,078,896</p></td></tr> <tr> <td width=168 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.75in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Robert A. Berman (4)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Chief Executive Officer and Director</font></p></td> <td width=48 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:35.7pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2017</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2016</p></td> <td width=83 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 228,077</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 300,000</p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;$ 200,000</p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;-</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 566,896</p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 300,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td width=85 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63.8pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $&nbsp;&nbsp;&nbsp; 528,077</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 1,066,896</p></td></tr> <tr> <td width=168 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.75in; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Michael J. Catelani (5)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Chief Operating Officer and Chief Financial Officer </font></p></td> <td width=48 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:35.7pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2017</p></td> <td width=83 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:62.2pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 174,561</p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td width=84 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ 385,859</p></td> <td width=78 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:58.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td width=85 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:63.8pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp; $ &nbsp;&nbsp;&nbsp;560,420</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-31.5pt'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Dr. Kumar has served as the Company&#146;s Executive Chairman of the Board since August 2016.&nbsp; On July 6, 2017 Dr. Kumar was appointed President and Chief Executive Officer of the Company.&nbsp; </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-31.5pt'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Amounts in the Option Awards column represent the aggregate grant date fair value of stock option awards made during the fiscal years ended October 31, 2017 and 2016 for each Named Executive Officer in accordance with Accounting Standards Codification (&#147;ASC&#148;) 718 and also reflects the repricing of outstanding options for Dr. Kumar and Mr. Catelani on September 6, 2017.&nbsp; See the section entitled &#147;Option Re-Pricing&#148; below.&nbsp; A discussion of assumptions used in valuation of option awards may be found in Note 2 to our Consolidated Financial Statements for fiscal year ended October 31, 2017, included elsewhere in this Annual Report on Form 10-K.&nbsp;</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(3)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Amounts in the All Other Compensation column reflect, for each Named Executive Officer, the sum of the incremental cost to us of all perquisites and personal benefits, which for Dr. Kumar consisted solely of compensation for use of a home office, and for Mr. Berman consisted solely of severance obligations related to his resignation on July 6, 2017.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(4)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Mr. Berman resigned his position as President and Chief Executive Officer and as a director on July 6, 2017.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:115%; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(5)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Mr. Catelani has served as the Company&#146;s Chief Financial Officer since November&nbsp;1, 2016.&nbsp; On July 6, 2017, Mr. Catelani was appointed Chief Operating Officer of the Company. </font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black; LINE-HEIGHT:115%'>39</font></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Employment Agreements</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><u><font style=COLOR:black>Consulting Agreement with Dr. Amit Kumar</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>On September 19, 2012, the Company entered into a Consulting Agreement with Dr. Amit Kumar (the &#147;Kumar Agreement&#148;) pursuant to which Dr. Kumar agreed to provide business consulting services for an initial annual consulting fee of $120,000. &nbsp;On June 15, 2015, Dr. Kumar was appointed Vice Chairman of the Company and Executive Chairman of Anixa Diagnostics Corporation, a wholly-owned subsidiary of the Company. &nbsp;As a result of this appointment, Dr. Kumar&#146;s cash compensation was increased to $300,000 by the Board. &nbsp;</font>On August 23, 2016, Dr. Kumar was appointed Executive Chairman of the Company, and on July 6, 2017 Dr. Kumar was appointed President and Chief Executive Officer of the Company.&nbsp; <font style=COLOR:black>The terms of the Kumar Agreement still remain in effect.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>If Dr. Kumar&#146;s services are terminated by the Company or he terminates his services for any reason or no reason, the Company shall be obligated to pay to Dr. Kumar only any earned compensation and/or bonus due under the Kumar Agreement and any unpaid reasonable and necessary expenses, due to him through the date of termination. &nbsp;All such payments shall be made in a lump sum immediately following termination.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><u><font style=COLOR:black>Employment Agreement with Robert Berman</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.75in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">On September 19, 2012, the Company entered into an Employment Agreement with Mr. Berman (the &#147;Berman Agreement&#148;) to serve as President and Chief Executive Officer of the Company. &nbsp;Pursuant to the Berman Agreement, Mr. Berman initially received an annual base salary of $290,000, which was increased to $300,000 by the Board effective November 1, 2013.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On July 6, 2017, Mr. Berman resigned as President and Chief Executive Officer and as a director.&nbsp; Pursuant to the terms of a separation agreement entered into on August 16, 2017 between Mr. Berman and the Company, Mr. Berman is entitled to receive severance payments in an aggregate amount of $300,000 to be paid in four separate tranches with the final payment occurring on June 1, 2018. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Stock Options</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The following table sets forth certain information with respect to unexercised stock options held by the Named Executive Officers outstanding on October 31, 2017:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>40</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.4pt" cellpadding=0 cellspacing=0> <tr> <td width=576 colspan=5 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE</font></p></td></tr> <tr> <td width=576 colspan=5 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Option Awards </font></p></td></tr> <tr> <td width=131 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:98.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Name</font></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number of Securities Underlying Unexercised Options (#) <br>Exercisable</font></p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:86.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Number of Securities Underlying Unexercised Options (#) <br>Un-Exercisable</font></p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Option Exercise Price<br>($)</font></p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 2.7pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Option Expiration Date</font></p></td></tr> <tr> <td width=131 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:98.2pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Dr. Amit Kumar</font></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.25in; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp; 320,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp; 106,667</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp; 213,333</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40,000(1)</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;111,111(2)</p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:86.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp; 88,889(2)</p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:81pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$0.67</p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>9/19/2022</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>9/19/2022</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>9/19/2022</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>11/8/2023</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>2/18/2026</p></td></tr> <tr> <td width=131 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:98.2pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Robert A. Berman</font></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp; 320,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp; 106,667</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp; 213,333</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40,000(1)</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;200,000(3)</p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:86.3pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$2.920</p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>7/6/2022</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>7/6/2022</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>7/6/2022</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>7/6/2022</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>7/6/2022</p></td></tr> <tr> <td width=131 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:98.2pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Michael J. Catelani </font></p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=115 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:86.3pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp; 50,000(4)</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>200,000(5)</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></td> <td width=108 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:81pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>$0.67</p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>11/15/2026</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:3.3pt 0in 2.7pt; TEXT-AUTOSPACE:' align=center>7/6/2027</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style=COLOR:black>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Options vested and became exercisable in 36 consecutive monthly installments, beginning December 31, 2013 and continuing through November 30, 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style=COLOR:black>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Options vest and become exercisable in 36 consecutive monthly installments, beginning March 31, 2016 and continuing through February 28, 2019.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style=COLOR:black>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Options were to vest and become exercisable in 36 consecutive monthly installments, beginning March 31, 2016 and continuing through February 28, 2019.&nbsp; However, pursuant to a separation agreement between the Company and Mr. Berman, the options vested and became exercisable upon Mr. Berman&#146;s resignation on July 6, 2017.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style=COLOR:black>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>Options vest and become exercisable in one installment of 16,666 on November 1, 2017 and the remainder in eight consecutive quarterly installments, beginning January 31, 2018 and continuing through October 31, 2019.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style=COLOR:black>(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Options vest and become exercisable in one installment of 50,000 on July 6, 2018 and the remainder in twelve consecutive quarterly installments, beginning October 31, 2018 and continuing through July 31, 2021.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>41</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>The following table summarizes stock option grants during fiscal year 2017. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:500pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=553 colspan=5 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:414.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>GRANTS OF PLAN BASED AWARDS TABLE</p></td></tr> <tr> <td width=145 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:108.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Name</p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Grant Date</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>All Other Option Awards: Number of Securities Underlying Options </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>(#)</p></td> <td width=72 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.75in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Exercise Price of Option Awards </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>($)</p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:85.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Grant Date Fair Value </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>($) (1)</p></td></tr> <tr> <td width=145 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:108.9pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>Michael J. Catelani</p></td> <td width=102 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:76.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>11/15/16</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>7/6/17</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 50,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>200,000</p></td> <td width=72 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:0.75in; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p></td> <td width=114 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:85.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 215,330</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 170,529</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style=COLOR:black>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Grant date fair value reflects the repricing of options on September 6, 2017.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>During fiscal 2017, no stock options were exercised by Named Executive Officers.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:115%; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u>Option Re-Pricing</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>On September 6, 2017, the compensation committee of the Company re-priced certain issued and outstanding stock options to purchase in the aggregate 2,029,600 shares of Company common stock for all of the current officers, directors and employees of the Company (the &#147;Re-Priced Options&#148;) pursuant to the authority granted to the compensation committee by the Board of Directors of the Company.&nbsp; The new exercise price of the Re-Priced Options is $0.67, the closing sales price of the Company&#146;s common stock on September 6, 2017.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>All other terms of the previously granted Re-Priced Options remain the same, including without limitation, the number of shares underlying the options granted, the vesting periods of the options, and the expiration dates of the options. &nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>The Company recorded additional stock-based compensation expense resulting from the incremental value of the fair value of the Re-Priced Options compared to the fair value of the original options immediately prior to the re-pricing of approximately $261,000 in fiscal year ended October 31, 2017.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>42</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>The following stock option grants and related stock option agreements issued to the Company&#146;s Named Executive Officers and directors were affected by the re-pricing:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:500pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=186 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:139.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Name</p></td> <td width=90 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center># of Shares</p></td> <td width=92 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Old Option<br>&nbsp;Price</p></td> <td width=94 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:70.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>New Option Price</p></td> <td width=92 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Expiration<br>&nbsp;Date</p></td></tr> <tr> <td width=186 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:139.25pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>Dr. Amit Kumar</p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>320,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>106,667</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>213,333</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 40,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>200,000</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.92</p></td> <td width=94 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:70.85pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>9/19/22</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>9/19/22</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>9/19/22</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>11/8/23</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>2/18/26</p></td></tr> <tr> <td width=186 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:139.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>Dr. John Monahan</p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;&nbsp;&nbsp; 6,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 12,000</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$3.13</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$5.30</p></td> <td width=94 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:70.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>8/23/26</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>1/3/27</p></td></tr> <tr> <td width=186 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:139.25pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>Lewis H. Titterton, Jr.</p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;&nbsp;&nbsp; 2,400</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 30,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 16,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 40,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>120,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 16,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 16,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 16,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;&nbsp;&nbsp; 6,000</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.92</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.82</p></td> <td width=94 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:70.85pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>11/30/17</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>9/19/22</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>12/31/22</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>2/15/23</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>11/8/23</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>12/31/23</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>1/2/25</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>1/14/26</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>7/17/27</p></td></tr> <tr> <td width=186 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:139.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>Dr. Arnold Baskies</p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;&nbsp;&nbsp; 6,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 12,000</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$3.13</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$5.30</p></td> <td width=94 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:70.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>8/23/26</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>1/3/27</p></td></tr> <tr> <td width=186 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:139.25pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>Dale Fox</p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;&nbsp;&nbsp; 6,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 12,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 12,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 12,000</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.575</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$2.92</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$5.30</p></td> <td width=94 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:70.85pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>8/8/24</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>1/2/25</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>1/14/26</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>1/3/27</p></td></tr> <tr> <td width=186 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:139.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>Michael J. Catelani</p></td> <td width=90 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:67.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp; 50,000</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>200,000</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$4.85</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.96</p></td> <td width=94 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:70.85pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$0.67</p></td> <td width=92 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:68.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>11/15/26</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>7/6/27</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u>Potential Payments upon Termination or Change in Control</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Dr. Amit Kumar</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Options granted Dr. Kumar on February 18, 2016 provide for the vesting of the unvested portion of his options to be accelerated and such accelerated options to become immediately exercisable if Dr. Kumar is terminated without cause or upon a change in control as defined below. &nbsp;The intrinsic value of options granted on February 18, 2016 would be $122,667, which was calculated by multiplying (a) 88,889 options (being the number of options granted to him on February 18, 2016 that would be accelerated) by (b) an amount equal to the excess of (x) our closing share price on October 31, 2017 of $2.05 and (y) the options&#146; exercise price of $0.67 per share.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style=COLOR:black>Michael J. Catelani</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Options granted Mr. Catelani on July 6, 2017 provide for the vesting of the unvested portion of his options to be accelerated and such accelerated options to become immediately exercisable if Mr. Catelani is terminated without cause or upon a change in control as defined below. &nbsp;The intrinsic value of options granted on July 6, 2017 would be $276,000, which was calculated by multiplying (a) 200,000 options (being the number of options granted to him on July 6, 2017 that would be accelerated) by (b) an amount equal to the excess of (x) our closing share price on October 31, 2016 of $2.05 and (y) the options&#146; exercise price of $0.67 per share. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Under the 2010 Share Incentive Plan, &#147;change in control&#148; means:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Change in Ownership: &nbsp;A change in ownership of the Company occurs on the date that any one person, or more than one person acting as a group, acquires ownership of stock of the Company that, together with stock held by such person or group, constitutes more than 50% of the total fair market value or total voting power of the stock of the Company, excluding the acquisition of additional stock by a person or more than one person acting as a group who is considered to own more than 50% of the total fair market value or total voting power of the stock of the Company.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>43</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Change in Effective Control: &nbsp;A change in effective control of the Company occurs on the date that either:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; MARGIN:0in 0in 0pt 1.25in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Any one person, or more than one person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company possessing 30% or more of the total voting power of the stock of the Company; or</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1.25in; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; MARGIN:0in 0in 0pt 1.25in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>a majority of the members of the Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board before the date of the appointment or election; provided, that this paragraph will apply only to the Company if no other corporation is a majority shareholder.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.25in'><font style="FONT-SIZE:12pt; FONT-FAMILY:Symbol; COLOR:black">&#183;<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Change in Ownership of Substantial Assets: &nbsp;A change in the ownership of a substantial portion of the Company&#146;s assets occurs on the date that any one person, or more than one person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 40% of the total gross fair market value of the assets of the Company immediately before such acquisition or acquisitions. &nbsp;For this purpose, &#147;gross fair market value&#148; means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>It is the intent that this definition be construed consistent with the definition of &#147;Change of Control&#148; as defined under Code Section 409A and the applicable treasury regulations, as amended from time to time.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Director&#146;s Compensation</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:40.5pt'><font style="BACKGROUND:white; COLOR:black">There is no present arrangement for cash compensation of directors for services in that capacity. &nbsp;Consistent with the non-employee director compensation approved on March 28, 2013 for calendar year 2013, on November 8, 2013, the Board approved an amendment to the 2010 Share Incentive Plan to provide that on January 1<sup>st</sup> of each year commencing on January 1, 2014, each non-employee director (a &#147;Director Participant&#148;) of the Company at that time shall automatically be granted a 10 year nonqualified stock option to purchase 12,000 shares of common stock (or 16,000 in the case of the Chairman of the Board to the extent he qualifies as a Director Participant), with an exercise price equal to the closing price on the date of grant, that will vest in four equal quarterly installments in the year of grant. &nbsp;In addition, each person who is a Director Participant and joins the Board after January 1 of any year, shall be granted on the date such person joins the Board, a nonqualified stock option to purchase 12,000 shares of common stock (or 16,000 in the case of the Chairman of the Board) pro-rated based upon the number of calendar quarters remaining in the calendar year in which such person joins the Board (rounded up for partial quarters).&nbsp; In addition to the foregoing, Dr. Monahan and Mr. Titterton, and in lieu of the foregoing, Messrs. Johnson and Williams, were each granted a nonqualified stock option to purchase 50,000 shares of common stock on September 22, 2017.&nbsp; Further, on September 22, 2017, Mr. Williams was granted an additional nonqualified stock option to purchase 50,000 shares of common stock.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="BACKGROUND:white; COLOR:black">44</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">Our employee directors, Dr. Amit Kumar and Robert A. Berman, did not receive any additional compensation for services provided as a director during fiscal year 2017. &nbsp;The following table sets forth compensation of Bruce F. Johnson, Dr. John Monahan, Lewis H. Titterton, Jr., and Richard H. Williams, our non-employee directors, and Dr. Arnold Baskies and Dale Fox, our former non-employee directors, for fiscal year 2017: </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <div align=center> <table width=733 bordercolor=transparent style="WIDTH:550.1pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:14.75pt> <td width=100% colspan=4 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:14.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>DIRECTORS&#146; COMPENSATION</p></td></tr> <tr style=HEIGHT:48.5pt> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:48.5pt; BORDER-RIGHT:0px; WIDTH:30.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Name</font></p></td> <td width=24% nowrap style="BORDER-TOP:0px; HEIGHT:48.5pt; BORDER-RIGHT:0px; WIDTH:24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Option Awards</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>($) (1)</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:48.5pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>All Other</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>Compensation</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>($) (2)</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:48.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Total</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>Compensation</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>($)</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Bruce F. Johnson (3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=24% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$&nbsp;&nbsp; 94,722</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 113,500</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:23%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 208,222</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dr. John Monahan</font></p></td> <td width=24% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 150,195</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 113,500</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 263,695</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Lewis H. Titterton, Jr.</font></p></td> <td width=24% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 137,255</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 113,500</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:23%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 250,755</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Richard H. Williams (3)</font></p></td> <td width=24% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 189,444</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 113,500</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$ 302,944</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dr. Arnold Baskies (3)</font></p></td> <td width=24% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$&nbsp;&nbsp; 79,109</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:23%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$&nbsp;&nbsp; 79,109</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=30% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dale Fox (3)</font></p></td> <td width=24% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$&nbsp;&nbsp; 58,739</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td width=23% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>$&nbsp;&nbsp; 58,739</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style="BACKGROUND:white; COLOR:black">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amounts in the Option Awards column represent the aggregate grant date fair value of stock option awards made during the fiscal year ended October 31, 2017, in accordance with ASC 718 and also reflects the repricing of outstanding options for Drs. Monahan and Baskies and Messrs. Titterton and Fox on September 6, 2017.&nbsp; </font><font style=COLOR:black>See the section entitled &#147;Option Re-Pricing&#148; above. &nbsp;</font><font style="BACKGROUND:white; COLOR:black">A discussion of assumptions used in valuation of option awards may be found in Note 2 to our Consolidated Financial Statements for fiscal year ended October 31, 2017, included elsewhere in this Annual Report on Form 10-K.&nbsp; At October 31, 2017, Bruce Johnson, Dr. John Monahan, Lewis Titterton and Richard Williams held unexercised stock options to purchase 100,400, 68,000, 310,000 and 100,000 shares respectively, of our common stock. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style="BACKGROUND:white; COLOR:black">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On September 22, 2017, each non-employee director was awarded 50,000 shares of common stock under the 2010 Share Incentive Plan.&nbsp; The closing price of the Company&#146;s common stock on the date of the award was $2.27. &nbsp;Amounts in the All Other Compensation column represent the market value of the shares on the date they were awarded. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'><font style="BACKGROUND:white; COLOR:black">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dr. Baskies and Mr. Fox resigned as directors, and Messrs. Johnson and Williams became directors, on September 22, 2017.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="BACKGROUND:white; COLOR:black">45</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-1in'>Item 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=SOCBOMRSM>Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</a></u></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The following table sets forth certain information with respect to our common s</font>tock beneficially owned as of January 4, 2018 (or exercisable within 60 days of such date) by (a) each person who is known by our management to be the beneficial owner of more than 5% of our outstanding common stock, (b) each of our directors and executive officers, and (c) all directors and executive officers as a group: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:500pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=289 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:2pt 0in; TEXT-AUTOSPACE:ideograph-numeric'><font style=FONT-SIZE:12pt>Name and Address of Beneficial Owner</font></p></td> <td width=180 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt>Amount and Nature of Beneficial Ownership</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt>(1)(2)(3)(4)</font></p></td> <td width=120 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=FONT-SIZE:12pt>Percent of Class<br>(5)</font></p></td></tr> <tr> <td width=589 colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:441.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in; TEXT-AUTOSPACE:ideograph-numeric' align=center><i><font style=FONT-SIZE:12pt>Directors and Officers of the Company</font></i></p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font lang=FR>Dr. Amit Kumar</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3150 Almaden Expressway, Suite 250</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>San Jose, CA 95118</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>939,741</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>5.4%</p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Bruce F. Johnson</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3150 Almaden Expressway, Suite 250</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>San Jose, CA 95118</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>665,317</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>4.0%</p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Dr. John Monahan</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3150 Almaden Expressway, Suite 250</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>San Jose, CA 95118</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>80,500</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>*%</p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Lewis H. Titterton, Jr.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3150 Almaden Expressway, Suite 250</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>San Jose, CA 95118</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>1,109,044</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>6.6%</p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Richard H. Williams</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3150 Almaden Expressway, Suite 250</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>San Jose, CA 95118</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>125,000</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>*%</p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font lang=FR>Michael J. Catelani</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3150 Almaden Expressway, Suite 250</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>San Jose, CA 95118</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>20,838</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>*%</p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>All Directors and Executive Officers as a Group (6 persons)</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>2,940,440</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>16.5%</p></td></tr> <tr> <td width=589 colspan=3 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:441.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:2pt 0in; TEXT-AUTOSPACE:ideograph-numeric' align=center><i><font style=FONT-SIZE:12pt>5% Stockholders of the Company</font></i></p></td></tr> <tr> <td width=289 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:216.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Bruce Eames</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>3 Greenway Plaza, Ste. 200</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Houston, TX 77046</p></td> <td width=180 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:135pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>1,088,046</p></td> <td width=120 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1.25in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>6.6%</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>* Less than 1%.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A beneficial owner of a security includes any person who directly or indirectly has or shares voting power and/or investment power with respect to such security or has the right to obtain such voting power and/or investment power within sixty (60) days.&nbsp; Except as otherwise noted, each designated beneficial owner in this Annual Report on Form 10-K has sole voting power and investment power with respect to the shares of common stock beneficially owned by such person.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes 173,333 shares, 48,500 shares, 30,500 shares, 186,500 shares, 25,000 shares, 20,838 shares and 484,671 shares which Dr. Amit Kumar, Bruce F. Johnson, Dr. John Monahan, Lewis H. Titterton, Jr., Richard H. Williams, Michael J. Catelani and all directors and executive officers as a group, respectively, have the right to acquire within 60 days upon exercise of options granted pursuant to the 2010 <font style=COLOR:black>Share Incentive Plan</font>.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes 2,000 shares, 2,000 shares and 4,000 shares that Dr. Amit Kumar, Lewis H. Titterton, Jr. and all directors and executive officers as a group, respectively, have the right to acquire within 60 days upon exercise of warrants purchased by them in the private placement on July 15, 2014.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Includes 640,000 shares, 12,000 shares, 86,000 shares and 738,000 shares which Dr. Amit Kumar, Bruce F. Johnson, Lewis H. Titterton, Jr. and all directors and executive officers as a group, respectively, have the right to acquire within 60 days pursuant to option agreements with the Company.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based on 16,609,399 shares of common stock outstanding as of January 4, 2018.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>46</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><b><u>Change in Control</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We are not aware of any arrangement that might result in a change in control of the Company in the future.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.25in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'>&nbsp;</p> <h5 style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Equity Compensation Plan Information</font></h5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>The following is information as of October 31, 2017 about shares of our common stock that may be issued upon the exercise of options, warrants and rights under all equity compensation plans in effect as of that date, including our 2003 Share Incentive Plan and our 2010 Share Incentive Plan.&nbsp; See Note 5 to Consolidated Financial Statements for more information on these plans.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:500pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=133 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center><b><font style=COLOR:black>Plan category</font></b></p></td> <td width=126 colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Number of securities to be issued upon exercise of outstanding options, warrants and rights</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>(a)</font></b></p></td> <td width=126 colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:94.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Weighted average exercise price of outstanding options, warrants and rights</font></b></p></td> <td width=150 colspan=2 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:112.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black>Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))</font></b></p></td></tr> <tr> <td width=133 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:99.9pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Equity compensation plans not approved by security holders (1)(2)</font></p></td> <td width=125 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:93.45pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>3,447,846</font></p></td> <td width=126 colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:94.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>$1.56</font></p></td> <td width=150 colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:112.5pt; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>69,226</font></p></td> <td width=1 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></td></tr> <tr> <td width=166 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=155 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=155 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=185 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 1in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'><font style=COLOR:black>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>On<font style=COLOR:black> April 23, 2003 the Board adopted the 2003 Share Incentive Plan.&nbsp; Officers, key employees and non-employee directors of, and consultants to, the Company or any of its subsidiaries and affiliates were eligible to participate in the 2003 Share Incentive Plan.&nbsp; The 2003 Share Incentive Plan provided for the grant of stock options, stock appreciation rights, stock awards, performance awards and stock units (the &#147;2003 Benefits&#148;).&nbsp; The maximum number of shares of common stock available for issuance under the 2003 Share Incentive Plan was 2,800,000.&nbsp; </font>The 2003 Share Incentive Plan was administered by the Stock Option Committee through June 2004, from June 2004 through July 2010, by the Board of Directors, from July 2010 through August 2012, by the Stock Option Committee, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 to July 2015, by the Board of Directors and since July 2015 by the Compensation Committee, which determined the option price, term and provisions of the 2003 Benefits.&nbsp; <font style=COLOR:black>The 2003 Share Incentive Plan contains provisions for equitable adjustment of the 2003 Benefits in the event of a merger, consolidation, reorganization, recapitalization, stock dividend, stock split, reverse stock split, spinoff, combination of shares, exchange of shares, dividends in kind or other like change in capital structure or distribution (other than normal cash dividends) to stockholders of the Company.&nbsp; The 2003 Share Incentive Plan terminated with respect to additional grants on April 21, 2013.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:; TEXT-INDENT:-0.5in'><font style=COLOR:black>(2) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On July 14, 2010 the Board adopted the 2010 Share Incentive Plan.&nbsp; Officers, key employees and non-employee directors of, and consultants to, the Company or any of its subsidiaries and affiliates are eligible to participate in the 2010 Share Incentive Plan.&nbsp; The 2010 Share Incentive Plan provides for the grant of stock options, stock appreciation rights, stock awards, and performance awards and stock units (the &#147;2010 Benefits&#148;).&nbsp; The maximum number of shares of common stock available for issuance under the 2010 Share Incentive Plan was initially 600,000 shares.&nbsp; On July 6, 2011 and August 29, 2012, the 2010 Share Incentive Plan was amended by our Board to increase the maximum number of shares of common stock that may be granted to 1,080,000 and 1,200,000 shares, respectively.&nbsp; </font>On November 8<font style=LETTER-SPACING:-0.15pt>, 2013</font>, the Board approved an amendment to provide that effective and following November <font style=LETTER-SPACING:-0.15pt>8, 2013</font>, the maximum aggregate number of shares available for issuance will be 800,000 shares.&nbsp; Additionally, commencing on the first business day in 2014 and on the first business day of each calendar year thereafter, the maximum aggregate number of shares available for issuance shall be replenished such that, as of such first business day, the maximum aggregate number of shares available for issuance shall be 800,000 shares. &nbsp;<font style=COLOR:black>Current and future non-employee directors are automatically granted </font>a 10 year nonqualified stock option to purchase 12,000 shares of Common Stock (or 16,000 in the case of the Chairman of the Board) <font style=COLOR:black>on </font>January 1<sup>st</sup> of each year that will vest in four equal quarterly installments<font style=COLOR:black>.&nbsp; </font>The 2010 Share Incentive Plan was administered by the Stock Option Committee through August 2012, from August 2012 through November 2012, by the Executive Committee of the Board of Directors, from November 2012 through July 2015, by the Board of Directors and since July 2015, by the Compensation Committee, which determines the option price, term and provisions of the 2010 Benefits.<font style=COLOR:black>&nbsp; The 2010 Share Incentive Plan terminates with respect to additional grants on July 14, 2020.&nbsp; The Board may amend, suspend or terminate the 2010 Share Incentive Plan at any time. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in' align=center><font style=COLOR:black>47</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:-0.5in' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name=CRRTDI><u>Certain Relationships and Related Transactions, and Director Independence</u>.</a></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u>Transactions with Related Persons</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>Aside from compensation arrangements with executive officers described above, there are no other transactions entered into by the Company with related persons.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><b><u>Related Person Transaction Approval Policy</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=COLOR:black>While we have no written policy regarding approval of transactions between us and a related person, our Board, as matter of appropriate corporate governance, reviews and approves all such transactions, to the extent required by applicable rules and regulations. &nbsp;Generally, management would present to the Board for approval at the next regularly scheduled Board meeting any related person transactions proposed to be entered into by us. &nbsp;The Board may approve the transaction if it is deemed to be in the best interests of our stockholders and the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u><font style=COLOR:black>Director Independence</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Our Board oversees the activities of our management in the handling of the business and affairs of our company.&nbsp; Our common stock trades on the NASDAQ Capital Markets and we are subject to listing requirements which include the requirement that our Board be comprised of a majority of &#147;independent&#148; directors.&nbsp; Bruce Johnson, Dr. John Monahan, Lewis Titterton and Richard Williams currently meet the definition of &#147;independent&#148; as defined by the SEC.&nbsp; The Board of Directors has separately designated audit, nominating and compensation committees. Our director, Dr. Amit Kumar, is an employee of the Company and as such does not qualify as an &#147;independent&#148; director.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Item 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name=PAFS><u>Principal Accounting Audit Fees and Services</u>.</a></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;The following table describes fees for professional audit services rendered and billed by Haskell &amp; White LLP, our present independent registered public accounting firm and principal accountant, for the audit of our consolidated financial statements and for other services during fiscal years 2017 and 2016.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><u><font style=COLOR:black>Type of Fee</font></u></p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2017</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2016</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Audit Fees (1)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>81,125 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>79,910 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Audit Related Fees (2)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>19,620</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>7,500</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Tax Fees (3)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>24,000</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>25,025</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>All Other Fees (4)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>49,350</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>12,450</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>174,095 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>124,885 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(1)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Audit fees for fiscal years 2017 and 2016 represent fees billed for services rendered by Haskell &amp; White LLP for the audit of our consolidated financial statements and review of our quarterly reports on Form 10-Q.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(2)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Audit related fees for fiscal years 2017 and 2016 represent fees billed for services rendered by Haskell &amp; White LLP in connection with our Registration Statements filed during fiscal years 2017 and 2016.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(3)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Tax Fees for fiscal years 2017 and 2016 represent fees billed for services rendered by Haskell &amp; White LLP for the preparation of Federal and State income tax returns.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; LINE-HEIGHT:normal; TEXT-AUTOSPACE:; TEXT-INDENT:-0.25in'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>(4)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp; </font></font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; COLOR:black'>All other fees for fiscal years 2017 and 2016 represent fees billed for services rendered by Haskell &amp; White LLP in connection with the&nbsp;preparation of comfort letters and research of various tax subjects.</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:115%; TEXT-AUTOSPACE:' align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:115%'>48</font></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><u>Procedures For Board of Directors Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditor </u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our Board was responsible for reviewing and approving, in advance, any audit and any permissible non-audit engagement or relationship between us and our independent registered public accounting firm.&nbsp; On July 9, 2015, the Board established an Audit Committee which assumed these responsibilities.&nbsp; Haskell &amp; White LLP&#146;s engagement to conduct our fiscal year 2017 audit was approved by our Board on July 17, 2017.&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><font style=COLOR:black><a name=P4>PART IV</a></font></p> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-1in'><font style=COLOR:black>Item 15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><a name=Exhibits>Exhibits, Financial Statement Schedules</a></u></font></h4> <h4 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt 1in; TEXT-AUTOSPACE:; TEXT-INDENT:-1in'><font style=COLOR:black>(a)(1)(2) <u>Financial Statement Schedules</u></font></h4> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 2in; TEXT-AUTOSPACE:; TEXT-INDENT:-1in'><font style=COLOR:black>See accompanying &#147;Index to Consolidated Financial Statements.&#148;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'><b><font style=COLOR:black>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Exhibits</u></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>3.1</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certificate of Incorporation, as amended.&nbsp; (Incorporated by reference to Form 10-Q for the fiscal quarter ended July 31, 1992 and Form S-3, dated February 11, 2014.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>3.2</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment to the Certificate of Incorporation. (Incorporated by reference to Form 10-K for the fiscal year ended October 31, 2013.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>3.3</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certificate of Amendment to the Certificate of Incorporation. (Incorporated by reference to Exhibit 3.1 on Form 8-K, dated September 4, 2014.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>3.4</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock. (Incorporated by reference to Exhibit 3.1 of our Form 8-K, dated September 10, 2014.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>3.5</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amended and Restated By-laws. (Incorporated by reference to Exhibit 3.1 to our Form 8-K dated, November 8, 2012.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>3.6</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certificate of Amendment to the Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 on Form 8-K, dated June 25, 2015.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>4.1</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Form of Warrant issued to investors in connection with the Company&#146;s registered direct offering. (Incorporated by reference to Exhibit 4.1 to Form 8-K, dated July 15, 2014.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>4.2</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Form of Warrant to be issued to Adaptive Capital LLC (Incorporated by reference to Exhibit 4.2 to our Form 10-K, dated December 7, 2016.).</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.1</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>2003 Share Incentive Plan.&nbsp; (Incorporated by reference to Exhibit 4 to our Form S-8 dated May 5, 2003.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.2</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 1 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(e) to our Form S-8 dated November 9, 2004.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=64 style="HEIGHT:15.75pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.3</font></p></td> <td width=1193 style="HEIGHT:15.75pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 2 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2006.)</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center>49<b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b> <p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.4</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 3 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2006.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.5</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 4 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(g) to our Form S-8 dated September 21, 2007.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.6</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 5 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(g) to our Form S-8 dated January 21, 2009.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.7</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 6 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.5 to our Form 8-K, dated July 20, 2010.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.8</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated July 20, 2010.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.9</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 1 to the 2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated July 7, 2011.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.10</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 2 to the 2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated September 5, 2012.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.11</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amendment No. 3 to the 2010 Share Incentive Plan (Incorporated by reference to Exhibit 10.1 to our Form 10-Q for the fiscal quarter ended January 31, 2014.)</font></p></td></tr> <tr style=HEIGHT:49.5pt> <td width=51 style="HEIGHT:49.5pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.12</font></p></td> <td width=682 style="HEIGHT:49.5pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Consulting Agreement, dated as of September 19, 2012, between the Company and Amit Kumar.&nbsp; (Incorporated by reference to Exhibit 10.37 to our Form 10-K for the fiscal year ended October 31, 2012.)&nbsp; (Portions of Section 4 of this exhibit have been redacted and filed separately with the Commission in accordance with a request for, and related Order by the Commission, dated May 3, 2013, File No. 0-11254-CF#29240, granting confidential treatment for portions of Section 4 of this exhibit to pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.13</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Letter Agreement, dated October 17, 2016, between the Company and Mike Catelani. (Incorporated by reference to Exhibit 10.21 to our Form 10-K, dated December 7, 2016.)</font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=51 style="HEIGHT:31.5pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.14</font></p></td> <td width=682 style="HEIGHT:31.5pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>License Agreement, dated November 13, 2017, between Certainty Therapeutics, Inc. and The Wistar Institute of Anatomy and Biology. (Filed herewith)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission)</font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=51 style="HEIGHT:31.5pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>10.15</font></p></td> <td width=682 style="HEIGHT:31.5pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Collaboration Agreement, dated November 17, 2017, between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc. (Filed herewith)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>21</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Subsidiaries of ITUS Corporation. (Filed herewith.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>23.1</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Consent of Haskell &amp; White LLP.&nbsp; (Filed herewith.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>31.1</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated January 9, 2018.&nbsp; (Filed herewith.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>31.2</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated January 9, 2018.&nbsp; (Filed herewith.)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=51 style="HEIGHT:15.75pt; WIDTH:38.3pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>32.1</font></p></td> <td width=682 style="HEIGHT:15.75pt; WIDTH:511.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Statement of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated January 9, 2018.&nbsp; (Furnished herewith.)</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>50</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center>&nbsp;</p> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:28.35pt> <td width=64 style="HEIGHT:28.35pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>32.2</font></p></td> <td width=1193 style="HEIGHT:28.35pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Statement of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated January 9, 2018.&nbsp; (Furnished herewith.)</font></p></td></tr> <tr style=HEIGHT:47.25pt> <td width=64 style="HEIGHT:47.25pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>99.1</font></p></td> <td width=1193 style="HEIGHT:47.25pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Collaborative Research Agreement, dated July 14, 2015, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Incorporated by reference to Exhibit 99.1 to our Form 10-K, dated December 7, 2016.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</font></p></td></tr> <tr style=HEIGHT:47.25pt> <td width=64 style="HEIGHT:47.25pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>99.2</font></p></td> <td width=1193 style="HEIGHT:47.25pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>First Amendment to The Collaborative Research Agreement, dated August 4, 2016, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Incorporated by reference to Exhibit 99.2 to our Form 10-K, dated December 7, 2016.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</font></p></td></tr> <tr style=HEIGHT:34.5pt> <td width=64 style="HEIGHT:34.5pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>99.3</font></p></td> <td width=1193 style="HEIGHT:34.5pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Second Amendment to The Collaborative Research Agreement, dated August 1, 2017, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Filed herewith.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</font></p></td></tr> <tr style=HEIGHT:47.25pt> <td width=64 style="HEIGHT:47.25pt; WIDTH:48pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>99.4</font></p></td> <td width=1193 style="HEIGHT:47.25pt; WIDTH:895pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Collaborative Research Agreement, dated August 4, 2016, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology. (Incorporated by reference to Exhibit 99.2 to our Form 10-K, dated December 7, 2016.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center>51<b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b> <p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center><b><u><font style=COLOR:black>SIGNATURES</font></u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <table width=606 bordercolor=transparent style="WIDTH:454.8pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=300 nowrap style="HEIGHT:15.75pt; WIDTH:224.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=307 colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:230.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>ITUS CORPORATION</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=300 nowrap style="HEIGHT:15.75pt; WIDTH:224.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=307 colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:230.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=300 nowrap style="HEIGHT:15.75pt; WIDTH:224.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=31 nowrap style="HEIGHT:15.75pt; WIDTH:23.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:&nbsp;&nbsp;&nbsp;&nbsp;</font></p></td> <td width=275 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:206.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>/s/ Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=300 nowrap style="HEIGHT:15.75pt; WIDTH:224.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=31 nowrap style="HEIGHT:15.75pt; WIDTH:23.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=275 nowrap style="HEIGHT:15.75pt; WIDTH:206.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=300 nowrap style="HEIGHT:15.75pt; WIDTH:224.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=31 nowrap style="HEIGHT:15.75pt; WIDTH:23.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=275 nowrap style="HEIGHT:15.75pt; WIDTH:206.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chairman of the Board, President and</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=300 nowrap style="HEIGHT:15.75pt; WIDTH:224.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>January 9, 2018</font></p></td> <td width=31 nowrap style="HEIGHT:15.75pt; WIDTH:23.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=275 nowrap style="HEIGHT:15.75pt; WIDTH:206.55pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Executive Officer</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:40.5pt'><font style=COLOR:black>Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.</font></p> <table width=600 bordercolor=transparent style="WIDTH:6.25in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:&nbsp; </font></p></td> <td width=269 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:201.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>/s/ Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dr. Amit Kumar</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chairman of the Board, President and</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Executive Officer</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>January 9, 2018</font></p></td> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>(Principal Executive Officer)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:&nbsp; </font></p></td> <td width=269 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:201.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>/s/ Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Michael J. Catelani</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Operating Officer and</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Chief Financial Officer </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>(Principal Financial</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>January 9, 2018</font></p></td> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>and Accounting Officer)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black'>By:&nbsp; </font></p></td> <td width=269 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:201.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>/s/ Bruce F. Johnson</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Bruce F. Johnson</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>January 9, 2018</font></p></td> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Director</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:&nbsp; </font></p></td> <td width=269 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:201.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>/s/ John Monahan</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Dr. John Monahan </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>January 9, 2018</font></p></td> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Director</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:&nbsp; </font></p></td> <td width=269 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:201.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>/s/ Lewis H. Titterton, Jr.</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Lewis H. Titterton, Jr.</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>January 9, 2018</font></p></td> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Director</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>By:&nbsp; </font></p></td> <td width=269 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:201.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>/s/ Richard H. Williams</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Richard H. Williams</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=297 nowrap style="HEIGHT:15.75pt; WIDTH:223.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>January 9, 2018</font></p></td> <td width=34 nowrap style="HEIGHT:15.75pt; WIDTH:25.15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=269 nowrap style="HEIGHT:15.75pt; WIDTH:201.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Director</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>52</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>EXHIBITS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'> <table width=750 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr height=42 style=HEIGHT:31.5pt> <td width=62 height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; BORDER-LEFT:0px" align=right valign=top> <p align=left>3.1</p></td> <td width=717 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:538pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Certificate of Incorporation, as amended.&nbsp; (Incorporated by reference to Form 10-Q for the fiscal quarter ended July 31, 1992 and Form S-3, dated February 11, 2014.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>3.2</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment to the Certificate of Incorporation. (Incorporated by reference to Form 10-K for the fiscal year ended October 31, 2013.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>3.3</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Certificate of Amendment to the Certificate of Incorporation. (Incorporated by reference to Exhibit 3.1 on Form 8-K, dated September 4, 2014.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>3.4</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock. (Incorporated by reference to Exhibit 3.1 of our Form 8-K, dated September 10, 2014.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>3.5</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amended and Restated By-laws. (Incorporated by reference to Exhibit 3.1 to our Form 8-K dated, November 8, 2012.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>3.6</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Certificate of Amendment to the Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 on Form 8-K, dated June 25, 2015.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" align=right valign=top> <p align=justify>4.1</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Form of Warrant issued to investors in connection with the Company&#146;s registered direct offering. (Incorporated by reference to Exhibit 4.1 to Form 8-K, dated July 15, 2014.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>4.2</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Form of Warrant to be issued to Adaptive Capital LLC (Incorporated by reference to Exhibit 4.2 to our Form 10-K, dated December 7, 2016.).</p></td></tr> <tr height=21 style=HEIGHT:15.75pt> <td height=21 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.1</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>2003 Share Incentive Plan.&nbsp; (Incorporated by reference to Exhibit 4 to our Form S-8 dated May 5, 2003.)</p></td></tr> <tr height=21 style=HEIGHT:15.75pt> <td height=21 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" valign=top> <p align=justify>&nbsp;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" valign=top> <p align=justify>&nbsp;</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.2</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 1 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(e) to our Form S-8 dated November 9, 2004.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.3</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 2 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2006.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.4</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 3 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2006.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.5</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 4 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(g) to our Form S-8 dated September 21, 2007.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.6</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 5 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 4(g) to our Form S-8 dated January 21, 2009.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.7</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 6 to the 2003 Share Incentive Plan. (Incorporated by reference to Exhibit 10.5 to our Form 8-K, dated July 20, 2010.)</p></td></tr> <tr height=21 style=HEIGHT:15.75pt> <td height=21 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.8</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated July 20, 2010.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.9</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 1 to the 2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated July 7, 2011.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.10</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 2 to the 2010 Share Incentive Plan. (Incorporated by reference to Exhibit 10.1 to our Form 8-K, dated September 5, 2012.)</p></td></tr> <tr height=42 style=HEIGHT:31.5pt> <td height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.11</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Amendment No. 3 to the 2010 Share Incentive Plan (Incorporated by reference to Exhibit 10.1 to our Form 10-Q for the fiscal quarter ended January 31, 2014.)</p></td></tr> <tr height=126 style=HEIGHT:94.5pt> <td height=126 style="BORDER-TOP:0px; HEIGHT:94.5pt; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" align=right valign=top> <p align=justify>10.12</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top> <p align=justify>Consulting Agreement, dated as of September 19, 2012, between the Company and Amit Kumar.&nbsp; (Incorporated by reference to Exhibit 10.37 to our Form 10-K for the fiscal year ended October 31, 2012.)&nbsp; (Portions of Section 4 of this exhibit have been redacted and filed separately with the Commission in accordance with a request for, and related Order by the Commission, dated May 3, 2013, File No. 0-11254-CF#29240, granting confidential treatment for portions of Section 4 of this exhibit to pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended.)</p></td></tr></table></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' /> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>53</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center> <table width=750 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0 align=left> <tr height=42 style=HEIGHT:31.5pt> <td width=62 height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; BORDER-LEFT:0px" valign=top>10.13</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Letter Agreement, dated October 17, 2016, between the Company and Mike Catelani. (Incorporated by reference to Exhibit 10.21 to our Form 10-K, dated December 7, 2016.)</td></tr> <tr height=63 style=HEIGHT:47.25pt> <td width=62 height=63 style="BORDER-TOP:0px; HEIGHT:47.25pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>10.14</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>License Agreement, dated November 13, 2017, between Certainty Therapeutics, Inc. and The Wistar Institute of Anatomy and Biology. (Filed herewith)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission)</td></tr> <tr height=65 style=HEIGHT:48.75pt> <td width=62 height=65 style="BORDER-TOP:0px; HEIGHT:48.75pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>10.15</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Collaboration Agreement, dated November 17, 2017, between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc. (Filed herewith)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission)</td></tr> <tr height=21 style=HEIGHT:15.75pt> <td width=62 height=21 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; BORDER-LEFT:0px" valign=top>21</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Subsidiaries of ITUS Corporation. (Filed herewith.)</td></tr> <tr height=21 style=HEIGHT:15.75pt> <td width=62 height=21 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>23.1</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Consent of Haskell &amp; White LLP.&nbsp; (Filed herewith.)</td></tr> <tr height=42 style=HEIGHT:31.5pt> <td width=62 height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>31.1</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated January 9, 2018.&nbsp; (Filed herewith.)</td></tr> <tr height=42 style=HEIGHT:31.5pt> <td width=62 height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>31.2</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated January 9, 2018.&nbsp; (Filed herewith.)</td></tr> <tr height=42 style=HEIGHT:31.5pt> <td width=62 height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>32.1</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Statement of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated January 9, 2018.&nbsp; (Furnished herewith.)</td></tr> <tr height=42 style=HEIGHT:31.5pt> <td width=62 height=42 style="BORDER-TOP:0px; HEIGHT:31.5pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; BORDER-LEFT:0px" valign=top>32.2</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Statement of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated January 9, 2018.&nbsp; (Furnished herewith.)</td></tr> <tr height=84 style=HEIGHT:63pt> <td width=62 height=84 style="BORDER-TOP:0px; HEIGHT:63pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>99.1</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Collaborative Research Agreement, dated July 14, 2015, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Incorporated by reference to Exhibit 99.1 to our Form 10-K, dated December 7, 2016.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</td></tr> <tr height=88 style=HEIGHT:66pt> <td width=62 height=88 style="BORDER-TOP:0px; HEIGHT:66pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>99.2</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>First Amendment to The Collaborative Research Agreement, dated August 4, 2016, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Incorporated by reference to Exhibit 99.2 to our Form 10-K, dated December 7, 2016.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</td></tr> <tr height=84 style=HEIGHT:63pt> <td width=62 height=84 style="BORDER-TOP:0px; HEIGHT:63pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>99.3</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Second Amendment to The Collaborative Research Agreement, dated August 1, 2017, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology (Filed herewith.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.)</td></tr> <tr height=84 style=HEIGHT:63pt> <td width=62 height=84 style="BORDER-TOP:0px; HEIGHT:63pt; BORDER-RIGHT:0px; WIDTH:47pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>99.4</td> <td width=743 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:557pt; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; BORDER-LEFT:0px" valign=top>Collaborative Research Agreement, dated August 4, 2016, between Anixa Diagnostic Corporation and The Wistar Institute of Anatomy and Biology. (Incorporated by reference to Exhibit 99.2 to our Form 10-K, dated December 7, 2016.)&nbsp; (Portions of this exhibit have been redacted pursuant to a request for confidential treatment. The redacted portions have been separately filed with the Securities and Exchange Commission.) </td></tr></table></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>54</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 24pt; TEXT-AUTOSPACE:'>INDEX&nbsp;TO&nbsp;CONSOLIDATED FINANCIAL&nbsp;STATEMENTS<br>OCTOBER 31, 2017</p> <table width=733 bordercolor=transparent style="WIDTH:550pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=83 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:62pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Page</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#ReportOf>Report of Independent Registered Public Accounting Firm</a></font></p></td> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>F-1</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#BS>Consolidated Balance Sheets as of October 31, 2017 and 2016</a></font></p></td> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>F-2</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#SO>Consolidated Statements of Operations for the years ended October 31, 2017 and 2016</a></font></p></td> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>F-3</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#SSE>Consolidated Statements of Shareholders&#146; Equity for the years ended October 31, 2017 and 2016</a></font></p></td> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>F-4</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#CFS>Consolidated Statements of Cash Flows for the years ended October 31, 2017 and 2016</a></font></p></td> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>F-5</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=616 nowrap style="HEIGHT:15.75pt; WIDTH:462pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black><a href=#Notes>Notes to Consolidated Financial Statements</a></font></p></td> <td width=83 nowrap style="HEIGHT:15.75pt; WIDTH:62pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>F-6 &#150; F-21</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>Additional information required by schedules called for under Regulation S-X is either not applicable or is included in the consolidated financial statements or notes thereto.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=COLOR:black><a name=ReportOf>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:95%; TEXT-AUTOSPACE:'><font style=LINE-HEIGHT:95%>To the Board of Directors and Shareholders</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:95%; TEXT-AUTOSPACE:'><b><i><font style=LINE-HEIGHT:95%>ITUS Corporation</font></i></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; LINE-HEIGHT:95%; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>We have audited the accompanying consolidated balance sheets of <b><i>ITUS Corporation</i></b> (the&nbsp;&#147;Company&#148;) as of October 31, 2017 and 2016, and the related consolidated statements of operations, shareholders&#146; equity, and cash flows for each of the years ended October 31, 2017 and 2016. These consolidated financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company has determined that it is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company as of October 31, 2017 and 2016, and the consolidated results of its operations and its cash flows for each of the years ended October 31, 2017 and 2016, in conformity with accounting principles generally accepted in the United States.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>/s/ Haskell &amp; White LLP</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>HASKELL &amp; WHITE LLP</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 30pt; TEXT-AUTOSPACE:ideograph-numeric'>Irvine, California<br>January 9, 2018</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:12pt>F-1<b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></font> <p><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p></div> <div style=page:WordSection3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><a name=BS>CONSOLIDATED BALANCE&nbsp;SHEETS</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750.25pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>October 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2017</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>October 31,</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2016</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><u><font style=COLOR:black>ASSETS </font></u></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Current assets:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Cash and cash equivalents </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,339,374 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2,488,323 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Short&#150;term investments in certificates of deposit</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:12pt'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,500,000 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>750,000 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Prepaid expenses and other current assets</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>174,566 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>162,069 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total current assets </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>7,013,940 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,400,392 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Patents, net of accumulated amortization of $1,290,336 and $965,040, respectively</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,745,775 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2,071,071 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 nowrap style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Property and equipment, net of accumulated depreciation of $35,725 and $46,950, respectively</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:12pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>52,701 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>156,644 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=711 style="HEIGHT:16.5pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total assets </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>8,812,416 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>$</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>5,628,107 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=711 style="HEIGHT:16.5pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:windowtext 1.5pt double; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><u><font style=COLOR:black>LIABILITIES&nbsp;AND&nbsp;SHAREHOLDERS&#146;&nbsp;EQUITY</font></u></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Current liabilities:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accounts payable </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>480,324 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>373,224 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accrued expenses</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>409,169 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>95,532 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total current liabilities</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>889,493 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>468,756 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Patent acquisition obligation (Note 4)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,171,876 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total liabilities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>889,493 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,640,632 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=711 nowrap style="HEIGHT:15pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Commitments and contingencies (Notes 6 and 7)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=711 nowrap style="HEIGHT:15pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Shareholders&#146; equity:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 nowrap style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Preferred stock, par value $100 per share; 19,860 shares authorized; no shares <br>&nbsp;&nbsp;&nbsp; issued or outstanding</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=711 style="HEIGHT:31.5pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Series A convertible preferred stock, par value $100 per share; 140 shares <br>&nbsp;&nbsp;&nbsp; authorized, -0- and 140 shares issued and outstanding at October 31, 2017 and 2016, respectively</font></p></td> <td width=2% style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>14,000 </font></p></td></tr> <tr style=HEIGHT:31.5pt> <td width=711 style="HEIGHT:31.5pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Common stock, par value $.01 per share; 24,000,000 shares authorized; <br>&nbsp;&nbsp;&nbsp; 16,602,759 and 8,752,387 shares issued and outstanding at October 31, 2017 and 2016, respectively</font></p></td> <td width=2% style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>166,028 </font></p></td> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:31.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:31.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>87,524 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Additional paid-in capital</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>163,931,079 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>152,051,144 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accumulated deficit </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:12pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(156,174,184)</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(151,165,193)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total shareholders&#146; equity&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:12pt'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>7,922,923 </font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>987,475 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=711 style="HEIGHT:15.75pt; WIDTH:533.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=711 style="HEIGHT:16.5pt; WIDTH:533.5pt; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total liabilities and shareholders&#146; equity </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>8,812,416 </font></p></td> <td width=2% nowrap style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>5,628,107 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>The accompanying notes are an integral part of these statements.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p></div> <div style=page:WordSection4> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:' align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style=FONT-SIZE:12pt>F-2</font></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES</b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:11pt><a name=SO>CONSOLIDATED STATEMENTS&nbsp;OF&nbsp;OPERATIONS</a></font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=FONT-SIZE:11pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=30% colspan=5 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:30%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>For the years ended <br>October 31,</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;2017</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;2016</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Revenue</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>362,500 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>300,000 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Operating costs and expenses:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Inventor royalties and contingent legal fees</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>91,451 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>111,192 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Litigation and licensing expenses</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>13,105 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>106,224 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amortization of patents</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>325,296 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>325,296 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Research and development expenses (including non-cash stock option <br>&nbsp;&nbsp;&nbsp; compensation expenses of $288,187 and $259,930, respectively)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;1,597,550</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;1,556,459</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Marketing, general and administrative expenses (including non-cash stock <br>&nbsp;&nbsp;&nbsp; option compensation expense of $934,585 and $613,631, respectively)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;4,410,682</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.66%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.34%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;2,709,841</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total operating costs and expenses</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>6,438,084 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,809,012 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Loss from operations</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(6,075,584)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(4,509,012)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp; </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Gain on extinguishment of patent acquisition obligation (Note 4)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,547,608 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Interest expense (Notes 4 and 5)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(500,455)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(519,946)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Interest income</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>19,440 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>12,530 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Loss before income taxes</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,008,991)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,016,428)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Provision for income taxes (Note 7)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-&nbsp;&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net loss</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,008,991)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,016,428)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Deemed dividend to preferred stockholder (Note 5)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(2,008,775)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net loss attributable to common stockholders</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(7,017,766)</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:11.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,016,428)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:16.5pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net loss per share:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Basic and diluted </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(0.58)</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2.66%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:11.34%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(0.57)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2.66%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:16.5pt; WIDTH:11.34%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Weighted average common shares outstanding:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.34%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Basic and diluted </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:12pt'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>12,197,340</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:11.34%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>8,739,453</font></p></td></tr></table></div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>The accompanying notes are an integral part of these statements. </p></div> <div style=page:WordSection5> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:12pt>F-3</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><a name=SSE>CONSOLIDATED STATEMENTS&nbsp;OF&nbsp;SHAREHOLDERS&#146; EQUITY</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>FOR&nbsp;THE&nbsp;YEARS&nbsp;ENDED&nbsp;OCTOBER 31, 2017 and 2016</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=1067 bordercolor=transparent style="WIDTH:800pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=18% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Series A</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Convertible</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; COLOR:black">Preferred Stock</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Additional</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Paid-in</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; COLOR:black">Capital</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Total</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Shareholders&#146;</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; COLOR:black">Equity</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=19% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:19.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Common Stock</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Accumulated</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style="FONT-SIZE:9pt; COLOR:black">Deficit</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.74%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Shares</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Par Value</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Shares</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.52%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:9pt; COLOR:black">Par Value</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">BALANCE, October 31, 2015</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">140 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">14,000 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">8,724,878 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">87,249 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">151,101,117 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(146,148,765)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">5,053,601 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Stock option compensation to employees and consultants</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">873,561 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">873,561 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued upon exercise of stock options</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">12,676 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">127 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">33,454 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">33,581 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued to consultants</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">10,833 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">108 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">31,252 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">31,360 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued to acquire patents</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">4,000 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">40 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">11,760 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">11,800 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Net Loss</font></p></td> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.74%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(5,016,428)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(5,016,428)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">BALANCE, October 31, 2016</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">140 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">14,000 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">8,752,387 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">87,524 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">152,051,144 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(151,165,193)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">987,475 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Stock option compensation to employees and consultants</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">1,222,772 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">1,222,772 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued upon exercise of stock options</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">40,220 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">402 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">6,871 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">7,273 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued to consultants and directors</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">209,463 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">2,095 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">484,329 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">486,424 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=27% nowrap style="HEIGHT:15.75pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Redemption of convertible preferred stock</font></p></td> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(140)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(14,000)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(3,486,000)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15.75pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(3,500,000)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued to repay patent acquisition obligation</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">947,606 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">9,476 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">2,842,818 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">2,852,294 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued in shareholder rights offering</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">1,989,207 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">19,892 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">4,183,410 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">4,203,302 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued in registered direct offering</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">3,425,376 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">34,254 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">3,177,534 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">3,211,788 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Common stock issued in at-the-market offering</font></p></td> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">1,238,500 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">12,385 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">3,448,201 </font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">3,460,586 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">Net Loss</font></p></td> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.74%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(5,008,991)</font></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(5,008,991)</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=27% nowrap style="HEIGHT:15pt; WIDTH:27.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.74%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.76%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=27% nowrap style="HEIGHT:15.75pt; WIDTH:27.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">BALANCE, October 31, 2017</font></p></td> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:6.74%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">-</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">16,602,759 </font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">166,028 </font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">163,931,079 </font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">(156,174,184)</font></p></td> <td width=1% nowrap style="HEIGHT:15.75pt; WIDTH:1.76%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:9pt; COLOR:black">$</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:7.76%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:9pt; COLOR:black">7,922,923 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:12pt>The accompanying notes are an integral part of this statement. </font></p></div> <div style=page:WordSection6> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:12pt>F-4</font></p> <div style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 8pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><a name=CFS>CONSOLIDATED STATEMENTS&nbsp;OF&nbsp;CASH&nbsp;FLOWS</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <div align=center> <table width=1000 bordercolor=transparent style="WIDTH:750pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>For the years ended <br>October 31,</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;2017</font></p></td> <td width=2% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2016</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Cash flows from operating activities:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net loss</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,008,991)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,016,428)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Stock option compensation to employees and consultants</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,222,772 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>873,561 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Common stock issued to consultants and directors</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>486,424 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>31,360 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Amortization of patents</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>325,296 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>325,296 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accretion of interest on patent acquisition obligations to interest expense</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>228,026 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>519,946 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Common stock issued to acquire patent license</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>11,800 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Depreciation and amortization of property and equipment</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>43,216 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>33,333 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Loss on disposal of property and equipment</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>45,915 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Gain on extinguishment of patent acquisition obligation</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(1,547,608)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Change in operating assets and liabilities:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Prepaid expenses and other current assets</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(12,497)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(35,541)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accounts payable</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>107,100 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(1,479)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accrued expenses</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>313,637 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>89,470 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Royalties and contingent legal fees payable</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(213,017)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net cash used in operating activities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(3,796,710)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(3,381,699)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Cash flows from investing activities:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Disbursements to acquire short-term investments in certificates of deposit&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,501,000)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(1,900,000)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Proceeds from maturities of short-term investments in certificates of deposit&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2,751,000 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,550,000 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Proceeds from sale of property and equipment</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>45,000 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Purchase of property and equipment</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(30,188)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(146,521)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net cash (used in) provided by investing activities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(2,735,188)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,503,479 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Cash flows from financing activities:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Proceeds from sale of common stock in shareholder rights offering</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,203,302 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Proceeds from sale of common stock in registered direct offering</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,211,788 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Proceeds from sale of common stock in at-the-market offering</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,460,586 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:1pt> <td width=70% style="HEIGHT:1pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Redemption of convertible preferred stock&nbsp; </font></p></td> <td width=2% style="HEIGHT:1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:1pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(500,000)</font></p></td> <td width=2% style="HEIGHT:1pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:1pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:1pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Payments made on secured debenture</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(3,000,000)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Proceeds from exercise of employee stock options</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>7,273 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>33,581 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Royalty payment applied to patent acquisition obligation</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(36,257)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:30pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net cash provided by (used in) financing activities</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>7,382,949 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(2,676)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Net increase (decrease) in cash and cash equivalents </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>851,051 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(1,880,896)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Cash and cash equivalents at beginning of year</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2,488,323 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,369,219 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Cash and cash equivalents at end of year</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,339,374 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2,488,323 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Supplemental cash flow information:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Cash payments for interest</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>272,429 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2.82%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2.82%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:16.5pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Supplemental disclosure of non-cash financing activities:</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=70% nowrap style="HEIGHT:16.5pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Redemption of Series A convertible preferred stock into secured debenture (Note 5)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,000,000 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2.82%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15.85pt> <td width=70% style="HEIGHT:15.85pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Common stock issued to pay patent acquisition obligation (Note 4)</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.85pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.85pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2,852,294 </font></p></td> <td width=2% style="HEIGHT:15.85pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.85pt; BORDER-RIGHT:0px; WIDTH:2.82%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.85pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>The accompanying notes are an integral part of these statements. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-5</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p></div> <div style=page:WordSection7> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b><a name=Notes>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>BUSINESS&nbsp;AND&nbsp;FUNDING</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Description of Business </u>&nbsp;&nbsp;&nbsp;&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>As used herein, &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; the &#147;Company&#148; or &#147;ITUS&#148; means ITUS Corporation and its wholly-owned subsidiaries.&nbsp; <font style=COLOR:black>From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &nbsp;Commencing in October 2012 the primary operations of the Company involved the development, acquisition, licensing, and enforcement of patented technologies that were either owned or controlled by the Company.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&#147;Anixa&#148;), to develop a platform for non-invasive blood tests for the early detection of cancer.&nbsp; That platform is called Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212;</font><font style=COLOR:black>.&nbsp; In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&#147;Wistar&#148;), the nation&#146;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. &nbsp;In August of 2016 and again in August of 2017, ITUS announced the renewal and expansion of our relationship with Wistar. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>From October of 2015 through January of 2017, ITUS announced that we had demonstrated the efficacy of our Cchek</font><font style="FONT-FAMILY:Symbol; COLOR:black">&#212; </font><font style=COLOR:black>early cancer detection platform with 15 different types of cancer, including:&nbsp; breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar and prostate.&nbsp; Breast, lung, colon and prostate cancers represent the four largest categories of cancer worldwide.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>In November of 2017, the Company announced the formation of a new subsidiary, Certainty Therapeutics, Inc. (&#147;Certainty&#148;), to develop immuno-therapy drugs against cancer.&nbsp; Certainty entered into a license agreement with Wistar pursuant to which Certainty was granted an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by Wistar relating to Wistar&#146;s chimeric endocrine receptor targeted therapy technology (such technology being akin to chimeric antigen receptor T-cell (&#147;CAR-T&#148;) technology). &nbsp;We plan to initially focus on the development of a treatment for ovarian cancer, but we also may pursue future applications of the technology for the development of treatments for additional solid tumors.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On November 20, 2017, we announced that Certainty entered into a collaboration agreement with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&#147;Moffitt&#148;) to advance toward human clinical testing the CAR-T technology licensed by Certainty from Wistar aimed initially at treating ovarian cancer.&nbsp; Certainty intends to work with researchers at Moffitt to complete studies necessary to submit an Investigational New Drug application with the U.S. Food and Drug Administration.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' /> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the next several quarters, we expect Cchek&#153; and Certainty&#146;s ovarian cancer treatment to be the primary focus of the Company. &nbsp;As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&nbsp; We do not expect these activities to be a significant part of the Company&#146;s ongoing operations nor do we expect these activities to require material financial resources or attention of senior management.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' /> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-6</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Over the past several quarters, our revenue was derived from technology licensing and the sale of patented technologies, including revenue from the settlement of litigation. &nbsp;In addition to Anixa and Certainty, the Company may make investments in and form new companies to develop additional emerging technologies.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Funding </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>As of the date of filing of our last annual report on Form 10-K, there was substantial doubt about our ability to continue as a going concern due to the limited amount of cash, cash equivalents and short-term investments we held as compared to our projected cash needs for the ensuing 12 months.&nbsp; We evaluated our cash position and future plans for the Company and embarked on a plan to ensure we had sufficient resources to execute our plans.&nbsp; Accordingly, over the past twelve months, we raised nearly $12 million through multiple financing arrangements, including a shareholder rights offering, a registered direct offering, and an at-the-market equity offering, and satisfied debt obligations through payments of cash and common stock.&nbsp; With no significant debt and approximately $6.8 million in cash, cash equivalents and short-term investments as of October 31, 2017, we believe that we have alleviated substantial doubt about our ability to continue as a going concern.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Based on currently available information as of January 9, 2018, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next 12 months.&nbsp; However, our projections of future cash needs and cash flows may differ from actual results.&nbsp; If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies that are synergistic with or complimentary to our technologies, we may be required to obtain more working capital.&nbsp; We may seek to obtain working capital during our fiscal year ended 2018 or thereafter through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&nbsp; We cannot be certain that additional funding will be available on acceptable terms, or at all.&nbsp; If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders. &nbsp;Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. &nbsp;We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all. &nbsp;If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&nbsp; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="BACKGROUND:white; COLOR:black">During the year ended October 31, 2017, cash used in operating activities was approximately $3,797,000. &nbsp;Cash used in investing activities was approximately $2,735,000, resulting from the purchase of certificates of deposit totaling $5,501,000 which was offset by the proceeds on maturities of certificates of deposit totaling $2,751,000 and the sale of property and equipment of $45,000 offset by the purchase of property and equipment of approximately $30,000. &nbsp;Cash provided by financing activities was approximately $7,383,000, resulting from the sale of common stock in a shareholder rights offering, an at-the-market offering and a registered direct offering of approximately $4,203,000, $3,461,000 and $3,212,000, respectively, and the proceeds from exercise of stock options of approximately $7,000, offset by payments made on a secured debenture of $3,000,000 and redemption of convertible preferred stock of $500,000.&nbsp; As a result, our cash, cash equivalents, and short-term investments at October 31, 2017 increased approximately $3,601,000 to approximately $6,839,000 from approximately $3,238,000 at the end of fiscal year 2016.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-7</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>SUMMARY&nbsp;OF&nbsp;SIGNIFICANT&nbsp;ACCOUNTING&nbsp;POLICIES</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Basis of Presentation</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries.&nbsp; All intercompany transactions have been eliminated.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>&nbsp;</font><u>Revenue Recognition</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style=COLOR:black>Patent Licensing</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&nbsp;&nbsp;These arrangements typically include some combination of the following:&nbsp;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&nbsp;&nbsp;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&nbsp;&nbsp;Pursuant to the terms of these agreements, we had no further obligations. &nbsp;&nbsp;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Inventor Royalties and Contingent Legal Fees</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Research and Development Expenses</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Research and development expenses, consisting primarily of employee compensation, payments to third parties for research and development activities and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-8</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Fair Value Measurements</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>Accounting Standards Codification (&#147;ASC&#148;) 820 &#147;Fair Value Measurements and Disclosures&#148; (&#147;ASC 820&#148;)</font> defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements.&nbsp; In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below.&nbsp; If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-AUTOSPACE:'>Level 3 &#150; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.&nbsp; These inputs reflect management&#146;s own assumptions about the assumptions a market participant would use in pricing the instrument.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2017:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=38% style="HEIGHT:15.75pt; WIDTH:38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;</font><font style=COLOR:black>&nbsp;</font></p></td> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Level 1</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;Level 2</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;Level 3</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;Total</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=38% style="HEIGHT:15.75pt; WIDTH:38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=38% style="HEIGHT:15.75pt; WIDTH:38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Money market funds &#150; <br>&nbsp;&nbsp;&nbsp; Cash and cash equivalents</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,079,282 </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,079,282 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=38% style="HEIGHT:15.75pt; WIDTH:38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certificates of deposit - <br>&nbsp;&nbsp;&nbsp; Short term investments</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,500,000 </font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.94%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>3,500,000 </p></td></tr> <tr style=HEIGHT:16.5pt> <td width=38% style="HEIGHT:16.5pt; WIDTH:38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total financial assets</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,079,282 </font></p></td> <td width=1% style="HEIGHT:16.5pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,500,000 </font></p></td> <td width=1% style="HEIGHT:16.5pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=1% style="HEIGHT:16.5pt; WIDTH:1.94%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>6,579,282 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=666 bordercolor=transparent style="WIDTH:499.7pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:16.65pt> <td width=38% style="HEIGHT:16.65pt; WIDTH:38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:16.65pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Level 1</font></p></td> <td width=2% style="HEIGHT:16.65pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:16.65pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Level 2</font></p></td> <td width=2% style="HEIGHT:16.65pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:16.65pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Level 3</font></p></td> <td width=2% style="HEIGHT:16.65pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:16.65pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Total</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=38% style="HEIGHT:15.75pt; WIDTH:38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=38% nowrap style="HEIGHT:15.75pt; WIDTH:38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Money market funds &#150; <br>&nbsp;&nbsp; Cash and cash equivalents</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,899,136 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,899,136 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=38% style="HEIGHT:15.75pt; WIDTH:38%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Certificates of deposit - <br>&nbsp;&nbsp;&nbsp; Short term investments</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>750,000 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>750,000 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=38% style="HEIGHT:16.5pt; WIDTH:38%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Total financial assets</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,899,136 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>750,000 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2,649,136 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-9</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=44% nowrap style="HEIGHT:15.75pt; WIDTH:44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Level 1</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Level 2</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Level 3</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Total</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=44% style="HEIGHT:15.75pt; WIDTH:44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=9% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.1%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=44% style="HEIGHT:15.75pt; WIDTH:44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Patent acquisition obligation</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=9% style="HEIGHT:15.75pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.4%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=9% style="HEIGHT:15.75pt; WIDTH:9%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,171,876 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.1%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,171,876 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The following table sets forth a summary of the changes in the fair value of the Company&#146;s Level 3 financial liabilities that are measured at fair value on a recurring basis:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=80% style="HEIGHT:15.75pt; WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><u><font style=COLOR:black>Patent acquisition obligation:</font></u></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=18% style="HEIGHT:15.75pt; WIDTH:18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=80% style="HEIGHT:15.75pt; WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Balance October 31, 2015</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=18% style="HEIGHT:15.75pt; WIDTH:18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3,688,187 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=80% style="HEIGHT:15.75pt; WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accretion of interest on patent obligation</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=18% style="HEIGHT:15.75pt; WIDTH:18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>519,946 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=80% style="HEIGHT:15.75pt; WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Royalty payment applied to patent acquisition obligation</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:18%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(36,257)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=80% style="HEIGHT:15.75pt; WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Balance October 31, 2016</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=18% style="HEIGHT:15.75pt; WIDTH:18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4,171,876 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=80% style="HEIGHT:15.75pt; WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accretion of interest on patent obligation</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=18% style="HEIGHT:15.75pt; WIDTH:18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>228,026 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=80% style="HEIGHT:15.75pt; WIDTH:80%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Extinguishment of patent obligation</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(4,399,902)</font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=80% style="HEIGHT:16.5pt; WIDTH:80%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Balance October 31, 2017</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=18% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:18%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&nbsp; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Cash and Cash Equivalents</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:40.5pt'>Cash equivalents consists of highly liquid, short-term investments with original maturities of three months or less when purchased.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Short-term Investments</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At October 31, 2017 and 2016, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $3,500,000 and $750,000, respectively, that were classified as short-term investments and reported at fair value.&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Patents</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Our only identifiable intangible assets are patents and patent rights.&nbsp; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&nbsp; No patent acquisition costs were capitalized during the years ended October 31, 2017 and 2016.&nbsp; We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2017 and 2016, respectively.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Impairment</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-10</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Income Taxes</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&nbsp; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Stock-Based Compensation</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u>Stock Option Compensation Expense </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &#147;Stock Compensation&#148; (&#147;ASC 718&#148;).&nbsp; <font style=COLOR:black>In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model.&nbsp; For options vesting if the trading price of the Company&#146;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. </font>We recognize compensation expense for stock option awards over the requisite or implied service period of the grant.&nbsp; With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable.&nbsp; We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $1,223,000 and $874,000, during the years ended October 31, 2017 and 2016, respectively. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Included in stock-based compensation cost for employees and directors during the years ended October 31, 2017 and 2016 was approximately $967,000 and $393,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested.&nbsp; As of October 31, 2017, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,091,000, which will be recognized over a weighted-average period of 1.7 years. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &#147;Equity-Based Payments to Non-Employees&#148; (&#147;ASC 505-50&#148;).&nbsp; In accordance with ASC 505-50, <font style=COLOR:black>we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model.&nbsp; F</font>or options vesting if the trading price of the Company&#146;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation.&nbsp; We recognize compensation expense for <font style=COLOR:black>service based stock options and options subject to market conditions</font> over the requisite or implied service period of the grant.&nbsp; For performance based awards, compensation expense is recognized when the performance target is achieved.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-11</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2017 and 2016 of approximately $3,000 and $-0-, respectively. &nbsp;Stock-based consulting expense for the years ended October 31, 2017 and 2016 did not include any amortization of compensation cost for stock options granted in prior periods but vested in the current period. &nbsp;As of October 31, 2017, there was unrecognized consulting expense related to non-vested stock options granted to consultants, related to service based options of approximately $44,000, which will be recognized over a weighted-average period of 2.1 years.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u>Fair Value Determination</u><u>&nbsp; </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time.&nbsp; <font style=COLOR:black>The stock options we granted during the year ended October 31, 2017 consisted of awards with 10-year terms that vest over 6 to 48 months. The stock options we granted during the year ended October 31, 2016 consisted of awards with 10-year terms that vest over 6 to 36 months&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2017 and 2016:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <div align=center> <table width=774 bordercolor=transparent style="WIDTH:580.45pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=74% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% colspan=3 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=2 valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style=COLOR:black>For the Year</font></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align=center><font style=COLOR:black>Ended October 31,</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=74% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=74% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style=COLOR:black>2017</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style=COLOR:black>2016</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=74% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Weighted average fair value at grant date</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">$1.72 </font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">$2.84 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=74% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Valuation assumptions:</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=74% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Expected life (years) </font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style=COLOR:black>5.63</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style=COLOR:black>5.70</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=74% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Expected volatility</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">119.2%</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">181.1%</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=74% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Risk-free interest rate</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">1.94%</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">1.26%</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=74% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:74%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Expected dividend yield</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">0%</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style="FONT-SIZE:11pt; COLOR:black">0%</font></p></td></tr></table></div> <div align=center>&nbsp;</div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.&nbsp; We use the simplified method, which is a weighted average of the vesting term and contractual term, to determine expected term.&nbsp; The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years.&nbsp; Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options.&nbsp; We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants.&nbsp; We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest.&nbsp; Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options.&nbsp; Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-12</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate.&nbsp; If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Net&nbsp;Loss&nbsp;Per&nbsp;Share of Common Stock </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In accordance with ASC 260, &#147;Earnings Per Share&#148;, basic net loss per common share (&#147;Basic EPS&#148;) is computed by dividing net loss by the weighted average number of common shares outstanding.&nbsp; Diluted net loss per common share (&#147;Diluted EPS&#148;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&nbsp; Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&nbsp; For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2017 and 2016, were options to purchase 3,447,846 and 3,086,472 shares, respectively, warrants to purchase 829,400 shares and 707,379 shares, respectively, preferred stock convertible into -0- and 739,958 shares, respectively.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Use of Estimates </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp; Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies.&nbsp; Actual results could differ from those estimates.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Effect of Recently Issued Pronouncements</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#147;ASU 2014-09&#148;), Revenue from Contracts with Customers.&nbsp; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &nbsp;This standard update is effective for&nbsp;interim and annual&nbsp;reporting periods beginning after December 15,&nbsp;2016, and were to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &nbsp;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &nbsp;We do not expect the adoption of ASU 2014-09 to have a material impact on our consolidated financial statements and related disclosures.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-13</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In August 2014, the FASB issued Accounting Standards Update 2014-15 (&#147;ASU 2014-15&#148;).&nbsp; This amendment requires management to assess an entity&#146;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption.&nbsp; We have provided additional footnote disclosure to our consolidated financial statements in accordance with ASU 2014-15 upon adoption of this amendment.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In November 2015, the FASB issued Accounting Standards Update 2015-17 (&#147;ASU 2015-17&#148;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &nbsp;Adoption of this standard is required for annual periods beginning after December 15, 2016. &nbsp;We do not anticipate that the adoption of this amendment will have an impact on our consolidated financial statements&nbsp;and related disclosures as we currently do not present deferred tax assets or liabilities.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#147;ASU 2016-02&#148;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &nbsp;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &nbsp;The requirements of this standard include a significant increase in required disclosures. &nbsp;We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&nbsp;and related disclosures, and our analysis is currently ongoing.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>In March 2016, the FASB issued Accounting Standards Update 2016-09 (&#147;ASU 2016-09&#148;) that changes the accounting for certain aspects of share-based payments to employees. &nbsp;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&#146;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &nbsp;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. We adopted ASU 2016-09 on November 1, 2017. &nbsp;We do not expect the adoption of this new guidance to have a material impact on our consolidated financial statements and related disclosures.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:11pt; COLOR:black">In May 2017, the FASB issued Accounting Standards Update 2017-09 (&#147;ASU 2017-09&#148;) that provides guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting. &nbsp;This update is effective for all entities for fiscal years beginning after December 15, 2017, and interim periods within those years.&nbsp; Early adoption is permitted.&nbsp; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements and related disclosures, and our analysis is ongoing.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:11pt; COLOR:black">In July 2017, the FASB issued Accounting Standards Update 2017-11 (&#147;ASU 2017-11&#148;) which changes the accounting for equity instruments that include a down round feature.&nbsp; For public entities, this update is effective for fiscal years beginning after December 15, 2018, and interim periods within those years.&nbsp; Early adoption is permitted. &nbsp;</font>We do not anticipate the adoption of this amendment will have an impact on our consolidated financial statements&nbsp;and related disclosures as we currently do not have any such equity instruments.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-14</p> <div style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Concentration of Credit Risks</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable.&nbsp; Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &nbsp;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &nbsp;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>One licensee accounted for 100% of revenues from patent licensing activities during fiscal year 2017. &nbsp;Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>ACCRUED EXPENSES</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Accrued liabilities consist of the following as of:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=5 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>October 31,</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>2017</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;</font><font style=COLOR:black>2016</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accrued severance costs</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>237,563 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>-</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Payroll and related expenses</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>51,643 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>49,901 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Accrued other</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>119,963 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>45,631 </font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=70% style="HEIGHT:16.5pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>409,169 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>95,532 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; COLOR:black">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>PATENT ACQUISITION OBLIGATION</u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:11pt; COLOR:black">In November 2013, we incurred a patent acquisition obligation due no later than November 2017 related to the acquisition of patents.&nbsp; The payment due in November 2017 was payable at the option of the Company in cash or common stock.&nbsp; We recorded interest expense of approximately $228,000 and $520,000, respectively, for the years ended October 31, 2017 and 2016, for the accretion of interest on patent acquisition obligation.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style="FONT-SIZE:11pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On March 27, 2017, the Company issued 947,606 shares of common stock in satisfaction of the obligation.&nbsp; The carrying value of the patent acquisition obligation at the date of extinguishment was approximately $4,400,000.&nbsp; The fair value of the shares of common stock issued to satisfy the obligation on the date of extinguishment was approximately $2,843,000, resulting in the recognition of a gain on the debt extinguishment of approximately $1,548,000.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>SHAREHOLDERS&#146; EQUITY</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Common Stock Issuances</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We account for stock granted to employees, directors and consultants based on the grant date market price of the underlying common stock.&nbsp;&nbsp; During the years ended October 31, 2017 and 2016, we issued 9,463 shares and 10,833 shares, respectively, of common stock to consultants for services rendered.&nbsp; We recorded consulting expense for the years ended October 31, 2017 and 2016 of approximately $32,000 and $31,000, respectively, for shares of common stock issued to consultants.&nbsp; During the year ended October 31, 2017 we issued 200,000 shares to directors for services rendered and recorded expense of $454,000.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-15</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 4.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-4.5pt'><u>Stock&nbsp;Option&nbsp;Plans</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>As of October 31, 2017, we have two stock option plans: the ITUS Corporation 2003 Share Incentive Plan (the &#147;2003 Share Plan&#148;) and the ITUS Corporation 2010 Share Incentive Plan (the &#147;2010 Share Plan&#148;) which were adopted by our Board of Directors on April 21, 2003 and July 14, 2010, respectively.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&nbsp; The 2003 Share Plan was administered by the Board of Directors or committees thereof, which determined the option price, term and provisions of each option.&nbsp; The exercise price with respect to all of the options granted under the 2003 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. &nbsp;In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the grant of future options on April 21, 2013. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Information regarding the 2003 Share Plan for the two years ended October 31, 2017 is as follows:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=47% nowrap style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;Price Per Share</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% nowrap style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;</font><font style=COLOR:black>Intrinsic Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% nowrap style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding at October 31, 2015</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>366,200 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>17.86 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Exercised</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(11,080)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2.58 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Forfeited</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(129,520)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>17.72 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding at October 31, 2016</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>225,600 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>18.69 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Exercised</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(5,800)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1.39 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Forfeited</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(189,200)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>21.55 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=47% nowrap style="HEIGHT:16.5pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding and Exercisable at <br>October 31, 2017</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>30,600 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:16.5pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3.16 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:16.5pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>20,148 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of October 31, 2017:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$&nbsp; 0.67 - $&nbsp; 17.50</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>30,600</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>1.13</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$3.16 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-16</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&nbsp; On the first business day of each calendar year the maximum aggregate number of shares available for future issuance is replenished such that 800,000 shares are available.&nbsp; The 2010 Share Plan is administered by the Board of Directors or committees thereof, which determines the option price, term and provisions of each option. The exercise price with respect to all of the options granted under the 2010 Share Plan was equal to the fair market value of the underlying common stock at the grant date.&nbsp; As of October 31, 2017, the 2010 Share Plan had 69,226 shares available for future grants.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>Information regarding the 2010 Share Plan as of October 31, 2017 is as follows: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=666 bordercolor=transparent style="WIDTH:499.7pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=47% nowrap style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;Price Per Share</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% nowrap style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Aggregate<br>&nbsp;Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>&nbsp;</font><font style=COLOR:black>Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% nowrap style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding at October 31, 2015</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>526,272 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3.33 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Granted</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>557,000 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2.92 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Exercised</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(2,400)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>4.25 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;&nbsp; </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding at October 31, 2016</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,080,872 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>3.12 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Granted</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>682,000 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2.03 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Exercised</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(44,400)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>0.67 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=47% style="HEIGHT:15.75pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Forfeited</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>(81,226)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>6.20 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:16.5pt> <td width=47% style="HEIGHT:16.5pt; WIDTH:47%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding at October 31, 2017</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,637,246 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:16.5pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1.50 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:16.5pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,381,380 </font></p></td></tr> <tr style=HEIGHT:17.25pt> <td width=47% style="HEIGHT:17.25pt; WIDTH:47%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Exercisable at October 31, 2017</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:15%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>909,024 </font></p></td> <td width=2% style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right>&nbsp;</p></td> <td width=2% style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:17.25pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1.72 </font></p></td> <td width=2% style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:17.25pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=15% style="HEIGHT:17.25pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>721,433 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2017:</p> <div align=center> <table width=846 bordercolor=transparent style="WIDTH:634.85pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <td width=15% colspan=3 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Options Outstanding</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <td width=20% colspan=3 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Options Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=5 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=20% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Contractual Life (in years)</font></p></td> <td width=20% nowrap style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=15% nowrap style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=bottom> <td width=20% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Outstanding</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <td width=15% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:15%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$0.67 </font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>1,001,000</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>8.14</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$0.67 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>522,778</font></p></td> <td width=20% style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>7.09</font></p></td> <td width=20% style="HEIGHT:15.75pt; WIDTH:20%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$0.67 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$2.27 - $7.00</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>636,246</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>6.69</font></p></td> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$2.80 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <td width=15% style="HEIGHT:15.75pt; WIDTH:15%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>386,246</font></p></td> <td width=20% style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>4.62</font></p></td> <td width=20% style="HEIGHT:15.75pt; WIDTH:20%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$3.14 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>In addition to options granted under the 2003 Share Plan and the 2010 Share Plan, during the years ended October 31, 2012 and 2013, the Board of Directors approved the grant of stock options to purchase 1,660,000 shares and 120,000 shares, respectively. </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=FONT-SIZE:11pt>F-17</font></p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'><font style=FONT-SIZE:11pt>Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan for the two years ended October 31, 2017 is as follows:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=58% nowrap style="HEIGHT:15.75pt; WIDTH:58.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=2 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:14.04%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average Exercise</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Price Per Share</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.04%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Aggregate</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Intrinsic</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Value</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=58% nowrap style="HEIGHT:15.75pt; WIDTH:58.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=58% nowrap style="HEIGHT:15.75pt; WIDTH:58.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:11.04%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Shares</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.7%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15.75pt> <td width=58% style="HEIGHT:15.75pt; WIDTH:58.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15.75pt; WIDTH:12.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=11% style="HEIGHT:15.75pt; WIDTH:11.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:16.5pt> <td width=58% style="HEIGHT:16.5pt; WIDTH:58.18%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding and exercisable at <br>&nbsp;&nbsp; October 31, 2016</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:11.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,780,000</font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:16.5pt; WIDTH:12.04%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>2.70 </font></p></td> <td width=2% style="HEIGHT:16.5pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=1% style="HEIGHT:16.5pt; WIDTH:1.7%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=11% style="HEIGHT:16.5pt; WIDTH:11.04%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:17.25pt> <td width=58% style="HEIGHT:17.25pt; WIDTH:58.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>Options Outstanding and exercisable at <br>&nbsp;&nbsp; October 31, 2017</font></p></td> <td width=11% style="BORDER-TOP:0px; HEIGHT:17.25pt; BORDER-RIGHT:0px; WIDTH:11.04%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,780,000</font></p></td> <td width=2% style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=12% style="HEIGHT:17.25pt; WIDTH:12.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1.58 </font></p></td> <td width=2% style="HEIGHT:17.25pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="HEIGHT:17.25pt; WIDTH:1.7%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style=COLOR:black>$</font></p></td> <td width=11% style="HEIGHT:17.25pt; WIDTH:11.04%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style=COLOR:black>1,443,480 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The following table summarizes information about stock options outstanding and exercisable that were not granted under the 2003 Share Plan or the 2010 Share Plan as of October 31, 2017:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=4 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Remaining</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Contractual Life</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>(in years)</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=23% nowrap style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Number</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Outstanding<u> </u>and<u> </u></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercisable</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=3 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Weighted</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Average</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Price</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=23% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:23%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" rowspan=2 valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>Range of</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><font style=COLOR:black>Exercise Prices</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <tr style=HEIGHT:15.75pt> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$0.67 </font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>1,046,000</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>4.91</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center>&nbsp;</p></td> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$0.67 </font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$ 2.58 - $ 5.56</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>734,000</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>4.36</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=23% style="HEIGHT:15.75pt; WIDTH:23%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style=COLOR:black>$2.88 </font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black>&nbsp; </font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><u><font style=COLOR:black>Re-Priced Stock Options</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>On September 6, 2017 the Board of Directors re-priced 2,029,600 issued and outstanding stock options (the &#147;Re-Priced Options&#148;) for all of the officers, directors and employees of the Company.&nbsp; The new exercise price of the Re-Priced Options is $0.67, the closing sales price of the Company&#146;s common stock on September 6, 2017.&nbsp; All other terms of the previously granted Re-Priced Options remain the same.&nbsp; The Company recorded additional stock-based compensation of approximately $261,000, as of September 6, 2017, related to this re-pricing.&nbsp; This amount was determined to be the incremental value of the fair value of the Re-Priced Options compared to the fair value of the original option immediately before the re-pricing.&nbsp; Accordingly, 18,200 stock options in the 2003 Share Plan with exercise prices of $2.58, 965,400 stock options in the 2010 Share Plan with exercise prices ranging from $0.82 to $5.30 and 1,046,000 stock options that were not granted under the 2003 Share Plan or the 2010 Share plan with exercise prices of $2.58, were re-priced.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Preferred Stock</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:11pt; COLOR:black">On November 11, 2016, the holder of all our outstanding Series A Preferred Stock (the &#147;Series A Preferred&#148;) with an aggregate stated value of $3,500,000 exercised its right of redemption to receive such amount from proceeds from the sale of the Company&#146;s equity securities.&nbsp;&nbsp;On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &#147;Series A Redemption Terms&#148;). &nbsp;Pursuant to the Series A Redemption Terms, on December 9, 2016 the holder of the Series A Preferred received (i) $500,000 in cash, (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which was due on or before June 1, 2017 and the remainder of which was due November 11, 2017 (the &#147;Redemption Debenture&#148;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&#146;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing (the &#147;Redemption Warrant&#148;). The Redemption Debenture was secured by a lien on the Company&#146;s assets and prohibited the Company from incurring any senior indebtedness&nbsp;other than equipment financing in connection with the Company&#146;s business.&nbsp; The Redemption Debenture was paid in full during fiscal year 2017.&nbsp; Interest expense during the year ended October 31, 2017 in connection with the Redemption Debenture was approximately $272,000.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-18</p> <div style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style="FONT-SIZE:11pt; COLOR:black">The difference between the fair value of the consideration given to the holder of our Series A Preferred and the carrying value of the Series A Preferred represents a return to the preferred stockholder which is treated in a similar manner as that of dividends paid on preferred stock.&nbsp; In the redemption, the Series A Preferred holder received $500,000 in cash, the Redemption Debenture with a present value of approximately $2,999,000 and the Redemption Warrant with a fair value of approximately $2,801,000, determined using the Black Scholes pricing model, and waived the Series A Preferred&#146;s conversion right with an intrinsic value of approximately $792,000, resulting in total consideration given to the Series A Preferred holder of approximately $5,508,000.&nbsp; The difference between the fair value of the consideration and the $3,500,000 carrying value of the Series A Preferred resulted in a deemed dividend to the Series A Preferred holder of approximately $2,008,000.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><u>Common Stock Purchase Warrants</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:40.5pt'>As of October 31, 2017, we had warrants to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019, warrants to purchase 309,400 shares of common stock at $10.00 per share expiring on July 15, 2019 and warrants to purchase 500,000 shares of common stock at $5.03 per share expiring on November 30, 2021.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:40.5pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>COMMITMENTS AND CONTINGENCIES </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u><font style=COLOR:black>Leases</font></u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>We lease approximately 2,000 square feet of office space at 3150 Almaden Expressway, San Jose, California (our principal executive offices) from an unrelated party pursuant to a lease that expires September 30, 2019.&nbsp; Our base rent is approximately $4,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.&nbsp; We also lease approximately 3,000 square feet of office space at 12100 Wilshire Boulevard, Los Angeles, California (our former executive offices) from an unrelated party pursuant to a lease that expires May 31, 2019.&nbsp; Our base rent is approximately $11,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.&nbsp; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>During the fourth quarter of fiscal 2017 we vacated the office space at 12100 Wilshire Boulevard, Los Angeles, California and as of October 31, 2017 we have accrued an expense of approximately $84,000 related to future rents of the unused facilities.</font> &nbsp;As of October 31, 2017, our non-cancelable operating lease commitments for the years ending October 31, 2018 and 2019 were approximately $182,000 and $125,000, respectively.&nbsp; Rent expense for the years ended October 31, 2017 and 2016, was approximately $229,000 and $188,000, respectively.&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'><u>Litigation Matters</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN-LEFT:0in; TEXT-AUTOSPACE:; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in'><font style=COLOR:black>Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &nbsp;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-19</p> <div style=TEXT-ALIGN:center align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>INCOME TAXES</u>&nbsp;&nbsp;&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:'>Income tax provision (benefit) consists of the following:</p> <div align=center>&nbsp;</div> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0> <tr> <td> <td colspan=5 style="BORDER-BOTTOM:#000000 1px solid" align=center>Year Ended October 31,</td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom><font style=COLOR:black> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style=COLOR:black>2017</font></p></font></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=center><font style=COLOR:black>&nbsp;2016</font></p></td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Federal:</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Current</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>-</font></p></td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Deferred</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>(12,534,000)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>(1,631,000)</font></p></td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>State:</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Current</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>-</font></p></td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Deferred</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>(4,351,000)</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>(134,000)</font></p></td></tr> <tr style="HEIGHT:15.75pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:70%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>Adjustment to valuation allowance <br>&nbsp;&nbsp;&nbsp;&nbsp; related to net deferred tax assets</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>16,885,000</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric">&nbsp;</p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>1,765,000</font></p></td></tr> <tr style="HEIGHT:16.5pt; PAGE-BREAK-INSIDE:avoid"> <td width=70% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:70%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>-</font></p></td> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=2% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric"><font style=COLOR:black>$</font></p></td> <td width=12% nowrap style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric" align=right><font style=COLOR:black>-</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>The tax effects of temporary differences that give rise to significant portions of the deferred tax asset, net, at October 31, 2017 and 2016, are as follows:</p> <div align=center> <table width=667 bordercolor=transparent style="WIDTH:500pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:11pt; COLOR:black">2017</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=center><font style="FONT-SIZE:11pt; COLOR:black">&nbsp;2016</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Long-term deferred tax assets:</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Federal and state NOL and tax credit carryforwards</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">18,961,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">33,079,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Deferred compensation</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">3,718,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">6,232,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Intangibles</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">543,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">713,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Other</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">205,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">289,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Subtotal</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">23,427,000 </font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=12% style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">40,313,000 </font></p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=70% style="HEIGHT:15pt; WIDTH:70%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Less: valuation allowance</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">(23,427,000)</font></p></td> <td width=2% style="HEIGHT:15pt; WIDTH:2.16%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'>&nbsp;</p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">(40,313,000)</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=70% style="HEIGHT:15.75pt; WIDTH:70%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:20pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">Deferred tax asset, net</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">-</font></p></td> <td width=2% style="HEIGHT:15.75pt; WIDTH:2.16%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric'><font style="FONT-SIZE:11pt; COLOR:black">$</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:ideograph-numeric' align=right><font style="FONT-SIZE:11pt; COLOR:black">-</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>&nbsp;As of October 31, 2017, we had tax net operating loss and tax credit carryforwards of approximately $83,579,000 and $1,257,000, respectively, available within statutory limits (expiring at various dates between 2018 and 2037), to offset any future regular Federal corporate taxable income and taxes payable.&nbsp; If the tax benefits relating to deductions of option holders&#146; income are ultimately realized, those benefits will be credited directly to additional paid-in capital.&nbsp; Certain changes in stock ownership can result in a limitation on the amount of net operating loss and tax credit carryovers that can be utilized each year. As of October 31, 2017, management has not determined the extent of any such limitations, if any.</p> <p text-autospace: 0in 12pt; 0.5in? text-align: roman?,?serif?; ; new margin: text-indent: style="FONT-SIZE:12pt; FONT-FAMILY:" times justify; align=justify><font style='FONT-FAMILY:"Times New Roman","serif"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As a result of the change in future Federal statutory tax rates due to the passing of the Tax Cuts and Jobs Act of 2017, management has determined that the deferred tax assets and liabilities should no longer be valued at a federal statutory rate of 34% but rather at the rate in which the benefit of the deferred tax asset or liability will be realized by the Company.&nbsp; As such, the Federal statutory rate used to value the Company's deferred tax assets and liabilities is 21%.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'><font style=COLOR:black>We had New York&nbsp;and&nbsp;California tax net operating loss carryforwards of approximately $72,483,000 and&nbsp;$9,656,000, respectively,&nbsp;as of October 31, 2017, available within statutory limits (expiring at various dates between 2018 and 2037), to offset future corporate taxable income and taxes payable, if any, under certain computations of such taxes.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-20</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b><font style=FONT-SIZE:9pt> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font></b></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><a href=#(TOC)><font color=#0066cc>Table of Contents</font></a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center><b>ITUS CORPORATION AND SUBSIDIARIES<br></b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>We have provided a valuation allowance against our deferred tax asset due to our current and historical pre-tax losses and the uncertainty regarding their realizability.&nbsp; The primary differences from the Federal statutory rate of 34% and the effective rate of 0% is attributable to certain permanent differences and a change in the valuation allowance.&nbsp; The following is a reconciliation of income taxes at the Federal statutory tax rate to income tax expense (benefit):</p> <div align=center> <table width=666 bordercolor=transparent style="WIDTH:499.7pt; BORDER-COLLAPSE:collapse" cellpadding=0 cellspacing=0 align=center> <tr style=HEIGHT:15.75pt> <td width=42% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% colspan=9 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Year Ended October 31,</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=42% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% colspan=4 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>2017</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% colspan=4 style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>&nbsp;2016</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=42% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Income tax benefit at U.S. <br>&nbsp; Federal statutory income <br>&nbsp; Tax rate</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(1,703,000)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(34.0%)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(1,706,000)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(34.0%)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=42% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>State income taxes</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(443,000)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(8.84%)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(411,000)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(8.2%)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=42% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Permanent differences</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(10,000)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(0.20%)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>2,000 </font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>0.1%</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=42% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Expiring net operating <br>&nbsp;&nbsp; losses, credits and other</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-&nbsp;</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>350,000 </font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>7.0%</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=42% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Rate Changes</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>19,041,000</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>380.13%</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=42% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Change in valuation <br>&nbsp;&nbsp; allowance</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(16,885,000) </font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>(337.09%)</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>1,765,000 </font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>&nbsp;</font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>35.1%</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr> <tr style=HEIGHT:16.5pt> <td width=42% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:42%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Income tax provision</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>0.0%</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>$</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>-</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td> <td width=2% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <td width=12% style="BORDER-TOP:0px; HEIGHT:16.5pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal" align=right><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>0.0%</font><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'></font></p></td></tr></table></div> <div align=center>&nbsp;</div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in'>During the two fiscal years ended October 31, 2017, we incurred no Federal and no State income taxes.&nbsp; We have no unrecognized tax benefits as of October 31, 2017 and 2016 and we account for interest and penalties related to income tax matters in marketing, general and administrative expenses.&nbsp; Tax years to which our net operating losses relate remain open to examination by Federal authorities and other jurisdictions to the extent which the net operating losses have yet to be utilized.</p></div> <div style=page:WordSection8> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:' align=center>F-21</p></div></body>
<!-- EDGAR Validation Code: ADE83BC1 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>2
<FILENAME>exhibit10_14.htm
<DESCRIPTION>EXHIBIT 10.14
<TEXT>
<HTML>
<head><title>Exhibit 10.14</title> </head> <body vlink=purple link=blue lang=EN-US> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; page:WordSection1' align=right><b>Exhibit 10.14</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; page:WordSection1' align=right>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection1' align=center><b>Confidential Treatment Requested by ITUS Corporation,</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection1' align=center><b>IRS Employer Identification No. 11-2622630</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection1' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection1' align=center><b>***CONFIDENTIAL TREATMENT REQUESTED*** </b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; page:WordSection1' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection1'>Note: Confidential treatment requested with respect to certain portions hereof denoted with &#147;[***]&#148;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection1'>LICENSE AGREEMENT</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>This <font style=TEXT-TRANSFORM:uppercase>LICENSE AGREEMENT</font> (the &#147;<u>Agreement</u>&#148;) Is made as of the 13<sup>th</sup> day of November, 2017 (the &#147;<u>Effective Date</u>&#148;), by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a nonprofit corporation organized and existing under the laws of the Commonwealth of Pennsylvania located at 3601 Spruce Street, Philadelphia, PA 19104 (&#147;<u>Wistar</u>&#148;), and Certainty Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware with principal offices located at 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (&#147;<u>Company</u>&#148;). </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; page:WordSection1'>BACKGROUND</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>WHEREAS, Wistar owns or controls certain intellectual property as specifically described in Schedule I attached hereto and incorporated herein by reference (as further defined hereinafter, the &#147;<u>Licensed Patents</u>&#148;); </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>WHEREAS, Company is a majority owned corporation of ITUS Corporation, a corporation organized and existing under the laws of the State of Delaware with a principal place of business located at 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (&#147;<u>ITUS</u>&#148;); </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>WHEREAS, Wistar and ITUS entered into an exclusive option agreement on May 18, 2017 granting ITUS a period of time in which to <b>(i)</b> evaluate the Licensed Patents, potential products arising therefrom and markets therefor and <b>(ii)</b> elect to negotiate a license with Wistar for the use of the Licensed Patents (the &#147;<u>Option</u>&#148;);</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>WHEREAS, in accordance with the terms and conditions set forth in the Option, Company wishes to enter into an exclusive license agreement granting to Company certain rights in and to the Licensed Patents;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>WHEREAS, Company is capable of and committed to developing and commercializing products utilizing such rights; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>WHEREAS, concurrent with the execution of this Agreement, Wistar will be receiving an equity interest in the Company; and</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> <p align=center>1 <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </p> <p style=page:WordSection1 /> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>WHEREAS, Wistar is willing to grant such a license to Company, in consideration of Company&#146;s satisfaction of its obligations hereunder, and for other good and valuable consideration as set forth herein.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, and intending to be legally bound hereby, the parties hereto agree as follows:</p> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037533><a name=_Toc474936073><a name=_Toc474935649><a name=_Toc474935255><a name=_Toc474935091><a name=_Toc474934955><a name=_Ref443022537><a name=_Toc382253456><a name=_Toc382253426><a name=_Toc382236781><a name=_Toc382236241><a name=_Toc382235971><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Article 1 - </font>DEFINITIONS</a></h1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>The following terms, as used herein, shall have the following meanings: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236782><a name=_Toc382236242><a name=_Toc382235972><b>1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Affiliate</u>&#148; means, when used with reference to a Person, any Person directly or indirectly controlling, controlled by or under common control with, such Person.&nbsp; For the purposes of this definition, &#147;control&#148; means the direct or indirect ownership of over fifty percent (50%) of the outstanding voting securities of a Person, or the right to receive over fifty percent (50%) of the profits or earnings of a Person, or the ability to control the decisions of a Person</a><a name=_Toc381818710><a name=_Toc381818781><a name=_Toc381818865>.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236783><a name=_Toc382236243><a name=_Toc382235973><b>1.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Agreement</u>&#148; has the meaning set forth in the Preamble.</a><a name=_Toc381818711><a name=_Toc381818782><a name=_Toc381818866>&nbsp; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236784><a name=_Toc382236244><a name=_Toc382235974><b>1.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Anti-Corruption Laws</u>&#148; shall mean any anti-bribery and anti-corruption laws, rules, regulations applicable to a party under this Agreement (each as amended from time to time) including the Prevention of Corruption Act (cap.241) of Singapore, the U.S. Anti-Kickback Law, U.S. Foreign Corrupt Practices Act, the UK Bribery Act 2010 and the OECD Convention Against the Bribery of Foreign Government Officials in International Business Transactions, together with any applicable implementing legislation, including any applicable local law addressing bribery or corruption.</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Bankruptcy Event</u>&#148; means, with respect to any Person, any of the following:<a name=_Toc381818712><a name=_Toc381818783><a name=_Toc381818867></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>such Person shall commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any substantial part of its property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a general assignment for the benefit of creditors, or shall fail generally to pay its debts as they become due, or shall take any corporate action to authorize any of the foregoing;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>an involuntary case or other proceeding shall be commenced against such Person seeking liquidation, reorganization or other relief with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it or any substantial part of its property, and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of sixty (60) days; or an order for relief shall be entered against such Person under the federal bankruptcy laws as now or hereafter in effect; or</p> <p align=center>2 <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>a receiver or trustee shall be appointed with respect to such Person or all or substantially all of the assets of such Person.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236785><a name=_Toc382236245><a name=_Toc382235975><b>1.5.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Bar Date</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>7.1.1.<a name=_Toc381818713><a name=_Toc381818784><a name=_Toc381818868></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236786><a name=_Toc382236246><a name=_Toc382235976><b>1.6.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Calendar Quarter</u>&#148; means each three (3) month period, or any portion thereof, beginning on January 1, April 1, July 1 and October 1 of each year.</a><a name=_Toc381818714><a name=_Toc381818785><a name=_Toc381818869><a name=_Toc381818715><a name=_Toc381818786><a name=_Toc381818870></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236788><a name=_Toc382236248><a name=_Toc382235978><a name=_Toc381818716><a name=_Toc381818787><a name=_Toc381818871><b>1.7.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Clinical Trials</u>&#148; means any administration of Licensed Products to humans for the purpose of demonstrating the safety or efficacy of the Licensed Product.<a name=_Toc381818717><a name=_Toc381818788><a name=_Toc381818872> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236789><a name=_Toc382236249><a name=_Toc382235979><b>1.8.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Commercialization Plan</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>4.2.1.<a name=_Toc381818718><a name=_Toc381818789><a name=_Toc381818873></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236790><a name=_Toc382236250><a name=_Toc382235980><b>1.9.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Company</u>&#148; has the meaning set forth in the Preamble.</a><a name=_Toc381818719><a name=_Toc381818790><a name=_Toc381818874></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236791><a name=_Toc382236251><a name=_Toc382235981><b>1.10.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Company Confidential Information</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>8.1.1.<a name=_Toc381818720><a name=_Toc381818791><a name=_Toc381818875> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236792><a name=_Toc382236252><a name=_Toc382235982><b>1.11.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Company IP</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>9.6(iii).<a name=_Toc381818721><a name=_Toc381818792><a name=_Toc381818876></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236793><a name=_Toc382236253><a name=_Toc382235983><b>1.12.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Confidential Information</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>8.1.1.<a name=_Toc381818722><a name=_Toc381818793><a name=_Toc381818877></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236794><a name=_Toc382236254><a name=_Toc382235984><b>1.13.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Control</u>&#148; or &#147;<u>Controlled</u>&#148; means, with respect to the Licensed Technical Information, possession of the ability (whether by sole, joint or other ownership interest, license or otherwise, other than pursuant to this Agreement) to, without violating the terms of any agreement with a third party, grant a license or sublicense or provide access or other rights in, to or under such Licensed Technical Information.</a><a name=_Toc381818723><a name=_Toc381818794><a name=_Toc381818878> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236795><a name=_Toc382236255><a name=_Toc382235985><b>1.14.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&nbsp;</a><a name=_Toc382236796><a name=_Toc382236256><a name=_Toc382235986><a name=_Toc381818724><a name=_Toc381818795><a name=_Toc381818879>&#147;<u>Dilution Protection Cap</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>3.1.2(ii).</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.15.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Documentation and Approvals</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>9.6(i).<a name=_Toc381818725><a name=_Toc381818796><a name=_Toc381818880></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236797><a name=_Toc382236257><a name=_Toc382235987><b>1.16.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>EAR</u>&#148; or &#147;<u>Export Administration Regulations</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>4.5.2.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.17.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Effective Date</u>&#148; has the meaning set forth in the Preamble.<a name=_Toc381818726><a name=_Toc381818797><a name=_Toc381818881></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236798><a name=_Toc382236258><a name=_Toc382235988><b>1.18.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&nbsp;&#147;<u>Equity Securities</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>1.1.3.1.2(v) </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.19.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>First Commercial Sale</u>&#148; means the first sale, transfer, disposition, performance, or practice for value of a Licensed Product<a name=_Toc381818727><a name=_Toc381818798><a name=_Toc381818882>.</a></p> <p align=center>3 <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> &nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236800><a name=_Toc382236260><a name=_Toc382235990><b>1.20.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Fully Diluted Capitalization</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>3.1.2(i).</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.21.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Funding Agency Interest</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>2.2.2.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.22.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>IND Filing</u>&#148; means the preparation and filing of a &#147;Notice of Claimed Investigational Exemption for a New Drug&#148; with the U.S. Food and Drug Administration (FDA), or any comparable filing in a foreign jurisdiction.<a name=_Toc381818729><a name=_Toc381818800><a name=_Toc381818884></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236801><a name=_Toc382236261><a name=_Toc382235991><b>1.23.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Indemnified Party</u>&#148; and &#147;<u>Indemnified Parties</u>&#148; have the meaning set forth in Section </a>6.3.<a name=_Toc381818730><a name=_Toc381818801><a name=_Toc381818885></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236802><a name=_Toc382236262><a name=_Toc382235992><b>1.24.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>ITAR</u>&#148; or &#147;<u>International Traffic in Arms Regulations</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>4.5.2.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.25.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Liability</u>&#148; and &#147;<u>Liabilities</u>&#148; have the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>6.2.<a name=_Toc381818731><a name=_Toc381818802><a name=_Toc381818886></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236804><a name=_Toc382236264><a name=_Toc382235994><a name=_Toc381818732><a name=_Toc381818803><a name=_Toc381818887><b>1.26.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Licensed Field</u>&#148; means chimeric endocrine receptor targeted therapy for any human therapeutic and diagnostic use. <a name=_Toc381818733><a name=_Toc381818804><a name=_Toc381818888></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236805><a name=_Toc382236265><a name=_Toc382235995><a name=_Ref381863733><b>1.27.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Licensed Patents</u>&#148; means <b>(i)</b> the patent applications set forth on </a>Schedule I hereto, <b>(ii)</b> all patents issuing from such applications, <b>(iii)</b> all continuations, continuations-in-part, additions, divisions, renewals, extensions, reexaminations and reissues of any of the foregoing, that claim the benefit of priority to the applications or patents referenced in (i) or (ii) hereof, and <b>(iv)</b>any patents in the Territory issuing from any applications filed after the Effective Date from which any of the patents or patent applications identified in (i), (ii), or (iii) claim priority.<a name=_Toc381818734><a name=_Toc381818805><a name=_Toc381818889></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236806><a name=_Toc382236266><a name=_Toc382235996><a name=_Ref381834973><b>1.28.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Licensed Products</u>&#148; means:</a> <a name=_Toc381818735><a name=_Toc381818806><a name=_Toc381818890></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>any product, the making, using, selling, offering for sale, or importing of which product would (without the license granted under this Agreement) infringe at least one pending Valid Claim (were it to have issued) or issued Valid Claim of the Licensed Patents in any country;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>any service, process or method, the performing or providing of which process or method would (without the license granted under this Agreement) infringe at least one pending Valid Claim (were it to have issued) or issued Valid Claim of the Licensed Patents in any country; and</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>any product or process that is not covered by the foregoing clauses (i) or (ii), but that uses, incorporates or is made, identified, developed, optimized, characterized, selected, derived or determined to have utility, in whole or in part, by the use or modification of <b>(a)</b> any Licensed Patent or any technology or invention covered thereby, <b>(b)</b> any Licensed Technical Information, or <b>(c)</b> any Licensed Product covered by the foregoing clauses (i) or (ii) or (iii). </p> <p align=center>4 <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236807><a name=_Toc382236267><a name=_Toc382235997><a name=_Toc382236828><a name=_Toc382236288><a name=_Toc382236018><b>1.29.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;Licensed Technical Information&#148; </a>means technical information, know-how, protocols, data, techniques and other information that are not generally known laboratory techniques that pertain to the Licensed Patents and are necessary in the manufacture, sale, or use of the Licensed Products (i) made or developed by Dr. Jose Conejo-Garcia or laboratory personnel working directly under his supervision at &nbsp;Wistar, (ii) owned and Controlled by Wistar, and (iii) in Wistar&#146;s possession as of the Effective Date.&nbsp; Licensed Technical Information shall exclude any of the foregoing information that is included in the written description of any of the Licensed Patents or any other patents or patent applications and shall also exclude (i) information that the Company can demonstrate by documentation: (a) was already known without restriction on use or disclosure prior to receipt of such information directly or indirectly from or on behalf of Wistar; (b) was or is independently developed without reference to or use of any of the Licensed Technical Information; (c) was or becomes generally known by the public other than by breach of this Agreement by Company, or other wrongful act of, Company; or (d) was received by Company from a third party who was not, at the time of receipt, under any obligation to Wistar or any other person to maintain the confidentiality of such information.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.30.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Minimum Annual Royalties</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>3.4.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.31.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Net Sales</u>&#148; means for each Licensed Product for any period, the gross amount actually collected by Company, its Affiliates and Sublicensees from third parties or end users for such Licensed Product including consideration in addition to cash less the following deductions: <b>(i)</b> customary trade, quantity and cash discounts actually allowed for Licensed Products, <b>(ii)</b> taxes levied on sale or transportation of Licensed Products and paid by or on behalf of Company, its Affiliates, or Sublicensees, and <b>(iii)</b> freight allowances, insurance and custom duties for Licensed Products.&nbsp; In the case of a sale or other transfer of a Licensed Product for which Company or a Sublicensee does not bill, Net Sales shall mean the amount received by Company and Sublicensees for the sale of such Licensed Product.&nbsp; If a Licensed Product is sold or otherwise transferred for consideration other than solely cash (whether or not at a discount), or if Licensed Product is billed or otherwise sold at a discounted price that is substantially lower than the customary prices charged by Company or Sublicensee, Net Sales shall mean what is actually received by the Company or Sublicensee in cash or other non-cash consideration, such non-cash consideration shall be calculated based on the fair market value of the consideration received.<a name=_Toc381818736><a name=_Toc381818807><a name=_Toc381818891></p> <p align=center>5 <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236808><a name=_Toc382236268><a name=_Toc382235998><b>1.32.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Non-Royalty Sublicensing </u></a><a name=_Toc381818737><a name=_Toc381818808><a name=_Toc381818892><u>Income&#148;</u> means the fair market value of any and all consideration received by Company and its Affiliates from Sublicensees (or which Company is entitled to receive, whether or not offset against amounts payable to Sublicensee under the Sublicense) under or otherwise in connection with its Sublicenses, including license issue fees, lump sum payments and other licensing fees, option fees, milestone payments, minimum annual royalties, distribution fees, joint marketing fees, equity or other payments of any kind whatsoever, irrespective of whether such consideration is received in the form of cash, barter, credit, stock, warrants, release from debt, goods or services, licenses back, a premium on the sale of equity (i.e., payments for equity that exceed the pre-Sublicense fair market value of the equity), equity exchanges, or any other form whatsoever.&nbsp; Notwithstanding the foregoing, Non-Royalty Sublicensing Income specifically excludes:&nbsp; (i) royalties on Net Sales pursuant to Section <font style=FONT-SIZE:10pt lang=AR-SA></font>3.2; and (ii) payments made by Sublicensee as consideration for the issuance of equity or debt securities of Company at the pre-Sublicense fair market value, provided that if a Sublicensee pays more than such fair market value for equity or debt securities then the portion in excess of fair market value shall be considered Non-Royalty Sublicensing Income and (iii) payments to Company for the purposes of funding the costs of future bona fide documented research of a Licensed Product to be conducted by the Company and (iv) payments received directly for Patenting Costs. For the purposes of Non-Royalty Sublicensing Income, the term &#147;fair market value&#148; means the cash consideration which Company, its Affiliates or any Sublicensees would realize from an unaffiliated, unrelated buyer in an arm&#146;s length sale of an identical item sold in the same quantity and at the same time and place of the transaction. Non-Royalty Sublicensing Income that is a percentage of milestone payments received by Company from a Sublicensee shall be available for credit against miles tone payments payable to Wistar by Company under Section 3.7.</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236809><a name=_Toc382236269><a name=_Toc382235999><b>1.33.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>OFAC</u>&#148; or &#147;<u>Office of Foreign Assets Control</u>&#148; has the meaning set forth in Section </a>4.5.2.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.34.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Option</u>&#148; has the meaning set forth in the Background. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.35.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Past Patenting Costs</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>7.1.1.<a name=_Toc381818738><a name=_Toc381818809><a name=_Toc381818893></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236810><a name=_Toc382236270><a name=_Toc382236000><b>1.36.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Patent Challenge</u>&#148; means any direct or indirect dispute, challenge, or assistance in the challenge of the validity, patentability, scope, construction, enforceability, non-infringe&shy;ment or Wistar&#146;s ownership of any issued patent comprising the Licensed Patents or any claims thereof, or opposition or assistance in the opposition of the grant of any letters patent comprising the Licensed Patents, in any legal or, administrative proceedings, including in a court of law, before the United States Patent and Trademark Office or other agency or tribunal in any jurisdiction, or in arbitration.</a><a name=_Toc381818739><a name=_Toc381818810><a name=_Toc381818894></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236811><a name=_Toc382236271><a name=_Toc382236001><b>1.37.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Patent Term Extension</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>0.<a name=_Toc381818740><a name=_Toc381818811><a name=_Toc381818895></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236814><a name=_Toc382236274><a name=_Toc382236004><b>1.38.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Patenting Costs</u>&#148; means any past or ongoing costs incurred or to be incurred, including government fees and attorneys&#146; fees, in the course of Prosecuting the Licensed Patents.</a><a name=_Toc381818743><a name=_Toc381818814><a name=_Toc381818898></p> <p align=center>6<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236815><a name=_Toc382236275><a name=_Toc382236005><b>1.39.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Performance Milestone(s)</u>&#148; has the meaning set forth in Section </a>4.2.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.40.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Performance Milestone Dates</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>4.2. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.41.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Performance Milestone Extension Fee</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>4.3.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.42.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Person</u>&#148; or &#147;<u>Persons</u>&#148; means any corporation, partnership, joint venture or any other entity or any natural person.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.43.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Proposed Product</u>&#148; means an actual or potential Licensed Product that is for an application, product, sub-field or indication in the Licensed Field, but for which a Licensed Product is not being actively developed or commercialized by Company, its Affiliates or Sublicensees.<a name=_Toc381818744><a name=_Toc381818815><a name=_Toc381818899> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236816><a name=_Toc382236276><a name=_Toc382236006><b>1.44.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Proposed Product Election Notice</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>2.5.2.<a name=_Toc381818745><a name=_Toc381818816><a name=_Toc381818900></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236817><a name=_Toc382236277><a name=_Toc382236007><b>1.45.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Proposed Product Notice</u>&#148; has the meaning set forth in Section </a>2.5.1.<a name=_Toc381818746><a name=_Toc381818817><a name=_Toc381818901></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236818><a name=_Toc382236278><a name=_Toc382236008><b>1.46.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&nbsp;&#147;<u>Proposed Product Sublicense</u>&#148; </a><a name=_Toc381818747><a name=_Toc381818818><a name=_Toc381818902>has the meaning set forth in Section 2.5.4.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236819><a name=_Toc382236279><a name=_Toc382236009><b>1.47.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Proposing Third Party</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>2.5.1. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236820><a name=_Toc382236280><a name=_Toc382236010><b>1.48.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Prosecution</u>&#148; or &#147;<u>Prosecuting</u>&#148; means preparation, filing, prosecution, issuance and maintenance of the Licensed Patents, including continuations, continuations-in-part, divisionals, extensions, re-examinations, reissues, supplemental examination, appeals, interferences, derivation proceedings, oppositions, all other proceedings before the United States Patent and Trademark Office (including the Patent Trial and Appeal Board) and foreign patent offices, and any judicial or other appeals of the foregoing.</a><a name=_Toc381818748><a name=_Toc381818819><a name=_Toc381818903> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236822><a name=_Toc382236282><a name=_Toc382236012><b>1.49.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Qualified Sublicensee</u>&#148; means a Sublicensee with <b>(a)</b> specific experience in the Licensed Field and <b>(b)</b> sufficient human and financial resources to develop and commercialize Licensed Products in the Licensed Field.</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.50.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Regulatory Approval</u>&#148; means, with respect to any jurisdiction, any and all approvals (including appropriate pricing and reimbursement approvals), product and/or establishment licenses, registrations or authorizations of any appropriate regulatory agency, department, bureau or other governmental entity, necessary for marketing a Licensed Product in such jurisdiction, as applicable. <a name=_Toc382236823><a name=_Toc382236283><a name=_Toc382236013><a name=_Toc381818750><a name=_Toc381818821><a name=_Toc381818905></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.51.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Royalty Term</u>&#148; has the meaning set forth in Section <a name=_Toc381818751><a name=_Toc381818822><a name=_Toc381818906><font style=FONT-SIZE:10pt lang=AR-SA></font>3.3.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236824><a name=_Toc382236284><a name=_Toc382236014><b>1.52.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Shares</u>&#148; has the meaning set forth in Section </a>3.1.2(i).</p> <p align=center>7<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.53.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Sublicense</u>&#148; means an agreement in which Company <b>(i)</b> grants or otherwise transfers any of the rights licensed to Company hereunder or other rights that are relevant to designing, developing, testing, making, using, selling, importation, exporting or distribution of Licensed Products in the Territory, <b>(ii)</b> agrees not to assert such rights or to sue, prevent or seek a legal remedy for the practice of same, or <b>(iii)</b> is under an obligation to grant, assign or transfer any such rights or non-assertion, or to forebear from granting or transferring such rights to any other entity, including by means of an option.&nbsp; Agreements expressly considered Sublicenses include licenses, option agreements, &#147;lock up&#148; agreements, right of first refusal agreements, non-assertion agreements, covenants not to sue, distribution agreements research and development agreements or similar agreements.&nbsp; For the avoidance of doubt, any Proposed Product Sublicense shall be a Sublicense as such term is used hereunder. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236825><a name=_Toc382236285><a name=_Toc382236015><b>1.54.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Sublicensee</u>&#148; means any non-Affiliate third party to which Company has granted a Sublicense.</a><a name=_Toc381818753><a name=_Toc381818824><a name=_Toc381818908></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236829><a name=_Toc382236289><a name=_Toc382236019><a name=_Toc381818754><a name=_Toc381818825><a name=_Toc381818909><a name=_Toc381818755><a name=_Toc381818826><a name=_Toc381818910><b>1.55.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Term</u>&#148; means the term of this Agreement, which shall commence on the Effective Date and shall remain in effect until the expiration of the Royalty Term in all countries in the Territory with respect to all Licensed Products, unless earlier terminated in accordance with the provisions of this Agreement.<a name=_Toc381818757><a name=_Toc381818828><a name=_Toc381818912></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236830><a name=_Toc382236290><a name=_Toc382236020><b>1.56.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Territory</u>&#148; means </a>the world.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236831><a name=_Toc382236291><a name=_Toc382236021><b>1.57.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&nbsp;&#147;<u>Third Party Payment(s)</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>3.2.2.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b>1.58.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&nbsp;&#147;<u>Third Party Proposed Product</u>&#148; has the meaning set forth in Section <font style=FONT-SIZE:10pt lang=AR-SA></font>2.5.1. <a name=_Toc381818758><a name=_Toc381818829><a name=_Toc381818913></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236832><a name=_Toc382236292><a name=_Toc382236022><b>1.59.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Valid Claim</u>&#148; means a claim of <b>(i)</b> a patent application included in the Licensed Patents that has been neither abandoned nor pending for more than ten (10) years or <b>(ii)</b> an issued Licensed Patent that has not been withdrawn, canceled or disclaimed or held invalid by a court or governmental authority of competent jurisdiction in an unappealed or unappealable decision no longer subject to discretionary review (for example, by way of writ of certiorari) or other review.</a><a name=_Toc381818759><a name=_Toc381818830><a name=_Toc381818914></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236833><a name=_Toc382236293><a name=_Toc382236023><b>1.60.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Wistar</u>&#148; has the meaning set forth in the Preamble.</a><a name=_Toc381818760><a name=_Toc381818831><a name=_Toc381818915></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236834><a name=_Toc382236294><a name=_Toc382236024><b>1.61.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Wistar Confidential Information</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>8.1.1.<a name=_Toc381818761><a name=_Toc381818832><a name=_Toc381818916></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236835><a name=_Toc382236295><a name=_Toc382236025><b>1.62.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Wistar Proposed Product</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>2.5.1.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 40.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236836><a name=_Toc382236296><a name=_Toc382236026><b>1.63.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Withholding Taxes</u>&#148; has the meaning set forth in Section </a><font style=FONT-SIZE:10pt lang=AR-SA></font>3.9.3. <a name=_Toc381818762><a name=_Toc381818833><a name=_Toc381818917></p> <p align=center>8<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037534><a name=_Toc474936074><a name=_Toc474935650><a name=_Toc474935256><a name=_Toc474935092><a name=_Toc474934956><a name=_Toc382253457><a name=_Toc382253427><a name=_Toc382236837><a name=_Toc382236297><a name=_Ref381833637><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'></font>Article 2 - </font>GRANT OF LICENSE</a></h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934957><a name=_Toc475037535><a name=_Toc474936075><a name=_Toc474935651><a name=_Toc474935257><a name=_Toc381818764><a name=_Toc381818835><a name=_Toc381818919><a name=_Toc381818950><a name=_Toc381818962><a name=_Toc381819054><a name=_Toc381819135><a name=_Toc381819163><b><font style=TEXT-DECORATION:none>2.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Grant of License</u><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236839><a name=_Ref381834930><b>2.1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Subject to the terms and conditions contained in this Agreement, Wistar hereby grants to Company an exclusive, royalty-bearing, transferable (as permitted under Section </a><b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>10.1), sublicensable (as permitted under Section <b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>2.4) license under the Licensed Patents and the Licensed Technical Information (such rights are unencumbered and available for licensing), solely to develop, make, have made, use, sell, offer for sale, export, and import the Licensed Products in the Licensed Field in the Territory during the Term.&nbsp; </h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934958><a name=_Toc475037536><a name=_Toc474936076><a name=_Toc474935652><a name=_Toc474935258><a name=_Toc381818765><a name=_Toc381818837><a name=_Toc381818921><a name=_Toc381818951><a name=_Toc381818963><a name=_Toc381819055><a name=_Toc381819136><a name=_Toc381819164><b><font style=TEXT-DECORATION:none>2.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Retained Rights</u><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236841><a name=_Ref491967469><b>2.2.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>Reservation by Wistar</u>.&nbsp; Notwithstanding anything to the contrary in this Agreement, Wistar reserves the right to <b>(i)</b> make, use,&nbsp; practice and further develop the Licensed Patents and Licensed Technical Information for non-commercial, educational and research purposes; <b>(ii)</b> grant to any academic, government, research or non-profit institution or organization the right to make, use and practice the Licensed Patents and Licensed Technical Information for non-commercial research and educational purposes; <b>(iii)</b> grant licenses under the Licensed Patents and Licensed Technical Information to any party for any field, product, service or territory other than the Licensed Products in the Licensed Field in the Territory for so long as Company has an exclusive license to the Licensed Patents and Licensed Technical Information for Licensed Products in the Licensed Field in the Territory.&nbsp; Wistar&#146;s reserved rights in research conducted pursuant to another bona fide collaborative research agreement (CRA) or similar contract between Wistar and Company shall be governed by the terms and conditions of such CRA or similar contract, as the case may be.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref381834552><a name=_Toc382236842><b>2.2.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>Funding Agency Interest</u>.&nbsp; Notwithstanding anything to the contrary in this Agreement, any and all licenses and other rights granted hereunder are limited by and subject to the rights and requirements of <b>(a)</b> the U.S. Government under any law or agreement, including rights and requirements which may attach as a result of U.S. Government sponsorship of research in connection with which an invention covered by the Licensed Patents was conceived or first actually reduced to practice, as set forth in 35 U.S.C. &#167;&#167;200-212, and 37 C.F.R. Part 401, or any successor statutes or regulations, and in relevant U.S. Government research grants or contracts with Wistar, as such rights and requirements may be amended or modified by law, rule or regulation, and <b>(b)</b> any local, state or philanthropic funding agencies or entities in inventions funded in whole or in part under any contract, grant or similar agreement with such agency or entity (collectively, the &#147;<u>Funding Agency Interest</u>&#148;). Such rights and requirements include <b>(i)</b> the grant of a nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the United States Government any of the Licensed Patents throughout the world (as set forth in 35 U.S.C. &#167;202(c)(4)), and <b>(ii)</b> the requirement that Licensed Products used or sold in the U.S. shall be manufactured substantially in the U.S. (as set forth in 35 U.S.C. &#167;204).</a>&nbsp; </h3> <p align=center>9<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref475017091><a name=_Ref474938873><a name=_Toc474934959><a name=_Toc475037537><a name=_Toc474936077><a name=_Toc474935653><a name=_Toc474935259><b><font style=TEXT-DECORATION:none>2.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>No Rights or Licenses by Implication</u></a><font style=TEXT-DECORATION:none>.&nbsp; No rights or licenses with respect to the Licensed Patents, Licensed Technical Information, or otherwise are granted or deemed granted hereunder or in connection herewith, other than those rights or licenses expressly granted in this Agreement.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967074><a name=_Ref474956000><a name=_Ref474939778><a name=_Ref474938997><a name=_Toc474934960><a name=_Toc475037538><a name=_Toc474936078><a name=_Toc474935654><a name=_Toc474935260><b><font style=TEXT-DECORATION:none>2.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Right to Sublicense</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall have the right to sublicense to any third party the rights conferred upon Company under this Agreement, subject to the following conditions:</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236845><b>2.4.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall provide </a><b>*** </b>written notice to Wistar prior to the effective date of any Sublicense. </h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>2.4.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b>***<i><u> </u></i></b></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236846><b>2.4.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>2.4.3Any Sublicense shall be in writing, shall be consistent with all of the terms and conditions of this Agreement, and shall incorporate terms and conditions sufficient to enable Company to comply with this Agreement. Without limiting the foregoing, each Sublicense shall </a><b>***.</b> <a name=_Toc382236847>Subject to Sections 2.4.2 and 2.4.3, Sublicensees shall be permitted to sublicense further any of their rights under any Sublicense.&nbsp; Each Sublicense shall contain an agreement and acknowledgment by the Sublicensee that such Sublicense and the Sublicensee are subject to the terms and conditions of the license granted to Company under this Agreement.</a>&nbsp; </h3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection1'>&nbsp;</p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236848><b>2.4.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Notwithstanding any Sublicense, Company shall remain primarily liable to Wistar for all of Company&#146;s duties and obligations contained in this Agreement, and any act or omission of a Sublicensee which would be a breach of this Agreement if performed by Company shall be deemed to be a breach by Company of this Agreement.</a> </h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>2.4.5.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b>***</b></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref474923245><a name=_Toc382236850><b>2.4.6.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>If Company becomes subject to a Bankruptcy Event, all payments then or thereafter due and owing to Company from its Sublicensees shall thereupon, and without any notice from Wistar to any such Sublicensee, become payable directly to Wistar for the account of Company; <i>provided</i>, <i>however</i>, that Wistar shall remit to Company any amount by which such payments exceed the amounts owed by Company to Wistar. </a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>2.4.7.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Wistar shall have the right to require any Sublicensee, as a condition for effectiveness of a Sublicense, to enter into an agreement with Wistar providing for the redirection of payments to Wistar as provided in Section <b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>2.4.6 in the event that Company becomes subject to a Bankruptcy Event and/or acknowledging that the Sublicense is terminated in the event of any termination of this Agreement, expect as otherwise provided in Section <b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>9.4.</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236851><b>2.4.8.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall furnish Wistar with a fully executed copy of any Sublicense agreement within thirty (30) days after execution without redaction.</a>&nbsp; </h3> <p align=center>10<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236852><b>2.4.9.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Any sublicense that is not in compliance with any of the provisions of this Section </a><b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>2.4 shall be void.</h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934961><a name=_Toc475037539><a name=_Toc474936079><a name=_Toc474935655><a name=_Toc474935261><b><font style=TEXT-DECORATION:none>2.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Wistar or Third Party Proposed Products</u></a><font style=TEXT-DECORATION:none>.</font><a name=_Toc381818768><a name=_Toc381818848><a name=_Toc381818932><a name=_Toc381818954><a name=_Toc381818966><a name=_Toc381819058><a name=_Toc381819139><a name=_Toc381819167></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>2.5.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b>***</b></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>2.5.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b>***</b></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>2.5.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b>***<i><u> </u></i></b></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236858><a name=_Ref382227239><a name=_Ref381834714><b>2.5.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><b>***</b></a></h3> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037541><a name=_Toc474936081><a name=_Toc474935657><a name=_Toc474935263><a name=_Toc474935093><a name=_Toc474934963><a name=_Toc382253458><a name=_Toc382253428><a name=_Toc382236865><a name=_Toc382236305><a name=_Ref381833598><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'> </font>Article 3 - </font>PAYMEN</a>TS</h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref475016867><a name=_Ref475016809><a name=_Ref475016406><a name=_Ref475016396><a name=_Ref475015992><a name=_Ref475015976><a name=_Ref474940065><a name=_Ref474939944><a name=_Ref474939676><a name=_Ref474939535><a name=_Ref474939179><a name=_Toc474934964><a name=_Toc475037542><a name=_Toc474936082><a name=_Toc474935658><a name=_Toc474935264><a name=_Ref491781914><a name=_Toc479090211><b><font style=TEXT-DECORATION:none>3.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Compensation</u></a><font style=TEXT-DECORATION:none>.</font><font style=TEXT-DECORATION:none>&nbsp; </font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:left; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1' align=left><a name=_Ref479161040><a name=_Ref491773098><b>3.1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>License Fee</u>.&nbsp; In partial consideration of the license granted hereunder, Company shall pay to Wistar a nonrefundable, non-creditable license fee of </a><b>*** </b>U.S. dollars ($<b>*** </b>USD) (the &#147;<u>License Fee</u>&#148;) due on the following schedule: </h3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) shall be paid upon execution of this Agreement; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) shall be paid upon the one (1) year anniversary of the Effective Date of this Agreement; and</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon the earliest to occur of <b>(a)</b> issuance of the first Valid Claim of a Licensed Patent, or <b>(b)</b> the third (3<sup>rd</sup>) anniversary of the Effective Date of this Agreement. </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:left; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1' align=left><a name=_Ref491777377><b>3.1.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>Issuance of Shares</u>.&nbsp; </a></h3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref492034362><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>In partial consideration of the licenses granted hereunder and upon the execution hereof, Company shall issue to Wistar fifty (50) shares of its common stock (the &#147;<u>Shares</u>&#148;), par value $0.01 per share, as will cause Wistar to own five percent (5%) of the Company on a fully diluted basis as of the date hereof that includes <b>(a)</b> any outstanding shares, <b>(b)</b> all outstanding vested and unvested options to acquire shares, <b>(c)</b> all outstanding warrants or other rights to purchase shares (on an as-exercised basis), <b>(d)</b> other convertible securities (on an as-converted basis), and (such aggregate number of shares described in clauses (a) through (d) is hereafter referred to as the &#147;<u>Fully Diluted Capitalization</u>&#148;), as of the Effective Date. Company shall have obtained the proper corporate approvals to issue the shares to Wistar as of the Effective Date.</a> </p> <p align=center>11<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref479161001><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Dilution Protection</u>.&nbsp; In partial consideration of the licenses granted hereunder, from the Effective Date through the date by which Company has cumulatively raised or expended at least </a><b>*** </b>U.S. dollars ($<b>*** </b>USD) (the &#147;<u>Dilution Protection Cap</u>&#148;), Company will issue to Wistar, from time to time and at no additional consideration, such additional number of shares of Company as will cause Wistar to continue to hold in the aggregate five percent (5%) of the total shares of Company on a fully diluted basis, assuming the exercise, conversion and exchange of all outstanding securities of Company for or into shares. For the avoidance of doubt, the Dilution Protection Cap specifically excludes non-cash charges incurred by Company. Within forty-five &nbsp;(45) days of the end of each Fiscal Quarter of the Company&#146;s October 31 year end Fiscal Year, Company shall provide Wistar with a report that shows total financial proceeds or direct expenditures that are to be counted toward the Dilution Protection Cap for the previous Fiscal Quarter. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Restrictions on Transferability</u>.&nbsp; The Shares shall not be transferable in the absence of a registration under the Securities Act of 1933, as amended, or an exemption therefrom. Company shall be entitled to give stop transfer instructions to the transfer agent with respect to the Shares in order to enforce the foregoing restrictions. The Shares shall also be subject to the restrictions on transfer set forth in the Equity Documents only so long as all other holders of common stock of the Company are subject to similar restrictions. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Restrictive Legend</u>.&nbsp; Each certificate representing the Shares shall bear substantially the following legends (in addition to any legends required under applicable securities laws):</p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in; page:WordSection1'><font style=TEXT-TRANSFORM:uppercase>THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT purposes only AND HAVE NOT BEEN REGISTERED</font> WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION<font style=TEXT-TRANSFORM:uppercase>UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SHARES MAY NOT BE OFFERED, SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM. </font><a name=_Ref492034784></h3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(v)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Preemptive Rights</u>.&nbsp; If the Company has raised or expended the Dilution Protection Cap limit and the Company &nbsp;proposes to sell any equity securities or securities that are convertible into equity securities of the Company (collectively, &#147;Equity Securities&#148;) in a financing, then Wistar and/or its Assignee (as defined below) will have the right to purchase up to that portion of the Equity Securities that equals Wistar&#146;s then current, fully diluted percentage ownership of the Company on the same terms and conditions as are offered with respect to such Equity Securities sold in such financing, provided that upon notification to Wistar that financing is conducted with general terms, Wistar or its Assignee will have five (5) business days to determine whether it will participate in purchasing Equity Securities as permitted under this Section. For the purposes of this clause 3.1.2(v) <i><font style=FONT-SIZE:10pt lang=AR-SA></font></i>1.1, the term &#147;Assignee&#148; means <b>(1)</b> any entity to which Wistar&#146;s preemptive rights have been assigned either by Wistar or another entity, or <b>(2)</b> any entity that is controlled by Wistar.</p> <p align=center>12<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(vi)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Right of Participation</u>. From the date hereof until the date on which the Dilution Protection Cap has been exceeded, upon the sale by the Company of common stock or securities convertible or exercisable into common stock for cash consideration (other than for an acquisition or strategic transaction, a &#147;Subsequent Financing&#148;), Wistar shall have the right to participate in up to an amount of the Subsequent Financing equal to five percent (5%) of the Subsequent Financing (the &#147;Participation Maximum&#148;) on the same terms, conditions and price provided for in the Subsequent Financing. The Company shall provide at least ten (10) business days&#146; prior notice to Wistar of a Subsequent Financing. Such notice shall include a description of the proposed terms of the Subsequent Financing and the amount of proceeds intended to be raised thereunder. If Wistar desires to participate in the Subsequent Financing, Wistar shall provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the fifth (5<sup>th</sup>) business day after notice was received. Such notice shall include the amount of such Wistar&#146;s participation, and shall represent and warrant that Wistar has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing notice.&nbsp; If the Company receives no such notice from Wistar as of such fifth (5<sup>th</sup>) business day, Wistar shall be deemed to have notified the Company that it does not elect to participate &nbsp;If Wistar elects to not participate in a Subsequent Financing, such election shall not waive Wistar&#146;s Dilution Protection rights under Section 3.1.2(ii).&nbsp; </a></p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref475017276><a name=_Ref492034964><b><font style=TEXT-DECORATION:none>3.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Royalties.</u></a><font style=TEXT-DECORATION:none>&nbsp; </font>&nbsp;</h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>3.2.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall pay to Wistar a running royalty on Net Sales of all Licensed Products in accordance with the table set forth below within thirty (30) days following the last day of the Calendar Quarter in which such royalty accrues:</h3> <div style=page:WordSection1> <table bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; MARGIN-LEFT:71.75pt; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr> <td width=96 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1in; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  MARGIN:0in 0in 6pt'><b>Royalty Percentage</b></p></td> <td width=426 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:319.5pt; BACKGROUND:#d9d9d9; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  MARGIN:0in 0in 6pt'><b>for that portion of aggregate Net Sales of Licensed Products: </b></p></td></tr> <tr> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><b>***</b></p></td> <td width=426 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:319.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><b>***</b></p></td></tr> <tr> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><b>***</b></p></td> <td width=426 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:319.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><b>***</b></p></td></tr> <tr> <td width=96 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:1in; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><b>***</b></p></td> <td width=426 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:319.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 6pt'><b>***</b></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection1'>&nbsp;</p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref474941107><b>3.2.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>In the event that Company, in order to exploit the licenses granted to it under this Agreement in any country, actually makes running royalty payments on net sales of a Licensed Product to one or more third parties (&#147;<u>Third Party Payments</u>&#148;) as consideration for a license to patent rights held by such parties that dominate the Licensed Patents in such country, Company shall have the right, on a country-by-country basis, to reduce the royalty payments otherwise due to Wistar under this Section </a>3.2 for such Licensed Product by fifty percent (50%) of the Third Party Payments actually made in the relevant reporting period; <i>provided</i>, <i>however</i>, <b>(a)</b> Company is entitled to offset the royalties owing to the third party on such net sales by means of an equivalent stacking provision, or one more favorable to Company than the above, <b>(b)</b> in no event shall the royalties due to Wistar for any Licensed Product in any country be reduced to less than fifty percent (50%) of the royalties otherwise payable under Section 3.2.1, and </h3> <p align=center>13<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in; page:WordSection1'> <b>(c)</b> any Third Party Payments that are not offset during the royalty reporting period when such payments are actually made shall not be creditable against payments arising in subsequent royalty reporting periods. As used in this Section 3.2.2&#184; a Licensed Patent is dominated if it cannot be practiced without infringing a valid claim of an issued patent. If Company determines that Third Party Payments are necessary, Company will notify Wistar of said determination in writing within thirty (30) calendar days of reaching said determination. </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474939950><a name=_Ref474938825><a name=_Toc474934966><a name=_Toc475037544><a name=_Toc474936084><a name=_Toc474935660><b><font style=TEXT-DECORATION:none>3.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Royalty Term</u></a><font style=TEXT-DECORATION:none>.&nbsp; The period during which the royalties set forth in Section </font><font style=TEXT-DECORATION:none>3.2.1 </font><font style=TEXT-DECORATION:none>shall be payable, on a Licensed Product-by-Licensed Product basis, shall commence on the Effective Date and continue until the later of <b>(i)</b> the expiration or termination of the last to expire Valid Claim of a patent covering the making, having made, use, sale, offering for sale, exportation or importation of such Licensed Product, and <b>(ii)</b> the fifteenth (15<sup>th</sup>) anniversary of the First Commercial Sale of such Licensed Product (each such period, a &#147;</font>Royalty Term<font style=TEXT-DECORATION:none>&#148;).</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491959387><a name=_Ref491959368><a name=_Ref474940120><a name=_Toc474934967><a name=_Toc475037545><a name=_Toc474936085><a name=_Toc474935661><a name=_Toc474935267><b><font style=TEXT-DECORATION:none>3.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Minimum Annual Royalties</u></a><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref474941109><a name=_Ref479164386><b>3.4.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall pay to Wistar as a non-refundable advance against royalties during the ensuing year, a minimum annual royalty of </a><b>*** </b>U.S. dollars ($<b>*** </b>USD) due on January 1<sup>st</sup> following the First Commercial Sale of the Licensed Product that is subject to the royalties set forth in Section 3.2.1 and on each January 1<sup>st</sup> thereafter (the &#147;<u>Minimum Annual Royalties</u>&#148;).</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>3.4.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Minimum Annual Royalties shall be available for credit against royalties only during the year in which such Minimum Annual Royalties are paid and shall not be available for credit in any other year. </h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc475037546><a name=_Toc474936086><a name=_Toc474935662><b><font style=TEXT-DECORATION:none>3.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Non-Royalty Sublicensing Income</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall pay to Wistar </font><b>*** </b><font style=TEXT-DECORATION:none>percent (</font><b>***</b><font style=TEXT-DECORATION:none>%) of Non-Royalty Sublicensing Income within thirty (30) days following the last day of the Calendar Quarter in which such Non-Royalty Sublicensing Income is paid to or received by the Company accrues in a form that can be chosen at the Wistar&#146;s option, including the form in which Company received or was paid such Non-Royalty Sublicensing Income, provided that if Wistar elects a form other than the form in which the Company received or was paid Non-Royalty Sublicensing Income, that Wistar and the Company will share equally the cost of converting the Non-Royalty Sublicensing Income received&nbsp; to the form that Wistar elects.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236873><a name=_Toc382236311><a name=_Ref474939681><a name=_Toc475037547><a name=_Toc474936087><a name=_Toc474935663><b><font style=TEXT-DECORATION:none>3.6<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Maintenance Fees</u></a><font style=TEXT-DECORATION:none>.&nbsp; In further consideration of the license granted to Company hereunder, Company shall pay to Wistar nonrefundable, non-creditable annual maintenance fees as follows until the date of the First Commercial Sale of a Licensed Product:</font></h2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref474956322><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($</a><b>*** </b>USD) upon the third and fourth anniversaries of the Effective Date; &nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon the fifth and sixth anniversaries of the Effective Date; and</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon the seventh anniversary of the Effective Date and on each anniversary of the Effective Date thereafter.</p> <p align=center>14<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474939569><a name=_Toc475037548><a name=_Toc474936088><a name=_Toc474935664><b><font style=TEXT-DECORATION:none>3.7<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Milestone Payments</u></a><font style=TEXT-DECORATION:none>.&nbsp; </font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>3.7.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall pay to Wistar milestone payments in the following amounts within thirty (30) days of each of the following events:</h3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon the enrollment of the first patient in a Phase I or a Phase I/II Clinical Trial by Company, its Affiliates or any Sublicensee for <b>***</b> Licensed Products;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon the enrollment of the first patient in a Phase II Clinical Trial by Company, its Affiliates or any Sublicensee for <b>*** </b>Licensed Products (for the avoidance of doubt, Phase II Clinical Trials include Phase IIa and Phase IIb Clinical Trials); </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon the enrollment of the first patient in a Phase III Clinical Trial or other pivotal Clinical Trial by Company, its Affiliates or any Sublicensee for <b>*** </b>Licensed Products;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon initial receipt by Company, its Affiliates or any Sublicensee of Regulatory Approval for <b>*** </b>Licensed Products;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(v)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon the First Commercial Sale of each Licensed Product by Company, its Affiliates or any Sublicensee; and </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(vi)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><b>*** </b>U.S. dollars ($<b>*** </b>USD) upon Company, its Affiliates and any Sublicensee achieving aggregate Net Sales of <b>*** </b>U.S. dollars ($<b>*** </b>USD) for Licensed Products. </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>3.7.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>These milestone payments shall not be credited against or otherwise reduce royalties or other compensation provided for in this Agreement. For clarity, each time a milestone is achieved with respect to a Licensed Product, then any milestone payments with respect to earlier milestones that have not yet been paid will be due and payable together with the milestone payment for the milestone that is actually achieved. For additional clarity, milestones are due and payable on Licensed Products and on products that, upon Regulatory Approval, would become Licensed Products.&nbsp; </h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934972><a name=_Toc382236878><a name=_Toc382236314><a name=_Ref382232854><a name=_Toc475037550><a name=_Toc474936090><a name=_Toc474935666><a name=_Toc474935272><b><font style=TEXT-DECORATION:none>3.8<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Reports</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall deliver to Wistar within thirty (30) days after the end of each Calendar Quarter, a complete and accurate report for that Calendar Quarter in the form specified in </font><font style=TEXT-DECORATION:none>Schedule II</font><font style=TEXT-DECORATION:none>attached hereto, certified by a senior financial officer of Company.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474939317><a name=_Toc474934973><a name=_Toc475037551><a name=_Toc474936091><a name=_Toc474935667><a name=_Toc474935273><b><font style=TEXT-DECORATION:none>3.9<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Payments</u></a><font style=TEXT-DECORATION:none>.</font><font style=TEXT-DECORATION:none>&nbsp; <a name=_Toc382236880>All dollar amounts referred to in this Agreement are expressed in United States dollars.&nbsp; Liability for royalties on Licensed Products manufactured by Company, its Affiliates or any Sublicensee shall accrue when a Licensed Product is sold, used or otherwise disposed of; <i>provided</i> <i>that</i>, if a partial payment is made, a royalty shall accrue pro rata to such partial payment.&nbsp; Any payments not paid to Wistar when due hereunder shall accrue interest from the due date until paid at a rate equal to the lesser of six percent (6%) per annum or the maximum interest rate allowed by applicable law, whichever is greater. Notwithstanding the foregoing, Wistar shall be entitled to treat any such late payment as a material breach of this Agreement, notwithstanding the payment of interest.&nbsp; </a></font></h2> <p align=center>15<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>3.9.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>All payments due hereunder shall be payable in U.S. dollars by a check made payable to the order of &#147;The Wistar Institute of Anatomy and Biology&#148; and drawn on a U.S. bank, or by wire transfer (ACH), and sent to the following:</h3> <div style=page:WordSection1> <table width=534 bordercolor=transparent style="WIDTH:400.5pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:1in" cellpadding=0 cellspacing=0> <tr style=HEIGHT:11.4pt> <td width=264 style="HEIGHT:11.4pt; WIDTH:2.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LAYOUT-GRID-MODE:line; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><b><u>For Payment By ACH/Wire:</u></b></p></td> <td width=18 style="HEIGHT:11.4pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LAYOUT-GRID-MODE:line; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><b></b>&nbsp;</p></td> <td width=252 style="HEIGHT:11.4pt; WIDTH:189pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LAYOUT-GRID-MODE:line; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in'><b><u>For Payment By Check (Mail To):</u></b></p></td></tr> <tr style=HEIGHT:13.65pt> <td width=264 style="HEIGHT:13.65pt; WIDTH:2.75in; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'><b>***</b></p></td> <td width=18 style="HEIGHT:13.65pt; WIDTH:13.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'><b><i><u></u></i></b>&nbsp;</p></td> <td width=252 style="HEIGHT:13.65pt; WIDTH:189pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt"> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-JUSTIFY:inter-ideograph'><b>***</b></p></td></tr></table></div> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 1in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in; page:WordSection1'>&nbsp;</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref491966293><b>3.9.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>Currency</u>. &nbsp;Where it is necessary to convert the amount of royalties due from another currency into U.S. dollars, conversion shall be made using one of the following rates as published or issued on the last business day of the Calendar Quarter in which such royalties have accrued:</a> </h3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>the spot rate or the mean of the buy and sell spot rates, if no single rate is published, as published by &#147;The Wall Street Journal;&#148; or </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>at the currency conversion rate published or issued at the close of business by a third party selected by Company, <i>provided</i> that Company has obtained Wistar&#146;s prior written consent to use such third party rate for calculation of royalties due to Wistar.</p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236881><a name=_Ref381834853><b>3.9.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>Fees and Taxes</u>.&nbsp; All payments under this Agreement shall be made without any deduction or withholding for or on account of any tax, except as expressly permitted in this Agreement.&nbsp; If any income or other taxes, withholdings or other deductions required by applicable law to be withheld or deducted from any of the payments made by or on behalf of Company hereunder (&#147;<u>Withholding Taxes</u>&#148;) are imposed on a payment by any applicable law, Company shall pay such Withholding Taxes to the proper taxing authority and, if available, evidence of such payment shall be secured and sent to Wistar within one (1) month of such payment.&nbsp; In the case of any Withholding Taxes imposed with respect to any payment hereunder, Company shall pay to Wistar an additional amount as is necessary to ensure that the amount actually received by Wistar with respect to such payment, free and clear of the Withholding Taxes (including any such Withholding Taxes imposed on such additional amount), shall equal the amount of the payment that would have been made if no such Withholding Taxes had applied.</a></h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934974><a name=_Toc382236882><a name=_Toc382236316><a name=_Ref381882729><a name=_Toc475037552><a name=_Toc474936092><a name=_Toc474935668><a name=_Toc474935274><b><font style=TEXT-DECORATION:none>3.10<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Records</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall keep, and shall cause its Affiliates and Sublicensees to keep, complete and accurate books and records of all Licensed Products sold which enable the royalties and other amounts payable hereunder to be verified.&nbsp; Upon reasonable prior notice to Company, its Affiliates or any Sublicensee and during normal business hours, an auditor paid for and selected by Wistar may inspect such books and records of Company, its Affiliates and Sublicensees for the three (3) year period immediately preceding the date of inspection to verify the correctness of the reports given to Wistar under Section </font><font style=TEXT-DECORATION:none>3.8</font><font style=TEXT-DECORATION:none>.&nbsp; If Wistar&#146;s auditor determines that Company, its Affiliate or any Sublicensee has underpaid royalties and other amounts payable by ten percent (10%) or more, Company shall pay the costs and expenses of the audit and the right of inspection shall extend to books and records for periods prior to such three (3) year period.&nbsp; Nothing contained in this Section </font><font style=TEXT-DECORATION:none>3.10</font><font style=TEXT-DECORATION:none> shall shorten the period established by any applicable statute of limitations.</font></h2> <p align=center>16<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> </p> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037553><a name=_Toc474936093><a name=_Toc474935669><a name=_Toc474935275><a name=_Toc474935094><a name=_Toc474934975><a name=_Toc382253459><a name=_Toc382253429><a name=_Toc382236883><a name=_Toc382236317><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'></font>Article 4 - </font>CERTAIN OBLIGATIONS OF COMPANY</a> </h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474941108><a name=_Ref474939702><a name=_Ref474939386><a name=_Ref474939339><a name=_Toc474934976><a name=_Toc382236884><a name=_Toc382236318><a name=_Toc475037554><a name=_Toc474936094><a name=_Toc474935670><a name=_Toc474935276><b><font style=TEXT-DECORATION:none>4.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Diligent Efforts</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company, acting itself and/or through its Sublicensees, <b>(i)</b> shall use best efforts to develop Licensed Products and to bring Licensed Products to market through a thorough, vigorous and diligent program for exploitation of the Licensed Patents and Licensed Technical Information and to continue active, diligent marketing efforts for Licensed Products throughout the Term, consistent with sound and reasonable business practices, and <b>(ii)</b> shall endeavor to keep Licensed Products reasonably available to the public.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474939706><a name=_Ref474939390><a name=_Ref474938787><a name=_Toc474934977><a name=_Toc382236885><a name=_Toc382236319><a name=_Toc475037555><a name=_Toc474936095><a name=_Toc474935671><a name=_Toc474935277><b><font style=TEXT-DECORATION:none>4.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Performance Milestones</u></a><font style=TEXT-DECORATION:none>.&nbsp; In addition to Company&#146;s diligence obligations in Section </font><font style=TEXT-DECORATION:none>4.1</font><font style=TEXT-DECORATION:none>, Company, acting itself and/or through its Sublicensees, shall perform or fulfill the following obligations (the &#147;</font>Performance Milestone(s)<font style=TEXT-DECORATION:none>&#148;) by the dates set forth below (the &#147;</font>Performance Milestone Date(s)<font style=TEXT-DECORATION:none>&#148;):</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236886><a name=_Ref381834334><b>4.2.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Within forty-five (45) days after the Effective Date, Company shall furnish Wistar with a written research and development plan describing the major tasks to be achieved in order to complete preclinical testing necessary to support clinical testing of Licensed Products, a timeline for achievement of such tasks, and an estimate of the number of staff and financial and other resources to be devoted to such preclinical testing, which for the avoidance of doubt, is the Company&#146;s preclinical testing plan with the H. Lee Moffitt&nbsp; Cancer Center and Research Institute, Inc.(&#147;<u>Commercialization Plan</u>&#148;);</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>4.2.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>***;</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>4.2.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>***;</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236887><b>4.2.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>***</a>; and<i> </i></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>4.2.5.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>***<i>.</i></h3> <h2 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491966925><a name=_Toc474934978><a name=_Toc382236889><a name=_Toc382236320><a name=_Toc475037556><a name=_Toc474936096><a name=_Toc474935672><a name=_Toc474935278><b><font style=TEXT-DECORATION:none>4.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Diligence Failure</u></a><font style=TEXT-DECORATION:none>.&nbsp; </font><i><font style=TEXT-DECORATION:none>***</font></i></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474939813><a name=_Ref474939640><a name=_Toc474934979><a name=_Toc475037557><a name=_Toc474936097><a name=_Toc474935673><a name=_Toc474935279><b><font style=TEXT-DECORATION:none>4.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Diligence Reports</u></a><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref491967287><a name=_Toc382236891><b>4.4.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall provide Wistar on December 1 of each year with written reports, setting forth in such detail as Wistar may reasonably request, the progress of the development, evaluation, testing and commercialization of the Licensed Products, including information on <b>(i)</b> the progress of matters related to Regulatory Approvals and <b>(ii) </b>progress made toward the objectives set forth in the Commercialization Plan, including any progress of securing Sublicenses and any progress of Sublicensees developing Licensed Products.&nbsp; Company also shall notify Wistar within thirty (30) days after the First Commercial Sale of a Licensed Product by Company, its Affiliates or any Sublicensee.</a></h3> <p align=center>17<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236892><b>4.4.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>In order that Wistar may provide the United States Department of Health and Human Services with information required under the Funding Agency Interest, Company shall, at its cost, prepare and provide written annual reports to Wistar containing sufficient information to enable the Department of Health and Human Services to evaluate Company&#146;s progress in the development of Licensed Products, but shall not contain information considered proprietary or confidential by Company.&nbsp; Such reports shall be provided no later than January 1<sup>st</sup> of each year.</a></h3> <h2 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491962914><a name=_Ref491962794><a name=_Ref474939958><a name=_Toc474934980><a name=_Toc475037558><a name=_Toc474936098><a name=_Toc474935674><a name=_Toc474935280><b><font style=TEXT-DECORATION:none>4.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Compliance with Laws</u></a><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236894><a name=_Ref491962651><b>4.5.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall <b>(a)</b> comply with all applicable laws, rules and regulations pertaining to the development, testing, manufacture, marketing, import or export of the Licensed Products; and <b>(b)</b> not employ, contract with or retain any Person directly or indirectly if such Person is: <b>(i)</b> excluded from a Federal health care program as outlined in Sections 1128 and 1156 of the Social Security Act (see the Office of Inspector General of the Department of Health and Human Services List of Excluded Individuals/Entities at </a>http://www.oig.hhs.gov/fraud/exclusions/exclusions_list.asp), <b>(ii)</b> debarred by any Health Authority, including (but not limited to) by the FDA under 21 U.S.C. 335a (see the FDA Office of Regulatory Affairs Debarment List at http://www.fda.gov/ICECI/EnforcementActions/FDADebarmentList/default.htm), or <b>(iii)</b> excluded from contracting with the federal government (see the Excluded Parties Listing System at www.sam.gov).&nbsp; </h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref491966710><b>4.5.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Without limiting Section </a><b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>4.5.1, Company acknowledges that the transfer and use by foreign nationals of certain commodities and technical data is subject to U.S. laws and regulations controlling the export and use by foreign nationals of such commodities and technical data, including the Arms Export Control Act, the International Traffic in Arms Regulations (&#147;<u>ITAR</u>&#148;), the Export Administration Regulations (&#147;<u>EAR</u>&#148;) and the laws and regulations implemented by the Office of Foreign Assets Control, U.S. Department of the Treasury (&#147;<u>OFAC</u>&#148;).&nbsp; These laws and regulations, among other things, prohibit or require a license for the export or use by foreign nationals of certain types of technical data to specified countries.&nbsp; Company shall comply with all such applicable U.S. laws and regulations.</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref491967533><b>4.5.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall be solely responsible for any violation of the provisions of this Section </a><b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>4.4 by Company, its Affiliates or any Sublicensees.</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236895><a name=_Ref381837479><a name=_Ref491967206><b>4.5.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Each party hereunder agrees that it has not and will not, either directly or indirectly, engage in bribery, or offer, or promise, or authorize to pay or make any improper payment of any monies or financial or other advantage, including cash, loan, gift, travel, entertainment, hospitality, facilitation payment, kickback, political or philanthropic contribution, anything of value, or any other perceived benefit to improperly obtain or retain a business advantage in violation of any Anti-Corruption Laws and further, each party hereunder agrees that it shall not take any action that would cause the other parties to be in violation of such Anti-Corruption Laws.</a>&nbsp; Any adjudicated breach of this Section 4.5.4 by a party shall allow the other parties hereunder to immediately terminate this Agreement.</h3> <p align=center>18<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>4.5.5.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>To the extent required by the Funding Agency Interest, all Licensed Products to be used or sold in the United States shall be manufactured substantially in the United States, and Company shall take such actions as are necessary to assure that it and its Affiliates and Sublicensees comply with the obligations imposed by this Section<b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>4.5<b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>4.5.</h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934981><a name=_Toc382236896><a name=_Toc382236323><a name=_Toc475037559><a name=_Toc474936099><a name=_Toc474935675><a name=_Toc474935281><b><font style=TEXT-DECORATION:none>4.6<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Conflict of Interest</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company acknowledges that Wistar&#146;s employees and staff members are subject to the applicable policies of Wistar, including policies regarding conflicts of interest, intellectual property and other matters.&nbsp; Company shall not enter into any oral or written agreement with such employee or staff member which conflicts with any such policy.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934982><a name=_Toc382236897><a name=_Toc382236324><a name=_Toc475037560><a name=_Toc474936100><a name=_Toc474935676><a name=_Toc474935282><b><font style=TEXT-DECORATION:none>4.7<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Patent Notices</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall mark the Licensed Products sold in the United States with all applicable patent numbers.&nbsp; All Licensed Products shipped to and/or sold in other countries shall be marked and labeled in such a manner as to conform with all applicable laws of the country where the Licensed Products are sold.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934983><a name=_Toc382236898><a name=_Toc382236325><a name=_Toc475037561><a name=_Toc474936101><a name=_Toc474935677><a name=_Toc474935283><b><font style=TEXT-DECORATION:none>4.8<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Regulatory Approvals</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall be responsible for obtaining and maintaining, at its cost and expense, all Regulatory Approvals.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b><font style=TEXT-DECORATION:none>4.9<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Information Rights</u><font style=TEXT-DECORATION:none>. The Company shall furnish the following reports to Wistar during the term of this Agreement: (1) Within ninety (90) days of the Company&#146;s fiscal year end, the Company shall provide to Wistar an unaudited balance sheet and statement of operations for such fiscal year; and (2) within forty-five (45) days following the end of the Company&#146;s first, second and third fiscal quarters, the Company shall provide to Wistar an unaudited balance sheet and statement of operations for such fiscal quarter.&nbsp; The reports provided by the Company to Wistar shall be in such form as determined in the sole discretion of the Company and shall be consistent with the reports that ITUS prepares for each of ITUS&#146; consolidated subsidiaries when preparing ITUS&#146; annual and quarterly financial statements.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b><font style=TEXT-DECORATION:none>4.10<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Stockholders&#146; Agreement</u><font style=TEXT-DECORATION:none>. If at any time, the Company enters into a stockholder&#146;s agreement affording rights to a stockholder of the Company, Wistar shall have the option to become a party to such agreement.</font></h2> <p align=center>19<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> </p> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037562><a name=_Toc474936102><a name=_Toc474935678><a name=_Toc474935284><a name=_Toc474935095><a name=_Toc474934984><a name=_Toc382253460><a name=_Toc382253430><a name=_Toc382236899><a name=_Toc382236326><a name=_Ref381833498><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'></font>Article 5 - </font>REPRESENTATIONS AND WARRANTIES</a></h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif";  FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934985><a name=_Toc475037563><a name=_Toc474936103><a name=_Toc474935679><a name=_Toc474935285><b><font style=TEXT-DECORATION:none>5.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Representations and Warranties</u></a><font style=TEXT-DECORATION:none>.</font>&nbsp; </h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236901><b>5.1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company represents and warrants that it is a corporation, duly organized, validly existing and in good standing under the laws of the State of Delaware, and has all requisite corporate power and authority to execute, deliver and perform this Agreement; and Wistar represents and warrants that it is a nonprofit corporation, duly organized, validly existing and in good standing under the laws of the Commonwealth of Pennsylvania, and has all requisite corporate power and authority to execute, deliver and perform this Agreement.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>5.1.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>In addition, Company represents and warrants to Wistar <b>(a)</b> that the issuance and delivery to Wistar of the Shares have been duly authorized by all requisite corporate action of Company and Company has full corporate power and lawful authority to issue and deliver the Shares on the terms and conditions contemplated herein, and when so issued and delivered, the Shares shall be validly issued and outstanding, fully paid and nonassessable, with no personal liability attaching to the ownership thereof, and not subject to preemptive or any similar rights of the stockholders of Company or any liens or encumbrances arising through Company; and <b>(b)</b> that <b>(i)</b> the authorized capital stock of Company consists of &nbsp;5,000 &nbsp;shares of common stock, of which 950 are issued and outstanding, <b>(ii)</b> there are no outstanding options, warrants, rights (including conversion or preemptive rights), or agreements for the purchase or acquisitions from the Company of any shares of Company&#146;s capital stock, <b>(iii)</b> no officer, director or stockholder of the Company or member of his or her immediate family are currently a party to any contract or arrangement (or has any interest in any entity that is a party to any contract or arrangement) with the Company (other than customary employment and equity investment agreements) or is indebted to the Company, nor is the Company indebted (or committed to make loans or extend or guarantee credit) to any of such individuals, and <b>(iv)</b> the Company has no liability or obligation, absolute or contingent (individually or in the aggregate), except obligations and liabilities incurred in the ordinary course of business, none of which, individually or in the aggregate, are material.</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236902><b>5.1.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company and Wistar each represent and warrant to the other that this Agreement, when executed and delivered by a party to this Agreement, shall be the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms.</a> </h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>5.1.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>Wistar&nbsp; Representations and Warranties.</u> Wistar represents and warrants that, to its knowledge&nbsp; &nbsp;(a)&nbsp; it is the sole and exclusive legal and beneficial owner of the entire right, title, and interest in and to the Licensed Patents, and is the record owner of all patent applications and issued patents that are Licensed Patents; (b) it has not granted any licenses or other contingent or non-contingent right, title, or interest under or relating to Licensed Patents, and is not under any obligation, that conflicts with this Agreement, including any of its&nbsp; representations, warranties, or obligations, or Company&#146;s rights or licenses hereunder;&nbsp; (c) there are no encumbrances, liens, or security interests involving any Licensed Patent; </h3> <p align=center>20<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in; page:WordSection1'> (d)&nbsp;&nbsp; there is no settled, pending, or threatened litigation alleging the unpatentability, invalidity, misuse, unregisterability, unenforceability, or noninfringement of, or error in any Licensed Patent challenging Wistar's ownership of, or right to practice or license, any Licensed Patent, or alleging any adverse right, title, or interest with respect thereto; and (e)it&nbsp; has no knowledge of any factual, legal, or other reasonable basis for any litigation described&nbsp; in this Section and has not received any written, oral, or other notice of any litigation described in this Section.&nbsp; This paragraph expressly does not make any representations and warranties regarding any allegations as to patentability made in unrebutted communications from any patent office as of the Effective Date of this Agreement.&nbsp; Wistar has not brought or threatened any claim against any third party alleging infringement of any Licensed Patent, nor, to its knowledge, is any third party infringing or, to its knowledge, preparing or threatening to infringe any patent, or practicing any claim of any patent application, included as a Licensed Patent.</p> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037564><a name=_Toc474936104><a name=_Toc474935680><a name=_Toc474935286><a name=_Toc474935096><a name=_Toc474934986><a name=_Toc382253461><a name=_Toc382253431><a name=_Toc382236903><a name=_Toc382236328><a name=_Ref381833408><a name=_Ref381833400><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'></font>Article 6 - </font>LIMITATION ON LIABILITY AND INDEMNIFICATION</a></h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934987><a name=_Toc382236904><a name=_Toc382236329><a name=_Toc475037565><a name=_Toc474936105><a name=_Toc474935681><a name=_Toc474935287><b><font style=TEXT-DECORATION:none>6.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Limitation on Liability</u></a><font style=TEXT-DECORATION:none>.&nbsp; IN NO EVENT SHALL WISTAR, ITS CURRENT AND FORMER TRUSTEES, MANAGERS, OFFICERS, AGENTS, EMPLOYEES, FACULTY, PERSONNEL, STAFF, STUDENTS OR VISITING SCIENTISTS BE LIABLE TO COMPANY, ITS SUCCESSORS, ASSIGNS, AFFILIATES, SUBLICENSEES OR THIRD PARTY FOR ANY LOSS OF PROFITS, LOSS OF BUSINESS, INTERRUPTION OF BUSINESS, OR FOR ANY INDIRECT, SPECIAL OR CONSEQUENTIAL DAMAGES OF ANY KIND, WHETHER UNDER THIS AGREEMENT OR OTHERWISE, EVEN IF SUCH PERSON HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSS. WISTAR SHALL NOT BE LIABLE TO COMPANY, ITS SUCCESSORS, ASSIGNS, AFFILIATES, SUBLICENSEES OR ANY THIRD PARTY WITH RESPECT TO ANY CLAIM ON ACCOUNT OF, OR ARISING FROM, THE USE OF THE LICENSED PATENTS OR LICENSED TECHNICAL INFORMATION OR THE MANUFACTURE, USE OR SALE OF LICENSED PRODUCTS OR ANY OTHER MATERIAL OR ITEM DERIVED FROM ANY OF THE FOREGOING.&nbsp; </font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b><font style=TEXT-DECORATION:none>6.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Exclusion of Consequential and Other Direct Damages</u><font style=TEXT-DECORATION:none>. &nbsp;To the fullest extent permitted by Law, Company shall not be liable to Wistar for any injury to or loss of goodwill, reputation, business production, revenues, profits, anticipated profits, contracts, or opportunities (irrespective of how these are classified as damages), or for any consequential, incidental, indirect, exemplary, special, punitive, or enhanced damages, whether arising out of breach of contract, tort (including negligence), or otherwise (including the entry into, performance or breach of this Agreement), regardless of whether such damage was foreseeable and whether or not the other party has been advised of the possibility of such damages.</font><font style=TEXT-DECORATION:none>.&nbsp; </font><a name=_Toc474934988><a name=_Toc382236905><a name=_Toc382236330><a name=_Toc475037566><a name=_Toc474936106><a name=_Toc474935682><a name=_Toc474935288><font style=TEXT-DECORATION:none>Exclusion of Consequential and Other Direct Damages. To the fullest extent permitted by Law, Company shall not be liable to Wistar for any injury to or loss of goodwill, reputation, business production, revenues, profits, anticipated profits, contracts, or opportunities (irrespective of how these are classified as damages), or for any consequential, incidental, indirect, exemplary, special, punitive, or enhanced damages, whether arising out of breach of contract, tort (including negligence), or otherwise (including the entry into, performance or breach of this Agreement), regardless of whether such damage was foreseeable and whether or not the other party has been advised of the possibility of such damages.</font></a></h2> <p align=center>21<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in; page:WordSection1'><font style=TEXT-DECORATION:none>OTHER THAN AS SET FORTH IN SETION 5.1.4, THE LICENSED PATENTS AND LICENSED TECHNICAL INFORMATION ARE PROVIDED ON AN &#147;AS IS&#148; BASIS AND WISTAR MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, WITH RESPECT TO THE LICENSED PATENTS, LICENSED TECHNICAL INFORMATION OR ANY LICENSED PRODUCTS INCLUDING REPRESENTATIONS OR WARRANTIES OF COMMERCIAL UTILITY, MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, VALIDITY OR ENFORCEABILITY OF THE LICENSED PATENTS, OR THAT THE USE OF THE LICENSED PATENTS, LICENSED TECHNICAL INFORMATION, LICENSED PRODUCTS OR ANY MATERIALS OR ITEMS DERIVED FROM ANY OF THE FOREGOING WILL NOT INFRINGE ANY PATENT, COPYRIGHT OR TRADEMARK OR OTHER PROPRIETARY OR PROPERTY RIGHTS OF OTHERS.&nbsp; WISTAR EXPRESSLY DISCLAIMS ANY WARRANTY THAT THE LICENSED PATENTS OR LICENSED TECHNICAL INFORMATION ARE FREE FROM THE RIGHTFUL CLAIMS OF ANY THIRD PARTY.&nbsp; </font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491955561><a name=_Ref474939424><a name=_Ref474939411><a name=_Ref474935324><a name=_Toc474934989><a name=_Toc382236906><a name=_Toc382236331><a name=_Toc475037567><a name=_Toc474936107><a name=_Toc474935683><a name=_Toc474935289><b><font style=TEXT-DECORATION:none>6.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Indemnification</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall indemnify and hold harmless Wistar, its current and former trustees, managers, officers, agents, employees, faculty, personnel, staff, students and visiting scientists (collectively and individually, the &#147;</font><u>Indemnified Parties</u><font style=TEXT-DECORATION:none>&#148; or &#147;</font><u>Indemnified Party</u><font style=TEXT-DECORATION:none>&#148;), from and against any and all liability, loss, damage, action, claim or expense (including attorney&#146;s fees) suffered or incurred by the Indemnified Parties due to claims by a Person not a party to this Agreement (individually, a &#147;</font><u>Liability</u><font style=TEXT-DECORATION:none>&#148; and collectively, the &#147;</font><u>Liabilities</u><font style=TEXT-DECORATION:none>&#148;) which result from or arise out of <b>(a)</b> this Agreement, the license granted hereunder and any Sublicense granted pursuant to this Agreement, <b>(b)</b> the development, use, manufacture, promotion, sale or other disposition of the Licensed Patents, Licensed Technical Information, or any Licensed Products by Company, its Affiliates, assignees, Sublicensees, vendors or other third parties, <b>(c)</b> the breach of any representation, warranty, or covenant of this Agreement by Company, or of a Sublicense by any Sublicensee, or <b>(d)</b> the successful enforcement by an Indemnified Party of its rights under this Section </font><font style=TEXT-DECORATION:none>6.2</font><font style=TEXT-DECORATION:none>.&nbsp; Wistar shall indemnify and hold harmless Company from and against any and all liability, loss, damage, action, claim or expense (including attorney&#146;s fees) suffered or incurred by the Indemnified Parties due to the breach of any representation, warranty, or covenant of this Agreement by Wistar.&nbsp; This indemnification obligation shall apply regardless of the negligence of the Indemnified Party. Without limiting the foregoing, Company shall indemnify and hold harmless the Indemnified Parties from and against any Liabilities resulting from</font> </h2> <p align=center>22<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236907><b>6.3.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>any product liability or other claim of any kind related to the use of a Licensed Product manufactured, sold or otherwise disposed of by Company, its assignees, Affiliates, and Sublicensees, vendors or other third parties;</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236908><b>6.3.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>any claim that the Licensed Patents, Licensed Technical Information or the design, composition, manufacture, use, sale or other disposition of any Licensed Product infringes or violates any patent, copyright, trademark or other intellectual property rights of any third party; or</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236909><b>6.3.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Clinical Trials or studies conducted by or on behalf of Company, its Affiliate or any Sublicensee relating to the Licensed Products, including any claim by or on behalf of a human subject of any such Clinical Trial or study, any claim arising from the procedures specified in any protocol used in any such Clinical Trial or study, any claim of deviation, authorized or unauthorized, from the protocols of any such Clinical Trial or study, and any claim resulting from or arising out of the manufacture or quality control by a third party of any substance administered in any Clinical Trial or study.</a></h3> <h2 style='FONT-SIZE:12pt; T FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934990><a name=_Toc475037568><a name=_Toc474936108><a name=_Toc474935684><a name=_Toc474935290><b><font style=TEXT-DECORATION:none>6.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Procedures</u></a><font style=TEXT-DECORATION:none>.&nbsp; The Indemnified Party shall promptly notify Company of any claim or action giving rise to a Liability subject to the provisions of Section </font><b><font style="FONT-SIZE:13pt; TEXT-DECORATION:none" lang=AR-SA>?</font></b><font style=TEXT-DECORATION:none>6.2</font><font style=TEXT-DECORATION:none>.&nbsp; Company shall have the right to defend any such claim or action, at its cost and expense, with counsel reasonably satisfactory to Wistar.&nbsp; Company shall not settle or compromise any such claim or action in a manner that <b>(i)</b> imposes any restrictions or obligations on any Indemnified Party without such Indemnified Party&#146;s prior written consent, or <b>(ii)</b> grants any rights to the Licensed Patents without Wistar&#146;s prior written consent.&nbsp; If Company fails or declines to assume the defense of any such claim or action within thirty (30) days after notice thereof, Wistar may assume the defense of such claim or action for the account and at the risk of Company, and any Liability related thereto shall be conclusively deemed a Liability of Company.&nbsp; Company shall pay promptly to the Indemnified Party any Liabilities to which the foregoing indemnity related, as incurred.&nbsp; The indemnification rights of the Indemnified Parties contained herein are in addition to all other rights which such Indemnified Parties may have at law or in equity or otherwise.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref475017138><a name=_Ref474939832><a name=_Toc474934991><a name=_Toc382236911><a name=_Toc382236333><a name=_Toc475037569><a name=_Toc474936109><a name=_Toc474935685><a name=_Toc474935291><b><font style=TEXT-DECORATION:none>6.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Insurance</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall maintain general liability and product liability insurance as follows:</font> </h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236912><a name=_Ref381837529><b>6.5.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>beginning with the Effective Date and for ten (10) years after the date of expiration or termination of this Agreement, general liability insurance in amounts not less than one million U.S. dollars ($1,000,000 USD) per incident and two million U.S. dollars &nbsp;($2,000,000 USD) in the aggregate; and</a> </h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236913><a name=_Ref381837533><b>6.5.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>beginning with the commencement of Clinical Trials and for ten (10) years after the date of expiration or termination of this Agreement, product liability insurance in amounts not less than ten million U.S. dollars ($10,000,000 USD) per incident and ten million dollars U.S. ($10,000,000 USD) in the aggregate.</a> </h3> <p align=center>23<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>6.5.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Such insurance shall be issued by an insurance company rated AA or better and naming Wistar as an additional insured.&nbsp; The minimum insurance amounts specified herein shall not be deemed a limitation on Company&#146;s indemnification liability under this Agreement.&nbsp; Company shall provide Wistar with copies of endorsements to such policies.&nbsp; Company shall notify Wistar at least thirty (30) days prior to cancellation of any such coverage.&nbsp; To the extent Company is awarded a business interruption insurance award which provides for lost profits, Company shall pay to Wistar reasonable royalties for the period of the award which payment shall be based upon projections of Net Sales of Licensed Products and the history of royalties paid hereunder for such Net Sales.</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236914><b>6.5.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company shall require any Sublicensee to maintain insurance under the same terms as set forth in Sections </a><b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>6.4.1<b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>6.4.16.5.1 and <b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>6.4.2<b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>6.4.2 above, including naming Wistar as an additional insured.</h3> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037570><a name=_Ref475017502><a name=_Toc474936110><a name=_Toc474935686><a name=_Toc474935292><a name=_Toc474935097><a name=_Toc474934992><a name=_Toc382253462><a name=_Toc382253432><a name=_Toc382236915><a name=_Toc382236334><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'></font>Article 7 - </font>PATENTS AND INFRINGEMENT</a></h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934993><a name=_Toc475037571><a name=_Toc474936111><a name=_Toc474935687><a name=_Toc474935293><b><font style=TEXT-DECORATION:none>7.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Prosecution of Patents</u></a><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236917><a name=_Ref381833865><b>7.1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Subject to Section 7.1 and its subsections, Wistar shall have the exclusive responsibility and control over the Prosecution of the Licensed Patents.&nbsp; Upon execution of this Agreement, Company shall reimburse Wistar for Patenting Costs incurred by Wistar prior to the Effective Date and not previously reimbursed by ITUS or Company under the Option (&#147;<u>Past Patenting Costs</u>&#148;).&nbsp; With respect to any Patenting Costs incurred by or on behalf of Wistar after the Effective Date, Company shall remit payment of such Patenting Costs within thirty (30) days after Company receives invoices for same.&nbsp; Notwithstanding the foregoing, at least sixty (60) days before a particular action is required for the protection of certain rights comprising the Licensed Patents (the &#147;<u>Bar Date</u>&#148;), Wistar shall have the right to request advance payment of reasonable estimated Patenting Costs for such action if such estimated Patenting Costs are at least twenty thousand U.S. dollars&nbsp; ($20,000 USD), and Company shall be obligated to pay the amount of such estimated Patenting Costs no less than thirty (30) days before the Bar Date.&nbsp; So long as Wistar&#146;s request is timely made, Wistar shall have no obligation to take or have taken such action, and no liability for failing to take such action, to protect the Licensed Patents at issue, unless the estimated Patenting Costs are timely paid by Company, even if the result is the irrevocable loss of rights.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236918><b>7.1.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>For each patent application and patent under the Licensed Patents, Wistar shall:&nbsp; prepare, file, and prosecute such patent application: maintain such patent; pay all fees and expenses associated with its activities pursuant to Section 7.1; keep Company currently informed of the filing and progress of all material aspects of the prosecution of such patent application and the issuance of patents from any such patent application; consult with Company concerning any decisions which could affect the scope or enforcement of any issued claims or the potential abandonment of such patent application or patent; and notify Company in writing of any additions, deletions, or changes in the status of such patent or patent application.</a></h3> <p align=center>24<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>7.1.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company and Wistar shall mutually determine the jurisdictions, other than the United States, where the Licensed Patents shall be Prosecuted.&nbsp; If Company declines to pay for Patenting Costs in any jurisdiction, Wistar may do so at its cost and expense but such patents and the subject matter of any application relating thereto shall be excluded from the definition of Licensed Patents.</h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236919><b>7.1.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>If Wistar elects not to Prosecute any patent or patent application included in the Licensed Patents, it shall notify Company at least sixty (60) days prior to taking, or not taking, any action which would result in abandonment, withdrawal, or lapse of such patent or patent application. Such patent application or patent shall no longer be a Licensed Patent and Company shall not have any further royalty or other payment obligation for such patent application or patent. Company shall then have the right to Prosecute such patent or patent application at its own cost and expense in Wistar&#146;s name.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236920><b>7.1.5.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Each party shall cooperate with the other party to execute all lawful papers and instruments and to make all rightful oaths and declarations as may be necessary in the Prosecution of all such patents and other applications and protections referred to in this Article 7.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref491967562><a name=_Toc382236921><b>7.1.6.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>All non-public information exchanged between the parties or between Wistar&#146;s patent counsel and Company regarding Prosecution and enforcement of the Licensed Patents, and all shared information regarding analyses or opinions of third party intellectual property, shall be deemed Confidential Information. In addition, the parties acknowledge and agree that, with regard to Prosecution and enforcement of the Licensed Patents, the interests of the parties as licensor and licensee are to obtain the strongest patent prosecution possible, and as such, are aligned and are legal in nature. The parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Licensed Patents or the Confidential Information, including privilege under the common interest doctrine and similar or related doctrines.</a></h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967569><a name=_Toc382236922><a name=_Toc382236336><a name=_Toc475037572><a name=_Toc474936112><a name=_Toc474935688><a name=_Toc474935294><a name=_Toc474934994><b><font style=TEXT-DECORATION:none>7.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Ownership</u></a>.<font style=TEXT-DECORATION:none>&nbsp; Wistar shall retain all right, title and interest in and to the Licensed Patents, Wistar Confidential Information and Licensed Technical Information regardless of which party Prosecutes the patents, subject to the express license granted to Company under Article 2 hereof.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474939461><a name=_Toc474934995><a name=_Toc475037573><a name=_Toc474936113><a name=_Toc474935689><a name=_Toc474935295><b><font style=TEXT-DECORATION:none>7.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Infringement</u></a><font style=TEXT-DECORATION:none>.</font>&nbsp; </h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236924><b>7.3.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Each party shall promptly notify the other party in writing of any infringement or possible infringement of any Licensed Patent in the Licensed Field.&nbsp; Company shall have the first right, but not the obligation, to prosecute such infringement in the Licensed Field at its own expense.&nbsp; Company shall use the same degree of diligence in prosecuting such infringement as it uses or would use in prosecuting infringement of its own patent rights.&nbsp; In the event Company elects to prosecute such infringement, Wistar shall cooperate with Company, at Company&#146;s reasonable request and Company&#146;s sole expense, in any such infringement action. Company shall reimburse Wistar for any such expense within thirty (30) days after Company&#146;s receipt of invoice for the same.</h3> <p align=center>25<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in; page:WordSection1'>Company shall keep Wistar informed of the status and progress of any action brought under this Section </a>7.3 and Company shall not settle or compromise any such suit in a manner that imposes any obligations or restrictions on Wistar or grants any rights to the Licensed Patents, Wistar Confidential Information or Licensed Technical Information without Wistar&#146;s prior written consent.&nbsp; Prior to commencing any such infringement action, Company shall consult with Wistar and shall consider the views of Wistar regarding the advisability of the proposed action and its effect on the public interest.&nbsp; If Company exercises its right to bring an infringement action against the alleged infringer, Company shall be obligated to defend any cross claim or counterclaim or action for declaratory judgment related to the Licensed Patents or Licensed Product.</p>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236925><b>7.3.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>If Company fails to prosecute such infringement within ninety (90) days after receiving notice thereof, Wistar shall have the right, but not the obligation, to prosecute such infringement at its own expense.&nbsp; In such event, Company shall cooperate with Wistar, at Company&#146;s sole expense.&nbsp; Wistar shall not settle or compromise any such suit in a manner that imposes any limitations or restrictions on the rights granted to Company in Article 2 hereof without Company&#146;s written consent.&nbsp; In any such settlement or compromise, consideration will be given in good faith to granting the infringer a Sublicense under the Licensed Patents in the Licensed Field on appropriate terms.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236926><b>7.3.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Any recovery obtained by the prosecuting party as a result of such proceeding, by settlement or otherwise, shall be applied first to the prosecuting party, an amount equal to its costs and expenses of the litigation, with the remainder to be paid fifty percent (50%) to Wistar and fifty percent (50%) to Company.</a></h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474934996><a name=_Toc382236927><a name=_Toc382236338><a name=_Toc475037574><a name=_Toc474936114><a name=_Toc474935690><a name=_Toc474935296><b><font style=TEXT-DECORATION:none>7.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Certain Notices</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company shall notify Wistar at least sixty (60) days before Company uses or exports the Licensed Patents or any Licensed Product in or to any country outside the United States to allow Wistar to make any patent filings or to take other actions necessary to protect the Licensed Patents.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref474939604><a name=_Ref474938770><a name=_Toc474934997><a name=_Toc382236928><a name=_Toc382236339><a name=_Toc475037575><a name=_Toc474936115><a name=_Toc474935691><a name=_Toc474935297><b>7.4.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b><u>Patent Term Extension Obligations</u></a>.&nbsp; Company shall keep Wistar fully informed of Company&#146;s and each Sublicensee&#146;s progress toward Regulatory Approval for commercial sale of each Licensed Product with respect to each Licensed Patent hereunder.&nbsp; Company shall assist Wistar in determining with respect to such Licensed Products if the Licensed Patents would be eligible for patent term extension pursuant to 35 U.S.C. &#167;&#167;156, and, as appropriate, applicable foreign patent laws (a &#147;Patent Term Extension&#148;).&nbsp; Company acknowledges that time is of the essence with respect to submission of any application for Patent Term Extension.&nbsp; Company shall give Wistar prompt oral notification when each of its or its Sublicensee&#146;s Licensed Products with respect to each Licensed Patent have received permission (under the provision of law under which the applicable regulatory review occurred) for commercial marketing or use, and shall confirm such notification in writing within five (5) business days of receipt of written notice of marketing approval from the regulatory agency.&nbsp;Wistar shall consider in good faith any request by Company that it or they apply for Patent Term Extension.&nbsp; Wistar shall have the right, but not the obligation, to apply for Patent Term Extension. </h3> <p align=center>26<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0in; page:WordSection1'>At Wistar&#146;s request, Company shall, in a timely manner, assist Wistar in preparing an application for Patent Term Extension in compliance with 35 U.S.C. &#167;156 et seq., and, as appropriate, any applicable foreign patent laws.&nbsp; Company and its Sublicensees shall cooperate fully with Wistar in preparing the applications for Patent Term Extension. Company agrees to join in such applications at Wistar&#146;s request.&nbsp; Company shall fully support such applications and shall provide such information as may be requested in support of such applications by Wistar or by the government.</p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref475017678><a name=_Toc474934998><a name=_Toc382236929><a name=_Toc382236340><a name=_Toc475037576><a name=_Toc474936116><a name=_Toc474935692><a name=_Toc474935298><b><font style=TEXT-DECORATION:none>7.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Licensed Patent Challenges</u></a><font style=TEXT-DECORATION:none>.&nbsp; In the event that Company or a Sublicensee or any of their Affiliates directly or indirectly brings, or assists in bringing, a Patent Challenge, then <b>(i)</b> Company shall provide Wistar with at least sixty (60) days&#146; notice prior to taking any such action, <b>(ii)</b> the parties consent that Section </font><font style=TEXT-DECORATION:none>10.9</font><font style=TEXT-DECORATION:none> shall apply; <b>(iii)</b> Company shall pay all costs, fees and expenses associated with such Patent Challenge that are incurred by Wistar and its trustees, managers, officers, agents, employees, faculty, affiliated investigators, personnel, and staff, including attorneys&#146; fees and all costs associated with administrative, judicial or other proceedings, within thirty (30) days after receiving an invoice from Wistar for same; <b>(iv)</b> the exclusive licenses granted in this Agreement shall, as of the date of initiation of said challenge or opposition, automatically convert to a non-exclusive license for the remainder of the Term, and Wistar shall have the right to grant licenses under the Licensed Patents to third parties, subject to the then-existing non-exclusive license provided herein; <b>(v)</b> any fees, royalties, milestones or revenues payable to Wistar hereunder shall double in amount if and when any Licensed Patent survives the Patent Challenge such that it remains valid in whole or in part; and <b>(vi)</b> at any time after the Patent Challenge is brought, Wistar may, at its option, terminate this Agreement according to Section </font><font style=TEXT-DECORATION:none>9.2</font><font style=TEXT-DECORATION:none>; <i>provided</i> that if any of subsections (i) through (vi) are held invalid or unenforceable for any reason, such invalidity or unenforceability shall not affect any of the other said subsections.&nbsp; Notwithstanding any provision of this Agreement to the contrary, Company shall not have the right to assume or participate in the defense, settlement or other disposition of such Patent Challenge through its status as a licensee under this Agreement, but shall pay associated costs, fees and expenses as provided in Section </font><b><font style="FONT-SIZE:13pt; TEXT-DECORATION:none" lang=AR-SA></font></b><font style=TEXT-DECORATION:none>7.5</font><font style=TEXT-DECORATION:none>(iii).&nbsp; The parties agree any challenge or opposition to a Licensed Patent by Company may be detrimental to Wistar, and that the above provisions shall constitute reasonable liquidated damages to reasonably compensate Wistar for any loss it may incur as a result of Company taking such action.</font></h2> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Ref381833698><font style=TEXT-TRANSFORM:uppercase>Article 8 - </font>CONFIDENTIALITY</a></h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935000><a name=_Toc475037578><a name=_Toc474936118><a name=_Toc474935694><a name=_Toc474935300><b><font style=TEXT-DECORATION:none>8.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Confidentiality</u></a><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236932><a name=_Ref381834310><b>8.1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>&#147;<u>Wistar Confidential Information</u>&#148; means <b>(i)</b> the Licensed Technical Information; <b>(ii)</b> any information provided to Company in connection with Prosecution under this Agreement, and <b>(iii)</b> any information or material that is sent to Company by Wistar prior to or after the Effective Date of this Agreement and marked &#147;Confidential&#148; or when the confidential nature of such information or material is apparent from context and subject matter.&nbsp; &#147;<u>Company Confidential Information</u>&#148; means <b>(a)</b> the Commercialization Plan, and <b>(b)</b> any reports prepared by Company and provided to Wistar pursuant to Sections &nbsp;</a>3.8, <b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>4.4.1 and 4.9. The terms of this Agreement but not the existence of this Agreement, constitute the Confidential Information of both parties hereunder. &#147;<u>Confidential Information</u>&#148; means the Wistar Confidential Information and Company Confidential Information, as applicable.</h3> <p align=center>27<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236933><a name=_Ref381837688><b>8.1.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>For the Term of this Agreement and a period of five (5) years thereafter, <b>(a)</b> Company shall maintain in confidence and shall not disclose to any third party any Wistar Confidential Information, and <b>(b)</b> Wistar shall maintain in confidence and shall not disclose to any third party any Company Confidential Information.&nbsp; Each party shall take all reasonable steps to protect the Confidential Information of the other party with the same degree of care used to protect its own confidential or proprietary information.&nbsp; Neither party shall use the Confidential Information of the other party for any purpose other than those contemplated by this Agreement. The foregoing obligations under this Section </a>8.1.2 shall not apply to:</h3> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>information that is known to the receiving party or independently developed by the receiving party prior to the time of disclosure without use of or reference to the other party&#146;s Confidential Information, in each case, to the extent evidenced by written records promptly disclosed to the furnishing party upon receipt of such Confidential Information;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>information disclosed to the receiving party by a third party that has a right to make such disclosure;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>information that becomes patented, published or otherwise part of the public domain as a result of acts by the furnishing party or a third party obtaining such information as a matter of right; or</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>information that is required to be disclosed by order of the FDA or similar authority or a court of competent jurisdiction or other government authority or agency; <i>provided</i> that the parties shall use their best efforts to obtain confidential treatment of such information by the agency, authority, or court.</p> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236934><b>8.1.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Wistar shall not be obligated to accept, and assumes no institutional liability or responsibility for, Company Confidential Information that Company furnishes to any employee of Wistar other than its business or legal officers as provided in this Agreement.&nbsp; If Company desires to furnish any Company Confidential Information to other employees of Wistar, Company shall so inform Wistar and Wistar shall decide whether such individual may receive some or all such Company Confidential Information and, if so, whether such individual shall sign a separate confidentiality agreement to govern the use and disclosure of such information.</a></h3> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935001><a name=_Toc382236935><a name=_Toc382236343><a name=_Toc475037579><a name=_Toc474936119><a name=_Toc474935695><a name=_Toc474935301><b><font style=TEXT-DECORATION:none>8.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Publication</u></a><font style=TEXT-DECORATION:none>.&nbsp; Company acknowledges that a basic objective of the research and development activities of Wistar is the generation of new knowledge and its expeditious dissemination.&nbsp; To further that objective, Wistar retains the right, at its discretion, to demonstrate, publish or publicize a description of the Licensed Patents and Licensed Technical Information and any results of research conducted by Wistar with or relating to the Licensed Patents or Licensed Technical Information.</font><font style=TEXT-DECORATION:none>&nbsp; </font></h2> <p align=center>28<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236936><a name=_Toc382236344><a name=_Toc474935002><a name=_Toc475037580><a name=_Toc474936120><a name=_Toc474935696><a name=_Toc474935302><b><font style=TEXT-DECORATION:none>8.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Use of Name; Publicity</u></a><font style=TEXT-DECORATION:none>. &nbsp;Company &nbsp;or ITUS shall not directly or indirectly use Wistar&#146;s name, or the name of any current or former trustee, manager, officer, agent, employee, faculty, affiliated investigator, personnel or staff thereof, without Wistar&#146;s prior written consent. Subject to Section 8.1, neither party shall issue any press release or other public statements related to this Agreement without the prior written consent of an authorized representative of the other party as to each such use; <i>provided</i> that, the parties and ITUS may make the factual statement that Company has an exclusive license from Wistar under one or more of the patents or patent applications comprising the Licensed Patents, &nbsp;and may discuss the terms of this License, intellectual property rights licensed under this license, payments made under this License, and regulatory status of any Licensed Products sold or for which regulatory approval is being sought to sell under this License, in filings of the Company or ITUS made with the Securities Exchange Commission (SEC) and in investor or road show presentations or on the Company&#146;s or ITUS&#146;s website.&nbsp; Company will provide Wistar with any proposed SEC filings that are required to be provided for review at least 24 hours prior to filing or disclosure.</font><font style=TEXT-DECORATION:none>&nbsp; Company or ITUS will consider in good faith any requests of Wistar to redact information from the proposed filings, and Company or ITUS will be permitted to make its filings if otherwise in compliance with this Agreement upon expiration of the 24 hour notice period.&nbsp; For the avoidance of doubt, Company or ITUS need not provide to Wistar any information that has previously been disclosed. </font>&nbsp;&nbsp;</h2> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><a name=_Toc475037581><a name=_Toc474936121><a name=_Toc474935697><a name=_Toc474935303><a name=_Toc474935099><a name=_Toc474935003><a name=_Toc382253464><a name=_Toc382253434><a name=_Toc382236937><a name=_Toc382236345><a name=_Ref381833720><font style=TEXT-TRANSFORM:uppercase><font style='FONT:7pt "Times New Roman"'></font>Article 9 - </font>TERM AND TERMINATION</a></h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935004><a name=_Toc382236938><a name=_Toc382236346><a name=_Toc475037582><a name=_Toc474936122><a name=_Toc474935698><a name=_Toc474935304><b><font style=TEXT-DECORATION:none>9.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Term</u></a><font style=TEXT-DECORATION:none>.&nbsp; This Agreement shall remain in effect until the expiration of the Term unless earlier terminated as provided hereunder.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref492036857><a name=_Ref475016161><a name=_Ref474939744><a name=_Ref474939584><a name=_Ref474939379><a name=_Toc474935005><a name=_Toc382236939><a name=_Toc382236347><a name=_Toc475037583><a name=_Toc474936123><a name=_Toc474935699><a name=_Toc474935305><b><font style=TEXT-DECORATION:none>9.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Termination by Wistar</u></a><font style=TEXT-DECORATION:none>.&nbsp; Upon the occurrence of any of the events set forth below, Wistar shall have the right to terminate this Agreement by giving written notice of termination, such termination to be effective with the giving of such notice, except that in the case of (iv), below, such termination shall occur automatically and without the necessity of notice by Wistar:</font></h2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>Company fails to pay any amount payable to Wistar within sixty (60) days after such amount becomes due;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>Company fails to pay the Patenting Costs as required by Section 7.1.1 within sixty (60) days after such amount becomes due;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>material breach by Company of any covenant or agreement (other than a breach referred to in clause (i) above) or any representation or warranty contained in this Agreement that is continuing sixty (60) days after Wistar gives Company written notice of such breach; notwithstanding the foregoing, if Company violates the laws, regulations or other legal authority in any jurisdiction relating to the development, use, storage, or marketing of the Licensed Products in a way that Wistar deems in its reasonable judgment to constitute a public safety or health hazard, Wistar may immediately terminate the license hereunder;<b> </b></p> <p align=center>29<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>Company becomes subject to a Bankruptcy Event; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(v)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>the dissolution or cessation of operations by Company; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(vi)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>Company or any of its Affiliates or Sublicensees bring a Patent Challenge against Wistar, or assists others in bringing a Patent Challenge against Wistar (except as required under a court order or subpoena); or</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(vii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>Company fails to perform or fulfill its diligence obligations or any Performance Milestone in accordance with the requirements of Sections 4.1 or 4.2 and that failure is continuing ninety (90) days after Wistar gives Company written notice of such breach; and</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref491967598><b><font style=FONT-SIZE:11pt>(viii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>Wistar&#146;s right of termination in this Section </a>9.2 shall be in addition and without prejudice to, and shall not constitute a waiver of, any right of Wistar for recovery of any monies then due to it hereunder or any other right or remedy Wistar may have at law, in equity or under this Agreement.</p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref474939764><a name=_Toc474935006><a name=_Toc475037584><a name=_Toc474936124><a name=_Toc474935700><a name=_Toc474935306><b><font style=TEXT-DECORATION:none>9.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Termination by Company</u></a><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236941><b>9.3.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company may terminate this Agreement upon sixty (60) days&#146; prior written notice to Wistar if Wistar is in material breach of this Agreement and such material breach remains uncured for sixty (60) days after Company gives Wistar written notice of such breach.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref475016145><a name=_Ref474928957><a name=_Toc382236942><a name=_Ref492036845><b>9.3.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>In addition, if the Company is in good standing and has paid all monies due to Wistar under this Agreement, Company shall have the right to terminate this Agreement at any time after the third anniversary of this Agreement with or without cause upon ninety (90) days prior written notice to Wistar.</a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>9.3.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Company&#146;s right of termination in this Section <b><font style=FONT-SIZE:11pt lang=AR-SA></font></b>9.3 shall be in addition and without prejudice to, and shall not constitute a waiver of, any right or remedy Company may have at law, in equity or under this Agreement.</h3> <h2 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967613><a name=_Ref474938978><a name=_Ref474938928><a name=_Toc474935007><a name=_Toc382236943><a name=_Toc382236349><a name=_Toc475037585><a name=_Toc474936125><a name=_Toc474935701><a name=_Toc474935307><b><font style=TEXT-DECORATION:none>9.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Effect on Sublicenses</u></a><font style=TEXT-DECORATION:none>.&nbsp; Upon expiration or earlier termination of this Agreement for any reason, Company shall promptly notify its Sublicensees of such expiration or termination.&nbsp; Upon notice by Wistar of its intent to terminate (or, if notice is not required, upon termination) of this Agreement, Company shall no longer have the authority to grant further Sublicenses. Any Sublicenses granted by Company under Section </font><b><font style="FONT-SIZE:13pt; TEXT-DECORATION:none" lang=AR-SA></font></b><font style=TEXT-DECORATION:none>2.4</font><font style=TEXT-DECORATION:none> of this Agreement shall terminate upon the expiration or earlier termination of this Agreement, unless Wistar, in its sole discretion, requests in writing that such Sublicense survive such expiration or termination and remain in force and effect, in which case such Sublicense shall be assigned to Wistar.</font></h2> <p align=center>30<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; TEXT-DECORATION:underline; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'> </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967619><a name=_Toc474935008><a name=_Toc382236944><a name=_Toc382236350><a name=_Toc475037586><a name=_Toc474936126><a name=_Toc474935702><a name=_Toc474935308><b><font style=TEXT-DECORATION:none>9.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Rights and Duties Upon Termination</a> or Expiration</u><font style=TEXT-DECORATION:none>.&nbsp; Upon termination or expiration of this Agreement for any reason:</font> </h2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>all rights and licenses granted to Company under the terms of this Agreement shall terminate and nothing herein shall be construed to release either party from any obligation that matured prior to the effective date of such termination or expiration; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>all Confidential Information of the furnishing party shall be promptly returned or destroyed, at the furnishing party&#146;s election; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>Company shall cease all production and sale of Licensed Products; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(iv)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>final reports in accordance with Section 3.8 shall be submitted to Wistar; and </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(v)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>all royalties and other payments, including any unreimbursed Patent Costs, accrued or due to Wistar as of the termination or expiration date shall become immediately payable.&nbsp; Notwithstanding the foregoing, after the effective date of termination of this Agreement, unless for breach by Company, Company and its Sublicensees may, for a period of six (6) months, sell all Licensed Products existing at the time of such termination or expiration, and complete Licensed Products in the process of manufacture at the time of such termination or expiration and sell the same, <i>provided</i> that Company shall comply with, and cause its Sublicensees to comply with, all of the terms of this Agreement, including, <b>(a)</b> Company shall pay to Wistar the running royalties and other payments as required hereinabove in Article 3, <b>(b)</b> insurance requirements as described in Section 6.5, and <b>(c)</b> Company shall submit the reports required by Section 3.8 hereof. </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935009><a name=_Toc382236945><a name=_Toc382236351><a name=_Ref382230879><a name=_Toc475037587><a name=_Toc474936127><a name=_Toc474935703><a name=_Toc474935309><b><font style=TEXT-DECORATION:none>9.6<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Disposition of Company Developments</u></a><font style=TEXT-DECORATION:none>.&nbsp; In the event this Agreement is terminated, Wistar&#146;s financial interest in and to the Licensed Patents may be harmed, due to lost patent term and other factors.&nbsp; Therefore, in the event of termination of this Agreement prior to expiration of the Term, Company shall:</font></h2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref381834293><b><font style=FONT-SIZE:11pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>provide Wistar with access to and, at Wistar&#146;s request, deliver to Wistar all documents, filings, data and other information in Company&#146;s possession relating to any of the Licensed Patents or Licensed Products, including all records required by regulatory authorities to be maintained with respect to Licensed Products, all regulatory filings, approvals, reports, records, correspondence and other regulatory materials (including any related to reimbursement or pricing approvals), and all documents, data and other information related to Clinical Trials and other studies of Licensed Products (collectively, &#147;<u>Documentation and Approvals</u>&#148;);</a> and </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b><font style=FONT-SIZE:11pt>(ii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>permit Wistar and its licensees and sublicensees to utilize, reference, cross reference, incorporate in applications and filings, and otherwise have the benefit of all Documentation and Approvals.; and </p> <p align=center>31<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.25in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref381834282><b><font style=FONT-SIZE:11pt>(iii)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b>provide to Wistar a copy of, and grant Wistar on mutually agreed terms a non-exclusive royalty-based, fully paid-up, perpetual, irrevocable, sublicensable license to, all patents and applications of Company and its Affiliates that improve or are otherwise related to the Licensed Patents or that cover a Licensed Product (&#147;<u>Company IP</u>&#148;).&nbsp; Wistar shall be free to use Company IP in the course of developing Licensed Products and/or otherwise exploiting the Licensed Patents, including licensing such rights to third parties.</a></p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967638><a name=_Toc474935010><a name=_Toc382236946><a name=_Toc382236352><a name=_Toc475037588><a name=_Toc474936128><a name=_Toc474935704><a name=_Toc474935310><b><font style=TEXT-DECORATION:none>9.7<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Provisions Surviving Termination</a> or Expiration</u><font style=TEXT-DECORATION:none>.&nbsp; Company&#146;s obligation to pay any amounts accrued but unpaid, and to discharge any obligations or responsibilities arising, prior to expiration or earlier termination of this Agreement shall survive such termination or expiration.&nbsp; In addition, Sections </font><font style=TEXT-DECORATION:none>2.2.1</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>3.10</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>4.5.3</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>7.1.6</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>7.2</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>9.2(viii)</font><font style=TEXT-DECORATION:none>, 9.3 </font><font style=TEXT-DECORATION:none>9.4</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>9.5</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>9.6</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>9.7</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>9.8</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>10.3</font><font style=TEXT-DECORATION:none>, </font><font style=TEXT-DECORATION:none>10.4</font><font style=TEXT-DECORATION:none> and </font><font style=TEXT-DECORATION:none>10.9</font><font style=TEXT-DECORATION:none> and Articles 1, 6 and 8, the defined terms and provisions used or referenced therein, and any other provisions required to interpret the rights and obligations of the parties arising prior to the termination or expiration date shall survive expiration or termination of this Agreement.</font></h2> <p style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><b><font style=TEXT-DECORATION:none>9.8<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Right to Payment Accrues During Term of Agreement</u><font style=TEXT-DECORATION:none>.&nbsp; Whenever a payment to Wistar with respect to sales of any Licensed Product is provided for in this Agreement, the right of Wistar to such payment shall accrue at the time such product is manufactured or produced during the Term of this Agreement.&nbsp; Therefore any inventory or stocks of such products existing prior to the expiration or earlier termination of this Agreement but sold thereafter shall generate payment to Wistar in accordance with the applicable percentage or other method for determining the amount of such payment provided in this Agreement.&nbsp; In such cases, Company shall promptly remit payment to Wistar after the receipt of consideration from sale of such products.</font></p> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in; page:WordSection1'><font style=TEXT-TRANSFORM:uppercase>Article 10 - </font>ADDITIONAL PROVISIONS</h1> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref382232733><a name=_Ref474939986><a name=_Ref474938855><a name=_Toc474935013><a name=_Toc475037592><a name=_Toc474936131><a name=_Toc474935707><a name=_Toc474935313><b><font style=TEXT-DECORATION:none>10.1<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Assignment</u></a><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236950><a name=_Ref381261499><b>10.1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp; </font></b>This Agreement shall be binding upon and shall inure to the benefit of the parties and their respective permitted assigns and successors in interest.&nbsp; Except as expressly permitted in this Agreement, Company shall not assign, delegate or subcontract any of its rights or obligations under this Agreement without the prior written consent of Wistar.</a> </h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1' align=justify><a name=_Toc382236951><b>10.1.2.<font style='FONT:7pt "Times New Roman"'>&nbsp; </font></b>No such consent shall be required to assign this Agreement to a successor in connection with a merger or consolidation of Company, or to the purchaser of all or substantially all the assets of Company, <i>provided</i> that:&nbsp; </a><a name=DocXTextRef58><b>(i)</b></a> Company is not in breach of this Agreement; <b>(ii)</b> such successor or purchaser shall agree in writing to be bound by the terms and conditions hereof prior to such assignment; <b>(iii)</b> Company shall provide Wistar with evidence to demonstrate that such successor or purchaser has or is likely to acquire, in a reasonable period of time, capital and personnel resources sufficient to fulfill the obligations it is assuming hereunder; <b>(iv)</b> Company shall notify Wistar in writing of any assignment and provide a copy of all assignment documents (pursuant to which such transferee shall have agreed in writing to be bound by the terms and conditions of this Agreement) to Wistar within thirty (30) days of assignment; and <a name=DocXTextRef59><b>(v)</b></a> <b>***</b>. </h3> <p align=center>32<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Ref381261501>&nbsp;</h3><a name=_Toc382236952><b>10.1.3.<font style='FONT:7pt "Times New Roman"'>&nbsp; </font></b>Failure of an assignee to agree to be bound by the terms hereof or failure of Company to notify Wistar and provide copies of assignment documentation shall be grounds for termination of this Agreement for default.&nbsp; Any attempted assignment in contravention of this Section </a>10.1 shall be null and void. No assignment shall relieve Company of any obligation it has accrued prior to such assignment.</p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935014><a name=_Toc382236953><a name=_Toc382236356><a name=_Toc475037593><a name=_Toc474936132><a name=_Toc474935708><a name=_Toc474935314><b><font style=TEXT-DECORATION:none>10.2<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>No Waiver</u></a><font style=TEXT-DECORATION:none>.&nbsp; A waiver by either party of a breach or violation of any provision of this Agreement shall not constitute or be construed as a waiver of any subsequent breach or violation of that provision or as a waiver of any breach or violation of any other provision of this Agreement.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967673><a name=_Toc474935015><a name=_Toc382236954><a name=_Toc382236357><a name=_Toc475037594><a name=_Toc474936133><a name=_Toc474935709><a name=_Toc474935315><b><font style=TEXT-DECORATION:none>10.3<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Independent Contractor</u></a><font style=TEXT-DECORATION:none>.&nbsp; Nothing herein shall be deemed to establish a relationship of principal and agent between Wistar and Company, nor any of their Sublicensees, Affiliates, agents or employees for any purpose whatsoever.&nbsp; This Agreement shall not be construed as constituting Wistar and Company, or Wistar and any Sublicensees, as partners, or as creating any other form of legal association or arrangement which could impose liability upon one party for the act or failure to act of the other party.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967679><a name=_Toc474935016><a name=_Toc382236955><a name=_Toc382236358><a name=_Toc475037595><a name=_Toc474936134><a name=_Toc474935710><a name=_Toc474935316><b><font style=TEXT-DECORATION:none>10.4<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Notices</u></a><font style=TEXT-DECORATION:none>.&nbsp; Any notice given under this Agreement shall be in writing and shall be deemed delivered when sent by prepaid, express, first class, certified or registered mail, or by overnight courier, with confirmed receipt, addressed to the parties as follows (or at such other addresses as the parties may notify each other in writing):</font></h2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  MARGIN:0in 0in 12pt 1in; page:WordSection1'>If to Wistar:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; page:WordSection1'>The Wistar Institute</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; page:WordSection1'>3601 Spruce Street</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; page:WordSection1'>Philadelphia, PA&nbsp; 19104</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 1in; page:WordSection1'>Attn:&nbsp; Office of Business Development</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 1in; page:WordSection1'>With a copy to:&nbsp; Attn:&nbsp; Vice President, General Counsel, Secretary and Government Relations</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 1in; page:WordSection1'>If to Company:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; page:WordSection1'>Certainty Therapeutics, Inc.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; page:WordSection1'>3150 Almaden Expressway, </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 1in; page:WordSection1'>Suite 250, San Jose, California 95118</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 1in; page:WordSection1'>Attn:&nbsp; Amit Kumar, Chief Executive Officer </p> <p align=center>33<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt 1in; page:WordSection1'> </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935017><a name=_Toc382236956><a name=_Toc382236359><a name=_Toc475037596><a name=_Toc474936135><a name=_Toc474935711><a name=_Toc474935317><b><font style=TEXT-DECORATION:none>10.5<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Entire Agreement</u></a><font style=TEXT-DECORATION:none>.&nbsp; This Agreement, together with the Equity Documents, embodies the entire understanding between the parties relating to the subject matter hereof and supersedes the Option and all prior understandings and agreements, whether written or oral.&nbsp; This Agreement may not be varied except by a written document signed by duly authorized representatives of both parties.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935018><a name=_Toc382236957><a name=_Toc382236360><a name=_Toc475037597><a name=_Toc474936136><a name=_Toc474935712><a name=_Toc474935318><b><font style=TEXT-DECORATION:none>10.6<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Severability</u></a><font style=TEXT-DECORATION:none>.&nbsp; Any of the provisions of this Agreement which are determined to be invalid or unenforceable in any jurisdiction shall be ineffective to the extent of such invalidity or unenforceability in such jurisdiction, without rendering invalid or unenforceable the remaining provisions hereof or affecting the validity or unenforceability of any of the terms of this Agreement in any other jurisdiction.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935019><a name=_Toc382236958><a name=_Toc382236361><a name=_Toc475037598><a name=_Toc474936137><a name=_Toc474935713><a name=_Toc474935319><b><font style=TEXT-DECORATION:none>10.7<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Headings; Interpretation</u></a><font style=TEXT-DECORATION:none>.&nbsp; Any article and section headings and captions used in this Agreement are for convenience of reference only and shall not affect its construction or interpretation. The words &#147;include&#148; or &#147;including&#148; shall be construed as incorporating, also, &#147;but not limited to&#148; or &#147;without limitation.&#148;&nbsp; The parties acknowledge that each party has read and negotiated the language used in this Agreement.&nbsp; Because all parties participated in negotiating and drafting this Agreement, no rule of construction shall apply to this Agreement which construes ambiguous language in favor of or against any party by reason of that party&#146;s role in drafting this Agreement.</font></h2> <h2 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc474935020><a name=_Toc382236959><a name=_Toc382236362><a name=_Toc475037599><a name=_Toc474936138><a name=_Toc474935714><a name=_Toc474935320><b><font style=TEXT-DECORATION:none>10.8<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>No Third Party Benefits</u></a><font style=TEXT-DECORATION:none>.&nbsp; Nothing in this Agreement, express or implied, is intended to confer on any Person other than the parties hereto or their permitted assigns, any benefits, rights or remedies.</font></h2> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif";  FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Ref491967687><a name=_Ref474940213><a name=_Toc474935021><a name=_Toc475037600><a name=_Toc474936139><a name=_Toc474935715><a name=_Toc474935321><b><font style=TEXT-DECORATION:none>10.9<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Disputes; Governing Law; Jurisdiction</a>; Arbitration</u><font style=TEXT-DECORATION:none>.</font></h2> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><a name=_Toc382236961><b>10.9.1.<font style='FONT:7pt "Times New Roman"'>&nbsp; </font></b>In the case of any dispute, claim, question or disagreement arising out of or relating to this Agreement, or the parties&#146; activities hereunder, including any question regarding the existence, validity or termination of this Agreement, the parties shall use all reasonable efforts to settle such dispute, claim, question or disagreement by amicable agreement, including by escalation to the President and Chief Executive Officer of Wistar and Chief Executive Officer of Company, if necessary, prior to commencement of arbitration.</a><a name=_Toc382236962> </a></h3> <h3 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'><b>10.9.2.<font style='FONT:7pt "Times New Roman"'>&nbsp; </font></b>This Agreement shall be construed, governed, interpreted and applied in accordance with the laws of the Commonwealth of Pennsylvania, without giving effect to conflict of law principles.&nbsp; Any controversy or claim arising out of or relating to this contract, or the breach thereof, shall be settled by arbitration administered by the American Arbitration Association in accordance with its Commercial Arbitration Rules, and judgment on the award rendered by&nbsp; the arbitrator(s) may be entered in any court having jurisdiction thereof.</h3> <p align=center>34<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 0.5in; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in; page:WordSection1'> </p> <h2 style='FONT-SIZE:12pt;  FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt 22.5pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'><a name=_Toc382236964><a name=_Toc382236364><a name=_Toc475037601><a name=_Toc474936140><a name=_Toc474935716><a name=_Toc474935322><a name=_Toc474935022><b><font style=TEXT-DECORATION:none>10.10<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font></b><u>Counterparts</u></a><font style=TEXT-DECORATION:none>.&nbsp; This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against the party whose signature appears thereon, but all of which taken together shall constitute but one and the same instrument.</font></h2><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:115%'> <div style=page:WordSection1></div> <p></font>&nbsp;</p> <div align=center>35</div> <div align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%; page:WordSection1'> </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in; page:WordSection1'>IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the Effective Date.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; page:WordSection1'>&nbsp;</p> <div style=page:WordSection1> <table bordercolor=transparent style=BORDER-COLLAPSE:collapse cellpadding=0 cellspacing=0> <tr> <td width=273 colspan=2 style="WIDTH:204.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=69 style="WIDTH:52.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=282 colspan=3 style="WIDTH:211.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><b><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>CERTAINTY THERAPEUTICS, INC.</font></b></p></td></tr> <tr> <td width=36 style="WIDTH:27pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>By:</font></p></td> <td width=237 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:177.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>/s/ Heather A. Steinman</font></p></td> <td width=69 style="WIDTH:52.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=24 style="WIDTH:17.9pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>By:</font></p></td> <td width=258 colspan=2 style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:193.5pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>/s/ Amit Kumar</font></p></td></tr> <tr> <td width=36 style="WIDTH:27pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=237 style="WIDTH:177.5pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"' lang=DE>Heather A. Steinman, Ph.D., M.B.A.</font></p></td> <td width=69 style="WIDTH:52.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=282 colspan=3 style="WIDTH:211.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Name: Amit Kumar</font></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Title: Chief Executive Officer</font></p></td></tr> <tr> <td width=36 style="WIDTH:27pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=237 style="WIDTH:177.5pt; BORDER-BOTTOM:medium none; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Vice President, Business Development and Executive Director, Technology Transfer</font></p></td> <td width=69 style="WIDTH:52.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=35 colspan=2 style="WIDTH:26pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=247 style="WIDTH:185.4pt; BORDER-BOTTOM:medium none; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td></tr> <tr> <td width=36 style="WIDTH:27pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Date:</font></p></td> <td width=237 style="WIDTH:177.5pt; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>November 9, 2017</font></p></td> <td width=69 style="WIDTH:52.1pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'>&nbsp;</p></td> <td width=35 colspan=2 style="WIDTH:26pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>Date:</font></p></td> <td width=247 style="WIDTH:185.4pt; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=top> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>November 13, 2017</font></p></td></tr> <tr> <td width=36 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=237 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=69 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=27 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=11 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px"> <td width=247 style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-BOTTOM:0px; BORDER-LEFT:0px" /></tr></table><div align=center>36</div></div></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV><div style=page:WordSection2><p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-WEIGHT:normal>LICENSE AGREEMENT</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-WEIGHT:normal>BETWEEN</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-WEIGHT:normal>THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-WEIGHT:normal>AND</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-TRANSFORM:uppercase;  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-WEIGHT:normal>CERTAINTY THERAPEUTICS, INC.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <h1 style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  TEXT-ALIGN:center; MARGIN:12pt 0in; TEXT-INDENT:0in'><a name=_Toc475037602><a name=_Toc474936141><a name=_Toc474935717><a name=_Toc474935323><a name=_Toc474935101><a name=_Toc474935023>INDEX OF SCHEDULES</a></h1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt' align=center>Schedule I &#150; Licensed Patents </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt' align=center>Schedule II &#150; Quarterly Report</p></div> <p align=center><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'>37<br></p> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font>  <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%'></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt'>Schedule I </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; LINE-HEIGHT:200%; TEXT-INDENT:0in' align=center><font style=TEXT-TRANSFORM:uppercase>Licensed Patents</font></p> <table width=618 bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:463.5pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; MARGIN-LEFT:9.9pt; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr style=HEIGHT:17.5pt> <td width=111 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:83.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>Inventors</font></p></td> <td width=134 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>Serial No.</font></p></td> <td width=97 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:73.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>App. Type</font></p></td> <td width=118 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:88.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>File Date</font></p></td> <td width=158 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:118.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style=FONT-SIZE:11pt>Title</font></p></td></tr> <tr style=HEIGHT:40.5pt> <td width=111 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:83.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal" lang=ES>Alfredo Perales-Puchalt, Jose Conejo-Garcia</font></p></td> <td width=134 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">62/059,068</font></p></td> <td width=97 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:73.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">PPA1</font></p></td> <td width=118 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:88.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">10/02/2014</font></p></td> <td width=158 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:118.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Methods and Compositions for Treating Cancer</font></p></td></tr> <tr style=HEIGHT:40.5pt> <td width=111 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:83.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal" lang=ES>Alfredo Perales-Puchalt, Jose Conejo-Garcia</font></p></td> <td width=134 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">62/202,824</font></p></td> <td width=97 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:73.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">PPA2</font></p></td> <td width=118 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:88.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">8/08/2015</font></p></td> <td width=158 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:118.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Methods and Compositions for Treating Cancer</font></p></td></tr> <tr style=HEIGHT:40.5pt> <td width=111 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:83.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal" lang=ES>Alfredo Perales-Puchalt, Jose Conejo-Garcia</font></p></td> <td width=134 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">PCT/US2015/053128 </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub No.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">WO 2016/054153</font></p></td> <td width=97 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:73.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">PCT</font></p></td> <td width=118 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:88.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">9/30/2015</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub Date: 4/07/2016</font></p></td> <td width=158 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:118.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Methods and Compositions for Treating Cancer</font></p></td></tr> <tr style=HEIGHT:40.5pt> <td width=111 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:83.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal" lang=ES>Alfredo Perales-Puchalt, Jose Conejo-Garcia</font></p></td> <td width=134 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">US15/515,442</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub No.</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">US 2017/0226176 A1</font></p></td> <td width=97 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:73.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">US National Phase</font></p></td> <td width=118 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:88.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">9/30/2015 (5/29/2017)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub Date: 8/10/2017</font></p></td> <td width=158 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:118.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Methods and Compositions for Treating Cancer</font></p></td></tr> <tr style=HEIGHT:40.5pt> <td width=111 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:83.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal" lang=ES>Alfredo Perales-Puchalt, Jose Conejo-Garcia</font></p></td> <td width=134 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">15847792.7</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub No. EP2300815A</font></p></td> <td width=97 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:73.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Europe National Phase</font></p></td> <td width=118 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:88.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">9/30/2015</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">(4/29/2017)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub Date: 8/09/2017</font></p></td> <td width=158 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:118.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Methods and Compositions for Treating Cancer</font></p></td></tr> <tr style=HEIGHT:40.5pt> <td width=111 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:83.05pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal" lang=ES>Alfredo Perales-Puchalt, Jose Conejo-Garcia</font></p></td> <td width=134 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:100.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">201580065382.9</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub No. CN 106999552</font></p></td> <td width=97 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:73.1pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">China National Phase</font></p></td> <td width=118 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:88.55pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">9/30/2015</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">(6/01/2017)</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Pub Date: 8/01/2017</font></p></td> <td width=158 style="BORDER-TOP:0px; HEIGHT:40.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:118.15pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:11pt; FONT-WEIGHT:normal">Methods and Compositions for Treating Cancer</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt' align=center>&nbsp;</p><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; LINE-HEIGHT:115%'> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif";  FONT-WEIGHT:bold; TEXT-ALIGN:center; MARGIN:0in 0in 12pt'><a name=ScheduleIV>Schedule II</a></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 10pt; LINE-HEIGHT:115%' align=center><font style=TEXT-TRANSFORM:uppercase>Quarterly Report </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:0.5in'>Per Section <font lang=AR-SA></font>3.8 of this Agreement, reports shall include at least the following, on a Licensed Product-by-Licensed Product and country-by-country basis: </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>A.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>the numbers or quantity of each Licensed Product sold by Company, its Affiliates and each Sublicensee during the Calendar Quarter; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>B.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>the gross amount billed and actually collected by Company, its Affiliates and Sublicensees for Licensed Products, and an accounting of any non-monetary consideration for each Licensed Product sold by Company, its Affiliates and each Sublicensee during the Calendar Quarter; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>C.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>deductions applicable to the sale of each Licensed Product during the Calendar Quarter, as provided in the definition of Net Sales;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>D.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>average sale price during the Calendar Quarter;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>E.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>exchange rates used for currency conversion under Section 3.9.2 for the Calendar Quarter and the basis and methodology used;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>F.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>total royalties due to Wistar under Section 3.2.1 for the Calendar Quarter, as well as a detailed accounting of how such payments were calculated; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>G.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>milestone payments due to Wistar;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>H.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Minimum Annual Royalties and maintenance fees due to Wistar; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>I.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>names and addresses of all Sublicensees of Company during the Calendar Quarter; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>J.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>Non-Royalty Sublicensing Income received during the Calendar Quarter from each Sublicensee, identifying the types of payment as further described in the definition of Non-Royalty Sublicensing Income; </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>K.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>description and product codes, or other Company identifier, of each Licensed Product sold during the Calendar Quarter; and</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-JUSTIFY:inter-ideograph; TEXT-INDENT:1in'><b>L.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></b>a list of countries in which a First Commercial Sale occurred in the Calendar Quarter.</p></div></body>
<!-- EDGAR Validation Code: 7C622400 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>3
<FILENAME>exhibit10_15.htm
<DESCRIPTION>EXHIBIT 10.15
<TEXT>
<HTML>
<head><title>Exhibit 10.15</title> </head> <body vlink=purple link=blue lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><b>Exhibit 10.15</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Confidential Treatment Requested by ITUS Corporation,</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>IRS Employer Identification No. 11-2622630</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>***CONFIDENTIAL TREATMENT REQUESTED*** </b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt'><b><font style=FONT-SIZE:12pt>Note: Confidential treatment requested with respect to certain portions hereof denoted with &#147;[***]&#148;</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt'><font style=FONT-SIZE:12pt>COLLABORATION AGREEMENT</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>THIS AGREEMENT is entered into on <a name=Text9>November 17, 2017</a> (hereinafter &#147;Effective Date) by and between H. Lee Moffitt Cancer Center and Research Institute, Inc. a non-profit Florida corporation organized pursuant to Section 1004.43, Florida Statutes, whose address is 12902 Magnolia Drive Tampa, Florida 33612 (&#147;Moffitt&#148;) and Certainty Therapeutics, Inc., a corporation duly organized under the laws of&nbsp; <a name=Text11>Delaware </a>&nbsp;whose address is 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (hereinafter "Company"). Moffitt and Company are hereinafter referred to individually as &#147;Party&#148; and collectively as &#147;Parties.&#148;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:12pt>WHEREAS, the Company has been formed to exploit certain Intellectual Property obtained in a license from The Wistar Institue of Anatomy and Biology pursuant to a License Agreement between The Wistar Institute of Anatomy and Biology (&#147;Wistar&#148;) and Company, dated November 13, 2017; </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>WHEREAS, Moffitt is a National Cancer Institute designated comprehensive cancer center, a statewide research institute, and a national resource for basic science, clinical research, and interdisciplinary approaches to research and patient treatment;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'>WHEREAS, Moffitt and Company <font style=LETTER-SPACING:-0.15pt>through their respective scientists and investigators wish to jointly engage in the basic and/or translational research project set forth in the Research Plan (defined below) </font>to perform preclinical testing necessary to support clinical testing in accordance with Good Laboratory Practices (GLP) and FDA requirements<font style=LETTER-SPACING:-0.15pt>.&nbsp; </font></p> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</font></h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; TEXT-DECORATION:none; FONT-WEIGHT:normal">ARTICLE 1&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>DEFINITIONS</font><font style=FONT-SIZE:12pt>.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>1.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>The foregoing recitals are hereby incorporated herein by reference and acknowledged as true and correct.&nbsp; Unless specifically set forth to the contrary in this Agreement, the following terms, whether use in the singular or plural, shall have the respective meanings set forth below.&nbsp; </font></h2> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;Anti-Corruption Laws&#148; shall mean any anti-bribery and anti-corruption laws, rules, regulations applicable to a party under this Agreement (each as amended from time to time) including the Prevention of Corruption Act (cap.241) of Singapore, the U.S. Anti-Kickback Law, U.S. Foreign Corrupt Practices Act, the UK Bribery Act 2010 and the OECD Convention Against the Bribery of Foreign Government Officials in International Business Transactions, together with any applicable implementing legislation, including any applicable local law addressing bribery or corruption.</font></h3> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>1</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0in'>&nbsp;</p> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Budget</u>&#148; shall mean the budget that was agreed to by the Parties to be used for the purpose of performing the Research Plan, attached hereto as Exhibit C, which is incorporated herein in its entirety.&nbsp; In the event Exhibit C is blank or is not attached hereto, then the Parties understand and agree that Company will not be providing funding for the Research Plan.&nbsp; </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Confidential Information</u>&#148; shall mean all information and materials, including but not limited to invention disclosures, proprietary technologies, economic information, business or research strategies, trade secrets and material embodiments thereof, furnished by or on behalf of such Party which would reasonably be considered to be proprietary or confidential, or that is marked &#147;confidential&#148; (or if provided in oral, visual or non-tangible form, made known at the time of disclosure to be confidential, but shall not include Data. </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(d)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&nbsp;&#147;<u>Data</u>&#148; shall mean Moffitt Data and Company Data.&nbsp; </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(e)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Invention</u>&#148; shall mean any and all discoveries, developments, improvements, modifications, formulations, analogs or homologs, materials, compositions of matter, cell lines, processes, machines, manufactures and other inventions (whether or not patentable) conceived, discovered, or otherwise made under or arises from the Research Plan.&nbsp;&nbsp; </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(f)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><b><font style=FONT-SIZE:12pt>"</font></b><u><font style=FONT-SIZE:12pt>Joint Inventions</font></u><b><font style=FONT-SIZE:12pt>"</font></b><font style=FONT-SIZE:12pt> shall mean Inventions arising from the Research Plan and invented jointly on one hand by Company employees or persons obligated to assign Inventions to Company and on the other hand by Moffitt employees. Moffitt and Company shall jointly own all Joint Inventions.</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(g)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Company Data</u>&#148; shall have the meaning set forth in Section 4.1.&nbsp; </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(h)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>"<u>Company Inventions</u>" shall mean Inventions arising from the Research Plan and invented solely by Company employees or persons obligated to assign their Inventions to Company. Company retains all right, title, and interest in and to all Company Inventions.</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(i)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Company Research Materials</u>&#148; shall mean (i) compound, cell line, mouse, vector, antibody, tissue, or any material transferred from Company to Moffitt while this Agreement is in full force and effect and (ii) is fully identified and described in Exhibit A, which is incorporated herein in its entirety.&nbsp; If Company Research Materials are not listed on or identified in Exhibit A, then the Parties understand and agree that Company will not be providing any Company Research Materials under this Agreement.&nbsp; </font></h3> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>2</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'>&nbsp;</p> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(j)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Moffitt Data</u>&#148; shall have the meaning set forth in Section 4.1 of this Agreement.&nbsp; </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(k)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><b><font style=FONT-SIZE:12pt>"</font></b><u><font style=FONT-SIZE:12pt>Moffitt Inventions</font></u><b><font style=FONT-SIZE:12pt>"</font></b><font style=FONT-SIZE:12pt> shall mean Inventions arising from the Research Plan and invented solely by its employees, including from its employees use of Third Party Research Materials.&nbsp; Moffitt has the full right and authority to protect and commercialize Moffitt Inventions.</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(l)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&nbsp;&#147;<u>Moffitt Research Materials</u>&#148; shall mean (i) compound, cell line, mouse, vector, antibody, tissue, or any material generated or created under the Research Plan and transferred from Moffitt to Company while this Agreement is in full force and effect and (ii) is fully identified and described in Exhibit A.&nbsp; Moffitt Research Materials includes progeny and derivatives of Moffitt Research Materials.&nbsp; If Moffitt Research Materials are not listed on or identified in Exhibit A, then the Parties understand and agree that Moffitt will not be providing any Moffitt Research Materials under this Agreement.&nbsp; </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(m)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;Third Party Research Materials&#148;&nbsp; shall mean mean any third party owned (i) compound, cell line, mouse, vector, antibody, tissue, or any material generated, created that Moffitt is required to use to conduct the Research Plan while this Agreement is in full force and effect and (ii) are identified and described in Exhibit A.</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(n)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Option Period</u>&#148; shall have the meaning set forth in Section 6.5. </font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(o)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Negotiation Period</u>&#148; shall have the meaning set forth in Section 6.5.</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(p)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&nbsp;&#147;<u>Research Plan</u>&#148; shall mean the research described in Exhibit B, which is incorporated herein in its entirety.&nbsp; The Research Plan may only be changed or amended by prior written agreement by the Parties.</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(q)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>&#147;<u>Term</u>&#148; shall have the meaning set forth in Section 7.1 of this Agreement.</font></h3> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 2&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>SUPPLY OF RESEARCH MATERIALS</font></u><font style=FONT-SIZE:12pt><u>.</u>&nbsp; </font></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>2.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Company agrees to provide Moffitt with the Company Research Materials to the extent set forth in Exhibit A.&nbsp; Company also may, at its discretion, provide Moffitt with certain information relating to the Research Materials.&nbsp; Moffitt agrees to provide Company with Moffitt Research Materials to the extent set forth in Exhibit A.&nbsp; </font></h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 3&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>RESEARCH ACTIVITIES</font></u><font style=FONT-SIZE:12pt><u>.</u>&nbsp; </font></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>3.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt and Company shall and use commercially reasonable efforts to undertake the Research Plan as set forth in Exhibit B.&nbsp; The Research Plan may be modified, supplemented, or amended, but only as agreed to in writing by both Parties. </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>3.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt will use any Company Research Materials provided to Moffitt solely for research purposes in accordance with the Research Plan.&nbsp; Moffitt will obtain written permission to use any Third Party Research Materials required to conduct the Research Plan.&nbsp; Moffitt will not use Company Research Materials, Moffitt Research Materials, or Third Party Research Materials to conduct studies or trials in human subjects, in clinical trials, or for in vitro or in vivo diagnostic purposes involving human subjects without the prior written consent of Company.&nbsp; Moffitt will not transfer any Company Research Materials to a third party.&nbsp; &nbsp;&nbsp;</font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>3</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>3.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Company will use Moffitt Research Materials and Third Party Research Materials solely for research purposes in accordance with the Research Plan. Company will not use Moffitt Research Materials or conduct studies or trials in human subjects, in clinical trials, or for in vitro or in vivo diagnostic purposes involving human subjects without the prior written consent of Moffitt. Company will not transfer Moffitt Research Materials to a third party.&nbsp; Company shall not use the Moffitt Research Material, Company Research Material, or Third Party Research Material to produce or manufacture products that will be sold, leased, licensed or transferred to any third party. </font></h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 4&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>DATA AND REPORTING</font><font style=FONT-SIZE:12pt>.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>4.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font>&#147;<font style=FONT-SIZE:12pt>Moffitt Data&#148; shall mean any data, results, analysis (including bioinformatic analysis), or other information generated by or in collaboration with Moffitt in its performance of the Research Plan or use of Company Research Materials or Third Party Research Materials.&nbsp; &#147;Company Data&#148; shall mean any data, results, analysis (including bioinformatic analysis), or other information generated by Company in its performance of the Research Plan or use of the Moffitt Research Materials.&nbsp; The Moffitt Data and Company Data shall be jointly owned by the Parties.&nbsp; &nbsp;&nbsp;The Research Plan and all Moffitt Data and Company Data generated from conducting the Research Plan shall be conducted and recorded in accordance with Good Laboratory Practices (GLP) and in a manner to support an Investigational New Drug Application with the FDA.&nbsp; From time to time, the Company and its authorized agents, may monitor the conduct of the Research Plan, and generation of Moffitt Data in accordance with these requirements and may visit Moffitt and meet with the Moffitt principal investigator(s) responsible for the performance of the Research Plan for the purpose of such monitoring.&nbsp; Any such monitoring or visits shall be scheduled with reasonable advance notice in coordination with Moffitt during normal business hours and under Moffitt&#146;s supervision.&nbsp; To the extent required by law, Moffitt shall also permit inspection by responsible legal and regulatory authorities with respect to the Research Plan and preclinical studies to be conducted in accordance with the Research Plan or as otherwise reasonably necessary to satisfy the request of such authorities related to this Research Plan.&nbsp; To the extent permitted by law and practicable, Moffitt shall notify Company of any such inspections. &nbsp;Throughout the Term, Moffitt shall maintain complete and accurate records of all Moffitt Data and provide Company a copy of such Moffitt Data at least quarterly and upon reasonable request by Company and its authorized agents at time intervals other than quarterly.&nbsp; Throughout the Term, Company shall maintain complete and accurate records of all Company Data and provide Moffitt a copy of such Company Data at least quarterly and upon reasonable request by Moffitt at time intervals other than quarterly.&nbsp; Within sixty days after the expiration or termination of this Agreement or completion of the Research Plan, whichever is earlier, Moffitt shall promptly provide a written report, and copy, of any and all of the Moffitt Data to Company. Within sixty days after the expiration or termination of this Agreement or completion of the Research Plan, whichever is earlier, Company shall promptly provide a written report, and copy, of any and all of the Company Data to Moffitt.</font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>4</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>4.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Company recognizes that Moffitt and any third party that may own rights in the Moffitt Data) may wish to publish the Data in scientific journals or present the Data at symposia or other academic meetings, and Company agrees that Moffitt (and any third party having rights in the Moffitt Data) will have the right to do so, solely in accordance with the following provisions.&nbsp; Moffitt will submit to Company any such proposed publication or presentation of the Data at least thirty (30) days prior to the submission for publication or presentation.&nbsp; If Company determines that the proposed publication or presentation contains patentable subject matter that requires protection, Company may require the delay of publication or presentation for an additional period of not more than thirty (30) days to permit the preparation and filing of a patent application.&nbsp; If Company, on its own, or after consultation with Wistar, determines that the proposed publication or presentation includes Company Confidential Information, it will so inform Moffitt, and Moffitt will delete such Company Confidential Information from any proposed disclosure as directed by Company.&nbsp; Notwithstanding the foregoing, once Company has reviewed a publication or presentation for written or oral disclosure and the additional period of 30 days to permit filing of a patent application has expired, Moffitt (and third parties) shall be allowed to freely disclose such publication or presentation in the future.&nbsp;&nbsp; If Moffitt makes any material changes to a publication or presentation, such publication or presentation must be re-submitted to Company for review in accordance with this Section 4.2. &nbsp;&nbsp;</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>4.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>The Parties may elect to collaborate together in writing a manuscript to be published in a respected scientific journal. For such jointly written manuscript, authorship shall be based on contributions to the Research Plan, in accordance with academic standards and custom.&nbsp; </font></h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 5&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>OWNERSHIP; NO IMPLIED LICENSE</font><font style=FONT-SIZE:12pt>.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>5.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt acknowledges and agrees that, notwithstanding any other provisions of this Agreement, (i) Company holds all right, title, and interest in and to the Company Research Materials and Company Confidential Information, and (ii) Company has the right to use or permit others to use the Company Research Materials and Company Confidential Information at any time for any lawful purpose.&nbsp; No option, license, or conveyance of rights, express or implied, is granted by Company to Moffitt in connection with any Company Research Materials or Company Confidential Information, except the right to use the Company Research Materials and Company Confidential Information in accordance with the terms of this Agreement.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>5.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Company acknowledges and agrees that, notwithstanding any other provisions of this Agreement, (i) Moffitt holds all right, title, and interest in and to the Moffitt Research Materials and Moffitt Confidential Information, and (ii) Moffitt has the right to use or permit others to use the Moffitt Research Materials and Moffitt Confidential Information at any time for any lawful purpose.&nbsp; No option, license, or conveyance of rights, express or implied, is granted by Moffitt to Company in connection with any Moffitt Research Materials or Moffitt Confidential Information, except the right to use the Moffitt Research Materials and Moffitt Confidential Information in accordance with the terms of this Agreement.&nbsp; For the avoidance of doubt, this does not affect the Company&#146;s joint ownership of the Moffitt Data as set forth in Section 4.1.</font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>5</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; TEXT-DECORATION:none; FONT-WEIGHT:normal">ARTICLE 6&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>INVENTIONS</font><font style=FONT-SIZE:12pt>.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>6.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Inventorship shall be determined by the patent laws of the United States and initial ownership shall follow inventorship.&nbsp; Each Party shall retain all of its right, title and interest in and to any and all inventions made prior to, or outside the activities of, this Agreement. Except as expressly set forth herein, no license, express or implied, is granted with respect to any patents, patent applications, know-how (whether patentable or unpatentable) or other intellectual property rights of the other Party.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>6.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt shall have the sole right to file, prosecute and maintain patent applications and patents with respect to Moffitt Inventions. &nbsp;Company shall have the sole right to file, prosecute and maintain patent applications and patents with respect to Company Inventions.&nbsp; </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>6.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>With respect to Joint Inventions, Company shall file, prosecute, and maintain patent applications on behalf of the Parties, at Company&#146;s sole expense.&nbsp; With respect to any Joint Invention, Company shall (a) consult with Moffitt and keep Moffitt fully informed of the progress of all patent applications and patents, including all issues relating to the preparation, filing, prosecution and maintenance of patent applications and patents that claim Joint Inventions, (b) consult with Moffitt and keep the Moffitt fully informed about Company&#146;s patent strategy with respect to patent applications that claim Joint Inventions, (c) provide to Moffitt advance copies of documents relevant to preparation, filing, prosecution and maintenance of the patent applications and patents that claim Joint Inventions sufficiently in advance of filing to allow Moffitt a reasonable opportunity to review and comment on such documents, (d) consider and implement all Moffitt comments on such patent filings, and (e) provide Moffitt with final copies of such documents.&nbsp; </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>6.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Company hereby grants Moffitt a royalty free, non sublicensable, non transferable, perpetual, non exclusive license to use and practice any Company Invention for its internal non-commercial research purposes.&nbsp; Moffitt hereby grants Company a royalty free, non sublicensable, non transferable, perpetual, non exclusive license to use and practice any Moffitt Invention for its internal, non-commercial research purposes.&nbsp; </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>6.5.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt hereby grants Company an option to a royalty-bearing, sublicensable, exclusive license in Moffitt Inventions and Moffitt&#146;s interest in Joint Inventions for such territories as Company may request.&nbsp; Company may exercise its option to such exclusive license at any time within six (6) months after Moffitt notifies Company of a new Invention.&nbsp; ("Option Period").&nbsp; In the event Company notifies Moffitt in writing that it wishes to exercise its option to an exclusive license during the Option Period, the Parties shall have six (6) months ("Negotiation Period") to agree on the terms of such license, which shall be negotiated in good faith under commercially reasonable terms.&nbsp; In the event that (a) Company fails to notify Moffitt of its desire to exercise its option to an exclusive license during the Option Period, or (b) Company notifies Moffitt that it does not wish to exercise its option to an exclusive license, or (c) the Parties are unable to agree on the terms of such license by the end of the Negotiation Period, then Moffitt shall have no further obligation to Company with respect to such Invention except that Company &#146;s internal research use license shall continue in effect. </font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>6</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>6.6.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt shall obtain all intellectual property rights in all data and intellectual property that any vendor or subcontractor Moffitt engages in performing the Research Plan.&nbsp; Any data that a vendor or subcontractor that Moffitt engages in performing the Development Plan generates or creates shall be treated as Moffitt Data jointly owned by Moffitt and the Company and any such subcontractor or vendor that Moffitt engages shall have no rights in and to such data, Moffitt also shall obtain all intellectual property rights in any new inventions that any vendor or subcontractor Moffitt engages develops in performing the Development Plan. To the extent that they are not Joint Inventions, any such inventions generated or created by a vendor or subcontractor that Moffitt engages in performing the Development Plan shall be treated as Moffitt Inventions, subject to Section 6.5.&nbsp; In the event that Moffitt engages a third party academic organization to perform any of the activities under the Research Plan, Moffitt shall use commercially reasonable efforts to obtain the greatest amount of data and intellectual property rights from such relationship.&nbsp; In any event, Moffitt shall ensure at a minimum, that any intellectual property that a third party academic organization creates or develops in the course of performing the Research Plan that is necessary for commercialization, shall be made available for license to Company on fair, reasonable, and non-discriminatory terms.&nbsp; </font></h2> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 7&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>TERM AND TERMINATION</font></u><font style=FONT-SIZE:12pt><u>.</u> </font></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>7.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>This Agreement will commence as of the Effective Date set forth in the first paragraph of this Agreement and unless terminated otherwise as provided herein, this Agreement will expire twenty-four (24) months from such date, unless extended upon mutual written agreement of the Parties (&#147;Term&#148;).</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>7.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Either Party may terminate this Agreement (i) upon any breach by the other Party of the terms or conditions of this Agreement, which breach cannot be, or is not, cured within thirty (30) days after the breaching Party receives written notice by the non-breaching Party regarding such breach or (ii) upon the other Party becoming bankrupt or making an assignment for the benefit of its creditors, upon appointment of a trustee or receiver for the other Party of all or substantially all of its property, or upon the filing of a voluntary or involuntary petition by or against the other Party under any bankruptcy or insolvency law, the reorganization or rearrangement provisions of the United States Bankruptcy Code, or any similar law, (iii) or upon the termination, death, or other nonavailability of the Moffitt principal investigator(s) responsible for conducting the Research Plan and the Parties cannot reach agreement on new principal investigators.&nbsp; The rights of termination under this Section 7 will not be affected in any way by a Party's waiver or failure to take action with respect to any previous breach or other circumstance giving rise to the rights of termination hereunder.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>7.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Termination of this Agreement for any reason will be without prejudice to any rights that will have accrued to the benefit of either Party prior to such termination.&nbsp; Sections 3-6, 8, and 10-13 shall survive termination or expiration of this Agreement.&nbsp; Upon expiration or termination of this Agreement, Moffitt (i) will immediately terminate the Research Plan, including without limitation ceasing all uses of the Company Research Materials and Company Confidential Information, and (ii) will, at the direction of Company, within thirty days after termination, destroy or return (a) all Company Research Materials supplied to it and (b) all copies of the Company Confidential Information (except that Moffitt may retain one copy of the Company Confidential Information solely for archival purposes, subject to the obligations of Section 8 below).&nbsp; Upon expiration or termination of this Agreement, Company (i) will immediately terminate the Research Plan, including without limitation ceasing all uses of the Moffitt Research Materials and Moffitt Confidential Information, and (ii) will, at the direction of Moffitt, within thirty days after termination, destroy or return (a) all Moffitt Research Materials supplied to it and (b) all copies of the Moffitt Confidential Information (except that Company may retain one copy of the Moffitt Confidential Information solely for archival purposes, subject to the obligations of Section 8 below).&nbsp; </font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>7</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'>&nbsp;</p> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 8&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>CONFIDENTIALITY AND USE</font><font style=FONT-SIZE:12pt>.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>8.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>To the extent permitted by law, the Parties shall safeguard the other Party&#146;s Confidential Information against disclosure to third parties with the same degree of care as it exercises with its own data of a similar nature. <font style="COLOR:black; LETTER-SPACING:-0.15pt">Moffitt and Company agree not to disclose Confidential Information to others (except to their employees, agents, independent contractors, consultants, or affiliates who are bound by a like obligation of confidentiality).</font> The Parties shall use the Confidential Information of the other Party in furtherance of performing or carrying out their respective obligations and duties under this Agreement. Confidential Information <font style="COLOR:black; LETTER-SPACING:-0.15pt">does not include information which:</font></font></h2> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(a)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>is publicly available prior to the date of this Agreement or becomes publicly available thereafter through no wrongful act of the receiving Party;</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(b)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>was known to the receiving Party prior to the date of disclosure or becomes known to the receiving Party thereafter from a third party having a bona fide right to disclose the information;</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(c)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>the receiving Party can demonstrate, through written documentation, was in the receiving Party&#146;s rightful possession on a non-confidential basis prior to disclosure by the providing Party hereunder;</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(d)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>the receiving Party can demonstrate, through written documentation, is disclosed to the receiving Party without restriction on further disclosure;</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(e)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>the receiving Party can demonstrate, through written documentation, is independently developed without the use of the providing Party&#146;s Confidential Information;</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(f)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>must reasonably be disclosed to regulatory authorities, provided that the receiving Party promptly notifies the providing Party to give the providing Party the opportunity to contest or limit the scope of such disclosure; or</font></h3> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>(g)<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>is obligated to produce pursuant to an order of a court of competent jurisdiction or a facially valid administrative, legislative or other subpoena or pursuant to applicable law, provided that the receiving Party promptly notifies the providing Party to give the providing Party the opportunity to contest or limit the scope of such order.</font></h3> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>8</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'>&nbsp;</p> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>8.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>The obligations of confidentiality and non use under this Section 8 shall continue for five (5) years after the Effective Date.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>8.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Use of Name; Publicity.&nbsp; The parties may make the factual statement that Company has entered into this Collaboration Agreement with Moffitt and may discuss the terms of this Agreement, the Research Plan, and progress and status of the completion of the Research Plan, in filings of the Company or ITUS made with the Securities Exchange Commission (SEC) and in investor or road show presentations.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'>&nbsp;</h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal"><u>ARTICLE 9&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></u></font><font style=FONT-SIZE:12pt><u>NOTICES.</u>&nbsp; </font></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>9.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Any request, notice, report, payment, approval or other communication required or permitted under this Agreement will be in writing, and will be deemed delivered (i) on the date of delivery when delivered personally; (ii) on the date sent by confirmed facsimile (followed by the actual document sent by commercial express courier specifying next day delivery, with written verification of receipt); (iii) one business day after deposit with a commercial overnight courier specifying next day delivery, with written verification of receipt; or (iv) on the date received when sent by registered or certified mail, return receipt requested, postage prepaid; and (v) on the date received when sent by electronic mail.&nbsp; All communications will be sent to the address set forth below or such other address as either Party may designate from time to time in accordance with this Section 9.1.</font></h2> <table bordercolor=transparent style=BORDER-COLLAPSE:collapse cellpadding=0 cellspacing=0> <tr> <td width=319 style="WIDTH:239.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><u>To Company : </u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Certainty Therapeutics, Inc.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>3150 Almaden Expressway, </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Suite 250, San Jose, California 95118</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Attn:&nbsp; Amit Kumar, Chief Executive Officer</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Email:&nbsp; ak@ITUScorp.com</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=319 style="WIDTH:239.4pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><u>To Moffitt:</u></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>H. Lee Moffitt Cancer Center and Research Institute, Inc.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Attention: Director, Office of Sponsored Research</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>12902 Magnolia Drive, MBC-OSR</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Tampa, FL&nbsp; 33612</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Fax:&nbsp; (813) 745-6804</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>awards@moffitt.org </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>With courtesy copies to:&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>H. Lee Moffitt Cancer Center and Research Institute, Inc.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Attention: Vice President for Research Administration</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font lang=IT>12902 Magnolia Drive, SRB-3</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font lang=IT>Tampa, FL&nbsp; 33612</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Fax:&nbsp; (813) 745-8709</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>H. Lee Moffitt Cancer Center and Research Institute, Inc.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Attn: L. David de la Parte, General Counsel</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>12902 Magnolia Drive</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Tampa, Florida 33612-9497</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr></table> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 12pt; TEXT-INDENT:0in'>&nbsp;</h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>9</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 10&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>GOVERNING LAW.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>10.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>This Agreement shall be governed by, and construed and interpreted in accordance with, the laws of the State of Florida without reference to conflict of laws principles or statutory rules of arbitration included therein. Any dispute or proceeding under this Agreement shall be subject to the exclusive jurisdiction and venue of the 13th Judicial Circuit in and for Hillsborough County, Florida and the parties hereby consent to the exclusive personal jurisdiction and venue of these courts.</font></h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; FONT-WEIGHT:normal">ARTICLE 11&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>WARRANTIES AND INDEMNIFICATION.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>11.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt accepts any Company Research Materials with the knowledge that they are experimental in nature and agree to comply with all laws and regulations for the shipping, handling and use thereof. COMPANY RESEARCH MATERIALS ARE BEING SUPPLIED &#147;AS IS&#148; WITH NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR WARRANTY AGAINST INFRINGEMENT.&nbsp; Company accepts the Moffitt Research Materials with the knowledge that they are experimental in nature and agree to comply with all laws and regulations for the shipping, handling and use thereof. MOFFITT RESEARCH MATERIALS ARE BEING SUPPLIED &#147;AS IS&#148; WITH NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR WARRANTY AGAINST INFRINGEMENT.&nbsp; </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>11.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>No indemnification for any loss, claim, damage, or liability is intended or provided by either Party under this Agreement.&nbsp; Each Party shall be liable for any loss, claim, damage or liability that said Party incurs as a result of said Party&#146;s activities under this Agreement.</font></h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><font style="FONT-SIZE:12pt; TEXT-DECORATION:none; FONT-WEIGHT:normal"><u>ARTICLE 12&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></u></font><font style="FONT-SIZE:12pt; COLOR:black"><u>PAYMENT SCHEDULE.</u>&nbsp; </font></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>12.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt shall be compensated by Company for its conduct of the Research Plan in accordance with the Budget as outlined in Exhibit C of this Agreement.&nbsp; The Budget sets forth the dollar amount and schedule for all payments owed to Moffitt under this Agreement.&nbsp; Unless otherwise agreed in writing by the Parties, such payment amount is inclusive of any and all applicable fees, personnel costs, and overhead. </font></h2> <h1 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:bold; MARGIN:0in 0in 12pt; TEXT-INDENT:0in'><u><font style="FONT-SIZE:12pt; TEXT-DECORATION:none; FONT-WEIGHT:normal">ARTICLE 13&nbsp;&nbsp;&nbsp;&nbsp; <font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>MISCELLANEOUS</font><font style=FONT-SIZE:12pt>.</font></u></h1> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.1.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>The Parties shall have separate agreements with their employees whereby the employees are obligated to assign all right, title, and interest in any Invention generated in the course of the Research Plan to such Party.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.2.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Company shall perform the Research Plan and its other obligations hereunder, and use the Moffitt Research Materials in compliance with all applicable laws, regulations and legal requirements, including but not limited to those relating to biotechnological research, handling and containment of biohazardous materials, and use or disclosure of patient information or materials.</font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>10</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.3.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt shall perform the Research Plan and its other obligations hereunder, and use the Company Research Materials in compliance with all applicable laws, regulations and legal requirements, including but not limited to those relating to biotechnological research, handling and containment of biohazardous materials, and use or disclosure of patient information or materials.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.4.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt shall (a) comply with all applicable laws, rules and regulations pertaining to the development, testing, manufacture, marketing, import or export of any licensed products; and (b) not employ, contract with or retain any person directly or indirectly in the performance of the Research Plan if such person is: (i) excluded from a Federal health care program as outlined in Sections 1128 and 1156 of the Social Security Act (see the Office of Inspector General of the Department of Health and Human Services List of Excluded Individuals/Entities at http://www.oig.hhs.gov/fraud/exclusions/exclusions_list.asp), (ii) debarred by any Health Authority, including (but not limited to) by the FDA under 21 U.S.C. 335a (see the FDA Office of Regulatory Affairs Debarment List at http://www.fda.gov/ICECI/EnforcementActions/FDADebarmentList/default.htm), or (iii) excluded from contracting with the federal government (see the Excluded Parties Listing System at www.sam.gov). </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.5.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt acknowledges that the transfer and use by foreign nationals of certain commodities and technical data is subject to U.S. laws and regulations controlling the export and use by foreign nationals of such commodities and technical data, including the Arms Export Control Act, the International Traffic in Arms Regulations (&#147;ITAR&#148;), the Export Administration Regulations (&#147;EAR&#148;) and the laws and regulations implemented by the Office of Foreign Assets Control, U.S. Department of the Treasury (&#147;OFAC&#148;).&nbsp; These laws and regulations, among other things, prohibit or require a license for the export or use by foreign nationals of certain types of technical data to specified countries.&nbsp; Moffitt shall comply with all such applicable U.S. laws and regulations in the performance of the Research Plan. </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.6.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Moffitt agrees that it has not and will not, either directly or indirectly, engage in bribery, or offer, or promise, or authorize to pay or make any improper payment of any monies or financial or other advantage, including cash, loan, gift, travel, entertainment, hospitality, facilitation payment, kickback, political or philanthropic contribution, anything of value, or any other perceived benefit to improperly obtain or retain a business advantage in violation of any Anti-Corruption Laws and further, each party hereunder agrees that it shall not take any action that would cause the other parties to be in violation of such Anti-Corruption Laws in the performance of the Research Plan.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.7.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>The Parties represent and warrant that they have the right and authority to enter into this Agreement and perform its obligations and grant the rights granted hereunder and that no pre-existing or future obligation, through contract or otherwise, will substantially interfere with or prevent them from performing its obligations or substantially interfere with or prevent them from exercising its rights hereunder.</font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>11</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <h3 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 1in; TEXT-INDENT:0in'>&nbsp;</h3> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.8.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Each Party shall not assign or transfer any rights, obligations or duties under this Agreement without the prior written consent of the other Party.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.9.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>This Agreement shall constitute the entire understanding between the Parties and supersedes any and all prior or contemporaneous representations, agreements and promises, written or oral, between the Parties regarding the subject matter of this Agreement. No modification, amendment, or waiver may be accomplished to the terms of the Agreement without the written consent of both Parties.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.10.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>This Agreement may be executed in one or more counterpart copies (including by facsimile, pdf, or other electronic delivery), which when joined, shall together constitute one agreement.&nbsp; </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.11.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>In the event that any provision of this Agreement shall be found invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.12.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>It is understood that this Agreement in no way alters any rights that the U.S. Government might have.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.13.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>The headings preceding the text of each section of this Agreement are for convenience only and shall not be construed to define, modify, expand, limit, or affect the construction of or to be taken into account in interpreting the substance of this Agreement.&nbsp; </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.14.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>The failure of any Party hereto to enforce at any time, or for any period of time, any provision of this Agreement shall not be construed as a waiver of either such provision or of the right of such Party thereafter to enforce each and every provision of this Agreement.</font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.15.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>Company shall comply with all applicable United States law and regulations controlling the export of certain commodities and technical data, including without limitation all Export Administration Regulations of the United States Department of Commerce.&nbsp; Among other things, these laws and regulations prohibit or require a license for the export of certain types of commodities and technical data to specified countries.&nbsp; Company hereby gives written assurance that it will comply with all applicable United States export control laws and regulations, that it bears sole responsibility for any violation of such laws and regulations by itself.&nbsp; </font></h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; MARGIN:0in 0in 12pt 0.5in; TEXT-INDENT:0in'><font style=FONT-SIZE:12pt>13.16.<font style='FONT:7pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </font></font><font style=FONT-SIZE:12pt>ITUS Corporation hereby absolutely, unconditionally and irrevocably guarantees to Moffitt the Company&#146;s timely and faithful payment of all financial obligations to Moffitt as set forth in Section 12 and the Budget in Exhibit C of this Agreement. </font></h2> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'><font style=FONT-SIZE:12pt>IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>12</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in'>&nbsp;</p> <table width=867 bordercolor=transparent style="WIDTH:650pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:0.6in" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15.75pt> <td width=42% colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=COLOR:black>CERTAINTY THERAPEUTICS, INC.</font></b></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=COLOR:black>H. LEE MOFFITT CANCER CENTER AND</font></b></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=COLOR:black>RESEARCH INSTITUTE, INC.</font></b></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>By:</font></p></td> <td width=42% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>/s/Amit Kumar</font></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>By:</font></p></td> <td width=42% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>/s/Margaret J. Fonner</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Name:</font></p></td> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Amit Kumar </font></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Name:</font></p></td> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Margaret J. Fonner, CRA</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Title:</font></p></td> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Chief Executive Officer (CEO)</font></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Title:</font></p></td> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>&nbsp;Director, Office of Sponsored Research</font></p></td></tr> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=42% colspan=2 nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style=COLOR:black>ITUS CORPORATION</font></b></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>By:</font></p></td> <td width=42% nowrap style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>/s/Michael J. Catelani</font></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Name:</font></p></td> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Michael Catelani</font></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Title:</font></p></td> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style=COLOR:black>Chief Operating Officer (COO)&nbsp;&nbsp;&nbsp; </font></p></td> <td width=4% nowrap style="HEIGHT:15.75pt; WIDTH:4%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=42% nowrap style="HEIGHT:15.75pt; WIDTH:42%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>13</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div><font style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"'><br clear=all style=PAGE-BREAK-BEFORE:always></font> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 3in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b><u>EXHIBIT A</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>DESCRIPTION AND QUANTITY OF MOFFITT RESEARCH MATERIALS, COMPANY RESEARCH MATERIALS AND THIRD PARTY RESEARCH MATERIALS</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=left> <table bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; MARGIN-LEFT:6.75pt; BORDER-LEFT:0px; MARGIN-RIGHT:6.75pt" cellpadding=0 cellspacing=0 align=left> <tr> <td width=223 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:166.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Moffitt Research Material</b></p></td> <td width=196 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:146.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Description of Material</b></p></td> <td width=220 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:165.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Quantity</b></p></td></tr> <tr style=HEIGHT:7.9pt> <td width=223 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:166.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b>***</b></p></td> <td width=196 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:146.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b>***</b></p></td> <td width=220 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:165.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b>***</b></p></td></tr> <tr> <td width=223 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:166.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Company Research Material</b></p></td> <td width=196 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:146.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Description of Material</b></p></td> <td width=220 style="BORDER-TOP:0px; BORDER-RIGHT:windowtext 1pt solid; WIDTH:165.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Quantity</b></p></td></tr> <tr style=HEIGHT:7.9pt> <td width=223 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:166.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b>***</b></p></td> <td width=196 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:146.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b>***</b></p></td> <td width=220 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:165.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in'><b>***</b></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <div align=left> <table bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; MARGIN-LEFT:6.75pt; BORDER-LEFT:0px; MARGIN-RIGHT:6.75pt" cellpadding=0 cellspacing=0 align=left> <tr> <td width=223 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:166.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Third Party Research Material</b></p></td> <td width=196 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:146.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Description of Material</b></p></td> <td width=220 style="BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:windowtext 1pt solid; WIDTH:165.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>Quantity</b></p></td></tr> <tr style=HEIGHT:7.9pt> <td width=223 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:166.9pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Master Cell Bank</p></td> <td width=196 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:146.65pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b>***</b></p></td> <td width=220 style="BORDER-TOP:0px; HEIGHT:7.9pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:165.25pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Quantity will be agreed upon by both Parties during the term of the Agreement</p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><br clear=all style=PAGE-BREAK-BEFORE:always>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>14</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 12pt' align=center><b><u>EXHIBIT B</u></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'><b><font style=FONT-SIZE:12pt>RESEARCH PLAN</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:4.5pt'>The <b><u>goal</u></b> of this project is to develop a new Chimeric Endocrine Receptor T cell (CERTcell&#153;) therapy against ovarian and prostate cancer, which is similar to chimeric antigen receptors (CARs) T cell therapy but instead using the natural receptor-ligand interactions between follicle-stimulating hormone (FSH) and its receptor (FSHR) expressed on ovarian tumor cells. Upon ligand:receptor interactions, these modified T cells are activated via signaling domains converting these T cells into potent and selective tumor cell killers. Specifically, this proposal will address the necessary preclinical optimization for subsequent clinical testing. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b></b>&nbsp;</p> <ol type=A style="MARGIN-BOTTOM:0in; MARGIN-TOP:0in"> <li style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u>BACKGROUND AND SUMMARY OF PUBLISHED RESULTS </u></b>(PMID: 27435394) </li></ol> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'><b><img width=634 height=47 style="HEIGHT:58px; WIDTH:663px" src=exhibitimage.jpg></b></p> <table bordercolor=transparent style="BORDER-TOP:0px; BORDER-RIGHT:0px; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; MARGIN-LEFT:0.5in; BORDER-LEFT:0px" cellpadding=0 cellspacing=0> <tr style=HEIGHT:54.85pt> <td width=662 style="BORDER-TOP:medium none; HEIGHT:54.85pt; BORDER-RIGHT:medium none; WIDTH:6.9in; BORDER-BOTTOM:medium none; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:5.4pt; BORDER-LEFT:medium none; PADDING-RIGHT:5.4pt" valign=top> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt' align=justify><b><font style=FONT-SIZE:9pt lang=EN-GB>Fig.1. Schematic depiction of FSHR-targeting CER constructs</font></b><font style=FONT-SIZE:9pt lang=EN-GB>. To target FSHR, we synthetized a construct expressing a signal peptide, followed by the two subunits of FSH (FSHb and CGa the latter common to LH and TSH), separated by a linker. This targeting motif was cloned in frame with a hinge domain from CD8a, followed by the transmembrane domain of CD8a, the intracellular domain of a co-stimulatory mediator (4-1BB and CD28 will be tested) and, finally, the activating CD3z domain.</font></p></td></tr></table> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.5in'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u></u></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 9pt; TEXT-INDENT:-9pt'><b>1</b>-In an effort to overcome the paucity of surface (targetable) antigens selectively expressed by tumor cells and not by healthy tissues, we identified FSHR as a targetable (cell surface) antigen present <u>on &gt;50 of ovarian carcinomas</u> of different histological types, including serous malignancies<font style="TEXT-DECORATION:none; COLOR:windowtext"><sup>1-3</sup></font>. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 9pt; TEXT-INDENT:-9pt'><b>2</b>-We demonstrated that in healthy adult women, the <u>FSHR is only expressed in the ovary</u> (granulosa cells<font style="TEXT-DECORATION:none; COLOR:windowtext"><sup>4</sup></font> and at low levels in the ovarian endothelium<font style="TEXT-DECORATION:none; COLOR:windowtext"><sup>5</sup></font>), but NOT in any other healthy tissue, including the brain<font style="TEXT-DECORATION:none; COLOR:windowtext"><sup>3</sup></font>. Given that oophorectomy is a standard procedure in the treatment of ovarian cancer, targeting the FSHR will not damage healthy tissues.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 9pt; TEXT-INDENT:-9pt'><b>3-</b>Human<b> </b>T cells expressing full-length FSH-redirected chimeric receptors (FSHCER T cells; <b>Fig.1</b>) mediate significant <u>therapeutic effects</u> (including tumor rejection) against 3 of 4 patient-derived tumors in vivo, compared to mock-transduced T cells. Consistently, the growth of established FSHR<sup>+</sup> human ovarian cancer CaOV3 tumors was significantly delayed in mice receiving a single injection of 6 million CERT cells, while administration of mock-transduced T cells allows tumor progression. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 9pt; TEXT-INDENT:-9pt'><b>4-</b>In immunocompetent mice growing syngeneic, orthotopic, and aggressive ovarian tumors, fully murine FSH-targeted T cells (carrying mouse FSH as a targeting motif for mouse FSHR) also increased survival <u>without any measurable toxicity</u>. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 9pt; TEXT-INDENT:-9pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b>B. <u>APPROACH</u></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u></u></b>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style=BACKGROUND:silver>PHASE I</font></u></b><b><font style=BACKGROUND:silver>. <font style=COLOR:red>Milestone</font>: Define the Maximum Tolerated Dose for FSHCER T cells and show safety <i>in vivo &nbsp;&nbsp;</i><font style=COLOR:#bfbfbf>.</font></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>We demonstrated that<b> </b>the administration of 2 doses of 1.5 million<b> </b>FSHCER T cells targeting murine FSHR into peritoneal ovarian cancer (ID8-<i>Vegf/Defb29</i>)-bearing immunocompetent mice delayed malignant progression without any alterations in hepatic enzymes, creatinine or any other obvious sign of toxicity<font style="TEXT-DECORATION:none; COLOR:windowtext"><sup>3</sup></font>. These experiments will <b>define the maximum tolerated dose for a single infusion of CERTcells</b>. Here, Moffitt will infuse tumor-free C57BL/6 mice (5/group) with <b>10<sup>6</sup></b>, <b>10<sup>7</sup></b>, or <b>2 X 10<sup>7</sup></b> <i><u>mouse</u></i> FSHCERTcells or HBSS (4 groups), and follow them for 5 months. Doses have been selected based on 5 years of experience with adoptive transfer of T cells in various preclinical models<sup><font style="TEXT-DECORATION:none; COLOR:windowtext">3</font>,<font style="TEXT-DECORATION:none; COLOR:windowtext">6-10</font></sup>. T cells will be initially infused <i>i.p.</i>, because this is the route endorsed by the NCI for targeting ovarian cancer in the clinic<font style="TEXT-DECORATION:none; COLOR:windowtext"><sup>11</sup></font>). In complementary experiments, Moffitt will also challenge NSG mice (5/group) with flank OVCAR3 cells (10<sup>6</sup>) and also treat them at day 14 with <b>10<sup>6</sup></b>, <b>10<sup>7</sup></b>, or <b>2 X 10<sup>7</sup></b> <i><u>human</u></i> FSHCERTcells or HBSS. These mice will be followed until tumors reach 2 cm in any dimension or signs of GVHD (general health deterioration; see below) become obvious. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>15</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:6pt 0in 0pt'><b>Readouts of potential toxicity. </b>In all mice, the following readouts will be monitored:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><u>General health status</u>: The health status of mice will be monitored closely over the first 24 h period, and daily thereafter for one week, then once weekly for the duration of the study. Euthanasia by CO2 will be performed when the following clinical signs associated with pain/distress are observed: Difficult breathing increased respiratory rate, decreased movements or reduced grooming and feeding. Alternatively, mice appearing significantly comprised (e.g. dehydrated, anorexic, dyspnic) will be immediately removed from the study and euthanized by CO2. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><u>Body weight</u>: Moffitt will measure and record body weight daily for the first week, and once per week until the conclusion of the study. If mice experience &gt;10% body weight loss in 24 h they will be euthanized. Otherwise, recorded body weight will be compared to control mice. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><u>IL-6</u>: Serum will be collected through retroorbital bleeding daily for the first 3 days after FSHCER T cell administration, and circulating levels of IL-6 (responsible for the cytokine release syndrome observed in some patients<font style="TEXT-DECORATION:none; COLOR:windowtext"><sup>12</sup></font>) will be quantified. Differences between treatment and control groups will be recorded.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><u>Liver and kidney function</u>: Serum will be also collected by Moffitt through retroorbital bleeding at days 10, 20 and 30 after FSHCERT cell administration, and at the end of the study. AST, ALT and creatinine will be quantified as markers of liver and hepatic function. Differences between treatment and control groups will be recorded.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><u>Cytokines in peritoneal fluid</u>: In different groups of mice treated with the maximum tolerated dose <i>vs.</i> HBSS (5/group), we will also collect peritoneal wash by perfusing the peritoneal cavity with 1 mL of saline at day 3 after FSHCER T cell administration. IL-6 and TNF-a will be determined through ELISA.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><u>Histology</u>: The liver, pancreas, intestine, heart, kidney, brain, and lung will be examined by Moffittfor evidence of tissue damage in H&amp;E staining as well as the presence of (CD45+) inflammatory infiltrates by IHC at the completion of the study. Leukocyte accumulation in healthy tissues will be compared.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>Phase I will be completed during year 1.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style=BACKGROUND:silver>PHASE II</font></u></b><b><font style=BACKGROUND:silver>. <font style=COLOR:red>Milestone</font>: Manufacturing of clinical grade materials for clinical use&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style=COLOR:#bfbfbf>.</font></font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b>Generation of clinical grade vectors for clinical use. </b>Moffitt will work with<b> ***</b>. In collaboration with them, Moffitt will produce <b>a master cell bank</b> using retro-viral vectors encoding the FSH-targeted construct and the proper packaging cells (e.g., pSFG retroviruses packaged in PG13 cells). Moffitt will sequence the vector containing the FSHCERT from 5&#146;LTR to the 3&#146;LTR to ensure that the construct is inserted without alterations to its sequence. We will then test the product to assure the safety of biological products, including: (1) sterility, (2) mycoplasma, and (3) adventitious viral agents, following FDA guidelines. Alternatively, we will consider the production of enough clinical grade CERTcell viral supernatant for a phase I trial through another third party vendor subject to Company approval.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>16</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'><b>Production of clinical grade materials for clinical use. </b>Moffitt will also optimize protocols for the production of human FSHCERT cells using reagents that will be used in the clinical trial and samples from the aphaeresis of 2 healthy donors. Moffitt will perform these experiments at the Cell Therapies Core of Moffitt Cancer Center, which has cutting-edge GMP facilities and experienced personnel for translation of cellular therapies. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>FSHCER constructs will be transduced by spinoculation on CD3/CD28-activated CD3<sup>+</sup> T cells enriched from minileukapheresis products and exposed to viral supernatant on retronectin coated plates in the presence of cytokines. Using FSHCERT cells generated in this manner, Moffitt will design a<i> </i>Q-PCR assay for determining the trafficking and persistence of adoptively transferred CERTcells <i>in vivo</i> in peripheral blood in our future clinical trial. In addition, Moffitt will optimize a flow cytometry analysis of transferred CERTcells based on the detection of FSH<font style=FONT-FAMILY:Symbol>b</font> on transduced (CD3<sup>+</sup>) T cells, by fluorescently labeling available anti-human FSH antibodies, or using a primary anti-FSH antibody and a fluorescently labeled secondary antibody. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>Studies including cryopreservation and storage at 4&#176;C will be performed in transduced CERTcells at the end of cell processing. CERTcells cryopreserved for 1, 3 and 6 months, or stored at 4&#176;C for 24, 48 and 72 hours, will be evaluated for cell viability, CERT expression and functional activity against FSHR-expressing (OVCAR3) tumor cells.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>Phase II will be completed between months 3 and 20.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:9pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><u><font style=BACKGROUND:silver>Subsequent goals</font></u></b><font style=BACKGROUND:silver>(outside scope of the Agreement that the parties may pursue)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><font style=COLOR:#bfbfbf>.</font></b></font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-INDENT:4.5pt'>The ultimate goal of this research collaboration is to move these interventions to a clinical trial. Our current expectations for clinical protocol planning and drafting, to be modified depending on the FDA&#146;s feedback, are outlined below:</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'>-The initial trial should be designed as an open-label, single-arm pilot clinical trial of autologous FSHR redirected T cells administered intraperitoneally in patients with recurrent, chemoresistant FSHR<sup>+</sup> ovarian carcinoma that expresses FSHR, as determined in previous biopsies or the original tumor by western-blot analysis. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'>-Clinical SOPs should be designed based on Moffitt&#146;spreclinical results and other ongoing trials using different CART cell formulations (e.g., https://clinicaltrials.gov/ct2/show/NCT02498912?term=muc+ovarian+cancer&amp;rank=6 ). </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'>-As for other ongoing CAR T cell trials, in some patients a lymphodepleting cyclophosphamide dose of 750 mg/m<sup>2</sup> will be administered 2-4 days prior to starting the T cell infusion.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'>-The primary toxicity that is anticipated is inflammation caused by killing of tumor cells that express the target, which will be preclinically addressed in Phase I. </p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'>-After setting the starting dose, a conventional dose escalation should be based on log (or, if required by FDA, half-log) increments.<i> </i>It is important to note that, because Moffitt will<i> </i>use endogenous FSH, the risk of anaphylaxis or immune targeting of CART cells previously described for xenogeneic (murine) scFvs is negligible. Equally important, the expression of the FSH receptor is limited to the ovary, which is routinely resected in ovarian cancer patients.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>17</p> <div style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:12pt 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'>-Under the scientific direction and oversight of Drs. Marco Davila and Daniel Abate-Daga, Moffitt will &nbsp;assist Certainty Therapeutics, Inc. &nbsp;with submission of the IB, IC, protocol, and other necessary documents to the Recombinant DNA Advisory Committee (RAC), the institutional biosafety committee (IBC), the IRB, the DSMB, the local Phase I committee for the trial site, and the FDA for approval. We anticipate that these necessary regulatory submissions could be completed by the end of the second year of this collaboration.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 4.3pt; TEXT-INDENT:-4.3pt'><b><u></u></b>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:4.5pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:4.5pt'><b><font style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"'>BIBLIOGRAPHY AND REFERENCES CITED</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'>&nbsp;</p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_1>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Zhang, X.Y.<i>, et al.</i> Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo. <i>Cancer Res</i> <b>69</b>, 6506-6514 (2009).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_2>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Al-Timimi, A., Buckley, C.H. &amp; Fox, H. An immunohistochemical study of the incidence and significance of human gonadotrophin and prolactin binding sites in normal and neoplastic human ovarian tissue. <i>Br J Cancer</i> <b>53</b>, 321-329 (1986).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_3>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Perales-Puchalt, A.<i>, et al.</i> Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target. <i>Clin Cancer Res</i> <b>23</b>, 441-453 (2017).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_4>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Simoni, M., Gromoll, J. &amp; Nieschlag, E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. <i>Endocr Rev</i> <b>18</b>, 739-773 (1997).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_5>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vannier, B., Loosfelt, H., Meduri, G., Pichon, C. &amp; Milgrom, E. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor. <i>Biochemistry</i> <b>35</b>, 1358-1366 (1996).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 34.55pt; TEXT-INDENT:-34.55pt'><a name=_ENREF_6>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amatangelo, M.D.<i>, et al.</i> Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition. <i>Cell Cycle</i> <b>12</b>, 2113-2119 (2013).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_7>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nesbeth, Y. &amp; Conejo-Garcia, J.R. Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity. <i>Clin Dev Immunol</i> <b>2010</b>, 139304 (2010).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_8>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nesbeth, Y.<i>, et al.</i> CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. <i>Cancer Res</i> <b>69</b>, 6331-6338 (2009).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_9>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nesbeth, Y.C.<i>, et al.</i> CD4+ T cells elicit host immune responses to MHC class II- ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells. <i>J Immunol</i> <b>184</b>, 5654-5662 (2010).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_10>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stephen, T.L.<i>, et al.</i> Transforming Growth Factor beta-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression. <i>Immunity</i> <b>41</b>, 427-439 (2014).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_11>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Walker, J.L.<i>, et al.</i> Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. <i>Gynecol Oncol</i> <b>100</b>, 27-32 (2006).</a></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Times New Roman","sans-serif"; COLOR:black; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.5in'><a name=_ENREF_12>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lee, D.W.<i>, et al.</i> T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. <i>Lancet</i> (2014).</a></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center><font style=FONT-SIZE:14pt><br clear=all style=PAGE-BREAK-BEFORE:always></font>18</p> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-INDENT:0in' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </h2> <h2 style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; FONT-WEIGHT:normal; TEXT-ALIGN:center; MARGIN:0in 0in 12pt; TEXT-INDENT:0in' align=center><b><u><font style=FONT-SIZE:12pt>EXHIBIT C</font></u></b></h2> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><b>BUDGET</b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p><br clear=all> <div align=center> <table width=984 bordercolor=transparent style="WIDTH:10.25in; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" cellpadding=0 cellspacing=0> <tr style=HEIGHT:15pt> <td width=47% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Principal Investigator: Conejo-Garcia, Jose</font></p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.66%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=75% colspan=5 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:75.1%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">BUDGET -YEARS 1 AND 2</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=9% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:9.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=14% colspan=3 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:14.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=55% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:55.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">PERSONNEL</font></p></td> <td width=15% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:15.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">YEAR 1</font></p></td> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">YEAR 2</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">TOTAL</font></p></td></tr> <tr style=HEIGHT:29.65pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:29.65pt; BORDER-RIGHT:0px; WIDTH:47.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">NAME</font></p></td> <td width=7% nowrap style="HEIGHT:29.65pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">ROLE ON</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">PROJECT</font></p></td> <td width=7% style="HEIGHT:29.65pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Percent</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Effort</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Devoted</font></p></td> <td width=7% nowrap style="HEIGHT:29.65pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Calendar</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Months</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Devoted</font></p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:29.65pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% colspan=2 nowrap style="HEIGHT:29.65pt; WIDTH:8.88%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Salary and </font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Fringe</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Benefits</font></p></td> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:29.65pt; BORDER-RIGHT:0px; WIDTH:8.42%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Salary and Fringe</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center><font style="FONT-SIZE:10pt; COLOR:black">Benefits</font></p></td> <td style="HEIGHT:29.65pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:29.65pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.78%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">KEY PERSONNEL (MCC A)</font></p></td> <td width=7% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=3% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=2 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. Conejo-Garcia</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">PI</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. Davila</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Co-I</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. Abate-Daga</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Co-I</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Dr. Kelley</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Co-I</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:17.5pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><b><font style="FONT-SIZE:10pt; COLOR:black">TECHNICAL STAFF (MCC B)</font></b></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% colspan=2 style="BORDER-TOP:0px; HEIGHT:17.5pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">TBN</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Post Doc</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=3% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <td width=7% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=75% colspan=5 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:75.1%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p 0in &#x2192? text-align: roman?,?serif?; 0pt; center; new margin: style="FONT-SIZE:12pt; FONT-FAMILY:" times align=center><font style="FONT-SIZE:10pt; COLOR:black"><strong>SUBTOTALS&nbsp;&nbsp;&nbsp;&nbsp;<font style=FONT-SIZE:25pt> &#x2192;</font> </strong><strong>&nbsp;</strong></font></p></td> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***</font></p></td> <td width=8% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:8.42%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***</font></p></td> <td width=7% colspan=2 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=47% nowrap style="HEIGHT:15pt; WIDTH:47.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.22%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=7% nowrap style="HEIGHT:15pt; WIDTH:7.66%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:71.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><u><font style="FONT-SIZE:10pt; COLOR:black">Materials and Supplies </font></u></p></td> <td width=3% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% nowrap style="BORDER-TOP:windowtext 1pt solid; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Glassware and Plasticware</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***&nbsp; </font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Beads for lmmunopurification and T cell expansion</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15.75pt> <td width=71% colspan=4 style="HEIGHT:15.75pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Antbodies (FACS, T cell expansion)</font></p></td> <td width=3% nowrap style="HEIGHT:15.75pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15.75pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15.75pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15.75pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">Reagents for Q-PCR</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'></p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>$ </p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">ELISAS, immunological analysis</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black"> </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black"></font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:10pt; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">cell culture</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><u><font style="FONT-SIZE:10pt; COLOR:black">Other Expenses </font></u></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% nowrap style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Comparative Medicine</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black"> </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black"></font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; FACS sorting</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Human Cells Procurement</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Generation and testing of a master cell bank (retrovirus)(Rimedion)</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black"> </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black"></font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Clinical supernatant production and testing (Rimedion)</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> </tr><tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Cell Therapy Core (4 tech transfer runs)</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="HEIGHT:15pt; WIDTH:0.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=6% nowrap style="HEIGHT:15pt; WIDTH:6.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="HEIGHT:15pt; WIDTH:71.28%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">&nbsp;&nbsp;&nbsp; Alliance Management Fee</font></p></td> <td width=3% nowrap style="HEIGHT:15pt; WIDTH:3.82%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="HEIGHT:15pt; WIDTH:1.6%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:6.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td></tr> <tr style=HEIGHT:15pt> <td width=47% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:47.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:7.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=3% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right>&nbsp;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=71% colspan=4 style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:71.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black"><strong>SUBTOTAL DIRECT COSTS</strong></font></p></td> <td width=3% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=71% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:71.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black"><strong>FACILITIES AND ADMINISTRATIVE COSTS @&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***</strong> </font></p></td> <td width=3% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">***</font></p></td></tr> <tr style=HEIGHT:15pt> <td width=71% colspan=4 nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:71.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black"><strong>TOTAL COSTS FOR TOTAL PERIOD</strong></font></p></td> <td width=3% nowrap style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:3.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.22%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:windowtext 1pt solid; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=7% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:7.66%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">458,684</font></p></td> <td width=1% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">701,671</font></p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:0.82%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'><font style="FONT-SIZE:10pt; COLOR:black">$ </font></p></td> <td width=6% style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:windowtext 1pt solid; WIDTH:6.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt' align=right><font style="FONT-SIZE:10pt; COLOR:black">1,160,355</font></p></td></tr></table></div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Moffitt may amend and re-allocate funds within the Budget from time to time at its sole discretion, as long as the total dollar amount of all payments owed to Moffitt under this Agreement are not changed as a result of the re-allocation.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>19</p> <div style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt' align=center> <hr> <DIV style="PAGE-BREAK-BEFORE: always"></DIV> </div> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Payment Schedule:&nbsp;$250,003 shall be invoiced upon execution of the Agreement</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 96pt'>$227,588 shall be invoiced at 6, 12, 18, and 24 months post-Effective Date of the Agreement</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>Payment is due within 45 days after receipt of invoice.</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><b><font style=COLOR:black>Invoice:</font></b></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Moffitt shall submit invoices to:</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'>&nbsp;</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Name: Dr. Amit Kumar</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>Email: ak@ituscorp.com</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'><font style=COLOR:black>CC: mcatelani@ituscorp.com</font></p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in' align=center>20</p> <p style='FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: A2E9363C -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>exhibit21.htm
<DESCRIPTION>EXHIBIT 21
<TEXT>
<HTML>
<head><title>Exhibit-21</title> </head> <body lang=EN-US> <div style=page:WordSection1> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right><b><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; COLOR:black'>Exhibit 21</font></b></p> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal' align=right>&nbsp;</p> <div align=center> <table bordercolor=transparent cellpadding=0 cellspacing=0> <tr> <td width=331 style="WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=1 style="WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /> <td width=260 style="WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" /></tr> <tr style=HEIGHT:14.25pt> <td width=592 colspan=3 style="HEIGHT:14.25pt; WIDTH:444pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:center; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=center><u><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>SUBSIDIARIES OF ITUS CORPORATION</font></u></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><u><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Name of Company and Name Doing Business</font></u></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><u><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Jurisdiction of Organization</font></u></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Anixa Diagnostic Corporation</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Certainty Therapeutics, Inc.</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>CopyTele International Ltd.</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>British Virgin Islands</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>CopyTele Marketing Inc.</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>British Virgin Islands</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>ITUS Patent Acquisition Corporation</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>J-Channel Industries Corporation</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Loyalty Conversion Systems Corporation</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Secure Web Conference Corporation</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; TEXT-ALIGN:right; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal' align=right>&nbsp;</p></td> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Encrypted Cellular Communications Corporation</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Auction Acceleration Corp.</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Cyber Instruments Technologies Corporation.</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Delaware</font></p></td></tr> <tr style=HEIGHT:14.25pt> <td width=331 style="HEIGHT:14.25pt; WIDTH:248.25pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>Meetrix IP, LLC</font></p></td> <td width=1 style="HEIGHT:14.25pt; WIDTH:0.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom /> <td width=260 style="HEIGHT:14.25pt; WIDTH:195pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign=bottom> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 9pt; LINE-HEIGHT:normal'><font style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"'>State of Texas</font></p></td></tr></table></div> <p style='FONT-SIZE:11pt; FONT-FAMILY:"Calibri","sans-serif"; MARGIN:0in 0in 8pt; LINE-HEIGHT:107%'>&nbsp;</p></div></body>
<!-- EDGAR Validation Code: 6D3FCA8A -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>exhibit23_1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<head><title>exhibit 23.1</title> </head> <body lang=EN-US> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1' align=right><b><font style=FONT-SIZE:12pt>Exhibit 23.1</font></b></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1' align=center> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1' align=center>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1' align=center>&nbsp;</p> <div style=page:WordSection1 align=center><b><font style=FONT-SIZE:12pt>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></b></div> <p style=page:WordSection1 /> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'><font style=FONT-SIZE:12pt>We consent to the incorporation by reference in Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 on Form S-3 (No. 333-193869), Amendment No. 1 to the Registration Statement on Form S-3 (No. 333-206782), Registration Statements on Form S-3 (Nos. 333-220963 and 333-217060) and the Registration Statement on Form S-8 (No. 333-202473) of ITUS Corporation (the &#147;Company&#148;) of our report dated January 9, 2018 relating to our audits of the Company&#146;s consolidated financial statements as of October 31, 2017 and 2016, and for each of the years then ended, included in the Company&#146;s Annual Report on Form 10-K for the year ended October 31, 2017.</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 2.5in; TEXT-AUTOSPACE:; TEXT-INDENT:0.5in; punctuation-wrap:simple; page:WordSection1'><font style=FONT-SIZE:12pt>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; HASKELL &amp; WHITE LLP</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'>&nbsp;</p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'><font style=FONT-SIZE:12pt>Irvine, California</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1'><font style=FONT-SIZE:12pt>January 9, 2018</font></p> <p style='FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:; punctuation-wrap:simple; page:WordSection1' align=center>&nbsp;</p></body>
<!-- EDGAR Validation Code: F89AEE5D -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exhibit31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<head><title>Exhibit 31.1</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000"> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right><b>Exhibit 31.1</b></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>AS ADOPTED PURSUANT TO</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:51px" align=justify>I, Dr. Amit Kumar,<font style=FONT-SIZE:10pt> </font>Chairman of the Board, President and Chief Executive Officer of ITUS Corporation, certify that:<font style=FONT-SIZE:10pt> </font></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">1.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>I have reviewed this Annual Report on Form 10-K of ITUS Corporation;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">2.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">3.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">4.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>The registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:148px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(a)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:146px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(b)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:146px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(c)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Evaluated the effectiveness of the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:145px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(d)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:0px" align=justify>Disclosed in this report any change in the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s internal control over financial reporting that occurred during the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s most recent fiscal quarter (the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s internal control over financial reporting; and</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">5.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>The registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s auditors and the audit committee of the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s board of directors (or persons performing the equivalent functions):</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:145px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(a)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s ability to record, process, summarize and report financial information; and</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:147px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:51px" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(b)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s internal control over financial reporting.</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p> <table bordercolor=transparent style="FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0> <tr style=FONT-SIZE:0px> <td width=384> <td width=246 /> </tr><tr> <td width=384 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Date: January 9, 2018</p></td> <td width=246 height=16 style="MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">/s/&nbsp;Amit Kumar</p></td></tr> <tr> <td width=384 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=246 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Dr. Amit Kumar</p></td></tr> <tr> <td width=384 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=246 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Chairman of the Board, President and Chief Executive Officer </p></td></tr></table> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px; TEXT-INDENT:51px" align=justify>&nbsp;</p></body>
<!-- EDGAR Validation Code: 1A975668 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exhibit31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<head><title>Exhibit 31.2</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000"> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right><b>Exhibit 31.2</b></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff>&nbsp;&nbsp;&nbsp;&nbsp;</font><font style=BACKGROUND-COLOR:#ffffff><b>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>AS ADOPTED PURSUANT TO</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:46px">I, Michael J. Catelani, Chief Operating Officer and Chief Financial Officer of ITUS Corporation, certify that:</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">1.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">I have reviewed this Annual Report on Form 10-K of ITUS Corporation;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">2.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">3.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">4.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">The registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:99px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(a)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:100px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(b)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:97px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(c)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Evaluated the effectiveness of the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:98px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(d)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Disclosed in this report any change in the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s internal control over financial reporting that occurred during the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s most recent fiscal quarter (the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s internal control over financial reporting; and</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">5.</p> <p style="FONT-SIZE:12pt; MARGIN:0px">The registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s auditors and the audit committee of the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s board of directors (or persons performing the equivalent functions):</p> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:98px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(a)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s ability to record, process, summarize and report financial information; and</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; HEIGHT:19px; WIDTH:100px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">(b)</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s internal control over financial reporting.</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <table bordercolor=transparent style="FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0> <tr style=FONT-SIZE:0px> <td width=324> <td width=270 /> </tr><tr> <td width=324 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Date: January 9, 2018</p></td> <td width=270 height=16 style="MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">/s/&nbsp;Michael J. Catelani</p></td></tr> <tr> <td width=324 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=270 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Michael J. Catelani</p></td></tr> <tr> <td width=324 height=33 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=270 height=33 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Chief Operating Officer and Chief Financial Officer </p></td></tr></table></body>
<!-- EDGAR Validation Code: 932B5AD8 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<head><title>Exhibit 32.1</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000"> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right><b>Exhibit 32.1</b></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>CERTIFICATION PURSUANT TO</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>18 U.S.C. SECTION 1350,<br></font><font style=BACKGROUND-COLOR:#ffffff>AS ADOPTED PURSUANT TO</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px">Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Dr. Amit Kumar, Chairman of the Board, President and Chief Executive Officer of ITUS Corporation, hereby certifies that:</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">1.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">The Company's Form 10-K Annual Report for the fiscal year ended October 31, 2017 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">2.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <table width=600 bordercolor=transparent style="FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0> <tr style=FONT-SIZE:0px> <td width=372> <td width=50% /> </tr><tr> <td width=372 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Date: January 9, 2018</p></td> <td width=50% height=16 style="MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">/s/ Amit Kumar</p></td></tr> <tr> <td width=372 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=50% height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Dr. Amit Kumar</p></td></tr> <tr> <td width=372 height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=50% height=16 style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Chairman of the Board, President and Chief Executive Officer</p></td></tr></table></body>
<!-- EDGAR Validation Code: CF995CD2 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exhibit32_2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<head><title>Exhibit 32.2</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000"> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right><b>Exhibit 32.2</b></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right>&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>CERTIFICATION PURSUANT TO</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>18 U.S.C. SECTION 1350,</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>AS ADOPTED PURSUANT TO</b></font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=BACKGROUND-COLOR:#ffffff><b>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></font></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:48px"> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Michael J. Catelani, Chief Operating Officer and Chief Financial Officer of ITUS Corporation, hereby certifies that:</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">1.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">The Company's Form 10-K Annual Report for the fiscal year ended October 31, 2017 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left" /> <p style="FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">2.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p> <p style="FONT-SIZE:12pt; CLEAR:left; MARGIN:0px">&nbsp;</p> <table width=600 bordercolor=transparent style="FONT-SIZE:10pt; WIDTH:600pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0> <tr style=FONT-SIZE:0px> <td> <td width=257 /> </tr><tr> <td style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Date: January 9, 2018</p></td> <td width=50% style="MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">/s/ Michael J. Catelani</p></td></tr> <tr> <td style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=50% style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Michael J. Catelani</p></td></tr> <tr> <td style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">&nbsp;</p></td> <td width=50% style="MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Chief Operating Officer and <div><font style=FONT-SIZE:12pt>Chief Financial Officer</font></div> <p /></td></tr></table> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br><br></p> <p style=MARGIN:0px><br></p></body>
<!-- EDGAR Validation Code: 7CD013C6 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>exhibitimage.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibitimage.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (" @(" 0(" @(# @(# P8$ P,#
M P<%!00&" <)" @'" @)"@T+"0H,"@@("P\+# T.#@\."0L0$1 .$0T.#@[_
MVP!# 0(# P,# P<$! <."0@)#@X.#@X.#@X.#@X.#@X.#@X.#@X.#@X.#@X.
M#@X.#@X.#@X.#@X.#@X.#@X.#@X.#@[_P  1"  N GL# 2(  A$! Q$!_\0
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MP?#CQ)?:&EQ;^'[K7+>3[2?G+2+*N%Y"GCKQ7Y'Q<W/%PLOLGZ7PVG'"SO\
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MBCY2=I8+_O=:/_'N?XN<>]?IU_P[4U;_ **Y!_X(S_\ '*/^':>K?]%<@_\
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&3R?^1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>11
<FILENAME>exhibits99_3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<HTML>
<head><title>Exhibit 99.3</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:Times New Roman; COLOR:#000000; MARGIN-TOP:0px"> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=right><b>Exhibit 99.3</b></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><b>Confidential Treatment Requested by ITUS Corporation,</b></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><b>IRS Employer Identification No. 11-2622630</b></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><b>***CONFIDENTIAL TREATMENT REQUESTED*** </b></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Note: Confidential treatment requested with respect to certain portions hereof denoted with &#147;[***]&#148;</p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><b>SECOND AMENDMENT TO THE COLLABORATIVE RESEARCH</b><font style=FONT-SIZE:14pt> </font><b>AGREEMENT</b></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>This <b>SECOND AMENDMENT TO THE</b> <b>COLLABORATIVE RESEARCH AGREEMENT</b> (the &#147;Second Amendment&#148;) is made as of the 1<sup>st</sup> day of August, 2017 (the &#147;Second Amendment Effective Date&#148;) by and between <b>THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY</b>, a Pennsylvania nonprofit corporation (&#147;Wistar&#148;) and<b> </b><font style="FONT-FAMILY:Times New Roman Bold,Times New Roman"><b>ANIXA DIAGNOSTIC CORPORATION</b></font>, a Delaware corporation (&#147;Collaborator&#148;). Wistar and Collaborator shall be referred to herein collectively as the &#147;Parties&#148;</p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:96px" align=justify>WHEREAS, the Parties entered into a collaborative research agreement on July 14, 2015, under which Collaborator agreed to support research in the laboratory of Frank J. Rauscher, III., Ph. D. (the &#147;CRA&#148;).</p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:96px" align=justify>WHEREAS, the Parties entered into a First Amendment to the Collaborative Research Agreement on August 4<sup>th</sup>, 2016 to extend the term, amend the Collaborative Research scope of work, increase the budget, and add an additional payment schedule to the CRA (the &#147;First Amendment&#148;); </p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:96px" align=justify>WHEREAS, the Parties would like to amend the CRA to extend the term and revise the scope of work and associated budget as set forth herein.</p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:96px" align=justify>NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, and intending to be legally bound hereby, the parties hereto agree as follows:</p> <p style=MARGIN:0px><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">1.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">All capitalized terms not expressly defined herein shall have the meanings ascribed to them in the CRA. </p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">2.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">The payment schedule table in Section 4.1 (Funding) of the CRA shall be deleted in its entirety and replaced with the following: </p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px" align=center><font style=FONT-SIZE:10pt>1</font></p> <hr> <p style="page-break-after:always;"></p> <p style="CLEAR:left; MARGIN:0px"><br></p> <table width=600 bordercolor=transparent style="FONT-SIZE:10pt; WIDTH:600pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0 align=center> <tr style=FONT-SIZE:0px> <td width=499> <td width=132 /> </tr><tr> <td width=499 style="BORDER-TOP:#000000 1px solid; BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px; BACKGROUND-COLOR:#d9d9d9" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Due Date</p></td> <td width=132 style="BORDER-TOP:#000000 1px solid; BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px; BACKGROUND-COLOR:#d9d9d9" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>Payment amount</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Effective Date </p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>*** </i>USD</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Within six (6) calendar months of the Effective Date</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>*** </i>USD</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Completion of Collaborative Research, or the anniversary of the Effective Date, whichever is sooner</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>***</i> USD (waived)</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>First Amendment Effective Date</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>***</i> USD</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Within six (6) calendar months of the First Amendment Effective Date</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>***</i> USD</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Completion of the Collaborative Research, or the first anniversary of the First Amendment Effective Date, whichever is sooner</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>***</i> USD</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Second Amendment Effective Date</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>***</i> USD</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Within six (6) calendar months of the Second Amendment Effective Date &nbsp;</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>***</i> USD</p></td></tr> <tr> <td width=499 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; BORDER-LEFT:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Completion of the Collaborative Research, or the first anniversary of the Second Amendment Effective Date, whichever is sooner</p></td> <td width=132 style="BORDER-RIGHT:#000000 1px solid; BORDER-BOTTOM:#000000 1px solid; MARGIN-TOP:0px" valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>$<i>***</i> USD</p></td></tr></table> <p>&nbsp;</p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">3.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Exhibit A of the CRA shall be deleted in its entirety and replaced with the attached Exhibit A-2.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">4.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Exhibit B of the CRA shall be deleted in its entirety and replaced with the attached Exhibit B-2.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">5.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">Except as expressly amended or modified herein, any and all the terms and conditions of the CRA and the First Amendment shall remain in full force and effect.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">6.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px">This Second Amendment, together with the CRA, and the First Amendment embody the entire understanding between the parties relating to the subject matter thereof and supersedes all prior understandings and agreements, whether written or oral.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:48px">7.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px"><u>Counterparts</u>. &nbsp;This Second Amendment shall become binding when any one or more counterparts hereof, individually or taken together, shall bear the signatures of Wistar and Collaborator. This Second Amendment may be executed in any number of counterparts, each of which shall be deemed an original as against the party whose signature appears thereon, but all of which taken together shall constitute but one and the same instrument.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px">IN WITNESS WHEREOF, the duly authorized representatives of the parties hereby execute this Second Amendment as of the dates below.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:48px">&nbsp;</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><font style=FONT-SIZE:10pt>2</font></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>&nbsp;</p> <hr> <p style="page-break-after:always;"></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center>&nbsp;</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px>&nbsp;</p> <p style=MARGIN:0px> <table width=600 bordercolor=transparent style="FONT-SIZE:10pt; WIDTH:600pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0> <tr> <td width=331 colspan=2 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px"><b>THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY</b></p></td> <td width=24 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td> <td width=260 colspan=2 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px"><b>ANIXA DIAGNOSTIC CORPORATION</b></p></td></tr> <tr> <td width=66 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>By:</p></td> <td width=265 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify><u>/s/ Heather A. Steinman </u></p></td> <td width=24 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td> <td width=60 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>By:</p></td> <td width=200 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify><u>/s/Amit Kumar</u></p></td></tr> <tr> <td width=66 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Name:</p></td> <td width=265 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Heather A. Steinman, Ph.D., M.B.A.</p></td> <td width=24 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td> <td width=60 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Name:</p></td> <td width=200 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Amit Kumar </p></td></tr> <tr> <td width=66 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Title:</p></td> <td width=265 style=MARGIN-TOP:0px rowspan=2 valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Vice President, Business Development and Executive Director, Technology Transfer</p></td> <td width=24 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td> <td width=60 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Title:</p></td> <td width=200 style=MARGIN-TOP:0px rowspan=2 valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Chief Executive Officer</p></td></tr> <tr> <td width=66 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td> <td width=24 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td> <td width=60 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td></tr> <tr> <td width=66 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Date:</p></td> <td width=265 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify><u>7/27/2017</u></p></td> <td width=24 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td> <td width=60 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Date:</p></td> <td width=200 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify><u>7/26/17</u></p></td></tr></table></p> <p style=MARGIN:0px><br>&nbsp;</p> <table width=400 bordercolor=transparent style="FONT-SIZE:10pt; WIDTH:400pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0> <tr style=FONT-SIZE:0px> <td width=61> <td width=240 /> </tr><tr> <td width=301 colspan=2 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">I have read, understand, and agree to the responsibilities of the Principle Investigator</p></td></tr> <tr> <td width=61 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>&nbsp;</p></td> <td width=240 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>&nbsp;</p></td></tr><tr> <td width=61 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>By:</p></td> <td width=240 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify><u>/s/Frank J. Rauscher III</u></p></td></tr> <tr> <td width=61 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Name:</p></td> <td width=240 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Frank J. Rauscher, III, Ph.D.</p></td></tr> <tr> <td width=61 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Title:</p></td> <td width=240 style=MARGIN-TOP:0px rowspan=2 valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px">Caspar Wistar Professor</p></td></tr> <tr> <td width=61 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px">&nbsp;</p></td></tr> <tr> <td width=61 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify>Date:</p></td> <td width=240 style=MARGIN-TOP:0px valign=top> <p style="FONT-SIZE:12pt; MARGIN:0px" align=justify><u>7/27/17</u></p></td></tr></table> <p style=MARGIN:0px>&nbsp;</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center>3</p> <p style=MARGIN:0px><br></p> <hr> <p style="page-break-after:always;"></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><b>Exhibit A-2</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b><i>Analysis of lymphoid and myeloid cell subsets using whole blood from tumor bearing patients</i></b></p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=justify><b>Overview and Rationale:</b> &nbsp;The Rauscher Laboratory remains committed to the spirit and science of the Anixa initiated project and looks forward to partnering in another year of interesting research. &nbsp;&nbsp;&nbsp;The project aims continue to be highly relevant to the overall scope of research interests in the Rauscher Laboratory specifically defining early, blood based markers of tumor initiation and progression and in addition, markers of therapeutic response. The focus will remain on defining and quantifying subsets lymphoid and myeloid progenitor cells in peripheral blood of tumor bearing and non-tumor bearing humans. The preliminary data suggests that the CChek, FACS based blood test combined with proprietary neural network based analysis has the capability of distinguishing these cell subsets and hence providing valid and valuable information to patients and clinicians regarding tumor presence, prognosis and response to therapy. &nbsp;In the coming year we will continue to collect data from patient samples in order to further establish the utility of the test.</p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=justify>The Rauscher Laboratory along with Wistar Core Facilities will continue to be the primary site for performance if this work. &nbsp;&nbsp;All of the work on human samples is subject to rigorous IRB protocol approvals, and the protocols are examined at both Wistar and the Institute providing the sample. </p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=justify><b>Specific Aims</b>: </p> <p style=MARGIN:0px align=justify><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:11pt; WIDTH:50px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:24px">1.</p> <p style="FONT-SIZE:11pt; PADDING-LEFT:50px; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Manage and oversee work of the scientists who will collect and process multiple human blood samples (estimated to be numbered at 5-20 samples per week) coming from multiple outside sources using the protocols developed and implemented for separation of white blood cells.&nbsp;Coordinate the identification and delivery of these de-identified samples to Wistar under defined protocols for preservation of fresh blood. &nbsp;&nbsp;Provide lab bench, desk space and computer facilities, lab supplies and disposal methods for human derived samples. Coordinate and liaison with Wistar Core facilities Phlebotomy and Cell Sorting for analysis of the blood cells and data acquisition. &nbsp;Provide proper ongoing and required training of lab personnel in handling human specimens. Keep all IRB approved protocols which oversee the project up to date and current with both personnel and techniques. &nbsp;Write and coordinate &nbsp;submission of new protocols for either new techniques or acquisition of new clinical partner sites for &nbsp;prosecution of the Project.</p> <p style="CLEAR:left; MARGIN:0px" align=justify><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:11pt; WIDTH:50px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:24px">2.</p> <p style="FONT-SIZE:11pt; PADDING-LEFT:50px; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Oversee the proper experimental procedures are followed in all aspects of handling and analysis of the samples and that each laboratory based person is properly trained on both experimental and safety issues. Obtain fresh whole blood from normal and tumor bearing individuals (across multiple types and stages of cancers) (following any necessary IRB approvals), consenting and de-identification of samples. Utilize optimized yet standard cell separation centrifugation techniques to isolate white blood cells.&nbsp;Incubate cells with antibody cocktails already defined and ensure sorting and processing via FACS &nbsp;analysis &nbsp;in the Wistar Core laboratory. &nbsp;Ensure data is collected in a timely fashion from the Core facility and transmitted for analysis to both onsite Anixa supported personnel and to the Company. &nbsp;Facilitate collection of any patient clinical data that is available from the Institution providing the sample per proper privacy guidelines.</p> <p style="CLEAR:left; MARGIN:0px" align=justify><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:11pt; WIDTH:48px; FLOAT:left; MARGIN-TOP:0px; TEXT-INDENT:24px">3. &nbsp;</p> <p style="FONT-SIZE:11pt; PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Such adjustments, and further research, testing, and procedures as the parties may agree to in a written amendment to this Agreement.</p> <p style="CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="CLEAR:left; MARGIN:0px">&nbsp;</p> <p style="CLEAR:left; MARGIN:0px" align=center>4<br></p> <p style=MARGIN:0px><br></p> <hr> <p style="page-break-after:always;"></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align=center><b>Exhibit B-2</b></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:12pt; MARGIN:0px"><i>***</i></p> <p style=MARGIN:0px><br><br></p> <p style=MARGIN:0px>&nbsp;</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center>5<br></p></body>
<!-- EDGAR Validation Code: 9B82A49A -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>12
<FILENAME>itus-20171031.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Mon Jan 08 23:26:37 EST 2018 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:itus="http://www.ITUScorp.com/20171031" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="itus-20171031.xsd"/>
  <context id="c0_AsOf31Oct2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c1_AsOf31Oct2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c2_AsOf31Oct2017_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c3_AsOf31Oct2016_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c4_AsOf31Oct2017_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c5_AsOf31Oct2016_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c6_From1Nov2016To31Oct2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c7_From1Nov2015To31Oct2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c8_From1Nov2016To31Oct2017_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c9_From1Nov2015To31Oct2016_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c10_From1Nov2016To31Oct2017_SellingAndMarketingExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c11_From1Nov2015To31Oct2016_SellingAndMarketingExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c12_AsOf31Oct2015_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c13_AsOf31Oct2015_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c14_AsOf31Oct2015_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c15_AsOf31Oct2015_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c16_AsOf31Oct2015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c17_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c18_From1Nov2015To31Oct2016_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c19_From1Nov2015To31Oct2016_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c20_AsOf31Oct2016_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c21_AsOf31Oct2016_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c22_AsOf31Oct2016_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c23_AsOf31Oct2016_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c25_From1Nov2016To31Oct2017_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c26_From1Nov2016To31Oct2017_PreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c27_From1Nov2016To31Oct2017_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c28_AsOf31Oct2017_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c29_AsOf31Oct2017_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c30_AsOf31Oct2017_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c31_AsOf4Jan2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2018-01-04</instant>
    </period>
  </context>
  <context id="c32_AsOf28Apr2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2017-04-28</instant>
    </period>
  </context>
  <context id="c33_From1Nov2016To31Oct2017_PatentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c34_From1Nov2016To31Oct2017_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c35_From1Nov2015To31Oct2016_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c36_From1Nov2016To31Oct2017_EmployeeStockOptionMember_EmployeesAndDirectorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:EmployeesAndDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c37_From1Nov2015To31Oct2016_EmployeeStockOptionMember_EmployeesAndDirectorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:EmployeesAndDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c38_AsOf31Oct2017_EmployeeStockOptionMember_EmployeesAndDirectorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:EmployeesAndDirectorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c39_From1Nov2016To31Oct2017_EmployeeStockOptionMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c40_From1Nov2015To31Oct2016_EmployeeStockOptionMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c41_AsOf31Oct2017_EmployeeStockOptionMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c42_From1Nov2016To31Oct2017_EmployeeStockOptionMember_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c43_From1Nov2016To31Oct2017_EmployeeStockOptionMember_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c44_From1Nov2015To31Oct2016_EmployeeStockOptionMember_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c45_From1Nov2015To31Oct2016_EmployeeStockOptionMember_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c46_From1Nov2016To31Oct2017_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c47_From1Nov2015To31Oct2016_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c48_From1Nov2016To31Oct2017_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c49_From1Nov2015To31Oct2016_WarrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c50_From1Nov2016To31Oct2017_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c51_From1Nov2015To31Oct2016_ConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c52_AsOf31Oct2017_MoneyMarketFundsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c53_AsOf31Oct2017_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c54_AsOf31Oct2017_MoneyMarketFundsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c55_AsOf31Oct2017_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c56_AsOf31Oct2017_CertificatesOfDepositMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c57_AsOf31Oct2017_CertificatesOfDepositMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c58_AsOf31Oct2017_CertificatesOfDepositMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c59_AsOf31Oct2017_CertificatesOfDepositMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c60_AsOf31Oct2017_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c61_AsOf31Oct2017_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c62_AsOf31Oct2017_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c63_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c64_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c65_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c66_AsOf31Oct2016_MoneyMarketFundsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c67_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c68_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c69_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c70_AsOf31Oct2016_CertificatesOfDepositMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c71_AsOf31Oct2016_FairValueInputsLevel1Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c72_AsOf31Oct2016_FairValueInputsLevel2Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c73_AsOf31Oct2016_FairValueInputsLevel3Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c74_From27Mar2017To27Mar2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <startDate>2017-03-27</startDate>
      <endDate>2017-03-27</endDate>
    </period>
  </context>
  <context id="c75_AsOf27Mar2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
    </entity>
    <period>
      <instant>2017-03-27</instant>
    </period>
  </context>
  <context id="c76_From1Nov2016To31Oct2017_CommonStockMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c77_From1Nov2015To31Oct2016_CommonStockMember_ConsultantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">itus:ConsultantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c78_From1Nov2016To31Oct2017_CommonStockMember_DirectorMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c79_AsOf31Oct2017_EmployeeStockOptionMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c80_From1Nov2011To31Oct2012_EmployeeStockOptionMember_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-11-01</startDate>
      <endDate>2012-10-31</endDate>
    </period>
  </context>
  <context id="c81_From1Nov2012To31Oct2013_EmployeeStockOptionMember_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-11-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="c82_AsOf6Sep2017_RePricedOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-09-06</instant>
    </period>
  </context>
  <context id="c83_From6Sep2017To6Sep2017_RePricedOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-09-06</startDate>
      <endDate>2017-09-06</endDate>
    </period>
  </context>
  <context id="c84_AsOf6Sep2017_RePricedOptionsMember_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-09-06</instant>
    </period>
  </context>
  <context id="c85_AsOf6Sep2017_RePricedOptionsMember_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-09-06</instant>
    </period>
  </context>
  <context id="c86_AsOf6Sep2017_RePricedOptionsMember_A2010SharePlanMember_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-09-06</instant>
    </period>
  </context>
  <context id="c87_AsOf6Sep2017_RePricedOptionsMember_A2010SharePlanMember_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-09-06</instant>
    </period>
  </context>
  <context id="c88_AsOf6Sep2017_RePricedOptionsMember_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">itus:RePricedOptionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-09-06</instant>
    </period>
  </context>
  <context id="c89_AsOf11Nov2016_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-11-11</instant>
    </period>
  </context>
  <context id="c90_From6Dec2016To6Dec2016_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-12-06</startDate>
      <endDate>2016-12-06</endDate>
    </period>
  </context>
  <context id="c91_From1Nov2016To31Oct2017_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c92_AsOf31Oct2017_WarrantWithExercisePriceOf925Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantWithExercisePriceOf925Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c93_AsOf31Oct2017_WarrantWithExercisePriceOf13875Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantWithExercisePriceOf13875Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c94_From1Nov2016To31Oct2017_WarrantWithExercisePriceOf13875Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantWithExercisePriceOf13875Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c95_AsOf31Oct2017_WarrantWithExercisePriceOf1000Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantWithExercisePriceOf1000Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c96_From1Nov2016To31Oct2017_WarrantWithExercisePriceOf1000Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantWithExercisePriceOf1000Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c97_AsOf31Oct2017_WarrantWithExercisePriceOf503Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantWithExercisePriceOf503Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c98_From1Nov2016To31Oct2017_WarrantWithExercisePriceOf503Member_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">itus:WarrantWithExercisePriceOf503Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c99_From1Nov2016To31Oct2017_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c100_AsOf31Oct2015_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c101_From1Nov2015To31Oct2016_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c102_AsOf31Oct2016_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c103_AsOf31Oct2017_A2003SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c104_AsOf31Oct2017_A2003SharePlanMember_RangeOfExercisePrices067To1755Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices067To1755Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c105_From1Nov2016To31Oct2017_A2003SharePlanMember_RangeOfExercisePrices067To1755Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2003SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices067To1755Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c106_From1Nov2016To31Oct2017_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c107_AsOf31Oct2015_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-10-31</instant>
    </period>
  </context>
  <context id="c108_From1Nov2015To31Oct2016_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2016-10-31</endDate>
    </period>
  </context>
  <context id="c109_AsOf31Oct2016_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c110_AsOf31Oct2017_A2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c111_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c112_From1Nov2016To31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c113_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices227To700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c114_From1Nov2016To31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:A2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices227To700Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c115_From1Nov2016To31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c116_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-31</instant>
    </period>
  </context>
  <context id="c117_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c118_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c119_From1Nov2016To31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices067Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices067Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c120_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c121_From1Nov2016To31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">itus:StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">itus:RangeOfExercisePrices258To556Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c122_AsOf31Oct2017_OfficeSpaceInSanJoseCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">itus:OfficeSpaceInSanJoseCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c123_From1Nov2016To31Oct2017_OfficeSpaceInSanJoseCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">itus:OfficeSpaceInSanJoseCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c124_AsOf31Oct2017_OfficeSpaceInLosAngelesCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">itus:OfficeSpaceInLosAngelesCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c125_From1Nov2016To31Oct2017_OfficeSpaceInLosAngelesCaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">itus:OfficeSpaceInLosAngelesCaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-01</startDate>
      <endDate>2017-10-31</endDate>
    </period>
  </context>
  <context id="c126_AsOf31Oct2017_FederalCorporateTaxableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">itus:FederalCorporateTaxableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c127_AsOf31Oct2017_NewYorkStateMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">itus:NewYorkStateMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <context id="c128_AsOf31Oct2017_CaliforniaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000715446</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">itus:CaliforniaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-31</instant>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPershares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="pure">
    <measure>xbrli:pure</measure>
  </unit>
  <unit id="sqft">
    <measure>utr:sqft</measure>
  </unit>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">3339374</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">2488323</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">3500000</us-gaap:ShortTermInvestments>
  <us-gaap:ShortTermInvestments unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">750000</us-gaap:ShortTermInvestments>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">174566</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">162069</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">7013940</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">3400392</us-gaap:AssetsCurrent>
  <itus:FiniteLivedPatentsNet unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">1745775</itus:FiniteLivedPatentsNet>
  <itus:FiniteLivedPatentsNet unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">2071071</itus:FiniteLivedPatentsNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">52701</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">156644</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">8812416</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">5628107</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">480324</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">373224</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">409169</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">95532</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">889493</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">468756</us-gaap:LiabilitiesCurrent>
  <itus:PatentAcquisitionObligation unitRef="usd" contextRef="c0_AsOf31Oct2017" xs:nil="true"/>
  <itus:PatentAcquisitionObligation unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">4171876</itus:PatentAcquisitionObligation>
  <us-gaap:Liabilities unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">889493</us-gaap:Liabilities>
  <us-gaap:Liabilities unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">4640632</us-gaap:Liabilities>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c0_AsOf31Oct2017" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c1_AsOf31Oct2016" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c0_AsOf31Oct2017" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">14000</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c2_AsOf31Oct2017_PreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c3_AsOf31Oct2016_PreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c5_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="0">14000</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">166028</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">87524</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">163931079</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">152051144</us-gaap:AdditionalPaidInCapital>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">-156174184</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">-151165193</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">7922923</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">987475</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">8812416</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">5628107</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">1290336</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">965040</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">35725</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">46950</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c2_AsOf31Oct2017_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c3_AsOf31Oct2016_PreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c2_AsOf31Oct2017_PreferredStockMember" decimals="INF">19860</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c3_AsOf31Oct2016_PreferredStockMember" decimals="INF">19860</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c2_AsOf31Oct2017_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c3_AsOf31Oct2016_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c2_AsOf31Oct2017_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c3_AsOf31Oct2016_PreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c5_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="0">100</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c5_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c5_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c5_AsOf31Oct2016_SeriesAPreferredStockMember" decimals="INF">140</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf31Oct2017" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Oct2016" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Oct2017" decimals="INF">24000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Oct2016" decimals="INF">24000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf31Oct2017" decimals="INF">16602759</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Oct2016" decimals="INF">8752387</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf31Oct2017" decimals="INF">16602759</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Oct2016" decimals="INF">8752387</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:Revenues unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">362500</us-gaap:Revenues>
  <us-gaap:Revenues unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">300000</us-gaap:Revenues>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">91451</us-gaap:RoyaltyExpense>
  <us-gaap:RoyaltyExpense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">111192</us-gaap:RoyaltyExpense>
  <itus:LitigationAndLicensingExpenses unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">13105</itus:LitigationAndLicensingExpenses>
  <itus:LitigationAndLicensingExpenses unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">106224</itus:LitigationAndLicensingExpenses>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">325296</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">325296</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">1597550</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">1556459</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">4410682</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">2709841</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">6438084</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">4809012</us-gaap:CostsAndExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-6075584</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-4509012</us-gaap:OperatingIncomeLoss>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">1547608</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">500455</us-gaap:InterestExpense>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">519946</us-gaap:InterestExpense>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">19440</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">12530</us-gaap:InvestmentIncomeInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-5008991</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-5016428</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-5008991</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-5016428</us-gaap:ProfitLoss>
  <us-gaap:DividendsPreferredStock unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">2008775</us-gaap:DividendsPreferredStock>
  <us-gaap:DividendsPreferredStock unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-7017766</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-5016428</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c6_From1Nov2016To31Oct2017" decimals="2">-0.58</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c7_From1Nov2015To31Oct2016" decimals="2">-0.57</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c6_From1Nov2016To31Oct2017" decimals="INF">12197340</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c7_From1Nov2015To31Oct2016" decimals="INF">8739453</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c8_From1Nov2016To31Oct2017_ResearchAndDevelopmentExpenseMember" decimals="0">288187</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c9_From1Nov2015To31Oct2016_ResearchAndDevelopmentExpenseMember" decimals="0">259930</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c10_From1Nov2016To31Oct2017_SellingAndMarketingExpenseMember" decimals="0">934585</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c11_From1Nov2015To31Oct2016_SellingAndMarketingExpenseMember" decimals="0">613631</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c12_AsOf31Oct2015_PreferredStockMember" decimals="INF">140</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c12_AsOf31Oct2015_PreferredStockMember" decimals="0">14000</us-gaap:StockholdersEquity>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c13_AsOf31Oct2015_CommonStockMember" decimals="INF">8724878</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c13_AsOf31Oct2015_CommonStockMember" decimals="0">87249</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c14_AsOf31Oct2015_AdditionalPaidInCapitalMember" decimals="0">151101117</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c15_AsOf31Oct2015_RetainedEarningsMember" decimals="0">-146148765</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c16_AsOf31Oct2015" decimals="0">5053601</us-gaap:StockholdersEquity>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c17_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">873561</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">873561</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c18_From1Nov2015To31Oct2016_CommonStockMember" decimals="INF">12676</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c18_From1Nov2015To31Oct2016_CommonStockMember" decimals="0">127</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c17_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">33454</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">33581</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c18_From1Nov2015To31Oct2016_CommonStockMember" decimals="INF">10833</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c18_From1Nov2015To31Oct2016_CommonStockMember" decimals="0">108</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c17_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">31252</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">31360</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c18_From1Nov2015To31Oct2016_CommonStockMember" decimals="INF">4000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c18_From1Nov2015To31Oct2016_CommonStockMember" decimals="0">40</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c17_From1Nov2015To31Oct2016_AdditionalPaidInCapitalMember" decimals="0">11760</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">11800</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c19_From1Nov2015To31Oct2016_RetainedEarningsMember" decimals="0">-5016428</us-gaap:ProfitLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c20_AsOf31Oct2016_PreferredStockMember" decimals="INF">140</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c20_AsOf31Oct2016_PreferredStockMember" decimals="0">14000</us-gaap:StockholdersEquity>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c21_AsOf31Oct2016_CommonStockMember" decimals="INF">8752387</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c21_AsOf31Oct2016_CommonStockMember" decimals="0">87524</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c22_AsOf31Oct2016_AdditionalPaidInCapitalMember" decimals="0">152051144</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c23_AsOf31Oct2016_RetainedEarningsMember" decimals="0">-151165193</us-gaap:StockholdersEquity>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">1222772</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">1222772</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="INF">40220</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="0">402</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">6871</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">7273</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <itus:StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors unitRef="shares" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="INF">209463</itus:StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors>
  <itus:StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors unitRef="usd" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="0">2095</itus:StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors>
  <itus:StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">484329</itus:StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors>
  <itus:StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">486424</itus:StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors>
  <us-gaap:StockRedeemedOrCalledDuringPeriodShares unitRef="shares" contextRef="c26_From1Nov2016To31Oct2017_PreferredStockMember" decimals="INF">-140</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
  <us-gaap:StockRedeemedOrCalledDuringPeriodValue unitRef="usd" contextRef="c26_From1Nov2016To31Oct2017_PreferredStockMember" decimals="0">-14000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
  <us-gaap:StockRedeemedOrCalledDuringPeriodValue unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">-3486000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
  <us-gaap:StockRedeemedOrCalledDuringPeriodValue unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-3500000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
  <itus:CommonStockIssuedToRepayPatentAcquisitionObligationShares unitRef="shares" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="INF">947606</itus:CommonStockIssuedToRepayPatentAcquisitionObligationShares>
  <itus:CommonStockIssuedToRepayPatentAcquisitionObligationValue unitRef="usd" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="0">9476</itus:CommonStockIssuedToRepayPatentAcquisitionObligationValue>
  <itus:CommonStockIssuedToRepayPatentAcquisitionObligationValue unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">2842818</itus:CommonStockIssuedToRepayPatentAcquisitionObligationValue>
  <itus:CommonStockIssuedToRepayPatentAcquisitionObligationValue unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">2852294</itus:CommonStockIssuedToRepayPatentAcquisitionObligationValue>
  <itus:StockIssuedDuringPeriodSharesRightsOffering unitRef="shares" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="INF">1989207</itus:StockIssuedDuringPeriodSharesRightsOffering>
  <itus:StockIssuedDuringPeriodValueRightsOffering unitRef="usd" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="0">19892</itus:StockIssuedDuringPeriodValueRightsOffering>
  <itus:StockIssuedDuringPeriodValueRightsOffering unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">4183410</itus:StockIssuedDuringPeriodValueRightsOffering>
  <itus:StockIssuedDuringPeriodValueRightsOffering unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">4203302</itus:StockIssuedDuringPeriodValueRightsOffering>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="INF">3425376</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="0">34254</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">3177534</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">3211788</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="INF">1238500</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c25_From1Nov2016To31Oct2017_CommonStockMember" decimals="0">12385</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c24_From1Nov2016To31Oct2017_AdditionalPaidInCapitalMember" decimals="0">3448201</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">3460586</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:ProfitLoss unitRef="usd" contextRef="c27_From1Nov2016To31Oct2017_RetainedEarningsMember" decimals="0">-5008991</us-gaap:ProfitLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c28_AsOf31Oct2017_CommonStockMember" decimals="INF">16602759</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c28_AsOf31Oct2017_CommonStockMember" decimals="0">166028</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c29_AsOf31Oct2017_AdditionalPaidInCapitalMember" decimals="0">163931079</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c30_AsOf31Oct2017_RetainedEarningsMember" decimals="0">-156174184</us-gaap:StockholdersEquity>
  <us-gaap:StockOptionPlanExpense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">1222772</us-gaap:StockOptionPlanExpense>
  <us-gaap:StockOptionPlanExpense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">873561</us-gaap:StockOptionPlanExpense>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">486424</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">31360</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-228026</itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense>
  <itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-519946</itus:AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense>
  <itus:CommonStockIssuedToAcquirePatentLicense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <itus:CommonStockIssuedToAcquirePatentLicense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">11800</itus:CommonStockIssuedToAcquirePatentLicense>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">43216</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">33333</us-gaap:DepreciationAndAmortization>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-45915</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">12497</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">35541</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">107100</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-1479</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">313637</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">89470</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <itus:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <itus:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-213017</itus:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-3796710</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-3381699</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquireShortTermInvestments unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">5501000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:PaymentsToAcquireShortTermInvestments unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">1900000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:ProceedsFromSaleOfShortTermInvestments unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">2751000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
  <us-gaap:ProceedsFromSaleOfShortTermInvestments unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">3550000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">45000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">30188</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">146521</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-2735188</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">1503479</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <itus:ProceedsFromIssuanceOfRightsOffering unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">4203302</itus:ProceedsFromIssuanceOfRightsOffering>
  <itus:ProceedsFromIssuanceOfRightsOffering unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <itus:ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">3211788</itus:ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering>
  <itus:ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">3460586</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">500000</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
  <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <itus:PaymentsMadeOnSecuredDebenture unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">3000000</itus:PaymentsMadeOnSecuredDebenture>
  <itus:PaymentsMadeOnSecuredDebenture unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">7273</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">33581</us-gaap:ProceedsFromStockOptionsExercised>
  <itus:PaymentToAcquireRoyaltyInterestInPatentRights unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <itus:PaymentToAcquireRoyaltyInterestInPatentRights unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">36257</itus:PaymentToAcquireRoyaltyInterestInPatentRights>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">7382949</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-2676</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">851051</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-1880896</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c16_AsOf31Oct2015" decimals="0">4369219</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">272429</us-gaap:InterestPaid>
  <us-gaap:InterestPaid unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:ConversionOfStockAmountConverted1 unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">3000000</us-gaap:ConversionOfStockAmountConverted1>
  <us-gaap:ConversionOfStockAmountConverted1 unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">2852294</us-gaap:StockIssued1>
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <dei:EntityRegistrantName contextRef="c6_From1Nov2016To31Oct2017">ITUS CORPORATION</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c6_From1Nov2016To31Oct2017">10-K</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c6_From1Nov2016To31Oct2017">--10-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c31_AsOf4Jan2018" decimals="INF">16609399</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat unitRef="usd" contextRef="c32_AsOf28Apr2017" decimals="0">22498909</dei:EntityPublicFloat>
  <dei:AmendmentFlag contextRef="c6_From1Nov2016To31Oct2017">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c6_From1Nov2016To31Oct2017">0000715446</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c6_From1Nov2016To31Oct2017">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c6_From1Nov2016To31Oct2017">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c6_From1Nov2016To31Oct2017">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c6_From1Nov2016To31Oct2017">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c6_From1Nov2016To31Oct2017">2017</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c6_From1Nov2016To31Oct2017">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c6_From1Nov2016To31Oct2017">2017-10-31</dei:DocumentPeriodEndDate>
  <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt&quot;&gt;1.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration:underline&quot;&gt;BUSINESS&amp;#xa0;AND&amp;#xa0;FUNDING&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Description of Business &lt;/font&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;As used herein, &amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221; &amp;#8220;our,&amp;#8221; the &amp;#8220;Company&amp;#8221; or &amp;#8220;ITUS&amp;#8221; means ITUS Corporation and its wholly-owned subsidiaries.&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &amp;#xa0;Commencing in October 2012 the primary operations of the Company involved the development, acquisition, licensing, and enforcement of patented technologies that were either owned or controlled by the Company.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&amp;#x201c;Anixa&amp;#x201d;), to develop a platform for non-invasive blood tests for the early detection of cancer.&amp;#xa0; That platform is called Cchek&amp;#x2122;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;.&amp;#xa0; In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&amp;#x201c;Wistar&amp;#x201d;), the nation&amp;#x2019;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. &amp;#xa0;In August of 2016 and again in August of 2017, ITUS announced the renewal and expansion of our relationship with Wistar. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;From October of 2015 through January of 2017, ITUS announced that we had demonstrated the efficacy of our Cchek&amp;#x2122; &lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;early cancer detection platform with 15 different types of cancer, including:&amp;#xa0; breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar and prostate.&amp;#xa0; Breast, lung, colon and prostate cancers represent the four largest categories of cancer worldwide.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;In November of 2017, the Company announced the formation of a new subsidiary, Certainty Therapeutics, Inc. (&amp;#8220;Certainty&amp;#8221;), to develop immuno-therapy drugs against cancer.&amp;#xa0; Certainty entered into a license agreement with Wistar pursuant to which Certainty was granted an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by Wistar relating to Wistar&amp;#8217;s chimeric endocrine receptor targeted therapy technology (such technology being akin to chimeric antigen receptor T-cell (&amp;#8220;CAR-T&amp;#8221;) technology). &amp;#xa0;We plan to initially focus on the development of a treatment for ovarian cancer, but we also may pursue future applications of the technology for the development of treatments for additional solid tumors.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;On November 20, 2017, we announced that Certainty entered into a collaboration agreement with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&amp;#8220;Moffitt&amp;#8221;) to advance toward human clinical testing the CAR-T technology licensed by Certainty from Wistar aimed initially at treating ovarian cancer.&amp;#xa0; Certainty intends to work with researchers at Moffitt to complete studies necessary to submit an Investigational New Drug application with the U.S. Food and Drug Administration.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Over the next several quarters, we expect Cchek&amp;#8482; and Certainty&amp;#8217;s ovarian cancer treatment to be the primary focus of the Company. &amp;#xa0;As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&amp;#xa0; We do not expect these activities to be a significant part of the Company&amp;#8217;s ongoing operations nor do we expect these activities to require material financial resources or attention of senior management.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Over the past several quarters, our revenue was derived from technology licensing and the sale of patented technologies, including revenue from the settlement of litigation. &amp;#xa0;In addition to Anixa and Certainty, the Company may make investments in and form new companies to develop additional emerging technologies.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Funding &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; background: white; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;a name=&quot;_aciHeader46&quot;&gt;&lt;/a&gt;&lt;font style=&quot;color: black;&quot;&gt;As of the date of filing of our last annual report on Form 10-K, there was substantial doubt about our ability to continue as a going concern due to the limited amount of cash, cash equivalents and short-term investments we held as compared to our projected cash needs for the ensuing 12 months. We evaluated our cash position and future plans for the Company and embarked on a plan to ensure we had sufficient resources to execute our plans.&amp;#xa0; Accordingly, over the past twelve months, we raised nearly $12 million through multiple financing arrangements, including a shareholder rights offering, a registered direct offering, and an at-the-market equity offering, and satisfied debt obligations through payments of cash and common stock. With no significant debt and approximately $6.8 million in cash, cash equivalents and short-term investments as of October 31, 2017, we believe that we have alleviated substantial doubt about our ability to continue as a going concern.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; background: white; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Based on currently available information as of January 9, 2018, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next 12 months.&amp;#xa0; However, our projections of future cash needs and cash flows may differ from actual results.&amp;#xa0; If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies that are synergistic with or complimentary to our technologies, we may be required to obtain more working capital.&amp;#xa0; We may seek to obtain working capital during our fiscal year ended 2018 or thereafter through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&amp;#xa0; We cannot be certain that additional funding will be available on acceptable terms, or at all.&amp;#xa0; If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders. &amp;#xa0;Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. &amp;#xa0;We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all. &amp;#xa0;If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&amp;#xa0; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;background: white; color: black;&quot;&gt;During the year ended October 31, 2017, cash used in operating activities was approximately $3,797,000. &amp;#xa0;Cash used in investing activities was approximately $2,735,000, resulting from the purchase of certificates of deposit totaling $5,501,000 which was offset by the proceeds on maturities of certificates of deposit totaling $2,751,000 and the sale of property and equipment of $45,000 offset by the purchase of property and equipment of approximately $30,000. &amp;#xa0;Cash provided by financing activities was approximately $7,383,000, resulting from the sale of common stock in a shareholder rights offering, an at-the-market offering and a registered direct offering of approximately $4,203,000, $3,461,000 and $3,212,000, respectively, and the proceeds from exercise of stock options of approximately $7,000, offset by payments made on a secured debenture of $3,000,000 and redemption of convertible preferred stock of $500,000.&amp;#xa0; As a result, our cash, cash equivalents, and short-term investments at October 31, 2017 increased approximately $3,601,000 to approximately $6,839,000 from approximately $3,238,000 at the end of fiscal year 2016.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
  <us-gaap:CollateralizedFinancings unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="-6">12000000</us-gaap:CollateralizedFinancings>
  <us-gaap:CashPeriodIncreaseDecrease unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">3601000</us-gaap:CashPeriodIncreaseDecrease>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">6839000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">3238000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;2.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration:underline&quot;&gt;SUMMARY&amp;#xa0;OF&amp;#xa0;SIGNIFICANT&amp;#xa0;ACCOUNTING&amp;#xa0;POLICIES&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Basis of Presentation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries.&amp;#xa0; All intercompany transactions have been eliminated.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent Licensing&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&amp;#xa0;&amp;#xa0;These arrangements typically include some combination of the following:&amp;#xa0;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&amp;#xa0;&amp;#xa0;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&amp;#xa0;&amp;#xa0;Pursuant to the terms of these agreements, we had no further obligations. &amp;#xa0;&amp;#xa0;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Inventor Royalties and Contingent Legal Fees&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Research and Development Expenses&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Research and development expenses, consisting primarily of employee compensation, payments to third parties for research and development activities and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Fair Value Measurements&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 820 &amp;#8220;Fair Value Measurements and Disclosures&amp;#8221; (&amp;#8220;ASC 820&amp;#8221;)&lt;/font&gt; defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements.&amp;#xa0; In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below.&amp;#xa0; If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in&quot;&gt;Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in&quot;&gt;Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in&quot;&gt;Level 3 &amp;#8211; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.&amp;#xa0; These inputs reflect management&amp;#8217;s own assumptions about the assumptions a market participant would use in pricing the instrument.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2017:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013; &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit - &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6,579,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 15.75pt; white-space: nowrap; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013; &lt;br /&gt;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit - &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 16.5pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,649,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 44%; height: 15.75pt; white-space: nowrap; width: 44%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 44%; height: 15.75pt; width: 44%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 44%; height: 15.75pt; width: 44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The following table sets forth a summary of the changes in the fair value of the Company&amp;#8217;s Level 3 financial liabilities that are measured at fair value on a recurring basis:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Patent acquisition obligation:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;519,946 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Royalty payment applied to patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(36,257)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;228,026 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Extinguishment of patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(4,399,902)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 16.5pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 18%; height: 16.5pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&amp;#xa0; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt&quot;&gt;Cash equivalents consists of highly liquid, short-term investments with original maturities of three months or less when purchased.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Short-term Investments&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; At October 31, 2017 and 2016, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $3,500,000 and $750,000, respectively, that were classified as short-term investments and reported at fair value.&amp;#xa0;&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Patents&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Our only identifiable intangible assets are patents and patent rights.&amp;#xa0; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&amp;#xa0; No patent acquisition costs were capitalized during the years ended October 31, 2017 and 2016.&amp;#xa0; We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2017 and 2016, respectively.&lt;a name=&quot;_DV_M82&quot;&gt;&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Impairment&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Income Taxes&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&amp;#xa0; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock-Based Compensation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock Option Compensation Expense &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &amp;#8220;Stock Compensation&amp;#8221; (&amp;#8220;ASC 718&amp;#8221;).&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model.&amp;#xa0; For options vesting if the trading price of the Company&amp;#8217;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. &lt;/font&gt;We recognize compensation expense for stock option awards over the requisite or implied service period of the grant.&amp;#xa0; With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable.&amp;#xa0; We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $1,223,000 and $874,000, during the years ended October 31, 2017 and 2016, respectively. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Included in stock-based compensation cost for employees and directors during the years ended October 31, 2017 and 2016 was approximately $967,000 and $393,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested.&amp;#xa0; As of October 31, 2017, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,091,000, which will be recognized over a weighted-average period of 1.7 years. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &amp;#8220;Equity-Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;).&amp;#xa0; In accordance with ASC 505-50, &lt;font style=&quot;COLOR:black&quot;&gt;we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model.&amp;#xa0; F&lt;/font&gt;or options vesting if the trading price of the Company&amp;#8217;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation.&amp;#xa0; We recognize compensation expense for &lt;font style=&quot;COLOR:black&quot;&gt;service based stock options and options subject to market conditions&lt;/font&gt; over the requisite or implied service period of the grant.&amp;#xa0; For performance based awards, compensation expense is recognized when the performance target is achieved.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2017 and 2016 of approximately $3,000 and $-0-, respectively. &amp;#xa0;Stock-based consulting expense for the years ended October 31, 2017 and 2016 did not include any amortization of compensation cost for stock options granted in prior periods but vested in the current period. &amp;#xa0;As of October 31, 2017, there was unrecognized consulting expense related to non-vested stock options granted to consultants, related to service based options of approximately $44,000, which will be recognized over a weighted-average period of 2.1 years.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Fair Value Determination&lt;/font&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time.&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;The stock options we granted during the year ended October 31, 2017 consisted of awards with 10-year terms that vest over 6 to 48 months. The stock options we granted during the year ended October 31, 2016 consisted of awards with 10-year terms that vest over 6 to 36 months&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2017 and 2016:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;For the Year&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted average fair value at grant date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$1.72 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$2.84 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Valuation assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected life (years) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;5.63&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;5.70&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;119.2%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;181.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;1.94%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;1.26%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.&amp;#xa0; We use the simplified method, which is a weighted average of the vesting term and contractual term, to determine expected term.&amp;#xa0; The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years.&amp;#xa0; Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options.&amp;#xa0; We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants.&amp;#xa0; We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest.&amp;#xa0; Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options.&amp;#xa0; Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate.&amp;#xa0; If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Net&amp;#xa0;Loss&amp;#xa0;Per&amp;#xa0;Share of Common Stock &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;In accordance with ASC 260, &amp;#8220;Earnings Per Share&amp;#8221;, basic net loss per common share (&amp;#8220;Basic EPS&amp;#8221;) is computed by dividing net loss by the weighted average number of common shares outstanding.&amp;#xa0; Diluted net loss per common share (&amp;#8220;Diluted EPS&amp;#8221;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&amp;#xa0; Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&amp;#xa0; For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2017 and 2016, were options to purchase 3,447,846 and 3,086,472 shares, respectively, warrants to purchase 829,400 shares and 707,379 shares, respectively, preferred stock convertible into -0- and 739,958 shares, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Use of Estimates &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&amp;#xa0; Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies.&amp;#xa0; Actual results could differ from those estimates.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Effect of Recently Issued Pronouncements&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In May 2014, the Financial Accounting Standards Board (&quot;FASB&quot;) issued Accounting Standards Update 2014-09 (&amp;#8220;ASU 2014-09&amp;#8221;), Revenue from Contracts with Customers.&amp;#xa0; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &amp;#xa0;This standard update is effective for&amp;#xa0;interim and annual&amp;#xa0;reporting periods beginning after December 15,&amp;#xa0;2016, and were to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &amp;#xa0;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &amp;#xa0;&lt;a name=&quot;_Hlk501045300&quot;&gt;We do not expect the adoption of ASU 2014-09 &lt;/a&gt;to have a material impact on our &lt;a name=&quot;_Hlk502247174&quot;&gt;consolidated financial statements and related disclosures.&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15 (&amp;#8220;ASU 2014-15&amp;#8221;).&amp;#xa0; This amendment requires management to assess an entity&amp;#8217;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption.&amp;#xa0; We have provided additional footnote disclosure to our consolidated financial statements in accordance with ASU 2014-15 upon adoption of this amendment.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;In November 2015, the FASB issued Accounting Standards Update 2015-17 (&amp;#8220;ASU 2015-17&amp;#8221;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &amp;#xa0;Adoption of this standard is required for annual periods beginning after December 15, 2016. &amp;#xa0;We do not anticipate that the adoption of this amendment will have an impact on our consolidated financial statements&amp;#xa0;and related disclosures as we currently do not present deferred tax assets or liabilities.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In February 2016, the FASB issued Accounting Standards Update 2016-02 (&amp;#8220;ASU 2016-02&amp;#8221;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &amp;#xa0;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &amp;#xa0;The requirements of this standard include a significant increase in required disclosures. &amp;#xa0;We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&amp;#xa0;and related disclosures, and our analysis is currently ongoing.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In March 2016, the FASB issued Accounting Standards Update 2016-09 (&amp;#8220;ASU 2016-09&amp;#8221;) that changes the accounting for certain aspects of share-based payments to employees. &amp;#xa0;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&amp;#8217;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &amp;#xa0;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. We adopted ASU 2016-09 on November 1, 2017. &amp;#xa0;We do not expect the adoption of this new guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In May 2017, the FASB issued Accounting Standards Update 2017-09 (&amp;#8220;ASU 2017-09&amp;#8221;) that provides guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting. &amp;#xa0;This update is effective for all entities for fiscal years beginning after December 15, 2017, and interim periods within those years.&amp;#xa0; Early adoption is permitted.&amp;#xa0; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements and related disclosures, and our analysis is ongoing.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In July 2017, the FASB issued Accounting Standards Update 2017-11 (&amp;#8220;ASU 2017-11&amp;#8221;) which changes the accounting for equity instruments that include a down round feature.&amp;#xa0; For public entities, this update is effective for fiscal years beginning after December 15, 2018, and interim periods within those years.&amp;#xa0; Early adoption is permitted. &amp;#xa0;&lt;/font&gt;We do not anticipate the adoption of this amendment will have an impact on our consolidated financial statements&amp;#xa0;and related disclosures as we currently do not have any such equity instruments.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Concentration of Credit Risks&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable.&amp;#xa0; Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &amp;#xa0;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &amp;#xa0;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;One licensee accounted for 100% of revenues from patent licensing activities during fiscal year 2017. &amp;#xa0;Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Basis of Presentation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries.&amp;#xa0; All intercompany transactions have been eliminated.&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Patent Licensing&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&amp;#xa0;&amp;#xa0;These arrangements typically include some combination of the following:&amp;#xa0;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&amp;#xa0;&amp;#xa0;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&amp;#xa0;&amp;#xa0;Pursuant to the terms of these agreements, we had no further obligations. &amp;#xa0;&amp;#xa0;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Inventor Royalties and Contingent Legal Fees&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Research and Development Expenses&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Research and development expenses, consisting primarily of employee compensation, payments to third parties for research and development activities and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Fair Value Measurements&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 820 &amp;#8220;Fair Value Measurements and Disclosures&amp;#8221; (&amp;#8220;ASC 820&amp;#8221;)&lt;/font&gt; defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements.&amp;#xa0; In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below.&amp;#xa0; If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in&quot;&gt;Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in&quot;&gt;Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in&quot;&gt;Level 3 &amp;#8211; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.&amp;#xa0; These inputs reflect management&amp;#8217;s own assumptions about the assumptions a market participant would use in pricing the instrument.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2017:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013; &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit - &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6,579,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 15.75pt; white-space: nowrap; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013; &lt;br /&gt;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit - &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 16.5pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,649,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 44%; height: 15.75pt; white-space: nowrap; width: 44%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 44%; height: 15.75pt; width: 44%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 44%; height: 15.75pt; width: 44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The following table sets forth a summary of the changes in the fair value of the Company&amp;#8217;s Level 3 financial liabilities that are measured at fair value on a recurring basis:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Patent acquisition obligation:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;519,946 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Royalty payment applied to patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(36,257)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;228,026 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Extinguishment of patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(4,399,902)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 16.5pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 18%; height: 16.5pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&amp;#xa0; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt&quot;&gt;Cash equivalents consists of highly liquid, short-term investments with original maturities of three months or less when purchased.&lt;/p&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:InvestmentPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Short-term Investments&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; At October 31, 2017 and 2016, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $3,500,000 and $750,000, respectively, that were classified as short-term investments and reported at fair value.&lt;/p&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
  <us-gaap:CertificatesOfDepositAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">3500000</us-gaap:CertificatesOfDepositAtCarryingValue>
  <us-gaap:CertificatesOfDepositAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">750000</us-gaap:CertificatesOfDepositAtCarryingValue>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c33_From1Nov2016To31Oct2017_PatentsMember">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Patents&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Our only identifiable intangible assets are patents and patent rights.&amp;#xa0; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&amp;#xa0; No patent acquisition costs were capitalized during the years ended October 31, 2017 and 2016.&amp;#xa0; We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2017 and 2016, respectively.&lt;/p&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Impairment&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.&lt;/p&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Income Taxes&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&amp;#xa0; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock-Based Compensation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock Option Compensation Expense &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &amp;#8220;Stock Compensation&amp;#8221; (&amp;#8220;ASC 718&amp;#8221;).&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model.&amp;#xa0; For options vesting if the trading price of the Company&amp;#8217;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. &lt;/font&gt;We recognize compensation expense for stock option awards over the requisite or implied service period of the grant.&amp;#xa0; With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable.&amp;#xa0; We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $1,223,000 and $874,000, during the years ended October 31, 2017 and 2016, respectively. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Included in stock-based compensation cost for employees and directors during the years ended October 31, 2017 and 2016 was approximately $967,000 and $393,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested.&amp;#xa0; As of October 31, 2017, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,091,000, which will be recognized over a weighted-average period of 1.7 years. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &amp;#8220;Equity-Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;).&amp;#xa0; In accordance with ASC 505-50, &lt;font style=&quot;COLOR:black&quot;&gt;we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model.&amp;#xa0; F&lt;/font&gt;or options vesting if the trading price of the Company&amp;#8217;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation.&amp;#xa0; We recognize compensation expense for &lt;font style=&quot;COLOR:black&quot;&gt;service based stock options and options subject to market conditions&lt;/font&gt; over the requisite or implied service period of the grant.&amp;#xa0; For performance based awards, compensation expense is recognized when the performance target is achieved.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2017 and 2016 of approximately $3,000 and $-0-, respectively. &amp;#xa0;Stock-based consulting expense for the years ended October 31, 2017 and 2016 did not include any amortization of compensation cost for stock options granted in prior periods but vested in the current period. &amp;#xa0;As of October 31, 2017, there was unrecognized consulting expense related to non-vested stock options granted to consultants, related to service based options of approximately $44,000, which will be recognized over a weighted-average period of 2.1 years.&lt;/p&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c34_From1Nov2016To31Oct2017_EmployeeStockOptionMember" decimals="0">1223000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c35_From1Nov2015To31Oct2016_EmployeeStockOptionMember" decimals="0">874000</us-gaap:ShareBasedCompensation>
  <itus:AmortizationRelatedToCompensationCost unitRef="usd" contextRef="c36_From1Nov2016To31Oct2017_EmployeeStockOptionMember_EmployeesAndDirectorsMember" decimals="0">967000</itus:AmortizationRelatedToCompensationCost>
  <itus:AmortizationRelatedToCompensationCost unitRef="usd" contextRef="c37_From1Nov2015To31Oct2016_EmployeeStockOptionMember_EmployeesAndDirectorsMember" decimals="0">393000</itus:AmortizationRelatedToCompensationCost>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized unitRef="usd" contextRef="c38_AsOf31Oct2017_EmployeeStockOptionMember_EmployeesAndDirectorsMember" decimals="0">1091000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c36_From1Nov2016To31Oct2017_EmployeeStockOptionMember_EmployeesAndDirectorsMember">P1Y255D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <itus:ConsultationExpense unitRef="usd" contextRef="c39_From1Nov2016To31Oct2017_EmployeeStockOptionMember_ConsultantMember" decimals="0">3000</itus:ConsultationExpense>
  <itus:ConsultationExpense unitRef="usd" contextRef="c40_From1Nov2015To31Oct2016_EmployeeStockOptionMember_ConsultantMember" decimals="0">0</itus:ConsultationExpense>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized unitRef="usd" contextRef="c41_AsOf31Oct2017_EmployeeStockOptionMember_ConsultantMember" decimals="0">44000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c39_From1Nov2016To31Oct2017_EmployeeStockOptionMember_ConsultantMember">P2Y36D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Fair Value Determination&lt;/font&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time.&amp;#xa0; &lt;font style=&quot;COLOR:black&quot;&gt;The stock options we granted during the year ended October 31, 2017 consisted of awards with 10-year terms that vest over 6 to 48 months. The stock options we granted during the year ended October 31, 2016 consisted of awards with 10-year terms that vest over 6 to 36 months&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2017 and 2016:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;For the Year&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted average fair value at grant date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$1.72 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$2.84 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Valuation assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected life (years) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;5.63&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;5.70&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;119.2%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;181.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;1.94%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;1.26%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.&amp;#xa0; We use the simplified method, which is a weighted average of the vesting term and contractual term, to determine expected term.&amp;#xa0; The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years.&amp;#xa0; Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options.&amp;#xa0; We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants.&amp;#xa0; We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest.&amp;#xa0; Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options.&amp;#xa0; Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate.&amp;#xa0; If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c34_From1Nov2016To31Oct2017_EmployeeStockOptionMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c42_From1Nov2016To31Oct2017_EmployeeStockOptionMember_MinimumMember">P6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c43_From1Nov2016To31Oct2017_EmployeeStockOptionMember_MaximumMember">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c35_From1Nov2015To31Oct2016_EmployeeStockOptionMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c44_From1Nov2015To31Oct2016_EmployeeStockOptionMember_MinimumMember">P6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c45_From1Nov2015To31Oct2016_EmployeeStockOptionMember_MaximumMember">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Net&amp;#xa0;Loss&amp;#xa0;Per&amp;#xa0;Share of Common Stock &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;In accordance with ASC 260, &amp;#8220;Earnings Per Share&amp;#8221;, basic net loss per common share (&amp;#8220;Basic EPS&amp;#8221;) is computed by dividing net loss by the weighted average number of common shares outstanding.&amp;#xa0; Diluted net loss per common share (&amp;#8220;Diluted EPS&amp;#8221;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&amp;#xa0; Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&amp;#xa0; For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2017 and 2016, were options to purchase 3,447,846 and 3,086,472 shares, respectively, warrants to purchase 829,400 shares and 707,379 shares, respectively, preferred stock convertible into -0- and 739,958 shares, respectively.&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c46_From1Nov2016To31Oct2017_EmployeeStockOptionMember" decimals="INF">3447846</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c47_From1Nov2015To31Oct2016_EmployeeStockOptionMember" decimals="INF">3086472</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c48_From1Nov2016To31Oct2017_WarrantMember" decimals="INF">829400</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c49_From1Nov2015To31Oct2016_WarrantMember" decimals="INF">707379</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c50_From1Nov2016To31Oct2017_ConvertiblePreferredStockMember" decimals="INF">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c51_From1Nov2015To31Oct2016_ConvertiblePreferredStockMember" decimals="INF">739958</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:UseOfEstimates contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Use of Estimates &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&amp;#xa0; Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies.&amp;#xa0; Actual results could differ from those estimates.&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Effect of Recently Issued Pronouncements&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In May 2014, the Financial Accounting Standards Board (&quot;FASB&quot;) issued Accounting Standards Update 2014-09 (&amp;#8220;ASU 2014-09&amp;#8221;), Revenue from Contracts with Customers.&amp;#xa0; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &amp;#xa0;This standard update is effective for&amp;#xa0;interim and annual&amp;#xa0;reporting periods beginning after December 15,&amp;#xa0;2016, and were to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &amp;#xa0;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &amp;#xa0;&lt;a name=&quot;_Hlk501045300&quot;&gt;We do not expect the adoption of ASU 2014-09 &lt;/a&gt;to have a material impact on our &lt;a name=&quot;_Hlk502247174&quot;&gt;consolidated financial statements and related disclosures.&lt;/a&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In August 2014, the FASB issued Accounting Standards Update 2014-15 (&amp;#8220;ASU 2014-15&amp;#8221;).&amp;#xa0; This amendment requires management to assess an entity&amp;#8217;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption.&amp;#xa0; We have provided additional footnote disclosure to our consolidated financial statements in accordance with ASU 2014-15 upon adoption of this amendment.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;In November 2015, the FASB issued Accounting Standards Update 2015-17 (&amp;#8220;ASU 2015-17&amp;#8221;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &amp;#xa0;Adoption of this standard is required for annual periods beginning after December 15, 2016. &amp;#xa0;We do not anticipate that the adoption of this amendment will have an impact on our consolidated financial statements&amp;#xa0;and related disclosures as we currently do not present deferred tax assets or liabilities.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In February 2016, the FASB issued Accounting Standards Update 2016-02 (&amp;#8220;ASU 2016-02&amp;#8221;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &amp;#xa0;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &amp;#xa0;The requirements of this standard include a significant increase in required disclosures. &amp;#xa0;We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&amp;#xa0;and related disclosures, and our analysis is currently ongoing.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in&quot;&gt;In March 2016, the FASB issued Accounting Standards Update 2016-09 (&amp;#8220;ASU 2016-09&amp;#8221;) that changes the accounting for certain aspects of share-based payments to employees. &amp;#xa0;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&amp;#8217;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &amp;#xa0;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. We adopted ASU 2016-09 on November 1, 2017. &amp;#xa0;We do not expect the adoption of this new guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In May 2017, the FASB issued Accounting Standards Update 2017-09 (&amp;#8220;ASU 2017-09&amp;#8221;) that provides guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting. &amp;#xa0;This update is effective for all entities for fiscal years beginning after December 15, 2017, and interim periods within those years.&amp;#xa0; Early adoption is permitted.&amp;#xa0; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements and related disclosures, and our analysis is ongoing.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In July 2017, the FASB issued Accounting Standards Update 2017-11 (&amp;#8220;ASU 2017-11&amp;#8221;) which changes the accounting for equity instruments that include a down round feature.&amp;#xa0; For public entities, this update is effective for fiscal years beginning after December 15, 2018, and interim periods within those years.&amp;#xa0; Early adoption is permitted. &amp;#xa0;&lt;/font&gt;We do not anticipate the adoption of this amendment will have an impact on our consolidated financial statements&amp;#xa0;and related disclosures as we currently do not have any such equity instruments.&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Concentration of Credit Risks&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable.&amp;#xa0; Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &amp;#xa0;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &amp;#xa0;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;One licensee accounted for 100% of revenues from patent licensing activities during fiscal year 2017. &amp;#xa0;Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016.&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013; &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit - &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.94%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,079,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,500,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6,579,282 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 15.75pt; white-space: nowrap; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Money market funds &amp;#x2013; &lt;br /&gt;&amp;#xa0;&amp;#xa0; Cash and cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 38%; height: 15.75pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Certificates of deposit - &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; Short term investments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; -&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 38%; height: 16.5pt; width: 38%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total financial assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,899,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;750,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2,649,136 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 44%; height: 15.75pt; white-space: nowrap; width: 44%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 1&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 2&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Level 3&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 44%; height: 15.75pt; width: 44%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 44%; height: 15.75pt; width: 44%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.4%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c52_AsOf31Oct2017_MoneyMarketFundsMember_FairValueInputsLevel1Member" decimals="0">3079282</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c53_AsOf31Oct2017_MoneyMarketFundsMember_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c54_AsOf31Oct2017_MoneyMarketFundsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c55_AsOf31Oct2017_MoneyMarketFundsMember" decimals="0">3079282</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c56_AsOf31Oct2017_CertificatesOfDepositMember_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c57_AsOf31Oct2017_CertificatesOfDepositMember_FairValueInputsLevel2Member" decimals="0">3500000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c58_AsOf31Oct2017_CertificatesOfDepositMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c59_AsOf31Oct2017_CertificatesOfDepositMember" decimals="0">3500000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c60_AsOf31Oct2017_FairValueInputsLevel1Member" decimals="0">3079282</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c61_AsOf31Oct2017_FairValueInputsLevel2Member" decimals="0">3500000</us-gaap:AssetsFairValueDisclosure>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GY1lUVWrWd1MFIV42ogD7LCavGUmZ4OrL2Xd+Pe32K8uaEGWU4pxv6/Ah0Myrb50JnZj+8bM0guDvRLx/A3T6ACO+Oy8byupVXtbE6JRHRYtNAdpX+obfJINjUCY6vJu3b] CSR-->
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c62_AsOf31Oct2017_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">6579282</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c63_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel1Member" decimals="0">1899136</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c64_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c65_AsOf31Oct2016_MoneyMarketFundsMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure unitRef="usd" contextRef="c66_AsOf31Oct2016_MoneyMarketFundsMember" decimals="0">1899136</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c67_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c68_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel2Member" decimals="0">750000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c69_AsOf31Oct2016_CertificatesOfDepositMember_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:InvestmentsFairValueDisclosure unitRef="usd" contextRef="c70_AsOf31Oct2016_CertificatesOfDepositMember" decimals="0">750000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c71_AsOf31Oct2016_FairValueInputsLevel1Member" decimals="0">1899136</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c72_AsOf31Oct2016_FairValueInputsLevel2Member" decimals="0">750000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c73_AsOf31Oct2016_FairValueInputsLevel3Member" xs:nil="true"/>
  <us-gaap:AssetsFairValueDisclosure unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">2649136</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c71_AsOf31Oct2016_FairValueInputsLevel1Member" xs:nil="true"/>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c72_AsOf31Oct2016_FairValueInputsLevel2Member" xs:nil="true"/>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c73_AsOf31Oct2016_FairValueInputsLevel3Member" decimals="0">4171876</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">4171876</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Patent acquisition obligation:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3,688,187 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;519,946 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Royalty payment applied to patent acquisition obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(36,257)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4,171,876 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accretion of interest on patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;228,026 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 80%; height: 15.75pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Extinguishment of patent obligation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(4,399,902)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 80%; height: 16.5pt; width: 80%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Balance October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 18%; height: 16.5pt; width: 18%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c16_AsOf31Oct2015" decimals="0">3688187</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <itus:InterestExpensePatentAcquisitionObligations unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">519946</itus:InterestExpensePatentAcquisitionObligations>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">4171876</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <itus:InterestExpensePatentAcquisitionObligations unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">228026</itus:InterestExpensePatentAcquisitionObligations>
  <itus:ExtinguishmentOfPatentObligation unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">4399902</itus:ExtinguishmentOfPatentObligation>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue unitRef="usd" contextRef="c0_AsOf31Oct2017" xs:nil="true"/>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;table style=&quot;width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;For the Year&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted average fair value at grant date&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$1.72 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$2.84 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Valuation assumptions:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected life (years) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;5.63&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;5.70&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected volatility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;119.2%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;181.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;1.94%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;1.26%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 15%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c6_From1Nov2016To31Oct2017" decimals="2">1.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c7_From1Nov2015To31Oct2016" decimals="2">2.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c6_From1Nov2016To31Oct2017">P5Y229D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c7_From1Nov2015To31Oct2016">P5Y255D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="3">1.192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="3">1.811</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="4">0.0194</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="4">0.0126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;3.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration:underline&quot;&gt;ACCRUED EXPENSES&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Accrued liabilities consist of the following as of:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;500pt&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accrued severance costs&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;237,563 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;51,643 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;49,901 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accrued other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;119,963 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;45,631 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;font style=&quot;font-family: times new roman, times, serif; display: none; font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;409,169 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;95,532 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;500pt&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accrued severance costs&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;237,563 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;51,643 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 12%; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;49,901 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Accrued other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;119,963 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;45,631 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;height: 16.5pt; width: 70%; padding: 0in; width: 70%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;font style=&quot;font-family: times new roman, times, serif; display: none; font-size: 10pt;&quot;&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;409,169 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;height: 16.5pt; width: 2%; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;font-size: 12pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;95,532 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
  <itus:AccruedSeveranceCostsCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">237563</itus:AccruedSeveranceCostsCurrent>
  <itus:AccruedSeveranceCostsCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" xs:nil="true"/>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">51643</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">49901</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">119963</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">45631</us-gaap:OtherAccruedLiabilitiesCurrent>
  <itus:PatentAcquisitionObligationTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 12pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;4.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&lt;font style=&quot;text-decoration:underline&quot;&gt;PATENT ACQUISITION OBLIGATION&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;In November 2013, we incurred a patent acquisition obligation due no later than November 2017 related to the acquisition of patents.&amp;#xa0; The payment due in November 2017 was payable at the option of the Company in cash or common stock.&amp;#xa0; We recorded interest expense of approximately $228,000 and $520,000, respectively, for the years ended October 31, 2017 and 2016, for the accretion of interest on patent acquisition obligation.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;On March 27, 2017, the Company issued 947,606 shares of common stock in satisfaction of the obligation.&amp;#xa0; The carrying value of the patent acquisition obligation at the date of extinguishment was approximately $4,400,000.&amp;#xa0; The fair value of the shares of common stock issued to satisfy the obligation on the date of extinguishment was approximately $2,843,000, resulting in the recognition of a gain on the debt extinguishment of approximately $1,548,000.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</itus:PatentAcquisitionObligationTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c74_From27Mar2017To27Mar2017" decimals="INF">947606</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <itus:PatentAcquisitionObligation unitRef="usd" contextRef="c75_AsOf27Mar2017" decimals="0">4400000</itus:PatentAcquisitionObligation>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c74_From27Mar2017To27Mar2017" decimals="0">2843000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c74_From27Mar2017To27Mar2017" decimals="0">1548000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;5.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration:underline&quot;&gt;SHAREHOLDERS&amp;#8217; EQUITY&lt;/font&gt;&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Common Stock Issuances&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;We account for stock granted to employees, directors and consultants based on the grant date market price of the underlying common stock.&amp;#xa0;&amp;#xa0; During the years ended October 31, 2017 and 2016, we issued 9,463 shares and 10,833 shares, respectively, of common stock to consultants for services rendered.&amp;#xa0; We recorded consulting expense for the years ended October 31, 2017 and 2016 of approximately $32,000 and $31,000, respectively, for shares of common stock issued to consultants.&amp;#xa0; During the year ended October 31, 2017 we issued 200,000 shares to directors for services rendered and recorded expense of $454,000.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 12pt 4.5pt; TEXT-INDENT:-4.5pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock&amp;#xa0;Option&amp;#xa0;Plans&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;As of October 31, 2017, we have two stock option plans: the ITUS Corporation 2003 Share Incentive Plan (the &amp;#8220;2003 Share Plan&amp;#8221;) and the ITUS Corporation 2010 Share Incentive Plan (the &amp;#8220;2010 Share Plan&amp;#8221;) which were adopted by our Board of Directors on April 21, 2003 and July 14, 2010, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&amp;#xa0; The 2003 Share Plan was administered by the Board of Directors or committees thereof, which determined the option price, term and provisions of each option.&amp;#xa0; The exercise price with respect to all of the options granted under the 2003 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. &amp;#xa0;In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the grant of future options on April 21, 2013. &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Information regarding the 2003 Share Plan for the two years ended October 31, 2017 is as follows:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;Intrinsic Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;366,200 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;17.86 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(11,080)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.58 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(129,520)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;17.72 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;225,600 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;18.69 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(5,800)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.39 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(189,200)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;21.55 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.24%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding and Exercisable at October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;30,600 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;20,148 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of October 31, 2017:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&amp;#xa0; 0.67 - $&amp;#xa0; 17.50&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;30,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.13&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; display: none;&quot;&gt;.&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&amp;#xa0; On the first business day of each calendar year the maximum aggregate number of shares available for future issuance is replenished such that 800,000 shares are available. &amp;#xa0;The 2010 Share Plan is administered by the Board of Directors or committees thereof, which determines the option price, term and provisions of each option. The exercise price with respect to all of the options granted under the 2010 Share Plan was equal to the fair market value of the underlying common stock at the grant date.&amp;#xa0; As of October 31, 2017, the 2010 Share Plan had 69,226 shares available for future grants.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;Information regarding the 2010 Share Plan as of October 31, 2017 is as follows: &lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Aggregate&lt;br /&gt;&amp;#xa0;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;526,272 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3.33 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;557,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.92 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(2,400)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,080,872 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3.12 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;682,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.03 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(44,400)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(81,226)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6.20 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 16.5pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,637,246 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.50 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,381,380 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.25pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56%; height: 17.25pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Exercisable at October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 17.25pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;909,024 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.72 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;721,433 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;The following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2017:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 634.85pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;846&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; colspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot; colspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;5&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot; rowspan=&quot;4&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life (in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot; rowspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;2&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;2&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;2&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,001,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;8.14&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;522,778&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;7.09&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$2.27 - $7.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;636,246&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6.69&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$2.80 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;386,246&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.62&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$3.14 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;In addition to options granted under the 2003 Share Plan and the 2010 Share Plan, during the years ended October 31, 2012 and 2013, the Board of Directors approved the grant of stock options to purchase 1,660,000 shares and 120,000 shares, respectively. &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt&quot;&gt;Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan for the two years ended October 31, 2017 is as follows:&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.04%; height: 15.75pt;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 58.18%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0; October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12.04%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.7%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11.04%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.25pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0; October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.04%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.58 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,443,480 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;The following table summarizes information about stock options outstanding and exercisable that were not granted under the 2003 Share Plan or the 2010 Share Plan as of October 31, 2017:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Outstanding&lt;font style=&quot;text-decoration:underline&quot;&gt; &lt;/font&gt;and&lt;font style=&quot;text-decoration:underline&quot;&gt; &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,046,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.91&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$ 2.58 - $ 5.56&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;734,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.36&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$2.88 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Re-Priced Stock Options&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;On September 6, 2017 the Board of Directors re-priced 2,029,600 issued and outstanding stock options (the &amp;#8220;Re-Priced Options&amp;#8221;) for all of the officers, directors and employees of the Company.&amp;#xa0; The new exercise price of the Re-Priced Options is $0.67, the closing sales price of the Company&amp;#8217;s common stock on September 6, 2017.&amp;#xa0; All other terms of the previously granted Re-Priced Options remain the same.&amp;#xa0; The Company recorded additional stock-based compensation of approximately $261,000, as of September 6, 2017, related to this re-pricing.&amp;#xa0; This amount was determined to be the incremental value of the fair value of the Re-Priced Options compared to the fair value of the original option immediately before the re-pricing.&amp;#xa0; Accordingly, 18,200 stock options in the 2003 Share Plan with exercise prices of $2.58, 965,400 stock options in the 2010 Share Plan with exercise prices ranging from $0.82 to $5.30 and 1,046,000 stock options that were not granted under the 2003 Share Plan or the 2010 Share plan with exercise prices of $2.58, were re-priced.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Preferred Stock&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;On November 11, 2016, the holder of all our outstanding Series A Preferred Stock (the &amp;#8220;Series A Preferred&amp;#8221;) with an aggregate stated value of $3,500,000 exercised its right of redemption to receive such amount from proceeds from the sale of the Company&amp;#8217;s equity securities.&amp;#xa0;&amp;#xa0;On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &amp;#8220;Series A Redemption Terms&amp;#8221;). &amp;#xa0;Pursuant to the Series A Redemption Terms, on December 9, 2016 the holder of the Series A Preferred received (i) $500,000 in cash, (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which was due on or before June 1, 2017 and the remainder of which was due November 11, 2017 (the &amp;#8220;Redemption Debenture&amp;#8221;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&amp;#8217;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing (the &amp;#8220;Redemption Warrant&amp;#8221;). The Redemption Debenture was secured by a lien on the Company&amp;#8217;s assets and prohibited the Company from incurring any senior indebtedness&amp;#xa0;other than equipment financing in connection with the Company&amp;#8217;s business.&amp;#xa0; The Redemption Debenture was paid in full during fiscal year 2017.&amp;#xa0; Interest expense during the year ended October 31, 2017 in connection with the Redemption Debenture was approximately $272,000.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;FONT-SIZE:11pt; COLOR:black&quot;&gt;The difference between the fair value of the consideration given to the holder of our Series A Preferred and the carrying value of the Series A Preferred represents a return to the preferred stockholder which is treated in a similar manner as that of dividends paid on preferred stock.&amp;#xa0; In the redemption, the Series A Preferred holder received $500,000 in cash, the Redemption Debenture with a present value of approximately $2,999,000 and the Redemption Warrant with a fair value of approximately $2,801,000, determined using the Black Scholes pricing model, and waived the Series A Preferred&amp;#8217;s conversion right with an intrinsic value of approximately $792,000, resulting in total consideration given to the Series A Preferred holder of approximately $5,508,000.&amp;#xa0; The difference between the fair value of the consideration and the $3,500,000 carrying value of the Series A Preferred resulted in a deemed dividend to the Series A Preferred holder of approximately $2,008,000.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Common Stock Purchase Warrants&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt&quot;&gt;As of October 31, 2017, we had warrants to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019, warrants to purchase 309,400 shares of common stock at $10.00 per share expiring on July 15, 2019 and warrants to purchase 500,000 shares of common stock at $5.03 per share expiring on November 30, 2021.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c76_From1Nov2016To31Oct2017_CommonStockMember_ConsultantMember" decimals="INF">9463</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c77_From1Nov2015To31Oct2016_CommonStockMember_ConsultantMember" decimals="INF">10833</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <itus:ConsultationExpense unitRef="usd" contextRef="c76_From1Nov2016To31Oct2017_CommonStockMember_ConsultantMember" decimals="0">32000</itus:ConsultationExpense>
  <itus:ConsultationExpense unitRef="usd" contextRef="c77_From1Nov2015To31Oct2016_CommonStockMember_ConsultantMember" decimals="0">31000</itus:ConsultationExpense>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c78_From1Nov2016To31Oct2017_CommonStockMember_DirectorMember" decimals="INF">200000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockOptionPlanExpense unitRef="usd" contextRef="c78_From1Nov2016To31Oct2017_CommonStockMember_DirectorMember" decimals="0">454000</us-gaap:StockOptionPlanExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c79_AsOf31Oct2017_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c79_AsOf31Oct2017_EmployeeStockOptionMember_A2010SharePlanMember" decimals="INF">69226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c80_From1Nov2011To31Oct2012_EmployeeStockOptionMember_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">1660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c81_From1Nov2012To31Oct2013_EmployeeStockOptionMember_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c82_AsOf6Sep2017_RePricedOptionsMember" decimals="INF">2029600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c82_AsOf6Sep2017_RePricedOptionsMember" decimals="2">0.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost unitRef="usd" contextRef="c83_From6Sep2017To6Sep2017_RePricedOptionsMember" decimals="0">261000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c84_AsOf6Sep2017_RePricedOptionsMember_A2003SharePlanMember" decimals="INF">18200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c84_AsOf6Sep2017_RePricedOptionsMember_A2003SharePlanMember" decimals="2">2.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c85_AsOf6Sep2017_RePricedOptionsMember_A2010SharePlanMember" decimals="INF">965400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c86_AsOf6Sep2017_RePricedOptionsMember_A2010SharePlanMember_MinimumMember" decimals="2">0.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c87_AsOf6Sep2017_RePricedOptionsMember_A2010SharePlanMember_MaximumMember" decimals="2">5.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c88_AsOf6Sep2017_RePricedOptionsMember_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">1046000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c88_AsOf6Sep2017_RePricedOptionsMember_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="2">2.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c89_AsOf11Nov2016_SeriesAPreferredStockMember" decimals="0">3500000</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockRedemptionTerms contextRef="c90_From6Dec2016To6Dec2016_SeriesAPreferredStockMember">Pursuant to the Series A Redemption Terms, on December 9, 2016 the holder of the Series A Preferred received (i) $500,000 in cash, (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which was due on or before June 1, 2017 and the remainder of which was due November 11, 2017 (the &amp;#8220;Redemption Debenture&amp;#8221;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&amp;#8217;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing (the &amp;#8220;Redemption Warrant&amp;#8221;)</us-gaap:PreferredStockRedemptionTerms>
  <us-gaap:InterestExpenseLongTermDebt unitRef="usd" contextRef="c91_From1Nov2016To31Oct2017_SeriesAPreferredStockMember" decimals="0">272000</us-gaap:InterestExpenseLongTermDebt>
  <us-gaap:PreferredStockRedemptionAmount unitRef="usd" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" decimals="0">500000</us-gaap:PreferredStockRedemptionAmount>
  <us-gaap:DebtInstrumentCarryingAmount unitRef="usd" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" decimals="0">2999000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:WarrantsAndRightsOutstanding unitRef="usd" contextRef="c4_AsOf31Oct2017_SeriesAPreferredStockMember" decimals="0">2801000</us-gaap:WarrantsAndRightsOutstanding>
  <us-gaap:ConversionOfStockAmountConverted1 unitRef="usd" contextRef="c91_From1Nov2016To31Oct2017_SeriesAPreferredStockMember" decimals="0">792000</us-gaap:ConversionOfStockAmountConverted1>
  <us-gaap:ConversionOfStockAmountIssued1 unitRef="usd" contextRef="c91_From1Nov2016To31Oct2017_SeriesAPreferredStockMember" decimals="0">5508000</us-gaap:ConversionOfStockAmountIssued1>
  <us-gaap:RedeemablePreferredStockDividends unitRef="usd" contextRef="c91_From1Nov2016To31Oct2017_SeriesAPreferredStockMember" decimals="0">2008000</us-gaap:RedeemablePreferredStockDividends>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c92_AsOf31Oct2017_WarrantWithExercisePriceOf925Member_CommonStockMember" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c93_AsOf31Oct2017_WarrantWithExercisePriceOf13875Member_CommonStockMember" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c92_AsOf31Oct2017_WarrantWithExercisePriceOf925Member_CommonStockMember" decimals="2">9.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c93_AsOf31Oct2017_WarrantWithExercisePriceOf13875Member_CommonStockMember" decimals="3">13.875</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <invest:InvestmentWarrantsExpirationDate contextRef="c94_From1Nov2016To31Oct2017_WarrantWithExercisePriceOf13875Member_CommonStockMember">2019-08-19</invest:InvestmentWarrantsExpirationDate>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c95_AsOf31Oct2017_WarrantWithExercisePriceOf1000Member_CommonStockMember" decimals="INF">309400</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c95_AsOf31Oct2017_WarrantWithExercisePriceOf1000Member_CommonStockMember" decimals="2">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <invest:InvestmentWarrantsExpirationDate contextRef="c96_From1Nov2016To31Oct2017_WarrantWithExercisePriceOf1000Member_CommonStockMember">2019-07-15</invest:InvestmentWarrantsExpirationDate>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c97_AsOf31Oct2017_WarrantWithExercisePriceOf503Member_CommonStockMember" decimals="INF">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c97_AsOf31Oct2017_WarrantWithExercisePriceOf503Member_CommonStockMember" decimals="2">5.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <invest:InvestmentWarrantsExpirationDate contextRef="c98_From1Nov2016To31Oct2017_WarrantWithExercisePriceOf503Member_CommonStockMember">2021-11-30</invest:InvestmentWarrantsExpirationDate>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c99_From1Nov2016To31Oct2017_A2003SharePlanMember">&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;Intrinsic Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;366,200 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;17.86 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(11,080)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.58 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(129,520)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;17.72 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;225,600 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;18.69 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(5,800)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.39 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(189,200)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;21.55 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56.24%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding and Exercisable at October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;30,600 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: justify; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;20,148 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c100_AsOf31Oct2015_A2003SharePlanMember" decimals="INF">366200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c100_AsOf31Oct2015_A2003SharePlanMember" decimals="2">17.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c101_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="INF">11080</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c101_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="2">2.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c101_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="INF">129520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c101_From1Nov2015To31Oct2016_A2003SharePlanMember" decimals="2">17.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c102_AsOf31Oct2016_A2003SharePlanMember" decimals="INF">225600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c102_AsOf31Oct2016_A2003SharePlanMember" decimals="2">18.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c99_From1Nov2016To31Oct2017_A2003SharePlanMember" decimals="INF">5800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c99_From1Nov2016To31Oct2017_A2003SharePlanMember" decimals="2">1.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c99_From1Nov2016To31Oct2017_A2003SharePlanMember" decimals="INF">189200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c99_From1Nov2016To31Oct2017_A2003SharePlanMember" decimals="2">21.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c103_AsOf31Oct2017_A2003SharePlanMember" decimals="INF">30600</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c103_AsOf31Oct2017_A2003SharePlanMember" decimals="2">3.16</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c103_AsOf31Oct2017_A2003SharePlanMember" decimals="0">20148</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c99_From1Nov2016To31Oct2017_A2003SharePlanMember">&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&amp;#xa0; 0.67 - $&amp;#xa0; 17.50&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;30,600&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.13&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$3.16 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; display: none;&quot;&gt;.&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c104_AsOf31Oct2017_A2003SharePlanMember_RangeOfExercisePrices067To1755Member" decimals="INF">30600</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c105_From1Nov2016To31Oct2017_A2003SharePlanMember_RangeOfExercisePrices067To1755Member">P1Y47D</itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c104_AsOf31Oct2017_A2003SharePlanMember_RangeOfExercisePrices067To1755Member" decimals="2">3.16</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember">&lt;table style=&quot;width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; colspan=&quot;2&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Aggregate&lt;br /&gt;&amp;#xa0;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;font style=&quot;color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;526,272 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3.33 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;557,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.92 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(2,400)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.25 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,080,872 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;3.12 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;682,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.03 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(44,400)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(81,226)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6.20 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 56%; height: 16.5pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding at October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,637,246 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.50 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 16.5pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,381,380 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.25pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 56%; height: 17.25pt; width: 56%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Exercisable at October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 17.25pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;909,024 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;/font&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.72 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;721,433 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c107_AsOf31Oct2015_A2010SharePlanMember" decimals="INF">526272</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c107_AsOf31Oct2015_A2010SharePlanMember" decimals="2">3.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c108_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="INF">557000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c108_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="2">2.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c108_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="INF">2400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c108_From1Nov2015To31Oct2016_A2010SharePlanMember" decimals="2">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c109_AsOf31Oct2016_A2010SharePlanMember" decimals="INF">1080872</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c109_AsOf31Oct2016_A2010SharePlanMember" decimals="2">3.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember" decimals="INF">682000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember" decimals="2">2.03</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember" decimals="INF">44400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember" decimals="2">0.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod unitRef="shares" contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember" decimals="INF">81226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember" decimals="2">6.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c110_AsOf31Oct2017_A2010SharePlanMember" decimals="INF">1637246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c110_AsOf31Oct2017_A2010SharePlanMember" decimals="2">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c110_AsOf31Oct2017_A2010SharePlanMember" decimals="0">1381380</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c110_AsOf31Oct2017_A2010SharePlanMember" decimals="INF">909024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c110_AsOf31Oct2017_A2010SharePlanMember" decimals="2">1.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c110_AsOf31Oct2017_A2010SharePlanMember" decimals="0">721433</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c106_From1Nov2016To31Oct2017_A2010SharePlanMember">&lt;table style=&quot;width: 634.85pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;846&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; colspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot; colspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;5&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot; rowspan=&quot;4&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life (in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot; rowspan=&quot;3&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;2&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;2&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot; rowspan=&quot;2&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,001,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;8.14&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;522,778&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;7.09&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$2.27 - $7.00&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;636,246&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;6.69&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$2.80 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;386,246&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.62&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$3.14 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c111_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">1001000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c112_From1Nov2016To31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member">P8Y51D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c111_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c111_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">522778</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c112_From1Nov2016To31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member">P7Y32D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c111_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c113_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member" decimals="INF">636246</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c114_From1Nov2016To31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member">P6Y251D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c113_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member" decimals="2">2.80</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c113_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member" decimals="INF">386246</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c114_From1Nov2016To31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member">P4Y226D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c113_AsOf31Oct2017_A2010SharePlanMember_RangeOfExercisePrices227To700Member" decimals="2">3.14</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c115_From1Nov2016To31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.04%; height: 15.75pt;&quot; colspan=&quot;2&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average Exercise&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Price Per Share&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Aggregate&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Intrinsic&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Value&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Shares&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 58.18%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0; October 31, 2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12.04%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2.70 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 1.7%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 11.04%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 17.25pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 58.18%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Options Outstanding and exercisable at &lt;br /&gt;&amp;#xa0;&amp;#xa0; October 31, 2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,780,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12.04%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1.58 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 1.7%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 11.04%; height: 17.25pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,443,480 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c116_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">1780000</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c116_AsOf31Oct2016_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="2">2.70</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber unitRef="shares" contextRef="c117_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="INF">1780000</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c117_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="2">1.58</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue unitRef="usd" contextRef="c117_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" decimals="0">1443480</itus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c115_From1Nov2016To31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">&lt;table style=&quot;width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Remaining&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Contractual Life&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(in years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Number&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Outstanding&lt;font style=&quot;text-decoration:underline&quot;&gt; &lt;/font&gt;and&lt;font style=&quot;text-decoration:underline&quot;&gt; &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercisable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;3&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Weighted&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Average&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Price&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; rowspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Range of&lt;/font&gt;&lt;/p&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Exercise Prices&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,046,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.91&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$0.67 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$ 2.58 - $ 5.56&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;734,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;4.36&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; width: 2%;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 23%; height: 15.75pt; width: 23%;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$2.88 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c118_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices067Member" decimals="INF">1046000</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c119_From1Nov2016To31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices067Member">P4Y332D</itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c118_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices067Member" decimals="2">0.67</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable unitRef="shares" contextRef="c120_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member" decimals="INF">734000</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable>
  <itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c121_From1Nov2016To31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member">P4Y131D</itus:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2>
  <itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c120_AsOf31Oct2017_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_RangeOfExercisePrices258To556Member" decimals="2">2.88</itus:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;6.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration:underline&quot;&gt;COMMITMENTS AND CONTINGENCIES &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Leases&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;We lease approximately 2,000 square feet of office space at 3150 Almaden Expressway, San Jose, California (our principal executive offices) from an unrelated party pursuant to a lease that expires September 30, 2019.&amp;#xa0; Our base rent is approximately $4,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.&amp;#xa0; We also lease approximately 3,000 square feet of office space at 12100 Wilshire Boulevard, Los Angeles, California (our former executive offices) from an unrelated party pursuant to a lease that expires May 31, 2019.&amp;#xa0; Our base rent is approximately $11,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.&amp;#xa0; &lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;During the fourth quarter of fiscal 2017 we vacated the office space at 12100 Wilshire Boulevard, Los Angeles, California and as of October 31, 2017 we have accrued an expense of approximately $84,000 related to future rents of the unused facilities.&lt;/font&gt; &amp;#xa0;As of October 31, 2017, our non-cancelable operating lease commitments for the years ending October 31, 2018 and 2019 were approximately $182,000 and $125,000, respectively.&amp;#xa0; Rent expense for the years ended October 31, 2017 and 2016, was approximately $229,000 and $188,000, respectively.&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Litigation Matters&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in&quot;&gt;&lt;font style=&quot;COLOR:black&quot;&gt;Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &amp;#xa0;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:AreaOfLand unitRef="sqft" contextRef="c122_AsOf31Oct2017_OfficeSpaceInSanJoseCaliforniaMember" decimals="0">2000</us-gaap:AreaOfLand>
  <us-gaap:LeaseExpirationDate1 contextRef="c123_From1Nov2016To31Oct2017_OfficeSpaceInSanJoseCaliforniaMember">2019-09-30</us-gaap:LeaseExpirationDate1>
  <us-gaap:OperatingLeasesRentExpenseMinimumRentals unitRef="usd" contextRef="c123_From1Nov2016To31Oct2017_OfficeSpaceInSanJoseCaliforniaMember" decimals="0">4000</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
  <itus:LeaseBaseRentAnnualIncrease unitRef="pure" contextRef="c123_From1Nov2016To31Oct2017_OfficeSpaceInSanJoseCaliforniaMember" decimals="2">0.03</itus:LeaseBaseRentAnnualIncrease>
  <us-gaap:AreaOfLand unitRef="sqft" contextRef="c124_AsOf31Oct2017_OfficeSpaceInLosAngelesCaliforniaMember" decimals="0">3000</us-gaap:AreaOfLand>
  <us-gaap:LeaseExpirationDate1 contextRef="c125_From1Nov2016To31Oct2017_OfficeSpaceInLosAngelesCaliforniaMember">2019-05-31</us-gaap:LeaseExpirationDate1>
  <us-gaap:OperatingLeasesRentExpenseMinimumRentals unitRef="usd" contextRef="c125_From1Nov2016To31Oct2017_OfficeSpaceInLosAngelesCaliforniaMember" decimals="0">11000</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
  <itus:LeaseBaseRentAnnualIncrease unitRef="pure" contextRef="c125_From1Nov2016To31Oct2017_OfficeSpaceInLosAngelesCaliforniaMember" decimals="2">0.03</itus:LeaseBaseRentAnnualIncrease>
  <us-gaap:AccruedRentCurrentAndNoncurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">84000</us-gaap:AccruedRentCurrentAndNoncurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">182000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">125000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">229000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">188000</us-gaap:LeaseAndRentalExpense>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;div style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; font-size: 11pt; &quot;&gt;
&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt&quot;&gt;7.&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;font style=&quot;text-decoration:underline&quot;&gt;INCOME TAXES&lt;/font&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0; &lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt&quot;&gt;Income tax provision (benefit) consists of the following:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Federal:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(12,534,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(1,631,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;State:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(4,351,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(134,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Adjustment to valuation allowance &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; related to net deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;16,885,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,765,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&lt;font class=&quot;a&quot;&gt;Income Tax Provision (Benefit)&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;The tax effects of temporary differences that give rise to significant portions of the deferred tax asset, net, at October 31, 2017 and 2016, are as follows:&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;&amp;#xa0;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Long-term deferred tax assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Federal and state NOL and tax credit carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;18,961,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;33,079,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Deferred compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;3,718,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;6,232,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Intangibles&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;543,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;713,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;205,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;289,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 20pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Subtotal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;23,427,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;40,313,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Less: valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;(23,427,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;(40,313,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 70%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Deferred tax asset, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;&quot;&gt;As of October 31, 2017, we had tax net operating loss and tax credit carryforwards of approximately $83,579,000 and $1,257,000, respectively, available within statutory limits (expiring at various dates between 2018 and 2037), to offset any future regular Federal corporate taxable income and taxes payable.&amp;#xa0; If the tax benefits relating to deductions of option holders&amp;#x2019; income are ultimately realized, those benefits will be credited directly to additional paid-in capital.&amp;#xa0; Certain changes in stock ownership can result in a limitation on the amount of net operating loss and tax credit carryovers that can be utilized each year. As of October 31, 2017, management has not determined the extent of any such limitations, if any.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;&quot;&gt;As a result of the change in future Federal statutory tax rates due to the passing of the Tax Cuts and Jobs Act of 2017, management has determined that the deferred tax assets and liabilities should no longer be valued at a federal statutory rate of 34% but rather at the rate in which the benefit of the deferred tax asset or liability will be realized by the Company. As such, the Federal statutory rate used to value the Company&apos;s deferred tax assets and liabilities is 21%.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-size: 11pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;We had New York and California tax net operating loss carryforwards of approximately $72,483,000 and&amp;#xa0; $9,656,000, respectively,&amp;#xa0;as of October 31, 2017, available within statutory limits (expiring at various dates between 2018 and 2037), to offset future corporate taxable income and taxes payable, if any, under certain computations of such taxes.&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;We have provided a valuation allowance against our deferred tax asset due to our current and historical pre-tax losses and the uncertainty regarding their realizability.&amp;#xa0; The primary differences from the Federal statutory rate of 34% and the effective rate of 0% is attributable to certain permanent differences and a change in the valuation allowance.&amp;#xa0; The following is a reconciliation of income taxes at the Federal statutory tax rate to income tax expense (benefit):&lt;/p&gt;&lt;br/&gt;&lt;table style=&quot;width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;9&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Income tax benefit at U.S. &lt;br /&gt;&amp;#xa0; Federal statutory income &lt;br /&gt;&amp;#xa0; Tax rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(1,703,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(34.0%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(1,706,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(34.0%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;State income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(443,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(8.84%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(411,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(8.2%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Permanent differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(10,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(0.20%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;2,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;0.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Expiring net operating &lt;br /&gt;&amp;#xa0;&amp;#xa0; losses, credits and other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;350,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;7.0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Rate Changes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;19,041,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;380.13%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Change in valuation &lt;br /&gt;&amp;#xa0;&amp;#xa0; allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(16,885,000) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(337.09%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;1,765,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;35.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Income tax provision&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;0.0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;0.0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;FONT-SIZE:11pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in&quot;&gt;During the two fiscal years ended October 31, 2017, we incurred no Federal and no State income taxes.&amp;#xa0; We have no unrecognized tax benefits as of October 31, 2017 and 2016 and we account for interest and penalties related to income tax matters in marketing, general and administrative expenses.&amp;#xa0; Tax years to which our net operating losses relate remain open to examination by Federal authorities and other jurisdictions to the extent which the net operating losses have yet to be utilized.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c126_AsOf31Oct2017_FederalCorporateTaxableMember" decimals="0">83579000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:TaxCreditCarryforwardAmount unitRef="usd" contextRef="c126_AsOf31Oct2017_FederalCorporateTaxableMember" decimals="0">1257000</us-gaap:TaxCreditCarryforwardAmount>
  <itus:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="2">0.21</itus:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c127_AsOf31Oct2017_NewYorkStateMember" decimals="0">72483000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards unitRef="usd" contextRef="c128_AsOf31Oct2017_CaliforniaMember" decimals="0">9656000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&amp;#xa0;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Federal:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(12,534,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(1,631,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;State:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Current&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Deferred&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(4,351,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;(134,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;Adjustment to valuation allowance &lt;br /&gt;&amp;#xa0;&amp;#xa0;&amp;#xa0;&amp;#xa0; related to net deferred tax assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;16,885,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;1,765,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt; page-break-inside: avoid;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;&lt;font class=&quot;a&quot;&gt;Income Tax Provision (Benefit)&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:CurrentFederalTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <us-gaap:CurrentFederalTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-12534000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-1631000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-4351000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-134000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">16885000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
  <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">1765000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;table style=&quot;width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;667&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;&amp;#xa0;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Long-term deferred tax assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Federal and state NOL and tax credit carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;18,961,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;33,079,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Deferred compensation&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;3,718,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;6,232,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Intangibles&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;543,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;713,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;205,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;289,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in 0in 0in 20pt; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Subtotal&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;23,427,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;40,313,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; width: 70%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Less: valuation allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;(23,427,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; width: 2.16%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&amp;#xa0;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;(40,313,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 0in 0in 20pt; width: 70%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;Deferred tax asset, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; width: 2.16%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt; -ms-text-autospace: ideograph-numeric;&quot;&gt;&lt;font style=&quot;color: black; font-size: 11pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <itus:FederalAndStateNOLAndTaxCreditCarryforwards unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">18961000</itus:FederalAndStateNOLAndTaxCreditCarryforwards>
  <itus:FederalAndStateNOLAndTaxCreditCarryforwards unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">33079000</itus:FederalAndStateNOLAndTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">3718000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">6232000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
  <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">543000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
  <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">713000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
  <us-gaap:DeferredTaxAssetsOther unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">205000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsOther unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">289000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">23427000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">40313000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c0_AsOf31Oct2017" decimals="0">23427000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c1_AsOf31Oct2016" decimals="0">40313000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsNet unitRef="usd" contextRef="c0_AsOf31Oct2017" xs:nil="true"/>
  <us-gaap:DeferredTaxAssetsNet unitRef="usd" contextRef="c1_AsOf31Oct2016" xs:nil="true"/>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c6_From1Nov2016To31Oct2017">&lt;table style=&quot;width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;&quot; width=&quot;666&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;9&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Year Ended October 31,&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;2017&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: center; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;2016&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Income tax benefit at U.S. &lt;br /&gt;&amp;#xa0; Federal statutory income &lt;br /&gt;&amp;#xa0; Tax rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(1,703,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(34.0%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(1,706,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(34.0%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;State income taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(443,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(8.84%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(411,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(8.2%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Permanent differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(10,000)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(0.20%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;2,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;0.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Expiring net operating &lt;br /&gt;&amp;#xa0;&amp;#xa0; losses, credits and other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;350,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;7.0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Rate Changes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;19,041,000&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;380.13%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 15.75pt;&quot;&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Change in valuation &lt;br /&gt;&amp;#xa0;&amp;#xa0; allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(16,885,000) &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;(337.09%)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;1,765,000 &lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;&amp;#xa0;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;35.1%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style=&quot;height: 16.5pt;&quot;&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;Income tax provision&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;0.0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;$&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;-&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;&amp;#xa0;&lt;/td&gt;
&lt;td style=&quot;background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;&quot; valign=&quot;bottom&quot;&gt;
&lt;p style=&quot;margin: 0in 0in 0pt; text-align: right; line-height: normal;&quot;&gt;&lt;font style=&quot;color: black; font-family: &apos;Times New Roman&apos;,&apos;serif&apos;; font-size: 12pt;&quot;&gt;0.0%&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-1703000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="3">0.340</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-1706000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="3">0.340</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-443000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="4">-0.0884</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">-411000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="3">-0.082</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-10000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
  <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="4">-0.0020</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
  <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">2000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
  <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="3">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
  <itus:IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" xs:nil="true"/>
  <itus:IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">350000</itus:IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="3">0.070</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
  <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">19041000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="4">3.8013</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
  <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" xs:nil="true"/>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c6_From1Nov2016To31Oct2017" decimals="0">-16885000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="4">-3.3709</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c7_From1Nov2015To31Oct2016" decimals="0">1765000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="3">0.351</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c6_From1Nov2016To31Oct2017" decimals="3">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations unitRef="pure" contextRef="c7_From1Nov2015To31Oct2016" decimals="3">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>itus-20171031.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Mon Jan 08 23:26:37 EST 2018 -->
<xs:schema elementFormDefault="qualified" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://www.ITUScorp.com/20171031" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:itus="http://www.ITUScorp.com/20171031" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20171031_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20171031_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20171031_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="itus-20171031_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet" id="itus_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet_Parentheticals" id="itus_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement" id="itus_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement_Parentheticals" id="itus_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ShareholdersEquityType2or3" id="itus_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS` EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ConsolidatedCashFlow" id="itus_r_ConsolidatedCashFlow">
        <link:definition>006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/BUSINESSANDFUNDING" id="itus_r_BUSINESSANDFUNDING">
        <link:definition>007 - Disclosure - BUSINESS AND FUNDING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" id="itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ACCRUEDEXPENSES" id="itus_r_ACCRUEDEXPENSES">
        <link:definition>009 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATION" id="itus_r_PATENTACQUISITIONOBLIGATION">
        <link:definition>010 - Disclosure - PATENT ACQUISITION OBLIGATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITY" id="itus_r_SHAREHOLDERSEQUITY">
        <link:definition>011 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIES" id="itus_r_COMMITMENTSANDCONTINGENCIES">
        <link:definition>012 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/INCOMETAXES" id="itus_r_INCOMETAXES">
        <link:definition>013 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/AccountingPoliciesByPolicy" id="itus_r_AccountingPoliciesByPolicy">
        <link:definition>014 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" id="itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ACCRUEDEXPENSESTables" id="itus_r_ACCRUEDEXPENSESTables">
        <link:definition>016 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables" id="itus_r_SHAREHOLDERSEQUITYTables">
        <link:definition>017 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/INCOMETAXESTables" id="itus_r_INCOMETAXESTables">
        <link:definition>018 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/BUSINESSANDFUNDINGDetails" id="itus_r_BUSINESSANDFUNDINGDetails">
        <link:definition>019 - Disclosure - BUSINESS AND FUNDING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" id="itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" id="itus_r_HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable">
        <link:definition>021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable" id="itus_r_ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable">
        <link:definition>022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Changes in the fair value of the Company's Level 3 financial liabilities measured at fair value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable" id="itus_r_WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable">
        <link:definition>023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/AccruedliabilitiesTable" id="itus_r_AccruedliabilitiesTable">
        <link:definition>024 - Disclosure - ACCRUED EXPENSES (Details) - Accrued liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATIONDetails" id="itus_r_PATENTACQUISITIONOBLIGATIONDetails">
        <link:definition>025 - Disclosure - PATENT ACQUISITION OBLIGATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYDetails" id="itus_r_SHAREHOLDERSEQUITYDetails">
        <link:definition>026 - Disclosure - SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GY1lUVWrWd1MFIV42ogD7LCavGUmZ4OrL2Xd+Pe32K8uaEGWU4pxv6/Ah0Myrb50JnZj+8bM0guDvRLx/A3T6ACO+Oy8byupVXtbE6JRHRYtMP+FWWg0FfbyJbMRMaEymA] CSR-->
      <link:roleType roleURI="http://www.ITUScorp.com/role/Informationregardingthe2003SharePlanTable" id="itus_r_Informationregardingthe2003SharePlanTable">
        <link:definition>027 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable" id="itus_r_Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable">
        <link:definition>028 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under the 2003 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/Informationregardingthe2010SharePlanTable" id="itus_r_Informationregardingthe2010SharePlanTable">
        <link:definition>029 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding the 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingunder2010SharePlanTable" id="itus_r_Stockoptionsoutstandingunder2010SharePlanTable">
        <link:definition>030 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" id="itus_r_InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable">
        <link:definition>031 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable" id="itus_r_Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable">
        <link:definition>032 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding not under 2003 Share Plan and 2010 Share Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIESDetails" id="itus_r_COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/INCOMETAXESDetails" id="itus_r_INCOMETAXESDetails">
        <link:definition>034 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable" id="itus_r_IncometaxprovisionbenefitTable">
        <link:definition>035 - Disclosure - INCOME TAXES (Details) - Income tax provision (benefit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" id="itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
        <link:definition>036 - Disclosure - INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable" id="itus_r_ReconciliationofincometaxesattheFederalstatutorytaxrateTable">
        <link:definition>037 - Disclosure - INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.ITUScorp.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
  <xs:element name="ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract"/>
  <xs:element name="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
  <xs:element name="AccruedLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AccruedLiabilitiesAbstract"/>
  <xs:element name="PatentAcquisitionObligationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_PatentAcquisitionObligationAbstract"/>
  <xs:element name="InformationRegardingThe2003SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_InformationRegardingThe2003SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract"/>
  <xs:element name="InformationRegardingThe2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_InformationRegardingThe2010SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingUnder2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsOutstandingUnder2010SharePlanAbstract"/>
  <xs:element name="InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract"/>
  <xs:element name="StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract"/>
  <xs:element name="IncomeTaxProvisionBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_IncomeTaxProvisionBenefitAbstract"/>
  <xs:element name="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
  <xs:element name="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
  <xs:element name="ValuationAssumptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ValuationAssumptionsAbstract"/>
  <xs:element name="FiniteLivedPatentsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_FiniteLivedPatentsNet"/>
  <xs:element name="PatentAcquisitionObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_PatentAcquisitionObligation"/>
  <xs:element name="LitigationAndLicensingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_LitigationAndLicensingExpenses"/>
  <xs:element name="StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors"/>
  <xs:element name="StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors"/>
  <xs:element name="CommonStockIssuedToRepayPatentAcquisitionObligationValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue"/>
  <xs:element name="CommonStockIssuedToRepayPatentAcquisitionObligationShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares"/>
  <xs:element name="StockIssuedDuringPeriodValueRightsOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_StockIssuedDuringPeriodValueRightsOffering"/>
  <xs:element name="StockIssuedDuringPeriodSharesRightsOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockIssuedDuringPeriodSharesRightsOffering"/>
  <xs:element name="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
  <xs:element name="CommonStockIssuedToAcquirePatentLicense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_CommonStockIssuedToAcquirePatentLicense"/>
  <xs:element name="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
  <xs:element name="ProceedsFromIssuanceOfRightsOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_ProceedsFromIssuanceOfRightsOffering"/>
  <xs:element name="ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering"/>
  <xs:element name="PaymentsMadeOnSecuredDebenture" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_PaymentsMadeOnSecuredDebenture"/>
  <xs:element name="PaymentToAcquireRoyaltyInterestInPatentRights" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
  <xs:element name="PatentAcquisitionObligationTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_PatentAcquisitionObligationTextBlock"/>
  <xs:element name="AccountingPoliciesbyPolicyPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_AccountingPoliciesbyPolicyPoliciesTable"/>
  <xs:element name="AccountingPoliciesbyPolicyPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
  <xs:element name="SHAREHOLDERSEQUITYTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYTablesTable"/>
  <xs:element name="SHAREHOLDERSEQUITYTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYTablesLineItems"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
  <xs:element name="InterestExpensePatentAcquisitionObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_InterestExpensePatentAcquisitionObligations"/>
  <xs:element name="ExtinguishmentOfPatentObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_ExtinguishmentOfPatentObligation"/>
  <xs:element name="AccruedSeveranceCostsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="itus_AccruedSeveranceCostsCurrent"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
  <xs:element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
  <xs:element name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
  <xs:element name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems"/>
  <xs:element name="FederalAndStateNOLAndTaxCreditCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
  <xs:element name="IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
  <xs:element name="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
  <xs:element name="AmortizationRelatedToCompensationCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_AmortizationRelatedToCompensationCost"/>
  <xs:element name="ConsultationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="itus_ConsultationExpense"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_SHAREHOLDERSEQUITYDetailsTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
  <xs:element name="COMMITMENTSANDCONTINGENCIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
  <xs:element name="COMMITMENTSANDCONTINGENCIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
  <xs:element name="LeaseBaseRentAnnualIncrease" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_LeaseBaseRentAnnualIncrease"/>
  <xs:element name="INCOMETAXESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="itus_INCOMETAXESDetailsTable"/>
  <xs:element name="INCOMETAXESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_INCOMETAXESDetailsLineItems"/>
  <xs:element name="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities"/>
  <xs:element name="A2003SharePlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_A2003SharePlanMember"/>
  <xs:element name="A2010SharePlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_A2010SharePlanMember"/>
  <xs:element name="CaliforniaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_CaliforniaMember"/>
  <xs:element name="ConsultantMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_ConsultantMember"/>
  <xs:element name="EmployeesAndDirectorsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_EmployeesAndDirectorsMember"/>
  <xs:element name="FederalCorporateTaxableMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_FederalCorporateTaxableMember"/>
  <xs:element name="NewYorkStateMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_NewYorkStateMember"/>
  <xs:element name="OfficeSpaceInLosAngelesCaliforniaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
  <xs:element name="OfficeSpaceInSanJoseCaliforniaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_OfficeSpaceInSanJoseCaliforniaMember"/>
  <xs:element name="PennsylvaniaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_PennsylvaniaMember"/>
  <xs:element name="RangeOfExercisePrices067Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices067Member"/>
  <xs:element name="RangeOfExercisePrices067To1755Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices067To1755Member"/>
  <xs:element name="RangeOfExercisePrices227To700Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices227To700Member"/>
  <xs:element name="RangeOfExercisePrices258To556Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RangeOfExercisePrices258To556Member"/>
  <xs:element name="RePricedOptionsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_RePricedOptionsMember"/>
  <xs:element name="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
  <xs:element name="WarrantWithExercisePriceOf1000Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantWithExercisePriceOf1000Member"/>
  <xs:element name="WarrantWithExercisePriceOf13875Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantWithExercisePriceOf13875Member"/>
  <xs:element name="WarrantWithExercisePriceOf503Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantWithExercisePriceOf503Member"/>
  <xs:element name="WarrantWithExercisePriceOf925Member" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_WarrantWithExercisePriceOf925Member"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="itus_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>itus-20171031_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Mon Jan 08 23:26:37 EST 2018 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedBalanceSheet" roleURI="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedIncomeStatement" roleURI="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedCashFlow" roleURI="http://www.ITUScorp.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_AccruedliabilitiesTable" roleURI="http://www.ITUScorp.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_IncometaxprovisionbenefitTable" roleURI="http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" roleURI="http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_FiniteLivedPatentsNet" xlink:href="itus-20171031.xsd#itus_FiniteLivedPatentsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="itus_FiniteLivedPatentsNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligation" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="itus_PatentAcquisitionObligation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_RoyaltyExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_LitigationAndLicensingExpenses" xlink:href="itus-20171031.xsd#itus_LitigationAndLicensingExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="itus_LitigationAndLicensingExpenses" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_InvestmentIncomeInterest" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_InterestExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_DividendsPreferredStock" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_StockOptionPlanExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="3" weight="1"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GY1lUVWrWd1MFIV42ogD7LCavGUmZ4OrL2Xd+Pe32K8uaEGWU4pxv6/Ah0Myrb50JnZj+8bM0guDvRLx/A3T6ACO+Oy8byupVXtbE6JRHRYtPrCGn9ZzBIR6bRzSocZ573] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockIssuedToAcquirePatentLicense" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToAcquirePatentLicense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="itus_CommonStockIssuedToAcquirePatentLicense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20171031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20171031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfRightsOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfRightsOffering"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="itus_ProceedsFromIssuanceOfRightsOffering" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentsMadeOnSecuredDebenture" xlink:href="itus-20171031.xsd#itus_PaymentsMadeOnSecuredDebenture"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="itus_PaymentsMadeOnSecuredDebenture" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20171031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="itus_AccruedSeveranceCostsCurrent" xlink:href="itus-20171031.xsd#itus_AccruedSeveranceCostsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="itus_AccruedSeveranceCostsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20171031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>itus-20171031_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Mon Jan 08 23:26:37 EST 2018 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedBalanceSheet" roleURI="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedIncomeStatement" roleURI="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ShareholdersEquityType2or3" roleURI="http://www.ITUScorp.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedCashFlow" roleURI="http://www.ITUScorp.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_BUSINESSANDFUNDING" roleURI="http://www.ITUScorp.com/role/BUSINESSANDFUNDING"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ACCRUEDEXPENSES" roleURI="http://www.ITUScorp.com/role/ACCRUEDEXPENSES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_PATENTACQUISITIONOBLIGATION" roleURI="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATION"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SHAREHOLDERSEQUITY" roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_INCOMETAXES" roleURI="http://www.ITUScorp.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_AccountingPoliciesByPolicy" roleURI="http://www.ITUScorp.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ACCRUEDEXPENSESTables" roleURI="http://www.ITUScorp.com/role/ACCRUEDEXPENSESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SHAREHOLDERSEQUITYTables" roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_INCOMETAXESTables" roleURI="http://www.ITUScorp.com/role/INCOMETAXESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" roleURI="http://www.ITUScorp.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable" roleURI="http://www.ITUScorp.com/role/ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable" roleURI="http://www.ITUScorp.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_AccruedliabilitiesTable" roleURI="http://www.ITUScorp.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Informationregardingthe2003SharePlanTable" roleURI="http://www.ITUScorp.com/role/Informationregardingthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable" roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Informationregardingthe2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/Informationregardingthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Stockoptionsoutstandingunder2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingunder2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_IncometaxprovisionbenefitTable" roleURI="http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" roleURI="http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ReconciliationofincometaxesattheFederalstatutorytaxrateTable" roleURI="http://www.ITUScorp.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_BUSINESSANDFUNDINGDetails" roleURI="http://www.ITUScorp.com/role/BUSINESSANDFUNDINGDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_PATENTACQUISITIONOBLIGATIONDetails" roleURI="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_INCOMETAXESDetails" roleURI="http://www.ITUScorp.com/role/INCOMETAXESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#DocumentAndEntityInformation" roleURI="http://www.ITUScorp.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_FiniteLivedPatentsNet" xlink:href="itus-20171031.xsd#itus_FiniteLivedPatentsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="itus_FiniteLivedPatentsNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligation" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="itus_PatentAcquisitionObligation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RoyaltyExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_LitigationAndLicensingExpenses" xlink:href="itus-20171031.xsd#itus_LitigationAndLicensingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="itus_LitigationAndLicensingExpenses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPreferredStock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodValueRightsOffering" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodValueRightsOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_StockIssuedDuringPeriodValueRightsOffering" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodSharesRightsOffering" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodSharesRightsOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="itus_StockIssuedDuringPeriodSharesRightsOffering" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20171031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockIssuedToAcquirePatentLicense" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToAcquirePatentLicense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="itus_CommonStockIssuedToAcquirePatentLicense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20171031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfRightsOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfRightsOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="itus_ProceedsFromIssuanceOfRightsOffering" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentsMadeOnSecuredDebenture" xlink:href="itus-20171031.xsd#itus_PaymentsMadeOnSecuredDebenture"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="itus_PaymentsMadeOnSecuredDebenture" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20171031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_StockIssued1" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/BUSINESSANDFUNDING">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ACCRUEDEXPENSES">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATION">
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationAbstract" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationAbstract"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationTextBlock" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_PatentAcquisitionObligationAbstract" xlink:to="itus_PatentAcquisitionObligationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="itus-20171031.xsd#itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:href="itus-20171031.xsd#itus_AccountingPoliciesbyPolicyPoliciesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="itus_AccountingPoliciesbyPolicyPoliciesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_UseOfEstimates" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ACCRUEDEXPENSESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="itus_SHAREHOLDERSEQUITYTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYTablesTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2003SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/INCOMETAXESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable">
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable">
    <loc xlink:type="locator" xlink:label="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:href="itus-20171031.xsd#itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_InterestExpensePatentAcquisitionObligations" xlink:href="itus-20171031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="itus_InterestExpensePatentAcquisitionObligations" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ExtinguishmentOfPatentObligation" xlink:href="itus-20171031.xsd#itus_ExtinguishmentOfPatentObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="itus_ExtinguishmentOfPatentObligation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20171031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable">
    <loc xlink:type="locator" xlink:label="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:href="itus-20171031.xsd#itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ValuationAssumptionsAbstract" xlink:href="itus-20171031.xsd#itus_ValuationAssumptionsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="itus_ValuationAssumptionsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="itus_AccruedLiabilitiesAbstract" xlink:href="itus-20171031.xsd#itus_AccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="itus_AccruedSeveranceCostsCurrent" xlink:href="itus-20171031.xsd#itus_AccruedSeveranceCostsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccruedLiabilitiesAbstract" xlink:to="itus_AccruedSeveranceCostsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" xbrldt:closed="true"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GY1lUVWrWd1MFIV42ogD7LCavGUmZ4OrL2Xd+Pe32K8uaEGWU4pxv6/Ah0Myrb50JnZj+8bM0guDvRLx/A3T6ACO+Oy8byupVXtbE6JRHRYtP23yUpVFaWwE95TBYhD59+] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_AccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Informationregardingthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2003SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2003SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices067To1755Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067To1755Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices067To1755Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20171031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Informationregardingthe2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Stockoptionsoutstandingunder2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices067Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices067Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices227To700Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices227To700Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices227To700Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices067Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices067Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices258To556Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices258To556Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="itus_RangeOfExercisePrices258To556Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20171031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable">
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxProvisionBenefitAbstract" xlink:href="itus-20171031.xsd#itus_IncomeTaxProvisionBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
    <loc xlink:type="locator" xlink:label="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:href="itus-20171031.xsd#itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20171031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable">
    <loc xlink:type="locator" xlink:label="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:href="itus-20171031.xsd#itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:href="itus-20171031.xsd#itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/BUSINESSANDFUNDINGDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CollateralizedFinancings" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CollateralizedFinancings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CollateralizedFinancings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfRightsOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfRightsOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="itus_ProceedsFromIssuanceOfRightsOffering" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentsMadeOnSecuredDebenture" xlink:href="itus-20171031.xsd#itus_PaymentsMadeOnSecuredDebenture"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="itus_PaymentsMadeOnSecuredDebenture" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashPeriodIncreaseDecrease" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RangeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="2" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_EmployeesAndDirectorsMember" xlink:href="itus-20171031.xsd#itus_EmployeesAndDirectorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_EmployeesAndDirectorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultantMember" xlink:href="itus-20171031.xsd#itus_ConsultantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_ConsultantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CertificatesOfDepositAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CertificatesOfDepositAtCarryingValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_AmortizationRelatedToCompensationCost" xlink:href="itus-20171031.xsd#itus_AmortizationRelatedToCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_AmortizationRelatedToCompensationCost" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultationExpense" xlink:href="itus-20171031.xsd#itus_ConsultationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_ConsultationExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATIONDetails">
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationAbstract" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationAbstract"/>
    <loc xlink:type="locator" xlink:label="itus_InterestExpensePatentAcquisitionObligations" xlink:href="itus-20171031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_PatentAcquisitionObligationAbstract" xlink:to="itus_InterestExpensePatentAcquisitionObligations" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_PatentAcquisitionObligationAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligation" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_PatentAcquisitionObligationAbstract" xlink:to="itus_PatentAcquisitionObligation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_PatentAcquisitionObligationAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_PatentAcquisitionObligationAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RangeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf925Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf925Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantWithExercisePriceOf925Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf13875Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf13875Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantWithExercisePriceOf13875Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf1000Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf1000Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantWithExercisePriceOf1000Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf503Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf503Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="itus_WarrantWithExercisePriceOf503Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2010SharePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="itus_A2003SharePlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_RePricedOptionsMember" xlink:href="itus-20171031.xsd#itus_RePricedOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="itus_RePricedOptionsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultantMember" xlink:href="itus-20171031.xsd#itus_ConsultantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="itus_ConsultantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DirectorMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DirectorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_DirectorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultationExpense" xlink:href="itus-20171031.xsd#itus_ConsultationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_ConsultationExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_StockOptionPlanExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockValue" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockRedemptionTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionTerms" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseLongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_InterestExpenseLongTermDebt" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockRedemptionAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionAmount" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemablePreferredStockDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_RedeemablePreferredStockDividends" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="invest_InvestmentWarrantsExpirationDate" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="invest_InvestmentWarrantsExpirationDate" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIESDetails">
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:href="itus-20171031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_OfficeSpaceInSanJoseCaliforniaMember" xlink:href="itus-20171031.xsd#itus_OfficeSpaceInSanJoseCaliforniaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="itus_OfficeSpaceInSanJoseCaliforniaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:href="itus-20171031.xsd#itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="itus_OfficeSpaceInLosAngelesCaliforniaMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfLand" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AreaOfLand"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_AreaOfLand" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_LeaseBaseRentAnnualIncrease" xlink:href="itus-20171031.xsd#itus_LeaseBaseRentAnnualIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_LeaseBaseRentAnnualIncrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_AccruedRentCurrentAndNoncurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/INCOMETAXESDetails">
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_INCOMETAXESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsTable" xlink:href="itus-20171031.xsd#itus_INCOMETAXESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="itus_INCOMETAXESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="itus_INCOMETAXESDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_FederalCorporateTaxableMember" xlink:href="itus-20171031.xsd#itus_FederalCorporateTaxableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="itus_FederalCorporateTaxableMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_NewYorkStateMember" xlink:href="itus-20171031.xsd#itus_NewYorkStateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="itus_NewYorkStateMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_CaliforniaMember" xlink:href="itus-20171031.xsd#itus_CaliforniaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="itus_CaliforniaMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" xlink:href="itus-20171031.xsd#itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="15" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>itus-20171031_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Mon Jan 08 23:26:37 EST 2018 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short&#8211;term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_FiniteLivedPatentsNet" xlink:href="itus-20171031.xsd#itus_FiniteLivedPatentsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_FiniteLivedPatentsNet_lbl" xml:lang="en-US">Patents, net of accumulated amortization of $1,290,336 and $965,040, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FiniteLivedPatentsNet" xlink:to="itus_FiniteLivedPatentsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Patents, accumulated amortization (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $35,725 and $46,950, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, accumulated depreciation (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligation" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PatentAcquisitionObligation_lbl" xml:lang="en-US">Patent acquisition obligation (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligation" xlink:to="itus_PatentAcquisitionObligation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_PatentAcquisitionObligation_lbl0" xml:lang="en-US">Patent Acquisition Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligation" xlink:to="itus_PatentAcquisitionObligation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Notes 6 and 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized, -0- and 140 shares issued and outstanding at October 31, 2017 and 2016, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred Stock, Value, Issued (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl" xml:lang="en-US">Equity Interest Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $.01 per share; 24,000,000 shares authorized; 16,602,759 and 8,752,387 shares issued and outstanding at October 31, 2017 and 2016, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">BALANCE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">BALANCE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Inventor royalties and contingent legal fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_LitigationAndLicensingExpenses" xlink:href="itus-20171031.xsd#itus_LitigationAndLicensingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_LitigationAndLicensingExpenses_lbl" xml:lang="en-US">Litigation and licensing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LitigationAndLicensingExpenses" xlink:to="itus_LitigationAndLicensingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses (including non-cash stock option compensation expenses of $288,187 and $259,930, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Non-cash Stock option compensation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Marketing, general and administrative expenses (including non-cash stock option compensation expense of $934,585 and $613,631, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total operating costs and expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on extinguishment of patent acquisition obligation (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0" xml:lang="en-US">Gain on extinguishment of patent acquisition obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense (Notes 4 and 5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes (Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Provision (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl0" xml:lang="en-US">Net Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl1" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStock_lbl" xml:lang="en-US">Deemed dividend to preferred stockholder (Note 5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">BALANCE (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">BALANCE (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock option compensation to employees and consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Common stock issued upon exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Common stock issued upon exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Options Exercised, Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Options Exercised, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common stock issued to consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common stock issued to consultants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Common stock issued to acquire patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Common stock issued to acquire patents (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors_lbl" xml:lang="en-US">Common stock issued to consultants and directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" xlink:to="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors_lbl" xml:lang="en-US">Common stock issued to consultants and directors (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" xlink:to="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Redemption of convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Redemption of convertible preferred stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue_lbl" xml:lang="en-US">Common stock issued to repay patent acquisition obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue" xlink:to="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares_lbl" xml:lang="en-US">Common stock issued to repay patent acquisition obligation (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares" xlink:to="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodValueRightsOffering" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodValueRightsOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockIssuedDuringPeriodValueRightsOffering_lbl" xml:lang="en-US">Common stock issued in shareholder rights offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodValueRightsOffering" xlink:to="itus_StockIssuedDuringPeriodValueRightsOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockIssuedDuringPeriodSharesRightsOffering" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodSharesRightsOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockIssuedDuringPeriodSharesRightsOffering_lbl" xml:lang="en-US">Common stock issued in shareholder rights offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesRightsOffering" xlink:to="itus_StockIssuedDuringPeriodSharesRightsOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Common stock issued in registered direct offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Common stock issued in registered direct offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Common stock issued in-at-the market offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Common stock issued in-at-the market offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option compensation to employees and consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl0" xml:lang="en-US">Stock or Unit Option Plan Expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Common stock issued to consultants and directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20171031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl" xml:lang="en-US">Accretion of interest on patent acquisition obligations to interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_CommonStockIssuedToAcquirePatentLicense" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToAcquirePatentLicense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_CommonStockIssuedToAcquirePatentLicense_lbl" xml:lang="en-US">Common stock issued to acquire patent license</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockIssuedToAcquirePatentLicense" xlink:to="itus_CommonStockIssuedToAcquirePatentLicense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Loss on disposal of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20171031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Disbursements to acquire short-term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0" xml:lang="en-US">Payments to Acquire Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xml:lang="en-US">Proceeds from maturities of short-term investments in certificates of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl0" xml:lang="en-US">Proceeds from Sale of Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfRightsOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfRightsOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ProceedsFromIssuanceOfRightsOffering_lbl" xml:lang="en-US">Proceeds from sale of common stock in shareholder rights offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ProceedsFromIssuanceOfRightsOffering" xlink:to="itus_ProceedsFromIssuanceOfRightsOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ProceedsFromIssuanceOfRightsOffering_lbl0" xml:lang="en-US">Proceeds From Issuance Of Rights Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ProceedsFromIssuanceOfRightsOffering" xlink:to="itus_ProceedsFromIssuanceOfRightsOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering_lbl" xml:lang="en-US">Proceeds from sale of common stock in registered direct offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:to="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock in Registered Direct Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:to="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock in at-the-market offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xml:lang="en-US">Redemption of convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl0" xml:lang="en-US">Payments for Repurchase of Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentsMadeOnSecuredDebenture" xlink:href="itus-20171031.xsd#itus_PaymentsMadeOnSecuredDebenture"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_PaymentsMadeOnSecuredDebenture_lbl" xml:lang="en-US">Payments made on secured debenture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentsMadeOnSecuredDebenture" xlink:to="itus_PaymentsMadeOnSecuredDebenture_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PaymentsMadeOnSecuredDebenture_lbl0" xml:lang="en-US">Payments Made On Secured Debenture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentsMadeOnSecuredDebenture" xlink:to="itus_PaymentsMadeOnSecuredDebenture_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of employee stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20171031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl" xml:lang="en-US">Royalty payment applied to patent acquisition obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Cash payments for interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Redemption of Series A convertible preferred stock into secured debenture (Note 5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Amount Converted (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Common stock issued to pay patent acquisition obligation (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="itus-20171031.xsd#itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract_lbl" xml:lang="en-US">Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Money market funds &#8211; Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xml:lang="en-US">Certificates of Deposit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_lbl" xml:lang="en-US">Patent acquisition obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:href="itus-20171031.xsd#itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Changes in the fair value of the Company&apos;s Level 3 financial liabilities measured at fair value [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_InterestExpensePatentAcquisitionObligations" xlink:href="itus-20171031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_InterestExpensePatentAcquisitionObligations_lbl" xml:lang="en-US">Accretion of interest on patent obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InterestExpensePatentAcquisitionObligations" xlink:to="itus_InterestExpensePatentAcquisitionObligations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_InterestExpensePatentAcquisitionObligations_lbl0" xml:lang="en-US">Interest Expense Patent Acquisition Obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InterestExpensePatentAcquisitionObligations" xlink:to="itus_InterestExpensePatentAcquisitionObligations_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_ExtinguishmentOfPatentObligation" xlink:href="itus-20171031.xsd#itus_ExtinguishmentOfPatentObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="itus_ExtinguishmentOfPatentObligation_lbl" xml:lang="en-US">Extinguishment of patent obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ExtinguishmentOfPatentObligation" xlink:to="itus_ExtinguishmentOfPatentObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:href="itus-20171031.xsd#itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract_lbl" xml:lang="en-US">Weighted average assumptions used in estimating the fair value of stock options [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average fair value at grant date (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccruedLiabilitiesAbstract" xlink:href="itus-20171031.xsd#itus_AccruedLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccruedLiabilitiesAbstract_lbl" xml:lang="en-US">Accrued liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccruedLiabilitiesAbstract" xlink:to="itus_AccruedLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccruedSeveranceCostsCurrent" xlink:href="itus-20171031.xsd#itus_AccruedSeveranceCostsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccruedSeveranceCostsCurrent_lbl" xml:lang="en-US">Accrued severance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccruedSeveranceCostsCurrent" xlink:to="itus_AccruedSeveranceCostsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Payroll and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationAbstract" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PatentAcquisitionObligationAbstract_lbl" xml:lang="en-US">Patent Acquisition Obligation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligationAbstract" xlink:to="itus_PatentAcquisitionObligationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_A2003SharePlanMember_lbl" xml:lang="en-US">2003 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2003SharePlanMember" xlink:to="itus_A2003SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_InformationRegardingThe2003SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_InformationRegardingThe2003SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_InformationRegardingThe2003SharePlanAbstract_lbl" xml:lang="en-US">Information regarding the 2003 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InformationRegardingThe2003SharePlanAbstract" xlink:to="itus_InformationRegardingThe2003SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options Outstanding, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Options Outstanding, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Exercised, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options Forfeited, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Forfeited, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl0" xml:lang="en-US">Options Outstanding and exercisable, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Options Outstanding and exercisable, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl0" xml:lang="en-US">Options Outstanding and exercisable, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding and exercisable under the 2003 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:to="itus_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices067To1755Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067To1755Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices067To1755Member_lbl" xml:lang="en-US">Range Of Exercise Prices $0.67 To $17.50 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices067To1755Member" xlink:to="itus_RangeOfExercisePrices067To1755Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20171031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Outstanding and Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_A2010SharePlanMember_lbl" xml:lang="en-US">2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2010SharePlanMember" xlink:to="itus_A2010SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_InformationRegardingThe2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_InformationRegardingThe2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_InformationRegardingThe2010SharePlanAbstract_lbl" xml:lang="en-US">Information regarding the 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InformationRegardingThe2010SharePlanAbstract" xlink:to="itus_InformationRegardingThe2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options Granted, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Options Outstanding, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Options Exercisable, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Options Exercisable, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_StockOptionsOutstandingUnder2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsOutstandingUnder2010SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding under 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:to="itus_StockOptionsOutstandingUnder2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices067Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices067Member_lbl" xml:lang="en-US">Range Of Exercise Prices $0.67 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices067Member" xlink:to="itus_RangeOfExercisePrices067Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Outstanding,Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Exercisable,Weighted Average Remaining Contractual Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices227To700Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices227To700Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices227To700Member_lbl" xml:lang="en-US">Range Of Exercise Prices $2.27 To $7.00 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices227To700Member" xlink:to="itus_RangeOfExercisePrices227To700Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl" xml:lang="en-US">Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract_lbl" xml:lang="en-US">Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract" xlink:to="itus_InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract_lbl" xml:lang="en-US">Stock options outstanding not under 2003 Share Plan and 2010 Share Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:to="itus_StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RangeOfExercisePrices258To556Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices258To556Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RangeOfExercisePrices258To556Member_lbl" xml:lang="en-US">Range Of Exercise Prices 2.58 To 5.56 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices258To556Member" xlink:to="itus_RangeOfExercisePrices258To556Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxProvisionBenefitAbstract" xlink:href="itus-20171031.xsd#itus_IncomeTaxProvisionBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_IncomeTaxProvisionBenefitAbstract_lbl" xml:lang="en-US">Income tax provision (benefit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncomeTaxProvisionBenefitAbstract" xlink:to="itus_IncomeTaxProvisionBenefitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Adjustment to valuation allowance related to net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:href="itus-20171031.xsd#itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract_lbl" xml:lang="en-US">The tax effects of temporary differences of the deferred tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20171031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl" xml:lang="en-US">Federal and state NOL and tax credit carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xml:lang="en-US">Deferred compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Subtotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:href="itus-20171031.xsd#itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract_lbl" xml:lang="en-US">Reconciliation of income taxes at the Federal statutory tax rate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax benefit at U.S. Federal statutory income Tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax benefit at U.S. Federal statutory income Tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:href="itus-20171031.xsd#itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl" xml:lang="en-US">Expiring net operating losses, credits and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:to="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xml:lang="en-US">Expiring net operating losses, credits and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Rate Changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Rate Changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GY1lUVWrWd1MFIV42ogD7LCavGUmZ4OrL2Xd+Pe32K8uaEGWU4pxv6/Ah0Myrb50JnZj+8bM0guDvRLx/A3T6ACO+Oy8byupVXtbE6JRHRYtPVjkM+ysQAGbyYeEl7Kpsu] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract_lbl" xml:lang="en-US">Operating costs and expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net loss per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average common shares outstanding:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental disclosure of non-cash financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ValuationAssumptionsAbstract" xlink:href="itus-20171031.xsd#itus_ValuationAssumptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ValuationAssumptionsAbstract_lbl" xml:lang="en-US">Valuation assumptions:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ValuationAssumptionsAbstract" xlink:to="itus_ValuationAssumptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_PatentAcquisitionObligationTextBlock" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PatentAcquisitionObligationTextBlock_lbl" xml:lang="en-US">Patent Acquisition Obligation [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligationTextBlock" xlink:to="itus_PatentAcquisitionObligationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Federal:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">State:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract_lbl" xml:lang="en-US">Long-term deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Employee Stock Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_EmployeesAndDirectorsMember" xlink:href="itus-20171031.xsd#itus_EmployeesAndDirectorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_EmployeesAndDirectorsMember_lbl" xml:lang="en-US">Employees and Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_EmployeesAndDirectorsMember" xlink:to="itus_EmployeesAndDirectorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultantMember" xlink:href="itus-20171031.xsd#itus_ConsultantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ConsultantMember_lbl" xml:lang="en-US">Consultant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultantMember" xlink:to="itus_ConsultantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DirectorMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DirectorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DirectorMember_lbl" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectorMember" xlink:to="us-gaap_DirectorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_RePricedOptionsMember" xlink:href="itus-20171031.xsd#itus_RePricedOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_RePricedOptionsMember_lbl" xml:lang="en-US">Re-Priced Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RePricedOptionsMember" xlink:to="itus_RePricedOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf925Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf925Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantWithExercisePriceOf925Member_lbl" xml:lang="en-US">Warrant with Exercise Price of $9.25 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf925Member" xlink:to="itus_WarrantWithExercisePriceOf925Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf13875Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf13875Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantWithExercisePriceOf13875Member_lbl" xml:lang="en-US">Warrant with Exercise Price of $13.875 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf13875Member" xlink:to="itus_WarrantWithExercisePriceOf13875Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf1000Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf1000Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantWithExercisePriceOf1000Member_lbl" xml:lang="en-US">Warrant with Exercise Price of $10.00 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf1000Member" xlink:to="itus_WarrantWithExercisePriceOf1000Member_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_WarrantWithExercisePriceOf503Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf503Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_WarrantWithExercisePriceOf503Member_lbl" xml:lang="en-US">Warrant with Exercise Price of $5.03 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf503Member" xlink:to="itus_WarrantWithExercisePriceOf503Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_OfficeSpaceInSanJoseCaliforniaMember" xlink:href="itus-20171031.xsd#itus_OfficeSpaceInSanJoseCaliforniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_OfficeSpaceInSanJoseCaliforniaMember_lbl" xml:lang="en-US">Office Space In San Jose California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OfficeSpaceInSanJoseCaliforniaMember" xlink:to="itus_OfficeSpaceInSanJoseCaliforniaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:href="itus-20171031.xsd#itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl" xml:lang="en-US">Office Space In Los Angeles California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:to="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_FederalCorporateTaxableMember" xlink:href="itus-20171031.xsd#itus_FederalCorporateTaxableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_FederalCorporateTaxableMember_lbl" xml:lang="en-US">Federal Corporate Taxable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalCorporateTaxableMember" xlink:to="itus_FederalCorporateTaxableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_NewYorkStateMember" xlink:href="itus-20171031.xsd#itus_NewYorkStateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_NewYorkStateMember_lbl" xml:lang="en-US">New York [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_NewYorkStateMember" xlink:to="itus_NewYorkStateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_CaliforniaMember" xlink:href="itus-20171031.xsd#itus_CaliforniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_CaliforniaMember_lbl" xml:lang="en-US">California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CaliforniaMember" xlink:to="itus_CaliforniaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CollateralizedFinancings" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CollateralizedFinancings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollateralizedFinancings_lbl" xml:lang="en-US">Collateralized Financings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollateralizedFinancings" xlink:to="us-gaap_CollateralizedFinancings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashPeriodIncreaseDecrease_lbl" xml:lang="en-US">Cash, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CertificatesOfDepositAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue_lbl" xml:lang="en-US">Certificates of Deposit, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:to="us-gaap_CertificatesOfDepositAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AmortizationRelatedToCompensationCost" xlink:href="itus-20171031.xsd#itus_AmortizationRelatedToCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AmortizationRelatedToCompensationCost_lbl" xml:lang="en-US">Amortization Related To Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AmortizationRelatedToCompensationCost" xlink:to="itus_AmortizationRelatedToCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_ConsultationExpense" xlink:href="itus-20171031.xsd#itus_ConsultationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConsultationExpense_lbl" xml:lang="en-US">Consultation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultationExpense" xlink:to="itus_ConsultationExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="itus_ConsultationExpense_lbl0" xml:lang="en-US">Consultation Expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultationExpense" xlink:to="itus_ConsultationExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockRedemptionTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionTerms_lbl" xml:lang="en-US">Preferred Stock, Redemption Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionTerms" xlink:to="us-gaap_PreferredStockRedemptionTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseLongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseLongTermDebt_lbl" xml:lang="en-US">Interest Expense, Long-term Debt (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseLongTermDebt" xlink:to="us-gaap_InterestExpenseLongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockRedemptionAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionAmount_lbl" xml:lang="en-US">Preferred Stock, Redemption Amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionAmount" xlink:to="us-gaap_PreferredStockRedemptionAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Long-term Debt, Gross (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants and Rights Outstanding (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversion of Stock, Amount Issued (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemablePreferredStockDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemablePreferredStockDividends_lbl" xml:lang="en-US">Redeemable Preferred Stock Dividends (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemablePreferredStockDividends" xlink:to="us-gaap_RedeemablePreferredStockDividends_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <loc xlink:type="locator" xlink:label="invest_InvestmentWarrantsExpirationDate" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_InvestmentWarrantsExpirationDate_lbl" xml:lang="en-US">Investment Warrants Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentWarrantsExpirationDate" xlink:to="invest_InvestmentWarrantsExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfLand" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AreaOfLand"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of Land (in Square Feet)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_LeaseBaseRentAnnualIncrease" xlink:href="itus-20171031.xsd#itus_LeaseBaseRentAnnualIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_LeaseBaseRentAnnualIncrease_lbl" xml:lang="en-US">Lease Base Rent Annual Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LeaseBaseRentAnnualIncrease" xlink:to="itus_LeaseBaseRentAnnualIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedRentCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRentCurrentAndNoncurrent" xlink:to="us-gaap_AccruedRentCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" xlink:href="itus-20171031.xsd#itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percentage Use For Deferred Tax Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" xlink:to="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:href="itus-20171031.xsd#itus_AccountingPoliciesbyPolicyPoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesTable_lbl" xml:lang="en-US">Accounting Policies, by Policy (Policies) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesTable" xlink:to="itus_AccountingPoliciesbyPolicyPoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="itus-20171031.xsd#itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccountingPoliciesbyPolicyPoliciesLineItems_lbl" xml:lang="en-US">Accounting Policies, by Policy (Policies) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="itus_AccountingPoliciesbyPolicyPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYTablesTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYTablesTable" xlink:to="itus_SHAREHOLDERSEQUITYTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYTablesLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Tables) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYTablesLineItems" xlink:to="itus_SHAREHOLDERSEQUITYTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding the 2003 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding the 2003 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding the 2010 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding the 2010 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) - Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Equity Award [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeMember_lbl" xml:lang="en-US">Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsTable" xlink:to="itus_SHAREHOLDERSEQUITYDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_SHAREHOLDERSEQUITYDetailsLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="itus_SHAREHOLDERSEQUITYDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:href="itus-20171031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsTable_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="itus_COMMITMENTSANDCONTINGENCIESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsTable" xlink:href="itus-20171031.xsd#itus_INCOMETAXESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_INCOMETAXESDetailsTable_lbl" xml:lang="en-US">INCOME TAXES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_INCOMETAXESDetailsTable" xlink:to="itus_INCOMETAXESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="itus_INCOMETAXESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_INCOMETAXESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_INCOMETAXESDetailsLineItems_lbl" xml:lang="en-US">INCOME TAXES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_INCOMETAXESDetailsLineItems" xlink:to="itus_INCOMETAXESDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl0" xml:lang="en-US">Accretion of interest on patent acquisition obligations to interest expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_AccruedSeveranceCostsCurrent_lbl0" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for employee severance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccruedSeveranceCostsCurrent" xlink:to="itus_AccruedSeveranceCostsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_AmortizationRelatedToCompensationCost_lbl0" xml:lang="en-US">Amount of amortization related to compensation cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AmortizationRelatedToCompensationCost" xlink:to="itus_AmortizationRelatedToCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_CommonStockIssuedToAcquirePatentLicense_lbl0" xml:lang="en-US">Amount of common stock issued during the period related to the patent license</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockIssuedToAcquirePatentLicense" xlink:to="itus_CommonStockIssuedToAcquirePatentLicense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares_lbl0" xml:lang="en-US">Number of shares of stock issued during the period pursuant to patent acquisitions obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares" xlink:to="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue_lbl0" xml:lang="en-US">Value of stock issued pursuant to repay patent acquisition obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue" xlink:to="itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ConsultationExpense_lbl1" xml:lang="en-US">Amount charged to consultation expense for the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultationExpense" xlink:to="itus_ConsultationExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities_lbl0" xml:lang="en-US">Percentage of domestic federal statutory tax rate used to value the deferred tax assets and liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" xlink:to="itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ExtinguishmentOfPatentObligation_lbl0" xml:lang="en-US">Extinguishment of patent obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ExtinguishmentOfPatentObligation" xlink:to="itus_ExtinguishmentOfPatentObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and tax carry forwards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalAndStateNOLAndTaxCreditCarryforwards" xlink:to="itus_FederalAndStateNOLAndTaxCreditCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_FiniteLivedPatentsNet_lbl0" xml:lang="en-US">Net carrying amount after accumulated amortization as of the balance sheet date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FiniteLivedPatentsNet" xlink:to="itus_FiniteLivedPatentsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl0" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to expiring net operating losses, credits and other.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:to="itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl0" xml:lang="en-US">The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred for royalties and legal fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_InterestExpensePatentAcquisitionObligations_lbl1" xml:lang="en-US">Interest expense recorded during the period for the accretion of interest on patent acquisition obligations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_InterestExpensePatentAcquisitionObligations" xlink:to="itus_InterestExpensePatentAcquisitionObligations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_LeaseBaseRentAnnualIncrease_lbl0" xml:lang="en-US">The percentage annual increase of base rent of lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LeaseBaseRentAnnualIncrease" xlink:to="itus_LeaseBaseRentAnnualIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_LitigationAndLicensingExpenses_lbl0" xml:lang="en-US">Litigation and licensing expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_LitigationAndLicensingExpenses" xlink:to="itus_LitigationAndLicensingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PatentAcquisitionObligation_lbl1" xml:lang="en-US">Obligation related to patent acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligation" xlink:to="itus_PatentAcquisitionObligation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PatentAcquisitionObligationTextBlock_lbl0" xml:lang="en-US">The entire disclosure related to the patent acquisition obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PatentAcquisitionObligationTextBlock" xlink:to="itus_PatentAcquisitionObligationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl0" xml:lang="en-US">The cash outflow from the purchase of royalty interests in patent rights is the amount of cash the patent user pays the owner of the patent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_PaymentsMadeOnSecuredDebenture_lbl1" xml:lang="en-US">The cash outflow for a Debenture.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentsMadeOnSecuredDebenture" xlink:to="itus_PaymentsMadeOnSecuredDebenture_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering_lbl1" xml:lang="en-US">Amount of cash inflow associated with the registered direct offering of common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:to="itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ProceedsFromIssuanceOfRightsOffering_lbl1" xml:lang="en-US">The cash inflow associated with the amount received from rights offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ProceedsFromIssuanceOfRightsOffering" xlink:to="itus_ProceedsFromIssuanceOfRightsOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl1" xml:lang="en-US">Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl1" xml:lang="en-US">Number of options outstanding and exercisable, including both vested and non-vested options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl0" xml:lang="en-US">The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl0" xml:lang="en-US">The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Weighted average remaining contractual term of outstanding and exercisable stock options, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents the reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors_lbl0" xml:lang="en-US">Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" xlink:to="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_StockIssuedDuringPeriodSharesRightsOffering_lbl0" xml:lang="en-US">Number of stock issued during the period for shareholder rights offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesRightsOffering" xlink:to="itus_StockIssuedDuringPeriodSharesRightsOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors_lbl0" xml:lang="en-US">Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" xlink:to="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="itus_StockIssuedDuringPeriodValueRightsOffering_lbl0" xml:lang="en-US">Equity impact of the value of stock issued during the period for shareholder right offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodValueRightsOffering" xlink:to="itus_StockIssuedDuringPeriodValueRightsOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_A2003SharePlanMember_lbl0" xml:lang="en-US">A2003 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2003SharePlanMember" xlink:to="itus_A2003SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_A2010SharePlanMember_lbl0" xml:lang="en-US">A2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_A2010SharePlanMember" xlink:to="itus_A2010SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_CaliforniaMember_lbl0" xml:lang="en-US">California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CaliforniaMember" xlink:to="itus_CaliforniaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ConsultantMember_lbl0" xml:lang="en-US">Consultant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ConsultantMember" xlink:to="itus_ConsultantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_EmployeesAndDirectorsMember_lbl0" xml:lang="en-US">Employees And Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_EmployeesAndDirectorsMember" xlink:to="itus_EmployeesAndDirectorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_FederalCorporateTaxableMember_lbl0" xml:lang="en-US">Federal Corporate Taxable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_FederalCorporateTaxableMember" xlink:to="itus_FederalCorporateTaxableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_NewYorkStateMember_lbl0" xml:lang="en-US">New York State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_NewYorkStateMember" xlink:to="itus_NewYorkStateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl0" xml:lang="en-US">Office Space In Los Angeles California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OfficeSpaceInLosAngelesCaliforniaMember" xlink:to="itus_OfficeSpaceInLosAngelesCaliforniaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_OfficeSpaceInSanJoseCaliforniaMember_lbl0" xml:lang="en-US">Office Space In San Jose California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_OfficeSpaceInSanJoseCaliforniaMember" xlink:to="itus_OfficeSpaceInSanJoseCaliforniaMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_PennsylvaniaMember" xlink:href="itus-20171031.xsd#itus_PennsylvaniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PennsylvaniaMember_lbl" xml:lang="en-US">Pennsylvania [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PennsylvaniaMember" xlink:to="itus_PennsylvaniaMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices067Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 067 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices067Member" xlink:to="itus_RangeOfExercisePrices067Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices067To1755Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 067 To 1755 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices067To1755Member" xlink:to="itus_RangeOfExercisePrices067To1755Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices227To700Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 227 To 700 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices227To700Member" xlink:to="itus_RangeOfExercisePrices227To700Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RangeOfExercisePrices258To556Member_lbl0" xml:lang="en-US">Range Of Exercise Prices 258 To 556 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RangeOfExercisePrices258To556Member" xlink:to="itus_RangeOfExercisePrices258To556Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_RePricedOptionsMember_lbl0" xml:lang="en-US">Re Priced Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_RePricedOptionsMember" xlink:to="itus_RePricedOptionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl0" xml:lang="en-US">Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:to="itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantWithExercisePriceOf1000Member_lbl0" xml:lang="en-US">Warrant With Exercise Price Of 1000 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf1000Member" xlink:to="itus_WarrantWithExercisePriceOf1000Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantWithExercisePriceOf13875Member_lbl0" xml:lang="en-US">Warrant With Exercise Price Of 13875 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf13875Member" xlink:to="itus_WarrantWithExercisePriceOf13875Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantWithExercisePriceOf503Member_lbl0" xml:lang="en-US">Warrant With Exercise Price Of 503 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf503Member" xlink:to="itus_WarrantWithExercisePriceOf503Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_WarrantWithExercisePriceOf925Member_lbl0" xml:lang="en-US">Warrant With Exercise Price Of 925 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_WarrantWithExercisePriceOf925Member" xlink:to="itus_WarrantWithExercisePriceOf925Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="itus_DocumentAndEntityInformationAbstract" xlink:href="itus-20171031.xsd#itus_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_DocumentAndEntityInformationAbstract" xlink:to="itus_DocumentAndEntityInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ExtinguishmentOfPatentObligation_lbl1" xml:lang="en-US">ExtinguishmentOfPatentObligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ExtinguishmentOfPatentObligation" xlink:to="itus_ExtinguishmentOfPatentObligation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" xlink:to="itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares_lbl1" xml:lang="en-US">CommonStockIssuedToRepayPatentAcquisitionObligationShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares" xlink:to="itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockIssuedDuringPeriodSharesRightsOffering_lbl1" xml:lang="en-US">StockIssuedDuringPeriodSharesRightsOffering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodSharesRightsOffering" xlink:to="itus_StockIssuedDuringPeriodSharesRightsOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl1" xml:lang="en-US">AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:to="itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl1" xml:lang="en-US">PaymentToAcquireRoyaltyInterestInPatentRights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_PaymentToAcquireRoyaltyInterestInPatentRights" xlink:to="itus_PaymentToAcquireRoyaltyInterestInPatentRights_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl2" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:to="itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors_lbl1" xml:lang="en-US">StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" xlink:to="itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStock_lbl0" xml:lang="en-US">Dividends, Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl0" xml:lang="en-US">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl0" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>itus-20171031_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Mon Jan 08 23:26:37 EST 2018 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedBalanceSheet" roleURI="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedIncomeStatement" roleURI="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ShareholdersEquityType2or3" roleURI="http://www.ITUScorp.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ConsolidatedCashFlow" roleURI="http://www.ITUScorp.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_BUSINESSANDFUNDING" roleURI="http://www.ITUScorp.com/role/BUSINESSANDFUNDING"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ACCRUEDEXPENSES" roleURI="http://www.ITUScorp.com/role/ACCRUEDEXPENSES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_PATENTACQUISITIONOBLIGATION" roleURI="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATION"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SHAREHOLDERSEQUITY" roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_INCOMETAXES" roleURI="http://www.ITUScorp.com/role/INCOMETAXES"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_AccountingPoliciesByPolicy" roleURI="http://www.ITUScorp.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ACCRUEDEXPENSESTables" roleURI="http://www.ITUScorp.com/role/ACCRUEDEXPENSESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SHAREHOLDERSEQUITYTables" roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_INCOMETAXESTables" roleURI="http://www.ITUScorp.com/role/INCOMETAXESTables"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" roleURI="http://www.ITUScorp.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable" roleURI="http://www.ITUScorp.com/role/ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable" roleURI="http://www.ITUScorp.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_AccruedliabilitiesTable" roleURI="http://www.ITUScorp.com/role/AccruedliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Informationregardingthe2003SharePlanTable" roleURI="http://www.ITUScorp.com/role/Informationregardingthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable" roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Informationregardingthe2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/Informationregardingthe2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Stockoptionsoutstandingunder2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingunder2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable" roleURI="http://www.ITUScorp.com/role/Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_IncometaxprovisionbenefitTable" roleURI="http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable" roleURI="http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_ReconciliationofincometaxesattheFederalstatutorytaxrateTable" roleURI="http://www.ITUScorp.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_BUSINESSANDFUNDINGDetails" roleURI="http://www.ITUScorp.com/role/BUSINESSANDFUNDINGDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_PATENTACQUISITIONOBLIGATIONDetails" roleURI="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#itus_r_INCOMETAXESDetails" roleURI="http://www.ITUScorp.com/role/INCOMETAXESDetails"/>
  <roleRef xlink:type="simple" xlink:href="itus-20171031.xsd#DocumentAndEntityInformation" roleURI="http://www.ITUScorp.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_PreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedPatentsNet" xlink:href="itus-20171031.xsd#itus_FiniteLivedPatentsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="FiniteLivedPatentsNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligation" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="PatentAcquisitionObligation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_PreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_RoyaltyExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LitigationAndLicensingExpenses" xlink:href="itus-20171031.xsd#itus_LitigationAndLicensingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="LitigationAndLicensingExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DividendsPreferredStock" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockIssuedToRepayPatentAcquisitionObligationValue" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CommonStockIssuedToRepayPatentAcquisitionObligationValue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CommonStockIssuedToRepayPatentAcquisitionObligationShares" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CommonStockIssuedToRepayPatentAcquisitionObligationShares" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueRightsOffering" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodValueRightsOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRightsOffering" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesRightsOffering" xlink:href="itus-20171031.xsd#itus_StockIssuedDuringPeriodSharesRightsOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRightsOffering" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_0" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" xlink:href="itus-20171031.xsd#itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockIssuedToAcquirePatentLicense" xlink:href="itus-20171031.xsd#itus_CommonStockIssuedToAcquirePatentLicense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="CommonStockIssuedToAcquirePatentLicense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:href="itus-20171031.xsd#itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfRightsOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfRightsOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfRightsOffering" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsMadeOnSecuredDebenture" xlink:href="itus-20171031.xsd#itus_PaymentsMadeOnSecuredDebenture"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsMadeOnSecuredDebenture" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20171031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentToAcquireRoyaltyInterestInPatentRights" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_StockIssued1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/BUSINESSANDFUNDING">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ACCRUEDEXPENSES">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATION">
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligationAbstract" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationAbstract"/>
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligationTextBlock" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PatentAcquisitionObligationAbstract" xlink:to="PatentAcquisitionObligationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/INCOMETAXES">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesbyPolicyPoliciesTable" xlink:href="itus-20171031.xsd#itus_AccountingPoliciesbyPolicyPoliciesTable"/>
    <loc xlink:type="locator" xlink:label="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:href="itus-20171031.xsd#itus_AccountingPoliciesbyPolicyPoliciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="AccountingPoliciesbyPolicyPoliciesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesTable" xlink:to="AccountingPoliciesbyPolicyPoliciesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_UseOfEstimates" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesbyPolicyPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ACCRUEDEXPENSESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYTablesTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYTablesTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYTablesLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="SHAREHOLDERSEQUITYTablesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesTable" xlink:to="SHAREHOLDERSEQUITYTablesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYTablesLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/INCOMETAXESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable">
    <loc xlink:type="locator" xlink:label="HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:href="itus-20171031.xsd#itus_HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="HierarchyForOurFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisAbstract" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CertificatesOfDepositMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable">
    <loc xlink:type="locator" xlink:label="ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:href="itus-20171031.xsd#itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="InterestExpensePatentAcquisitionObligations" xlink:href="itus-20171031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="InterestExpensePatentAcquisitionObligations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ExtinguishmentOfPatentObligation" xlink:href="itus-20171031.xsd#itus_ExtinguishmentOfPatentObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="ExtinguishmentOfPatentObligation" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentToAcquireRoyaltyInterestInPatentRights" xlink:href="itus-20171031.xsd#itus_PaymentToAcquireRoyaltyInterestInPatentRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="PaymentToAcquireRoyaltyInterestInPatentRights" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable">
    <loc xlink:type="locator" xlink:label="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:href="itus-20171031.xsd#itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ValuationAssumptionsAbstract" xlink:href="itus-20171031.xsd#itus_ValuationAssumptionsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract" xlink:to="ValuationAssumptionsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/AccruedliabilitiesTable">
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesAbstract" xlink:href="itus-20171031.xsd#itus_AccruedLiabilitiesAbstract"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZiwX1Z6rUqHVJXvfnkhcbdFVDB3Xzjr8GY1lUVWrWd1MFIV42ogD7LCavGUmZ4OrL2Xd+Pe32K8uaEGWU4pxv6/Ah0Myrb50JnZj+8bM0guDvRLx/A3T6ACO+Oy8byupVXtbE6JRHRYtOL7EezzkmdpVIcUsF9mwnk] CSR-->
    <loc xlink:type="locator" xlink:label="AccruedSeveranceCostsCurrent" xlink:href="itus-20171031.xsd#itus_AccruedSeveranceCostsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="AccruedSeveranceCostsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Informationregardingthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingThe2003SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_InformationRegardingThe2003SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2003SharePlanAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanTable" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingAndExercisableUnderThe2003SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices067To1755Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067To1755Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices067To1755Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20171031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Informationregardingthe2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingThe2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_InformationRegardingThe2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingThe2010SharePlanAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanTable" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Stockoptionsoutstandingunder2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_StockOptionsOutstandingUnder2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingUnder2010SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices067Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices067Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices227To700Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices227To700Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices227To700Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationRegardingStockOptionsGrantedNotUnder2003SharePlanOr2010SharePlanAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable" xlink:to="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable">
    <loc xlink:type="locator" xlink:label="StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:href="itus-20171031.xsd#itus_StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionsOutstandingNotUnder2003SharePlanAnd2010SharePlanAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_PlanNameAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices067Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices067Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices067Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RangeOfExercisePrices258To556Member" xlink:href="itus-20171031.xsd#itus_RangeOfExercisePrices258To556Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="RangeOfExercisePrices258To556Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="itus-20171031.xsd#itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" xlink:href="itus-20171031.xsd#itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable">
    <loc xlink:type="locator" xlink:label="IncomeTaxProvisionBenefitAbstract" xlink:href="itus-20171031.xsd#itus_IncomeTaxProvisionBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxProvisionBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable">
    <loc xlink:type="locator" xlink:label="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:href="itus-20171031.xsd#itus_TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FederalAndStateNOLAndTaxCreditCarryforwards" xlink:href="itus-20171031.xsd#itus_FederalAndStateNOLAndTaxCreditCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="FederalAndStateNOLAndTaxCreditCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheTaxEffectsOfTemporaryDifferencesOfTheDeferredTaxAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable">
    <loc xlink:type="locator" xlink:label="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:href="itus-20171031.xsd#itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" xlink:href="itus-20171031.xsd#itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/BUSINESSANDFUNDINGDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CollateralizedFinancings" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CollateralizedFinancings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CollateralizedFinancings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfRightsOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfRightsOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ProceedsFromIssuanceOfRightsOffering" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" xlink:href="itus-20171031.xsd#itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsMadeOnSecuredDebenture" xlink:href="itus-20171031.xsd#itus_PaymentsMadeOnSecuredDebenture"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="PaymentsMadeOnSecuredDebenture" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashPeriodIncreaseDecrease" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EmployeesAndDirectorsMember" xlink:href="itus-20171031.xsd#itus_EmployeesAndDirectorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="EmployeesAndDirectorsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsultantMember" xlink:href="itus-20171031.xsd#itus_ConsultantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ConsultantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RangeAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember_0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_EmployeeStockOptionMember_0" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CertificatesOfDepositAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CertificatesOfDepositAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmortizationRelatedToCompensationCost" xlink:href="itus-20171031.xsd#itus_AmortizationRelatedToCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="AmortizationRelatedToCompensationCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConsultationExpense" xlink:href="itus-20171031.xsd#itus_ConsultationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="ConsultationExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATIONDetails">
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligationAbstract" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligationAbstract"/>
    <loc xlink:type="locator" xlink:label="InterestExpensePatentAcquisitionObligations" xlink:href="itus-20171031.xsd#itus_InterestExpensePatentAcquisitionObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PatentAcquisitionObligationAbstract" xlink:to="InterestExpensePatentAcquisitionObligations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PatentAcquisitionObligationAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PatentAcquisitionObligation" xlink:href="itus-20171031.xsd#itus_PatentAcquisitionObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PatentAcquisitionObligationAbstract" xlink:to="PatentAcquisitionObligation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PatentAcquisitionObligationAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PatentAcquisitionObligationAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsTable" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="itus-20171031.xsd#itus_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConsultantMember" xlink:href="itus-20171031.xsd#itus_ConsultantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ConsultantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DirectorMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DirectorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_DirectorMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="RePricedOptionsMember" xlink:href="itus-20171031.xsd#itus_RePricedOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="RePricedOptionsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_RangeAxis" order="5.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="6.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WarrantWithExercisePriceOf925Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf925Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantWithExercisePriceOf925Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantWithExercisePriceOf13875Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf13875Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantWithExercisePriceOf13875Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantWithExercisePriceOf1000Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf1000Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantWithExercisePriceOf1000Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantWithExercisePriceOf503Member" xlink:href="itus-20171031.xsd#itus_WarrantWithExercisePriceOf503Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="WarrantWithExercisePriceOf503Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="7.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2010SharePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" xlink:href="itus-20171031.xsd#itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A2003SharePlanMember" xlink:href="itus-20171031.xsd#itus_A2003SharePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="A2003SharePlanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="SHAREHOLDERSEQUITYDetailsLineItems" order="8.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConsultationExpense" xlink:href="itus-20171031.xsd#itus_ConsultationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="ConsultationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_StockOptionPlanExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockValue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockRedemptionTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionTerms" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseLongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_InterestExpenseLongTermDebt" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockRedemptionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockRedemptionAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_PreferredStockRedemptionAmount" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RedeemablePreferredStockDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_RedeemablePreferredStockDividends" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="invest_InvestmentWarrantsExpirationDate" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="invest_InvestmentWarrantsExpirationDate" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:href="itus-20171031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="COMMITMENTSANDCONTINGENCIESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OfficeSpaceInSanJoseCaliforniaMember" xlink:href="itus-20171031.xsd#itus_OfficeSpaceInSanJoseCaliforniaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="OfficeSpaceInSanJoseCaliforniaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeSpaceInLosAngelesCaliforniaMember" xlink:href="itus-20171031.xsd#itus_OfficeSpaceInLosAngelesCaliforniaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="OfficeSpaceInLosAngelesCaliforniaMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsTable" xlink:to="COMMITMENTSANDCONTINGENCIESDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfLand" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AreaOfLand"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_AreaOfLand" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LeaseBaseRentAnnualIncrease" xlink:href="itus-20171031.xsd#itus_LeaseBaseRentAnnualIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="LeaseBaseRentAnnualIncrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_AccruedRentCurrentAndNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="COMMITMENTSANDCONTINGENCIESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/INCOMETAXESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="INCOMETAXESDetailsTable" xlink:href="itus-20171031.xsd#itus_INCOMETAXESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="INCOMETAXESDetailsLineItems" xlink:href="itus-20171031.xsd#itus_INCOMETAXESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="INCOMETAXESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FederalCorporateTaxableMember" xlink:href="itus-20171031.xsd#itus_FederalCorporateTaxableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="FederalCorporateTaxableMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NewYorkStateMember" xlink:href="itus-20171031.xsd#itus_NewYorkStateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="NewYorkStateMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CaliforniaMember" xlink:href="itus-20171031.xsd#itus_CaliforniaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="CaliforniaMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsTable" xlink:to="INCOMETAXESDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" xlink:href="itus-20171031.xsd#itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="INCOMETAXESDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.ITUScorp.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="itus-20171031.xsd#itus_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="15.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="16.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755017488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Jan. 04, 2018</div></th>
<th class="th"><div>Apr. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ITUS CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--10-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,609,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,498,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000715446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755455264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,339,374<span></span>
</td>
<td class="nump">$ 2,488,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short&#8211;term investments in certificates of deposit</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">174,566<span></span>
</td>
<td class="nump">162,069<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">7,013,940<span></span>
</td>
<td class="nump">3,400,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_FiniteLivedPatentsNet', window );">Patents, net of accumulated amortization of $1,290,336 and $965,040, respectively</a></td>
<td class="nump">1,745,775<span></span>
</td>
<td class="nump">2,071,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $35,725 and $46,950, respectively</a></td>
<td class="nump">52,701<span></span>
</td>
<td class="nump">156,644<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">8,812,416<span></span>
</td>
<td class="nump">5,628,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">480,324<span></span>
</td>
<td class="nump">373,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">409,169<span></span>
</td>
<td class="nump">95,532<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">889,493<span></span>
</td>
<td class="nump">468,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligation', window );">Patent acquisition obligation (Note 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,171,876<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">889,493<span></span>
</td>
<td class="nump">4,640,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 6 and 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized, -0- and 140 shares issued and outstanding at October 31, 2017 and 2016, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.01 per share; 24,000,000 shares authorized; 16,602,759 and 8,752,387 shares issued and outstanding at October 31, 2017 and 2016, respectively</a></td>
<td class="nump">166,028<span></span>
</td>
<td class="nump">87,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">163,931,079<span></span>
</td>
<td class="nump">152,051,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(156,174,184)<span></span>
</td>
<td class="num">(151,165,193)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">7,922,923<span></span>
</td>
<td class="nump">987,475<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">8,812,416<span></span>
</td>
<td class="nump">5,628,107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized, -0- and 140 shares issued and outstanding at October 31, 2017 and 2016, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized, -0- and 140 shares issued and outstanding at October 31, 2017 and 2016, respectively</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_FiniteLivedPatentsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net carrying amount after accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_FiniteLivedPatentsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligation related to patent acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755176480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Patents, accumulated amortization (in Dollars)</a></td>
<td class="nump">$ 1,290,336<span></span>
</td>
<td class="nump">$ 965,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation (in Dollars)</a></td>
<td class="nump">$ 35,725<span></span>
</td>
<td class="nump">$ 46,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">24,000,000<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">16,602,759<span></span>
</td>
<td class="nump">8,752,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">16,602,759<span></span>
</td>
<td class="nump">8,752,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in Dollars per share)</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value (in Dollars per share)</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">19,860<span></span>
</td>
<td class="nump">19,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755132864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 362,500<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Inventor royalties and contingent legal fees</a></td>
<td class="nump">91,451<span></span>
</td>
<td class="nump">111,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_LitigationAndLicensingExpenses', window );">Litigation and licensing expenses</a></td>
<td class="nump">13,105<span></span>
</td>
<td class="nump">106,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">325,296<span></span>
</td>
<td class="nump">325,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses (including non-cash stock option compensation expenses of $288,187 and $259,930, respectively)</a></td>
<td class="nump">1,597,550<span></span>
</td>
<td class="nump">1,556,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, general and administrative expenses (including non-cash stock option compensation expense of $934,585 and $613,631, respectively)</a></td>
<td class="nump">4,410,682<span></span>
</td>
<td class="nump">2,709,841<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">6,438,084<span></span>
</td>
<td class="nump">4,809,012<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(6,075,584)<span></span>
</td>
<td class="num">(4,509,012)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of patent acquisition obligation (Note 4)</a></td>
<td class="nump">1,547,608<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense (Notes 4 and 5)</a></td>
<td class="num">(500,455)<span></span>
</td>
<td class="num">(519,946)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">19,440<span></span>
</td>
<td class="nump">12,530<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(5,008,991)<span></span>
</td>
<td class="num">(5,016,428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(5,008,991)<span></span>
</td>
<td class="num">(5,016,428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Deemed dividend to preferred stockholder (Note 5)</a></td>
<td class="num">(2,008,775)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (7,017,766)<span></span>
</td>
<td class="num">$ (5,016,428)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted (in Dollars per share)</a></td>
<td class="num">$ (0.58)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted (in Shares)</a></td>
<td class="nump">12,197,340<span></span>
</td>
<td class="nump">8,739,453<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_LitigationAndLicensingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation and licensing expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_LitigationAndLicensingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642752064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash Stock option compensation expenses</a></td>
<td class="nump">$ 288,187<span></span>
</td>
<td class="nump">$ 259,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash Stock option compensation expenses</a></td>
<td class="nump">$ 934,585<span></span>
</td>
<td class="nump">$ 613,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754930272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF SHAREHOLDERS` EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Oct. 31, 2015</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 87,249<span></span>
</td>
<td class="nump">$ 151,101,117<span></span>
</td>
<td class="num">$ (146,148,765)<span></span>
</td>
<td class="nump">$ 5,053,601<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">BALANCE (in Shares) at Oct. 31, 2015</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">8,724,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">873,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">873,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">33,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued to consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">31,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued to consultants (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued to acquire patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">11,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued to acquire patents (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,016,428)<span></span>
</td>
<td class="num">(5,016,428)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Oct. 31, 2016</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 87,524<span></span>
</td>
<td class="nump">152,051,144<span></span>
</td>
<td class="num">(151,165,193)<span></span>
</td>
<td class="nump">987,475<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">BALANCE (in Shares) at Oct. 31, 2016</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">8,752,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock option compensation to employees and consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 402<span></span>
</td>
<td class="nump">6,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors', window );">Common stock issued to consultants and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,095<span></span>
</td>
<td class="nump">484,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors', window );">Common stock issued to consultants and directors (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption of convertible preferred stock</a></td>
<td class="num">$ (14,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,486,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption of convertible preferred stock (in Shares)</a></td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue', window );">Common stock issued to repay patent acquisition obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,476<span></span>
</td>
<td class="nump">2,842,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,852,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares', window );">Common stock issued to repay patent acquisition obligation (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">947,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_StockIssuedDuringPeriodValueRightsOffering', window );">Common stock issued in shareholder rights offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,892<span></span>
</td>
<td class="nump">4,183,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,203,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_StockIssuedDuringPeriodSharesRightsOffering', window );">Common stock issued in shareholder rights offering (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,989,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued in registered direct offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,254<span></span>
</td>
<td class="nump">3,177,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,211,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued in registered direct offering (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,425,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Common stock issued in-at-the market offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,385<span></span>
</td>
<td class="nump">3,448,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,460,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Common stock issued in-at-the market offering (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,238,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,008,991)<span></span>
</td>
<td class="num">(5,008,991)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Oct. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166,028<span></span>
</td>
<td class="nump">$ 163,931,079<span></span>
</td>
<td class="num">$ (156,174,184)<span></span>
</td>
<td class="nump">$ 7,922,923<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">BALANCE (in Shares) at Oct. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,602,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to patent acquisitions obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_CommonStockIssuedToRepayPatentAcquisitionObligationShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to repay patent acquisition obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_CommonStockIssuedToRepayPatentAcquisitionObligationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_StockIssuedDuringPeriodSharesIssuedForServicesConsultantsAndDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_StockIssuedDuringPeriodSharesRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued during the period for shareholder rights offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_StockIssuedDuringPeriodSharesRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_StockIssuedDuringPeriodValueIssuedForServicesToConsultantsAndDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_StockIssuedDuringPeriodValueRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock issued during the period for shareholder right offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_StockIssuedDuringPeriodValueRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation for stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754907424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (5,008,991)<span></span>
</td>
<td class="num">$ (5,016,428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option compensation to employees and consultants</a></td>
<td class="nump">1,222,772<span></span>
</td>
<td class="nump">873,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Common stock issued to consultants and directors</a></td>
<td class="nump">486,424<span></span>
</td>
<td class="nump">31,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">325,296<span></span>
</td>
<td class="nump">325,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense', window );">Accretion of interest on patent acquisition obligations to interest expense</a></td>
<td class="nump">228,026<span></span>
</td>
<td class="nump">519,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_CommonStockIssuedToAcquirePatentLicense', window );">Common stock issued to acquire patent license</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of property and equipment</a></td>
<td class="nump">43,216<span></span>
</td>
<td class="nump">33,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">45,915<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of patent acquisition obligation</a></td>
<td class="num">(1,547,608)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(12,497)<span></span>
</td>
<td class="num">(35,541)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">107,100<span></span>
</td>
<td class="num">(1,479)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">313,637<span></span>
</td>
<td class="nump">89,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(213,017)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(3,796,710)<span></span>
</td>
<td class="num">(3,381,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Disbursements to acquire short-term investments in certificates of deposit</a></td>
<td class="num">(5,501,000)<span></span>
</td>
<td class="num">(1,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from maturities of short-term investments in certificates of deposit</a></td>
<td class="nump">2,751,000<span></span>
</td>
<td class="nump">3,550,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(30,188)<span></span>
</td>
<td class="num">(146,521)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(2,735,188)<span></span>
</td>
<td class="nump">1,503,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ProceedsFromIssuanceOfRightsOffering', window );">Proceeds from sale of common stock in shareholder rights offering</a></td>
<td class="nump">4,203,302<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering', window );">Proceeds from sale of common stock in registered direct offering</a></td>
<td class="nump">3,211,788<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock in at-the-market offering</a></td>
<td class="nump">3,460,586<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock', window );">Redemption of convertible preferred stock</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentsMadeOnSecuredDebenture', window );">Payments made on secured debenture</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of employee stock options</a></td>
<td class="nump">7,273<span></span>
</td>
<td class="nump">33,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights', window );">Royalty payment applied to patent acquisition obligation</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(36,257)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">7,382,949<span></span>
</td>
<td class="num">(2,676)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">851,051<span></span>
</td>
<td class="num">(1,880,896)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">2,488,323<span></span>
</td>
<td class="nump">4,369,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">3,339,374<span></span>
</td>
<td class="nump">2,488,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash payments for interest</a></td>
<td class="nump">272,429<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Redemption of Series A convertible preferred stock into secured debenture (Note 5)</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued to pay patent acquisition obligation (Note 4)</a></td>
<td class="nump">$ 2,852,294<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of interest on patent acquisition obligations to interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccretionOfInterestOnPatentAcquisitionObligationsToInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_CommonStockIssuedToAcquirePatentLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of common stock issued during the period related to the patent license</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_CommonStockIssuedToAcquirePatentLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred for royalties and legal fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the purchase of royalty interests in patent rights is the amount of cash the patent user pays the owner of the patent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentToAcquireRoyaltyInterestInPatentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentsMadeOnSecuredDebenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a Debenture.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentsMadeOnSecuredDebenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow associated with the registered direct offering of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ProceedsFromIssuanceOfRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from rights offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ProceedsFromIssuanceOfRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest. Includes, but is not limited to, payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747832832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt">1.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration:underline">BUSINESS&#xa0;AND&#xa0;FUNDING</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Description of Business </font>&#xa0;&#xa0;&#xa0;&#xa0;</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or &#8220;ITUS&#8221; means ITUS Corporation and its wholly-owned subsidiaries.&#xa0; <font style="COLOR:black">From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. &#xa0;Commencing in October 2012 the primary operations of the Company involved the development, acquisition, licensing, and enforcement of patented technologies that were either owned or controlled by the Company.</font></p><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;"><font style="color: black;">In June of 2015, the Company announced the formation of a new subsidiary, Anixa Diagnostics Corporation (&#x201c;Anixa&#x201d;), to develop a platform for non-invasive blood tests for the early detection of cancer.&#xa0; That platform is called Cchek&#x2122;</font><font style="color: black;">.&#xa0; In July of 2015, ITUS announced a collaborative research agreement with The Wistar Institute (&#x201c;Wistar&#x201d;), the nation&#x2019;s first independent biomedical research institute and a leading National Cancer Institute designated cancer research center, for the purpose of validating our cancer detection methodologies and establishing protocols for identifying certain biomarkers in the blood which we identified and which are known to be associated with malignancies. &#xa0;In August of 2016 and again in August of 2017, ITUS announced the renewal and expansion of our relationship with Wistar. </font></p><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;"><font style="color: black;">From October of 2015 through January of 2017, ITUS announced that we had demonstrated the efficacy of our Cchek&#x2122; </font><font style="color: black;">early cancer detection platform with 15 different types of cancer, including:&#xa0; breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar and prostate.&#xa0; Breast, lung, colon and prostate cancers represent the four largest categories of cancer worldwide.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in"><font style="COLOR:black">In November of 2017, the Company announced the formation of a new subsidiary, Certainty Therapeutics, Inc. (&#8220;Certainty&#8221;), to develop immuno-therapy drugs against cancer.&#xa0; Certainty entered into a license agreement with Wistar pursuant to which Certainty was granted an exclusive worldwide, royalty-bearing license to use certain intellectual property owned or controlled by Wistar relating to Wistar&#8217;s chimeric endocrine receptor targeted therapy technology (such technology being akin to chimeric antigen receptor T-cell (&#8220;CAR-T&#8221;) technology). &#xa0;We plan to initially focus on the development of a treatment for ovarian cancer, but we also may pursue future applications of the technology for the development of treatments for additional solid tumors.&#xa0; </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in"><font style="COLOR:black">On November 20, 2017, we announced that Certainty entered into a collaboration agreement with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&#8220;Moffitt&#8221;) to advance toward human clinical testing the CAR-T technology licensed by Certainty from Wistar aimed initially at treating ovarian cancer.&#xa0; Certainty intends to work with researchers at Moffitt to complete studies necessary to submit an Investigational New Drug application with the U.S. Food and Drug Administration.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Over the next several quarters, we expect Cchek&#8482; and Certainty&#8217;s ovarian cancer treatment to be the primary focus of the Company. &#xa0;As part of our legacy operations, the Company remains engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.&#xa0; We do not expect these activities to be a significant part of the Company&#8217;s ongoing operations nor do we expect these activities to require material financial resources or attention of senior management.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Over the past several quarters, our revenue was derived from technology licensing and the sale of patented technologies, including revenue from the settlement of litigation. &#xa0;In addition to Anixa and Certainty, the Company may make investments in and form new companies to develop additional emerging technologies.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Funding </font></p><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; background: white; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><a name="_aciHeader46"></a><font style="color: black;">As of the date of filing of our last annual report on Form 10-K, there was substantial doubt about our ability to continue as a going concern due to the limited amount of cash, cash equivalents and short-term investments we held as compared to our projected cash needs for the ensuing 12 months. We evaluated our cash position and future plans for the Company and embarked on a plan to ensure we had sufficient resources to execute our plans.&#xa0; Accordingly, over the past twelve months, we raised nearly $12 million through multiple financing arrangements, including a shareholder rights offering, a registered direct offering, and an at-the-market equity offering, and satisfied debt obligations through payments of cash and common stock. With no significant debt and approximately $6.8 million in cash, cash equivalents and short-term investments as of October 31, 2017, we believe that we have alleviated substantial doubt about our ability to continue as a going concern.&#xa0; </font></p><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; background: white; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="color: black;">Based on currently available information as of January 9, 2018, we believe that our existing cash, cash equivalents, short-term investments and expected cash flows will be sufficient to fund our activities for the next 12 months.&#xa0; However, our projections of future cash needs and cash flows may differ from actual results.&#xa0; If current cash on hand, cash equivalents, short term investments and cash that may be generated from our business operations are insufficient to continue to operate our business, or if we elect to invest in or acquire a company or companies that are synergistic with or complimentary to our technologies, we may be required to obtain more working capital.&#xa0; We may seek to obtain working capital during our fiscal year ended 2018 or thereafter through sales of our equity securities or through bank credit facilities or public or private debt from various financial institutions where possible.&#xa0; We cannot be certain that additional funding will be available on acceptable terms, or at all.&#xa0; If we do identify sources for additional funding, the sale of additional equity securities or convertible debt could result in dilution to our stockholders. &#xa0;Additionally, the sale of equity securities or issuance of debt securities may be subject to certain security holder approvals or may result in the downward adjustment of the exercise or conversion price of our outstanding securities. &#xa0;We can give no assurance that we will generate sufficient cash flows in the future to satisfy our liquidity requirements or sustain future operations, or that other sources of funding, such as sales of equity or debt, would be available or would be approved by our security holders, if needed, on favorable terms or at all. &#xa0;If we fail to obtain additional working capital as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.&#xa0; Furthermore, such lack of funds may inhibit our ability to respond to competitive pressures or unanticipated capital needs, or may force us to reduce operating expenses, which would significantly harm the business and development of operations.</font></p><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="background: white; color: black;">During the year ended October 31, 2017, cash used in operating activities was approximately $3,797,000. &#xa0;Cash used in investing activities was approximately $2,735,000, resulting from the purchase of certificates of deposit totaling $5,501,000 which was offset by the proceeds on maturities of certificates of deposit totaling $2,751,000 and the sale of property and equipment of $45,000 offset by the purchase of property and equipment of approximately $30,000. &#xa0;Cash provided by financing activities was approximately $7,383,000, resulting from the sale of common stock in a shareholder rights offering, an at-the-market offering and a registered direct offering of approximately $4,203,000, $3,461,000 and $3,212,000, respectively, and the proceeds from exercise of stock options of approximately $7,000, offset by payments made on a secured debenture of $3,000,000 and redemption of convertible preferred stock of $500,000.&#xa0; As a result, our cash, cash equivalents, and short-term investments at October 31, 2017 increased approximately $3,601,000 to approximately $6,839,000 from approximately $3,238,000 at the end of fiscal year 2016.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6900241760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">2.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration:underline">SUMMARY&#xa0;OF&#xa0;SIGNIFICANT&#xa0;ACCOUNTING&#xa0;POLICIES</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Basis of Presentation</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries.&#xa0; All intercompany transactions have been eliminated.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="COLOR:black">&#xa0;</font><font style="text-decoration:underline">Revenue Recognition</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="COLOR:black">Patent Licensing</font></font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&#xa0;&#xa0;These arrangements typically include some combination of the following:&#xa0;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&#xa0;&#xa0;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&#xa0;&#xa0;Pursuant to the terms of these agreements, we had no further obligations. &#xa0;&#xa0;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Inventor Royalties and Contingent Legal Fees</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Research and Development Expenses</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Research and development expenses, consisting primarily of employee compensation, payments to third parties for research and development activities and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Fair Value Measurements</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Accounting Standards Codification (&#8220;ASC&#8221;) 820 &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;)</font> defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements.&#xa0; In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below.&#xa0; If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in">Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in">Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in">Level 3 &#8211; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.&#xa0; These inputs reflect management&#8217;s own assumptions about the assumptions a market participant would use in pricing the instrument.&#xa0; </p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2017:</font></p><br/><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;</font><font style="color: black;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Level 2</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Level 3</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; &#xa0;</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Money market funds &#x2013; <br />&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Certificates of deposit - <br />&#xa0;&#xa0;&#xa0; Short term investments</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000 </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">6,579,282 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:</font></p><br/><table style="width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 2</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 3</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 15.75pt; white-space: nowrap; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Money market funds &#x2013; <br />&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Certificates of deposit - <br />&#xa0;&#xa0;&#xa0; Short term investments</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 16.5pt; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2,649,136 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:</font></p><br/><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 44%; height: 15.75pt; white-space: nowrap; width: 44%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 2</font></p>
</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 3</font></p>
</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 44%; height: 15.75pt; width: 44%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 44%; height: 15.75pt; width: 44%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Patent acquisition obligation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The following table sets forth a summary of the changes in the fair value of the Company&#8217;s Level 3 financial liabilities that are measured at fair value on a recurring basis:</p><br/><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="text-decoration:underline"><font style="color: black;">Patent acquisition obligation:</font></font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2015</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3,688,187 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">519,946 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Royalty payment applied to patent acquisition obligation</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(36,257)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2016</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">228,026 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Extinguishment of patent obligation</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(4,399,902)</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 16.5pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 18%; height: 16.5pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&#xa0; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Cash and Cash Equivalents</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt">Cash equivalents consists of highly liquid, short-term investments with original maturities of three months or less when purchased.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Short-term Investments</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; At October 31, 2017 and 2016, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $3,500,000 and $750,000, respectively, that were classified as short-term investments and reported at fair value.&#xa0;&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Patents</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Our only identifiable intangible assets are patents and patent rights.&#xa0; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&#xa0; No patent acquisition costs were capitalized during the years ended October 31, 2017 and 2016.&#xa0; We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2017 and 2016, respectively.<a name="_DV_M82"></a></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Impairment</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Income Taxes</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&#xa0; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Stock-Based Compensation</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline">Stock Option Compensation Expense </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &#8220;Stock Compensation&#8221; (&#8220;ASC 718&#8221;).&#xa0; <font style="COLOR:black">In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model.&#xa0; For options vesting if the trading price of the Company&#8217;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. </font>We recognize compensation expense for stock option awards over the requisite or implied service period of the grant.&#xa0; With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable.&#xa0; We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $1,223,000 and $874,000, during the years ended October 31, 2017 and 2016, respectively. </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Included in stock-based compensation cost for employees and directors during the years ended October 31, 2017 and 2016 was approximately $967,000 and $393,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested.&#xa0; As of October 31, 2017, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,091,000, which will be recognized over a weighted-average period of 1.7 years. </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &#8220;Equity-Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;).&#xa0; In accordance with ASC 505-50, <font style="COLOR:black">we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model.&#xa0; F</font>or options vesting if the trading price of the Company&#8217;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation.&#xa0; We recognize compensation expense for <font style="COLOR:black">service based stock options and options subject to market conditions</font> over the requisite or implied service period of the grant.&#xa0; For performance based awards, compensation expense is recognized when the performance target is achieved.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2017 and 2016 of approximately $3,000 and $-0-, respectively. &#xa0;Stock-based consulting expense for the years ended October 31, 2017 and 2016 did not include any amortization of compensation cost for stock options granted in prior periods but vested in the current period. &#xa0;As of October 31, 2017, there was unrecognized consulting expense related to non-vested stock options granted to consultants, related to service based options of approximately $44,000, which will be recognized over a weighted-average period of 2.1 years.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline">Fair Value Determination</font><font style="text-decoration:underline">&#xa0; </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time.&#xa0; <font style="COLOR:black">The stock options we granted during the year ended October 31, 2017 consisted of awards with 10-year terms that vest over 6 to 48 months. The stock options we granted during the year ended October 31, 2016 consisted of awards with 10-year terms that vest over 6 to 36 months&#xa0; </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2017 and 2016:</p><br/><table style="width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%; height: 15.75pt; white-space: nowrap;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">For the Year</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2017</font></p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted average fair value at grant date</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$1.72 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$2.84 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Valuation assumptions:</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected life (years) </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">5.63</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">5.70</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected volatility</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">119.2%</font></p>
</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">181.1%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Risk-free interest rate</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">1.94%</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">1.26%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected dividend yield</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">0%</font></p>
</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">0%</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.&#xa0; We use the simplified method, which is a weighted average of the vesting term and contractual term, to determine expected term.&#xa0; The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years.&#xa0; Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options.&#xa0; We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants.&#xa0; We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future.&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest.&#xa0; Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options.&#xa0; Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate.&#xa0; If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Net&#xa0;Loss&#xa0;Per&#xa0;Share of Common Stock </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">In accordance with ASC 260, &#8220;Earnings Per Share&#8221;, basic net loss per common share (&#8220;Basic EPS&#8221;) is computed by dividing net loss by the weighted average number of common shares outstanding.&#xa0; Diluted net loss per common share (&#8220;Diluted EPS&#8221;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&#xa0; Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&#xa0; For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2017 and 2016, were options to purchase 3,447,846 and 3,086,472 shares, respectively, warrants to purchase 829,400 shares and 707,379 shares, respectively, preferred stock convertible into -0- and 739,958 shares, respectively.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Use of Estimates </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#xa0; Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies.&#xa0; Actual results could differ from those estimates.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Effect of Recently Issued Pronouncements</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#8220;ASU 2014-09&#8221;), Revenue from Contracts with Customers.&#xa0; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &#xa0;This standard update is effective for&#xa0;interim and annual&#xa0;reporting periods beginning after December 15,&#xa0;2016, and were to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &#xa0;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &#xa0;<a name="_Hlk501045300">We do not expect the adoption of ASU 2014-09 </a>to have a material impact on our <a name="_Hlk502247174">consolidated financial statements and related disclosures.</a></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In August 2014, the FASB issued Accounting Standards Update 2014-15 (&#8220;ASU 2014-15&#8221;).&#xa0; This amendment requires management to assess an entity&#8217;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption.&#xa0; We have provided additional footnote disclosure to our consolidated financial statements in accordance with ASU 2014-15 upon adoption of this amendment.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">In November 2015, the FASB issued Accounting Standards Update 2015-17 (&#8220;ASU 2015-17&#8221;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &#xa0;Adoption of this standard is required for annual periods beginning after December 15, 2016. &#xa0;We do not anticipate that the adoption of this amendment will have an impact on our consolidated financial statements&#xa0;and related disclosures as we currently do not present deferred tax assets or liabilities.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#8220;ASU 2016-02&#8221;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &#xa0;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &#xa0;The requirements of this standard include a significant increase in required disclosures. &#xa0;We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&#xa0;and related disclosures, and our analysis is currently ongoing.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In March 2016, the FASB issued Accounting Standards Update 2016-09 (&#8220;ASU 2016-09&#8221;) that changes the accounting for certain aspects of share-based payments to employees. &#xa0;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&#8217;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &#xa0;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. We adopted ASU 2016-09 on November 1, 2017. &#xa0;We do not expect the adoption of this new guidance to have a material impact on our consolidated financial statements and related disclosures.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In May 2017, the FASB issued Accounting Standards Update 2017-09 (&#8220;ASU 2017-09&#8221;) that provides guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting. &#xa0;This update is effective for all entities for fiscal years beginning after December 15, 2017, and interim periods within those years.&#xa0; Early adoption is permitted.&#xa0; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements and related disclosures, and our analysis is ongoing.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In July 2017, the FASB issued Accounting Standards Update 2017-11 (&#8220;ASU 2017-11&#8221;) which changes the accounting for equity instruments that include a down round feature.&#xa0; For public entities, this update is effective for fiscal years beginning after December 15, 2018, and interim periods within those years.&#xa0; Early adoption is permitted. &#xa0;</font>We do not anticipate the adoption of this amendment will have an impact on our consolidated financial statements&#xa0;and related disclosures as we currently do not have any such equity instruments.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Concentration of Credit Risks</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable.&#xa0; Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &#xa0;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &#xa0;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">One licensee accounted for 100% of revenues from patent licensing activities during fiscal year 2017. &#xa0;Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6635391424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">3.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration:underline">ACCRUED EXPENSES</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Accrued liabilities consist of the following as of:</p><br/><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="500pt" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">2017</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;</font><font style="color: black;">2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">Accrued severance costs</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">237,563 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">Payroll and related expenses</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">51,643 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">49,901 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">Accrued other</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">119,963 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">45,631 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">&#xa0;<font style="font-family: times new roman, times, serif; display: none; font-size: 10pt;">Total</font></td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">409,169 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">95,532 </font></p>
</td>
</tr>
</table><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642711312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PATENT ACQUISITION OBLIGATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligationAbstract', window );"><strong>Patent Acquisition Obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligationTextBlock', window );">Patent Acquisition Obligation [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; ">
<p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">4.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<font style="text-decoration:underline">PATENT ACQUISITION OBLIGATION</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In November 2013, we incurred a patent acquisition obligation due no later than November 2017 related to the acquisition of patents.&#xa0; The payment due in November 2017 was payable at the option of the Company in cash or common stock.&#xa0; We recorded interest expense of approximately $228,000 and $520,000, respectively, for the years ended October 31, 2017 and 2016, for the accretion of interest on patent acquisition obligation.&#xa0; </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:11pt; COLOR:black">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;On March 27, 2017, the Company issued 947,606 shares of common stock in satisfaction of the obligation.&#xa0; The carrying value of the patent acquisition obligation at the date of extinguishment was approximately $4,400,000.&#xa0; The fair value of the shares of common stock issued to satisfy the obligation on the date of extinguishment was approximately $2,843,000, resulting in the recognition of a gain on the debt extinguishment of approximately $1,548,000.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to the patent acquisition obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747827280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">5.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration:underline">SHAREHOLDERS&#8217; EQUITY</font>&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Common Stock Issuances</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">We account for stock granted to employees, directors and consultants based on the grant date market price of the underlying common stock.&#xa0;&#xa0; During the years ended October 31, 2017 and 2016, we issued 9,463 shares and 10,833 shares, respectively, of common stock to consultants for services rendered.&#xa0; We recorded consulting expense for the years ended October 31, 2017 and 2016 of approximately $32,000 and $31,000, respectively, for shares of common stock issued to consultants.&#xa0; During the year ended October 31, 2017 we issued 200,000 shares to directors for services rendered and recorded expense of $454,000.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt 4.5pt; TEXT-INDENT:-4.5pt"><font style="text-decoration:underline">Stock&#xa0;Option&#xa0;Plans</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">As of October 31, 2017, we have two stock option plans: the ITUS Corporation 2003 Share Incentive Plan (the &#8220;2003 Share Plan&#8221;) and the ITUS Corporation 2010 Share Incentive Plan (the &#8220;2010 Share Plan&#8221;) which were adopted by our Board of Directors on April 21, 2003 and July 14, 2010, respectively.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; The 2003 Share Plan provided for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&#xa0; The 2003 Share Plan was administered by the Board of Directors or committees thereof, which determined the option price, term and provisions of each option.&#xa0; The exercise price with respect to all of the options granted under the 2003 Share Plan since its inception was equal to the fair market value of the underlying common stock at the grant date. &#xa0;In accordance with the provisions of the 2003 Share Plan, the plan terminated with respect to the grant of future options on April 21, 2013. </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Information regarding the 2003 Share Plan for the two years ended October 31, 2017 is as follows:</p><br/><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average Exercise</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;Price Per Share</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Aggregate</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;</font><font style="color: black;">Intrinsic Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Shares</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">366,200 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">17.86 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(11,080)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2.58 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Forfeited</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(129,520)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">17.72 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2016</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">225,600 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">18.69 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(5,800)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1.39 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Forfeited</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(189,200)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">21.55 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 56.24%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding and Exercisable at October 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">30,600 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3.16 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">20,148 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The following table summarizes information about stock options outstanding and exercisable under the 2003 Share Plan as of October 31, 2017:</p><br/><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Contractual Life</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">(in years)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Range of</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Exercise Prices</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Outstanding</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$&#xa0; 0.67 - $&#xa0; 17.50</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">30,600</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1.13</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$3.16 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; display: none;">.</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The 2010 Share Plan provides for the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to key employees and consultants.&#xa0; On the first business day of each calendar year the maximum aggregate number of shares available for future issuance is replenished such that 800,000 shares are available. &#xa0;The 2010 Share Plan is administered by the Board of Directors or committees thereof, which determines the option price, term and provisions of each option. The exercise price with respect to all of the options granted under the 2010 Share Plan was equal to the fair market value of the underlying common stock at the grant date.&#xa0; As of October 31, 2017, the 2010 Share Plan had 69,226 shares available for future grants.&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Information regarding the 2010 Share Plan as of October 31, 2017 is as follows: </p><br/><table style="width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average Exercise</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;Price Per Share</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Aggregate<br />&#xa0;Intrinsic</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;</font><font style="color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Shares</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">526,272 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3.33 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Granted</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">557,000 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2.92 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(2,400)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4.25 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0; </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2016</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,080,872 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3.12 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Granted</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">682,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2.03 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(44,400)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">0.67 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Forfeited</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(81,226)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">6.20 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="padding: 0in; width: 56%; height: 16.5pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2017</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,637,246 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1.50 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,381,380 </font></p>
</td>
</tr>
<tr style="height: 17.25pt;">
<td style="background: #cceeff; padding: 0in; width: 56%; height: 17.25pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Exercisable at October 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 17.25pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">909,024 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1.72 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">721,433 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">The following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2017:</p><br/><table style="width: 634.85pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="846" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" colspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Options Outstanding</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;" colspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Options Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="5">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Contractual Life</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">(in years)</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;" rowspan="4">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Contractual Life (in years)</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Price</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;" rowspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="2">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Range of</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Prices</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="2">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Outstanding</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="2">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">1,001,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">8.14</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">522,778</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">7.09</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$2.27 - $7.00</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">636,246</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">6.69</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$2.80 </font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">386,246</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">4.62</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$3.14 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">In addition to options granted under the 2003 Share Plan and the 2010 Share Plan, during the years ended October 31, 2012 and 2013, the Board of Directors approved the grant of stock options to purchase 1,660,000 shares and 120,000 shares, respectively. </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">Information regarding stock options that were not granted under the 2003 Share Plan or the 2010 Share Plan for the two years ended October 31, 2017 is as follows:</font></p><br/><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.04%; height: 15.75pt;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Average Exercise</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Price Per Share</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Aggregate</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Intrinsic</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Shares</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12.04%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 58.18%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding and exercisable at <br />&#xa0;&#xa0; October 31, 2016</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,780,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12.04%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2.70 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.7%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11.04%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 17.25pt;">
<td style="padding: 0in; width: 58.18%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding and exercisable at <br />&#xa0;&#xa0; October 31, 2017</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,780,000</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 17.25pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12.04%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1.58 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 17.25pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 11.04%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,443,480 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The following table summarizes information about stock options outstanding and exercisable that were not granted under the 2003 Share Plan or the 2010 Share Plan as of October 31, 2017:</p><br/><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Contractual Life</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">(in years)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Outstanding<font style="text-decoration:underline"> </font>and<font style="text-decoration:underline"> </font></font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercisable</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Range of</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Prices</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">1,046,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">4.91</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$ 2.58 - $ 5.56</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">734,000</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">4.36</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$2.88 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="COLOR:black">Re-Priced Stock Options</font></font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">On September 6, 2017 the Board of Directors re-priced 2,029,600 issued and outstanding stock options (the &#8220;Re-Priced Options&#8221;) for all of the officers, directors and employees of the Company.&#xa0; The new exercise price of the Re-Priced Options is $0.67, the closing sales price of the Company&#8217;s common stock on September 6, 2017.&#xa0; All other terms of the previously granted Re-Priced Options remain the same.&#xa0; The Company recorded additional stock-based compensation of approximately $261,000, as of September 6, 2017, related to this re-pricing.&#xa0; This amount was determined to be the incremental value of the fair value of the Re-Priced Options compared to the fair value of the original option immediately before the re-pricing.&#xa0; Accordingly, 18,200 stock options in the 2003 Share Plan with exercise prices of $2.58, 965,400 stock options in the 2010 Share Plan with exercise prices ranging from $0.82 to $5.30 and 1,046,000 stock options that were not granted under the 2003 Share Plan or the 2010 Share plan with exercise prices of $2.58, were re-priced.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Preferred Stock</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">On November 11, 2016, the holder of all our outstanding Series A Preferred Stock (the &#8220;Series A Preferred&#8221;) with an aggregate stated value of $3,500,000 exercised its right of redemption to receive such amount from proceeds from the sale of the Company&#8217;s equity securities.&#xa0;&#xa0;On December 6, 2016, we entered into an agreement with the holder of the Series A Preferred setting forth the terms under which such redemption would take place (the &#8220;Series A Redemption Terms&#8221;). &#xa0;Pursuant to the Series A Redemption Terms, on December 9, 2016 the holder of the Series A Preferred received (i) $500,000 in cash, (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which was due on or before June 1, 2017 and the remainder of which was due November 11, 2017 (the &#8220;Redemption Debenture&#8221;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&#8217;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing (the &#8220;Redemption Warrant&#8221;). The Redemption Debenture was secured by a lien on the Company&#8217;s assets and prohibited the Company from incurring any senior indebtedness&#xa0;other than equipment financing in connection with the Company&#8217;s business.&#xa0; The Redemption Debenture was paid in full during fiscal year 2017.&#xa0; Interest expense during the year ended October 31, 2017 in connection with the Redemption Debenture was approximately $272,000.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">The difference between the fair value of the consideration given to the holder of our Series A Preferred and the carrying value of the Series A Preferred represents a return to the preferred stockholder which is treated in a similar manner as that of dividends paid on preferred stock.&#xa0; In the redemption, the Series A Preferred holder received $500,000 in cash, the Redemption Debenture with a present value of approximately $2,999,000 and the Redemption Warrant with a fair value of approximately $2,801,000, determined using the Black Scholes pricing model, and waived the Series A Preferred&#8217;s conversion right with an intrinsic value of approximately $792,000, resulting in total consideration given to the Series A Preferred holder of approximately $5,508,000.&#xa0; The difference between the fair value of the consideration and the $3,500,000 carrying value of the Series A Preferred resulted in a deemed dividend to the Series A Preferred holder of approximately $2,008,000.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Common Stock Purchase Warrants</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt">As of October 31, 2017, we had warrants to purchase 10,000 shares and 10,000 shares of common stock at $9.25 and $13.875 per share, respectively, expiring on August 19, 2019, warrants to purchase 309,400 shares of common stock at $10.00 per share expiring on July 15, 2019 and warrants to purchase 500,000 shares of common stock at $5.03 per share expiring on November 30, 2021.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747959968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">6.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration:underline">COMMITMENTS AND CONTINGENCIES </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline"><font style="COLOR:black">Leases</font></font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in"><font style="COLOR:black">We lease approximately 2,000 square feet of office space at 3150 Almaden Expressway, San Jose, California (our principal executive offices) from an unrelated party pursuant to a lease that expires September 30, 2019.&#xa0; Our base rent is approximately $4,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.&#xa0; We also lease approximately 3,000 square feet of office space at 12100 Wilshire Boulevard, Los Angeles, California (our former executive offices) from an unrelated party pursuant to a lease that expires May 31, 2019.&#xa0; Our base rent is approximately $11,000 per month and the lease provides for annual increases of approximately 3% and an escalation clause for increases in certain operating costs.&#xa0; </font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in"><font style="COLOR:black">During the fourth quarter of fiscal 2017 we vacated the office space at 12100 Wilshire Boulevard, Los Angeles, California and as of October 31, 2017 we have accrued an expense of approximately $84,000 related to future rents of the unused facilities.</font> &#xa0;As of October 31, 2017, our non-cancelable operating lease commitments for the years ending October 31, 2018 and 2019 were approximately $182,000 and $125,000, respectively.&#xa0; Rent expense for the years ended October 31, 2017 and 2016, was approximately $229,000 and $188,000, respectively.&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Litigation Matters</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN-LEFT:0in; MARGIN-RIGHT:0in; TEXT-INDENT:0.5in"><font style="COLOR:black">Other than suits we bring to enforce our patent rights we are not a party to any material pending legal proceedings other than that which arise in the ordinary course of business. &#xa0;We believe that any liability that may ultimately result from the resolution of these matters will not, individually or in the aggregate, have a material adverse effect on our financial position or results of operations.</font></p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747826480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">7.&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; <font style="text-decoration:underline">INCOME TAXES</font>&#xa0;&#xa0;&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt">Income tax provision (benefit) consists of the following:</p><br/><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2017</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Federal:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Current</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Deferred</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(12,534,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(1,631,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">State:</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Current</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Deferred</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(4,351,000)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(134,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Adjustment to valuation allowance <br />&#xa0;&#xa0;&#xa0;&#xa0; related to net deferred tax assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">16,885,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,765,000</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;"><font class="a">Income Tax Provision (Benefit)</font></font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">The tax effects of temporary differences that give rise to significant portions of the deferred tax asset, net, at October 31, 2017 and 2016, are as follows:</p><br/><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="padding: 0in; width: 70%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">2017</font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">&#xa0;2016</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Long-term deferred tax assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Federal and state NOL and tax credit carryforwards</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">18,961,000 </font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">33,079,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Deferred compensation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">3,718,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">6,232,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Intangibles</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">543,000 </font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">713,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Other</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">205,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">289,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in 0in 0in 20pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Subtotal</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">23,427,000 </font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">40,313,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Less: valuation allowance</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">(23,427,000)</font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">(40,313,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 70%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Deferred tax asset, net</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">-</font></p>
</td>
</tr>
</table><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;">As of October 31, 2017, we had tax net operating loss and tax credit carryforwards of approximately $83,579,000 and $1,257,000, respectively, available within statutory limits (expiring at various dates between 2018 and 2037), to offset any future regular Federal corporate taxable income and taxes payable.&#xa0; If the tax benefits relating to deductions of option holders&#x2019; income are ultimately realized, those benefits will be credited directly to additional paid-in capital.&#xa0; Certain changes in stock ownership can result in a limitation on the amount of net operating loss and tax credit carryovers that can be utilized each year. As of October 31, 2017, management has not determined the extent of any such limitations, if any.</p><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 12pt; text-indent: 0.5in;">As a result of the change in future Federal statutory tax rates due to the passing of the Tax Cuts and Jobs Act of 2017, management has determined that the deferred tax assets and liabilities should no longer be valued at a federal statutory rate of 34% but rather at the rate in which the benefit of the deferred tax asset or liability will be realized by the Company. As such, the Federal statutory rate used to value the Company's deferred tax assets and liabilities is 21%.</p><br/><p style="font-size: 11pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt; text-indent: 0.5in;"><font style="color: black;">We had New York and California tax net operating loss carryforwards of approximately $72,483,000 and&#xa0; $9,656,000, respectively,&#xa0;as of October 31, 2017, available within statutory limits (expiring at various dates between 2018 and 2037), to offset future corporate taxable income and taxes payable, if any, under certain computations of such taxes.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">We have provided a valuation allowance against our deferred tax asset due to our current and historical pre-tax losses and the uncertainty regarding their realizability.&#xa0; The primary differences from the Federal statutory rate of 34% and the effective rate of 0% is attributable to certain permanent differences and a change in the valuation allowance.&#xa0; The following is a reconciliation of income taxes at the Federal statutory tax rate to income tax expense (benefit):</p><br/><table style="width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="9" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">2017</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Income tax benefit at U.S. <br />&#xa0; Federal statutory income <br />&#xa0; Tax rate</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(1,703,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(34.0%)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(1,706,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(34.0%)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">State income taxes</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(443,000)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(8.84%)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(411,000)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(8.2%)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Permanent differences</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(10,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(0.20%)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">2,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">0.1%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Expiring net operating <br />&#xa0;&#xa0; losses, credits and other</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-&#xa0;</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">350,000 </font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">7.0%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Rate Changes</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">19,041,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">380.13%</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Change in valuation <br />&#xa0;&#xa0; allowance</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(16,885,000) </font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(337.09%)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">1,765,000 </font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">35.1%</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Income tax provision</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">0.0%</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">0.0%</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">During the two fiscal years ended October 31, 2017, we incurred no Federal and no State income taxes.&#xa0; We have no unrecognized tax benefits as of October 31, 2017 and 2016 and we account for interest and penalties related to income tax matters in marketing, general and administrative expenses.&#xa0; Tax years to which our net operating losses relate remain open to examination by Federal authorities and other jurisdictions to the extent which the net operating losses have yet to be utilized.</p><br/></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755117424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccountingPoliciesbyPolicyPoliciesLineItems', window );"><strong>Accounting Policies, by Policy (Policies) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Basis of Presentation</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">The consolidated financial statements include the accounts of ITUS Corporation and its wholly owned subsidiaries.&#xa0; All intercompany transactions have been eliminated.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Revenue Recognition</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured.</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline"><font style="COLOR:black">Patent Licensing</font></font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">In certain instances, our past revenue arrangements have provided for the payment of contractually determined fees in settlement of litigation and in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company.&#xa0;&#xa0;These arrangements typically include some combination of the following:&#xa0;(i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation.&#xa0;&#xa0;In such instances, the intellectual property rights granted have been perpetual in nature, extending until the expiration of the related patents.&#xa0;&#xa0;Pursuant to the terms of these agreements, we had no further obligations. &#xa0;&#xa0;As such, the earnings process was complete and revenue has been recognized upon the execution of the agreement, when collectability was reasonably assured, and when all other revenue recognition criteria were met.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Inventor Royalties and Contingent Legal Fees</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Inventor royalties and contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Research and Development Expenses</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Research and development expenses, consisting primarily of employee compensation, payments to third parties for research and development activities and other direct costs associated with developing a platform for non-invasive blood tests for early detection of cancer, are expensed in the consolidated financial statements in the year incurred.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Fair Value Measurements</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="COLOR:black">Accounting Standards Codification (&#8220;ASC&#8221;) 820 &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;)</font> defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements.&#xa0; In accordance with ASC 820, we have categorized our financial assets and liabilities, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below.&#xa0; If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows:</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in">Level 1 - Financial instruments whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market which we have the ability to access at the measurement date.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in">Level 2 - Financial instruments whose values are based on quoted market prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt 0.5in">Level 3 &#8211; Financial instruments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.&#xa0; These inputs reflect management&#8217;s own assumptions about the assumptions a market participant would use in pricing the instrument.&#xa0; </p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2017:</font></p><br/><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;</font><font style="color: black;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Level 2</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Level 3</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; &#xa0;</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Money market funds &#x2013; <br />&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Certificates of deposit - <br />&#xa0;&#xa0;&#xa0; Short term investments</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000 </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">6,579,282 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">The following table presents the hierarchy for our financial assets measured at fair value on a recurring basis as of October 31, 2016:</font></p><br/><table style="width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 2</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 3</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 15.75pt; white-space: nowrap; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Money market funds &#x2013; <br />&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Certificates of deposit - <br />&#xa0;&#xa0;&#xa0; Short term investments</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 16.5pt; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2,649,136 </font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt">The following table presents the hierarchy for our financial liabilities measured at fair value on the transaction date and then adjusted for the subsequent accretion of interest, as of October 31, 2016:</font></p><br/><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 44%; height: 15.75pt; white-space: nowrap; width: 44%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 2</font></p>
</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 3</font></p>
</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 44%; height: 15.75pt; width: 44%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 44%; height: 15.75pt; width: 44%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Patent acquisition obligation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The following table sets forth a summary of the changes in the fair value of the Company&#8217;s Level 3 financial liabilities that are measured at fair value on a recurring basis:</p><br/><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="text-decoration:underline"><font style="color: black;">Patent acquisition obligation:</font></font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2015</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3,688,187 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">519,946 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Royalty payment applied to patent acquisition obligation</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(36,257)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2016</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">228,026 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Extinguishment of patent obligation</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(4,399,902)</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 16.5pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 18%; height: 16.5pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Our non-financial assets that are measured on a non-recurring basis include our patents and property and equipment which are measured using fair value techniques whenever events or changes in circumstances indicate a condition of impairment exists.&#xa0; The estimated fair value of prepaid expenses, accounts payable and accrued expenses approximates their individual carrying amounts due to the short-term nature of these measurements.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Cash and Cash Equivalents</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:40.5pt">Cash equivalents consists of highly liquid, short-term investments with original maturities of three months or less when purchased.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Short-term Investments</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; At October 31, 2017 and 2016, we had certificates of deposit with maturities greater than 90 days and less than 12 months when acquired of $3,500,000 and $750,000, respectively, that were classified as short-term investments and reported at fair value.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"><font style="text-decoration:underline">Impairment</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Long-lived assets, including intangible assets that are amortized, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates potential impairment by comparing the carrying amount of the assets with the estimated undiscounted future cash flows associated with them. Should the analysis indicate that an asset is not recoverable, the carrying value of the asset would be reduced to fair value and a corresponding charge would be recognized.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">Intangible assets that are not amortized are reviewed for impairment at least annually. The Company evaluates potential impairment by comparing the carrying amount of the asset with its estimated fair value. Should the carrying amount exceed the estimated fair value, a corresponding charge would be recognized for the difference.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Income Taxes</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">We recognize deferred tax assets and liabilities for the estimated future tax effects of events that have been recognized in our financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&#xa0; A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Stock-Based Compensation</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">We maintain stock equity incentive plans under which we may grant non-qualified stock options, incentive stock options, stock appreciation rights, stock awards, performance and performance-based awards, or stock units to employees, non-employee directors and consultants.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Compensation Related Costs, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline">Stock Option Compensation Expense </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We account for stock options granted to employees and directors using the accounting guidance in ASC 718 &#8220;Stock Compensation&#8221; (&#8220;ASC 718&#8221;).&#xa0; <font style="COLOR:black">In accordance with ASC 718, we estimate the fair value of service based options and performance based options on the date of grant, using the Black-Scholes pricing model.&#xa0; For options vesting if the trading price of the Company&#8217;s common stock achieves a defined target, we use a Monte Carlo simulation in estimating the fair value at grant date. </font>We recognize compensation expense for stock option awards over the requisite or implied service period of the grant.&#xa0; With respect to performance based awards, compensation expense is recognized when the performance target is deemed probable.&#xa0; We recorded stock-based compensation expense, related to stock options granted to employees and directors, of approximately $1,223,000 and $874,000, during the years ended October 31, 2017 and 2016, respectively. </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Included in stock-based compensation cost for employees and directors during the years ended October 31, 2017 and 2016 was approximately $967,000 and $393,000, respectively, related to the amortization of compensation cost for stock options granted in prior periods but not yet vested.&#xa0; As of October 31, 2017, there was unrecognized compensation cost related to non-vested stock options granted to employees and directors, related to service based options of approximately $1,091,000, which will be recognized over a weighted-average period of 1.7 years. </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We account for stock options granted to consultants using the accounting guidance included in ASC 505-50 &#8220;Equity-Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;).&#xa0; In accordance with ASC 505-50, <font style="COLOR:black">we estimate the fair value of service based stock options and performance based options at each reporting period, using the Black-Scholes pricing model.&#xa0; F</font>or options vesting if the trading price of the Company&#8217;s common stock achieves a defined target we estimate the fair value at each reporting period using a Monte Carlo simulation.&#xa0; We recognize compensation expense for <font style="COLOR:black">service based stock options and options subject to market conditions</font> over the requisite or implied service period of the grant.&#xa0; For performance based awards, compensation expense is recognized when the performance target is achieved.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We recorded consulting expense, related to stock options granted to consultants, during the years ended October 31, 2017 and 2016 of approximately $3,000 and $-0-, respectively. &#xa0;Stock-based consulting expense for the years ended October 31, 2017 and 2016 did not include any amortization of compensation cost for stock options granted in prior periods but vested in the current period. &#xa0;As of October 31, 2017, there was unrecognized consulting expense related to non-vested stock options granted to consultants, related to service based options of approximately $44,000, which will be recognized over a weighted-average period of 2.1 years.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="text-decoration:underline">Fair Value Determination</font><font style="text-decoration:underline">&#xa0; </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We use the Black-Scholes pricing model in estimating the fair value of stock options which vest over a specific period of time.&#xa0; <font style="COLOR:black">The stock options we granted during the year ended October 31, 2017 consisted of awards with 10-year terms that vest over 6 to 48 months. The stock options we granted during the year ended October 31, 2016 consisted of awards with 10-year terms that vest over 6 to 36 months&#xa0; </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The following weighted average assumptions were used in estimating the fair value of stock options granted during the years ended October 31, 2017 and 2016:</p><br/><table style="width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%; height: 15.75pt; white-space: nowrap;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">For the Year</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2017</font></p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted average fair value at grant date</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$1.72 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$2.84 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Valuation assumptions:</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected life (years) </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">5.63</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">5.70</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected volatility</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">119.2%</font></p>
</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">181.1%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Risk-free interest rate</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">1.94%</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">1.26%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected dividend yield</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">0%</font></p>
</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">0%</font></p>
</td>
</tr>
</table><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.&#xa0; We use the simplified method, which is a weighted average of the vesting term and contractual term, to determine expected term.&#xa0; The simplified method was adopted since we do not believe that historical experience is representative of future performance because of the impact of the changes in our operations and the change in terms from historical options which vested immediately to terms including vesting periods of up to three years.&#xa0; Under the Black-Scholes pricing model, we estimated the expected volatility of our shares of common stock based upon the historical volatility of our share price over a period of time equal to the expected term of the options.&#xa0; We estimated the risk-free interest rate based on the implied yield available on the applicable grant date of a U.S. Treasury note with a term equal to the expected term of the underlying grants.&#xa0; We made the dividend yield assumption based on our history of not paying dividends and our expectation not to pay dividends in the future.&#xa0; </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Under ASC 718, the amount of stock-based compensation expense recognized is based on the portion of the awards that are ultimately expected to vest.&#xa0; Accordingly, if deemed necessary, we reduce the fair value of the stock option awards for expected forfeitures, which are forfeitures of the unvested portion of surrendered options.&#xa0; Based on our historical experience and future expectations, we have not reduced the amount of stock-based compensation expenses for anticipated forfeitures.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">We will reconsider use of the Black-Scholes pricing model if additional information becomes available in the future that indicates another model would be more appropriate.&#xa0; If factors change and we employ different assumptions in the application of ASC 718 in future periods, the compensation expense that we record under ASC 718 may differ significantly from what we have recorded in the current period.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Net&#xa0;Loss&#xa0;Per&#xa0;Share of Common Stock </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">In accordance with ASC 260, &#8220;Earnings Per Share&#8221;, basic net loss per common share (&#8220;Basic EPS&#8221;) is computed by dividing net loss by the weighted average number of common shares outstanding.&#xa0; Diluted net loss per common share (&#8220;Diluted EPS&#8221;) is computed by dividing net loss by the weighted average number of common shares and dilutive common share equivalents and convertible securities then outstanding.&#xa0; Diluted EPS for all years presented is the same as Basic EPS, as the inclusion of the effect of common share equivalents then outstanding would be anti-dilutive.&#xa0; For this reason, excluded from the calculation of Diluted EPS for the years ended October 31, 2017 and 2016, were options to purchase 3,447,846 and 3,086,472 shares, respectively, warrants to purchase 829,400 shares and 707,379 shares, respectively, preferred stock convertible into -0- and 739,958 shares, respectively.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Use of Estimates </font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt; TEXT-INDENT:0.5in">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#xa0; Estimates and assumptions are used for, but not limited to, determining stock-based compensation, asset impairment evaluations, tax assets and liabilities, license fee revenue, the allowance for doubtful accounts, depreciation lives and other contingencies.&#xa0; Actual results could differ from those estimates.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Effect of Recently Issued Pronouncements</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update 2014-09 (&#8220;ASU 2014-09&#8221;), Revenue from Contracts with Customers.&#xa0; This amendment updates addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. &#xa0;This standard update is effective for&#xa0;interim and annual&#xa0;reporting periods beginning after December 15,&#xa0;2016, and were to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. &#xa0;In July 2015, a one-year deferral of the effective date of the new guidance was approved. &#xa0;<a name="_Hlk501045300">We do not expect the adoption of ASU 2014-09 </a>to have a material impact on our <a name="_Hlk502247174">consolidated financial statements and related disclosures.</a></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In August 2014, the FASB issued Accounting Standards Update 2014-15 (&#8220;ASU 2014-15&#8221;).&#xa0; This amendment requires management to assess an entity&#8217;s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods ending after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption.&#xa0; We have provided additional footnote disclosure to our consolidated financial statements in accordance with ASU 2014-15 upon adoption of this amendment.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">In November 2015, the FASB issued Accounting Standards Update 2015-17 (&#8220;ASU 2015-17&#8221;) to simplify the presentation of deferred taxes. This amendment requires that all deferred tax assets and liabilities, along with any related valuation allowances, be classified as noncurrent on the balance sheet. &#xa0;Adoption of this standard is required for annual periods beginning after December 15, 2016. &#xa0;We do not anticipate that the adoption of this amendment will have an impact on our consolidated financial statements&#xa0;and related disclosures as we currently do not present deferred tax assets or liabilities.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In February 2016, the FASB issued Accounting Standards Update 2016-02 (&#8220;ASU 2016-02&#8221;) which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. &#xa0;The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. &#xa0;The requirements of this standard include a significant increase in required disclosures. &#xa0;We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements&#xa0;and related disclosures, and our analysis is currently ongoing.</p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt;  TEXT-INDENT:0.5in">In March 2016, the FASB issued Accounting Standards Update 2016-09 (&#8220;ASU 2016-09&#8221;) that changes the accounting for certain aspects of share-based payments to employees. &#xa0;The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee&#8217;s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. &#xa0;The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. We adopted ASU 2016-09 on November 1, 2017. &#xa0;We do not expect the adoption of this new guidance to have a material impact on our consolidated financial statements and related disclosures.</p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In May 2017, the FASB issued Accounting Standards Update 2017-09 (&#8220;ASU 2017-09&#8221;) that provides guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting. &#xa0;This update is effective for all entities for fiscal years beginning after December 15, 2017, and interim periods within those years.&#xa0; Early adoption is permitted.&#xa0; We began a detailed assessment of the impact that this guidance will have on our consolidated financial statements and related disclosures, and our analysis is ongoing.</font></p><br/><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in"><font style="FONT-SIZE:11pt; COLOR:black">In July 2017, the FASB issued Accounting Standards Update 2017-11 (&#8220;ASU 2017-11&#8221;) which changes the accounting for equity instruments that include a down round feature.&#xa0; For public entities, this update is effective for fiscal years beginning after December 15, 2018, and interim periods within those years.&#xa0; Early adoption is permitted. &#xa0;</font>We do not anticipate the adoption of this amendment will have an impact on our consolidated financial statements&#xa0;and related disclosures as we currently do not have any such equity instruments.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 12pt"><font style="text-decoration:underline">Concentration of Credit Risks</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Financial instruments that potentially subject us to concentrations of credit risk are cash equivalents, short-term investments and accounts receivable.&#xa0; Cash equivalents are primarily highly rated money market funds. Short-term investments are certificates of deposit within federally insured limits. &#xa0;Where applicable, management reviews our accounts receivable and other receivables for potential doubtful accounts and maintains an allowance for estimated uncollectible amounts. &#xa0;Our policy is to write-off uncollectable amounts at the time it is determined that collection will not occur. </p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">One licensee accounted for 100% of revenues from patent licensing activities during fiscal year 2017. &#xa0;Two licensees accounted for 67% and 33%, respectively, of revenues from patent licensing activities during fiscal year 2016.</p></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccountingPoliciesbyPolicyPoliciesLineItems', window );"><strong>Accounting Policies, by Policy (Policies) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 11pt; ">
<p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="text-decoration:underline">Patents</font></p><br/><p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">Our only identifiable intangible assets are patents and patent rights.&#xa0; We capitalize patent and patent rights acquisition costs and amortize the cost over the estimated economic useful life.&#xa0; No patent acquisition costs were capitalized during the years ended October 31, 2017 and 2016.&#xa0; We recorded patent amortization expense of approximately $325,000 and $325,000 during the years ended October 31, 2017 and 2016, respectively.</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccountingPoliciesbyPolicyPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccountingPoliciesbyPolicyPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75027168&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=75032840&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75027451&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75032840&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66011266&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2,12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877573&amp;loc=d3e87990-122713<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75025870&amp;loc=d3e40691-111596<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6648328048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;</font><font style="color: black;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Level 2</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Level 3</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; &#xa0;</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Money market funds &#x2013; <br />&#xa0;&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Certificates of deposit - <br />&#xa0;&#xa0;&#xa0; Short term investments</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000 </font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 1.94%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,079,282 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">3,500,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.94%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">6,579,282 </font></p>
</td>
</tr>
</table><table style="width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 2</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 3</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 15.75pt; white-space: nowrap; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Money market funds &#x2013; <br />&#xa0;&#xa0; Cash and cash equivalents</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 38%; height: 15.75pt; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Certificates of deposit - <br />&#xa0;&#xa0;&#xa0; Short term investments</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; -</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 38%; height: 16.5pt; width: 38%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Total financial assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,899,136 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">750,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2,649,136 </font></p>
</td>
</tr>
</table><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 44%; height: 15.75pt; white-space: nowrap; width: 44%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 1</font></p>
</td>
<td style="padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 9%; height: 15.75pt; white-space: nowrap; width: 9%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 2</font></p>
</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Level 3</font></p>
</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Total</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 44%; height: 15.75pt; width: 44%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 1pt 0px 0px; border-style: solid none none; border-color: windowtext currentColor currentColor; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 44%; height: 15.75pt; width: 44%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Patent acquisition obligation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.4%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 9%; height: 15.75pt; width: 9%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.1%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="text-decoration:underline"><font style="color: black;">Patent acquisition obligation:</font></font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2015</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3,688,187 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">519,946 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Royalty payment applied to patent acquisition obligation</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(36,257)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2016</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4,171,876 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Accretion of interest on patent obligation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">228,026 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 80%; height: 15.75pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Extinguishment of patent obligation</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 18%; height: 15.75pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(4,399,902)</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 80%; height: 16.5pt; width: 80%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Balance October 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 18%; height: 16.5pt; width: 18%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><table style="width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 16%; height: 15.75pt; white-space: nowrap;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">For the Year</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2017</font></p>
</td>
<td style="border-width: 1pt 0px; border-style: solid none; border-color: windowtext currentColor; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted average fair value at grant date</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$1.72 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$2.84 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Valuation assumptions:</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected life (years) </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">5.63</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">5.70</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected volatility</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">119.2%</font></p>
</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">181.1%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Risk-free interest rate</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">1.94%</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">1.26%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 68%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Expected dividend yield</font></p>
</td>
<td style="padding: 0in; width: 15%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">0%</font></p>
</td>
<td style="padding: 0in; width: 16%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">0%</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6694885200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="500pt" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" colspan="5" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">2017</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" colspan="2" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;</font><font style="color: black;">2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">Accrued severance costs</font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">237,563 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="height: 15.75pt; width: 12%; background: #cceeff; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">Payroll and related expenses</font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">51,643 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="height: 15.75pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="height: 15.75pt; width: 12%; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">49,901 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #cceeff; padding: 0in; width: 70%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">Accrued other</font></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">119,963 </font></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #cceeff; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #cceeff; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">45,631 </font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16.5pt; width: 70%; padding: 0in; width: 70%;" valign="bottom">&#xa0;<font style="font-family: times new roman, times, serif; display: none; font-size: 10pt;">Total</font></td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">409,169 </font></p>
</td>
<td style="height: 16.5pt; width: 2%; padding: 0in; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 2%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt; text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-top: 0px; height: 16.5pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; padding: 0in; width: 12%;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt; text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">95,532 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745887024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember', window );">2003 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYTablesLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average Exercise</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;Price Per Share</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Aggregate</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;</font><font style="color: black;">Intrinsic Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Shares</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">366,200 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">17.86 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(11,080)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2.58 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Forfeited</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(129,520)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">17.72 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2016</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">225,600 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">18.69 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(5,800)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1.39 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56.24%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Forfeited</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(189,200)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">21.55 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 56.24%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding and Exercisable at October 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">30,600 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: justify; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3.16 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">20,148 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Contractual Life</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">(in years)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Range of</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Exercise Prices</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt;" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Outstanding</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$&#xa0; 0.67 - $&#xa0; 17.50</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">30,600</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1.13</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$3.16 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; display: none;">.</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYTablesLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><table style="width: 499.7pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average Exercise</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;Price Per Share</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" colspan="2" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Aggregate<br />&#xa0;Intrinsic</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">&#xa0;</font><font style="color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; white-space: nowrap; width: 56%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Shares</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2015</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">526,272 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3.33 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Granted</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">557,000 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2.92 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(2,400)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">4.25 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0; </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2016</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,080,872 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">3.12 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Granted</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">682,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">2.03 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Exercised</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(44,400)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">0.67 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 56%; height: 15.75pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Forfeited</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">(81,226)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">6.20 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="padding: 0in; width: 56%; height: 16.5pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding at October 31, 2017</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,637,246 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1.50 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12%; height: 16.5pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1,381,380 </font></p>
</td>
</tr>
<tr style="height: 17.25pt;">
<td style="background: #cceeff; padding: 0in; width: 56%; height: 17.25pt; width: 56%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Exercisable at October 31, 2017</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 17.25pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">909,024 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="text-decoration:underline"></font>&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">1.72 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 17.25pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 17.25pt; width: 12%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: right;"><font style="color: black;">721,433 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table style="width: 634.85pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="846" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" colspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Options Outstanding</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;" colspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Options Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="5">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Contractual Life</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">(in years)</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;" rowspan="4">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Contractual Life (in years)</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; white-space: nowrap; width: 20%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; white-space: nowrap; width: 15%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Price</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;" rowspan="3">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="2">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Range of</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Prices</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="2">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Outstanding</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;" rowspan="2">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercisable</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">1,001,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">8.14</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">522,778</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">7.09</font></p>
</td>
<td style="background: #cceeff; padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$2.27 - $7.00</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">636,246</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">6.69</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$2.80 </font></p>
</td>
<td style="padding: 0in 5.4pt; width: 2.18%; height: 15.75pt;">&#xa0;</td>
<td style="padding: 0in 5.4pt; width: 15%; height: 15.75pt; width: 15%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">386,246</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">4.62</font></p>
</td>
<td style="padding: 0in 5.4pt; width: 20%; height: 15.75pt; width: 20%;">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$3.14 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember', window );">Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYTablesLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 14.04%; height: 15.75pt;" colspan="2" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Average Exercise</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Price Per Share</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Aggregate</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Intrinsic</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt;"><font style="color: black;">Value</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Shares</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 58.18%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12.04%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 11.04%; height: 15.75pt;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; width: 58.18%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding and exercisable at <br />&#xa0;&#xa0; October 31, 2016</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,780,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12.04%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2.70 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 1.7%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 11.04%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 17.25pt;">
<td style="padding: 0in; width: 58.18%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Options Outstanding and exercisable at <br />&#xa0;&#xa0; October 31, 2017</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 11.04%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,780,000</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 17.25pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 12.04%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1.58 </font></p>
</td>
<td style="padding: 0in; width: 2%; height: 17.25pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 1.7%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in; width: 11.04%; height: 17.25pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,443,480 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt;  border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Remaining</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Contractual Life</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">(in years)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; white-space: nowrap; width: 23%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Number</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Outstanding<font style="text-decoration:underline"> </font>and<font style="text-decoration:underline"> </font></font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercisable</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="3" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Weighted</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Average</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Price</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" rowspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">Range of</font></p>
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; text-align: center;"><font style="color: black;">Exercise Prices</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">1,046,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">4.91</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$0.67 </font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$ 2.58 - $ 5.56</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">734,000</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">4.36</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; width: 2%;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 23%; height: 15.75pt; width: 23%;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric; text-align: center;"><font style="color: black;">$2.88 </font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6911708784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" colspan="5" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">2017</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">&#xa0;2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Federal:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Current</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Deferred</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(12,534,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(1,631,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">State:</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Current</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Deferred</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(4,351,000)</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">(134,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">Adjustment to valuation allowance <br />&#xa0;&#xa0;&#xa0;&#xa0; related to net deferred tax assets</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">16,885,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">1,765,000</font></p>
</td>
</tr>
<tr style="height: 15.75pt; page-break-inside: avoid;">
<td style="padding: 0in; width: 70%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;"><font class="a">Income Tax Provision (Benefit)</font></font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">$</font></p>
</td>
<td style="border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black;">-</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><table style="width: 500pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="667" cellspacing="0" cellpadding="0">
<tr style="height: 15pt;">
<td style="padding: 0in; width: 70%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">2017</font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" colspan="2" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">&#xa0;2016</font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Long-term deferred tax assets:</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Federal and state NOL and tax credit carryforwards</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">18,961,000 </font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">33,079,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Deferred compensation</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">3,718,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">6,232,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Intangibles</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">543,000 </font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">713,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 10pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Other</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">205,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">289,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in 0in 0in 20pt; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Subtotal</font></p>
</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">23,427,000 </font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; width: 2%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">40,313,000 </font></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="background: #cceeff; padding: 0in; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="background: #cceeff; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="padding: 0in; width: 70%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Less: valuation allowance</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">(23,427,000)</font></p>
</td>
<td style="padding: 0in; width: 2.16%; height: 15pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;">&#xa0;</p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">(40,313,000)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in 0in 0in 20pt; width: 70%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">Deferred tax asset, net</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; width: 2.16%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; font-family: 'Times New Roman','serif'; font-size: 12pt; -ms-text-autospace: ideograph-numeric;"><font style="color: black; font-size: 11pt;">-</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="width: 499.7pt; border-collapse: collapse; margin-left: auto; margin-right: auto;" width="666" cellspacing="0" cellpadding="0">
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="9" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Year Ended October 31,</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">2017</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 12%; height: 15.75pt;" colspan="4" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: center; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;2016</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Income tax benefit at U.S. <br />&#xa0; Federal statutory income <br />&#xa0; Tax rate</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(1,703,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(34.0%)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(1,706,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(34.0%)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">State income taxes</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(443,000)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(8.84%)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(411,000)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(8.2%)</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Permanent differences</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(10,000)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(0.20%)</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">2,000 </font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">0.1%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Expiring net operating <br />&#xa0;&#xa0; losses, credits and other</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-&#xa0;</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">350,000 </font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">&#xa0;</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">7.0%</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt; white-space: nowrap;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Rate Changes</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">19,041,000</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">380.13%</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="background: #cceeff; padding: 0in 2.9pt 0in 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="padding: 0in; border: 0px currentColor; width: 42%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Change in valuation <br />&#xa0;&#xa0; allowance</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(16,885,000) </font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">(337.09%)</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="border-width: 0px 0px 1pt; border-style: none none solid; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">1,765,000 </font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 2%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="font-family: 'Times New Roman','serif'; font-size: 12pt;">&#xa0;</font></p>
</td>
<td style="padding: 0in; border: 0px currentColor; width: 12%; height: 15.75pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">35.1%</font></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 42%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">Income tax provision</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">0.0%</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in; width: 2%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">$</font></p>
</td>
<td style="background: #cceeff; border-width: 0px 0px 2.25pt; border-style: none none double; border-color: currentColor currentColor windowtext; padding: 0in 2.9pt 0in 0in; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">-</font></p>
</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 2%; height: 16.5pt;" valign="bottom">&#xa0;</td>
<td style="background: #cceeff; padding: 0in; border: 0px currentColor; width: 12%; height: 16.5pt;" valign="bottom">
<p style="margin: 0in 0in 0pt; text-align: right; line-height: normal;"><font style="color: black; font-family: 'Times New Roman','serif'; font-size: 12pt;">0.0%</font></p>
</td>
</tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746217312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS AND FUNDING (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollateralizedFinancings', window );">Collateralized Financings</a></td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities</a></td>
<td class="num">(3,796,710)<span></span>
</td>
<td class="num">$ (3,381,699)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities</a></td>
<td class="num">(2,735,188)<span></span>
</td>
<td class="nump">1,503,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Payments to Acquire Short-term Investments</a></td>
<td class="nump">5,501,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from Sale of Short-term Investments</a></td>
<td class="nump">2,751,000<span></span>
</td>
<td class="nump">3,550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from Sale of Property, Plant, and Equipment</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments to Acquire Property, Plant, and Equipment</a></td>
<td class="nump">30,188<span></span>
</td>
<td class="nump">146,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by (Used in) Financing Activities</a></td>
<td class="nump">7,382,949<span></span>
</td>
<td class="num">(2,676)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ProceedsFromIssuanceOfRightsOffering', window );">Proceeds From Issuance Of Rights Offering</a></td>
<td class="nump">4,203,302<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="nump">3,460,586<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering', window );">Proceeds from Issuance of Common Stock in Registered Direct Offering</a></td>
<td class="nump">3,211,788<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="nump">7,273<span></span>
</td>
<td class="nump">33,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentsMadeOnSecuredDebenture', window );">Payments Made On Secured Debenture</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock', window );">Payments for Repurchase of Convertible Preferred Stock</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashPeriodIncreaseDecrease', window );">Cash, Period Increase (Decrease)</a></td>
<td class="nump">3,601,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, Cash Equivalents, and Short-term Investments</a></td>
<td class="nump">$ 6,839,000<span></span>
</td>
<td class="nump">$ 3,238,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentsMadeOnSecuredDebenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a Debenture.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentsMadeOnSecuredDebenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow associated with the registered direct offering of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ProceedsFromIssuanceOfCommonStockInRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ProceedsFromIssuanceOfRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from rights offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ProceedsFromIssuanceOfRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralizedFinancings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the collateral (typically cash) that the entity receives in a financing transaction in exchange for securities lent. This item represents a liability in the financial statements of the lender of the securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(m)(1)(i)(A)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64840732&amp;loc=d3e113275-111724<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralizedFinancings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6757733472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CertificatesOfDepositAtCarryingValue', window );">Certificates of Deposit, at Carrying Value</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 325,296<span></span>
</td>
<td class="nump">$ 325,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years 229 days<span></span>
</td>
<td class="text">5 years 255 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">3,447,846<span></span>
</td>
<td class="nump">3,086,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">829,400<span></span>
</td>
<td class="nump">707,379<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">739,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 1,223,000<span></span>
</td>
<td class="nump">$ 874,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">48 months<span></span>
</td>
<td class="text">36 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Employees and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AmortizationRelatedToCompensationCost', window );">Amortization Related To Compensation Cost</a></td>
<td class="nump">$ 967,000<span></span>
</td>
<td class="nump">$ 393,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 1,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 255 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years 36 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConsultationExpense', window );">Consultation Expense</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AmortizationRelatedToCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization related to compensation cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AmortizationRelatedToCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConsultationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to consultation expense for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConsultationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CertificatesOfDepositAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate.  A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit).  Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties.  Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CertificatesOfDepositAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6757732736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">$ 6,579,282<span></span>
</td>
<td class="nump">$ 2,649,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,171,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">3,079,282<span></span>
</td>
<td class="nump">1,899,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Patent acquisition obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,171,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="nump">3,079,282<span></span>
</td>
<td class="nump">1,899,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="nump">3,079,282<span></span>
</td>
<td class="nump">1,899,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds &#8211; Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsHierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82895926&amp;loc=d3e24584-111560<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6912017728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Changes in the fair value of the Company's Level 3 financial liabilities measured at fair value - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract', window );"><strong>Changes in the fair value of the Company's Level 3 financial liabilities measured at fair value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance</a></td>
<td class="nump">$ 4,171,876<span></span>
</td>
<td class="nump">$ 3,688,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_InterestExpensePatentAcquisitionObligations', window );">Accretion of interest on patent obligation</a></td>
<td class="nump">228,026<span></span>
</td>
<td class="nump">519,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ExtinguishmentOfPatentObligation', window );">Extinguishment of patent obligation</a></td>
<td class="num">(4,399,902)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights', window );">Royalty payment applied to patent acquisition obligation</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(36,257)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4,171,876<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ChangesInTheFairValueOfTheCompanysLevel3FinancialLiabilitiesMeasuredAtFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ExtinguishmentOfPatentObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extinguishment of patent obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ExtinguishmentOfPatentObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_InterestExpensePatentAcquisitionObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense recorded during the period for the accretion of interest on patent acquisition obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_InterestExpensePatentAcquisitionObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PaymentToAcquireRoyaltyInterestInPatentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the purchase of royalty interests in patent rights is the amount of cash the patent user pays the owner of the patent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PaymentToAcquireRoyaltyInterestInPatentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6915737920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract', window );"><strong>Weighted average assumptions used in estimating the fair value of stock options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value at grant date (in Dollars per share)</a></td>
<td class="nump">$ 1.72<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ValuationAssumptionsAbstract', window );"><strong>Valuation assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">5 years 229 days<span></span>
</td>
<td class="text">5 years 255 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">119.20%<span></span>
</td>
<td class="nump">181.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.94%<span></span>
</td>
<td class="nump">1.26%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ValuationAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ValuationAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_WeightedAverageAssumptionsUsedInEstimatingTheFairValueOfStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6917274208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - Accrued liabilities - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccruedLiabilitiesAbstract', window );"><strong>Accrued liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_AccruedSeveranceCostsCurrent', window );">Accrued severance costs</a></td>
<td class="nump">$ 237,563<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related expenses</a></td>
<td class="nump">51,643<span></span>
</td>
<td class="nump">49,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">119,963<span></span>
</td>
<td class="nump">45,631<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 409,169<span></span>
</td>
<td class="nump">$ 95,532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccruedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccruedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_AccruedSeveranceCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for employee severance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_AccruedSeveranceCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745895792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PATENT ACQUISITION OBLIGATION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2017</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligationAbstract', window );"><strong>Patent Acquisition Obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_InterestExpensePatentAcquisitionObligations', window );">Interest Expense Patent Acquisition Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,026<span></span>
</td>
<td class="nump">$ 519,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions (in Shares)</a></td>
<td class="nump">947,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_PatentAcquisitionObligation', window );">Patent Acquisition Obligation</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,171,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="nump">2,843,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="nump">$ 1,548,000<span></span>
</td>
<td class="nump">$ 1,547,608<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_InterestExpensePatentAcquisitionObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense recorded during the period for the accretion of interest on patent acquisition obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_InterestExpensePatentAcquisitionObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligation related to patent acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_PatentAcquisitionObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_PatentAcquisitionObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762084912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 06, 2017</div></th>
<th class="th"><div>Dec. 06, 2016</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2013</div></th>
<th class="th"><div>Oct. 31, 2012</div></th>
<th class="th"><div>Nov. 11, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock or Unit Option Plan Expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,222,772<span></span>
</td>
<td class="nump">$ 873,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of Stock, Amount Converted (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">682,000<span></span>
</td>
<td class="nump">557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,637,246<span></span>
</td>
<td class="nump">1,080,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember', window );">2003 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">366,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionTerms', window );">Preferred Stock, Redemption Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant to the Series A Redemption Terms, on December 9, 2016 the holder of the Series A Preferred received (i) $500,000 in cash, (ii) a 12% secured debenture evidencing the remaining $3,000,000 amount to be redeemed, $1,000,000 of which was due on or before June 1, 2017 and the remainder of which was due November 11, 2017 (the &#8220;Redemption Debenture&#8221;), and (iii) a 5 year warrant to purchase 500,000 shares of the Company&#8217;s common stock at an exercise price equal to 10% below the thirty (30) day volume weighted average closing price of our common stock at closing (the &#8220;Redemption Warrant&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseLongTermDebt', window );">Interest Expense, Long-term Debt (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionAmount', window );">Preferred Stock, Redemption Amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,999,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and Rights Outstanding (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of Stock, Amount Converted (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">792,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of Stock, Amount Issued (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemablePreferredStockDividends', window );">Redeemable Preferred Stock Dividends (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,008,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Warrant with Exercise Price of $9.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Warrant with Exercise Price of $13.875 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Investment Warrants Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 19,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Warrant with Exercise Price of $10.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">309,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Investment Warrants Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 15,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Warrant with Exercise Price of $5.03 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Investment Warrants Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="nump">1,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember', window );">Re-Priced Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">2,029,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost (in Dollars)</a></td>
<td class="nump">$ 261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember', window );">Re-Priced Options [Member] | 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">965,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember', window );">Re-Priced Options [Member] | Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">1,046,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember', window );">Re-Priced Options [Member] | 2003 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">18,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember', window );">Re-Priced Options [Member] | Minimum [Member] | 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">0.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember', window );">Re-Priced Options [Member] | Maximum [Member] | 2010 Share Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember', window );">Consultant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,463<span></span>
</td>
<td class="nump">10,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConsultationExpense', window );">Consultation Expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember', window );">Consultant [Member] | Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ConsultationExpense', window );">Consultation Expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember', window );">Director [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock or Unit Option Plan Expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of warrants held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Sentence Column A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentWarrantsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ConsultationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to consultation expense for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ConsultationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest paid or due on all long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemablePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1377-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemablePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional share-based compensation cost recognized as a result of an occurrence of an event that accelerates its recognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf925Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf925Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf13875Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf13875Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf1000Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf1000Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf503Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=itus_WarrantWithExercisePriceOf503Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=itus_RePricedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=itus_RePricedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=itus_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6912032496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 Share Plan - 2003 Share Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="nump">225,600<span></span>
</td>
<td class="nump">366,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 18.69<span></span>
</td>
<td class="nump">$ 17.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options Exercised, Share</a></td>
<td class="num">(5,800)<span></span>
</td>
<td class="num">(11,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options Exercised, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 1.39<span></span>
</td>
<td class="nump">$ 2.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options Forfeited, Shares</a></td>
<td class="num">(189,200)<span></span>
</td>
<td class="num">(129,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options Forfeited, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 21.55<span></span>
</td>
<td class="nump">$ 17.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber', window );">Options Outstanding and Exercisable, Shares</a></td>
<td class="nump">30,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue', window );">Options Outstanding and Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 20,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2003SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding and exercisable, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6664812256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under the 2003 Share Plan - 2003 Share Plan [Member] - Range Of Exercise Prices $0.67 To $17.50 [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable', window );">Options Outstanding and Exercisable, Number | shares</a></td>
<td class="nump">30,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">1 year 47 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 3.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding and exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2003SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2003SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices067To1755Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices067To1755Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745786288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2010 Share Plan - 2010 Share Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2010 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="nump">1,080,872<span></span>
</td>
<td class="nump">526,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 3.12<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options Granted, Shares</a></td>
<td class="nump">682,000<span></span>
</td>
<td class="nump">557,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 2.03<span></span>
</td>
<td class="nump">$ 2.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options Exercised, Shares</a></td>
<td class="num">(44,400)<span></span>
</td>
<td class="num">(2,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options Exercised, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options Forfeited, Shares</a></td>
<td class="num">(81,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options Forfeited, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares</a></td>
<td class="nump">1,637,246<span></span>
</td>
<td class="nump">1,080,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 3.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 1,381,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable, Shares</a></td>
<td class="nump">909,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 1.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 721,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYDetailsInformationregardingthe2010SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746165120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan - 2010 Share Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">Range Of Exercise Prices $0.67 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">1,001,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 51 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number | shares</a></td>
<td class="nump">522,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">7 years 32 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember', window );">Range Of Exercise Prices $2.27 To $7.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number | shares</a></td>
<td class="nump">636,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding,Weighted Average Remaining Contractual Life</a></td>
<td class="text">6 years 251 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number | shares</a></td>
<td class="nump">386,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable,Weighted Average Remaining Contractual Life</a></td>
<td class="text">4 years 226 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_A2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_A2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices067Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices067Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices227To700Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices227To700Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6915567728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan - Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) - Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber', window );">Options Outstanding and exercisable, Shares</a></td>
<td class="nump">1,780,000<span></span>
</td>
<td class="nump">1,780,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice', window );">Options Outstanding and exercisable, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="nump">$ 2.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue', window );">Options Outstanding and exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 1,443,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SHAREHOLDERSEQUITYDetailsInformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding and exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding and exercisable, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price per share at which the shares are outstanding and exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6895836496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding not under 2003 Share Plan and 2010 Share Plan - Stock Options Not Granted Under 2003 Share Plan Or 2010 Share Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember', window );">Range Of Exercise Prices $0.67 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable', window );">Options Outstanding and Exercisable, Number | shares</a></td>
<td class="nump">1,046,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">4 years 332 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember', window );">Range Of Exercise Prices 2.58 To 5.56 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable', window );">Options Outstanding and Exercisable, Number | shares</a></td>
<td class="nump">734,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding and Exercisable, Weighted Average Remaining Contractual Life</a></td>
<td class="text">4 years 131 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice', window );">Options Outstanding and Exercisable, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 2.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance or issued but not exercised pertaining to the outstanding and exercisable stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptionsAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding and exercisable stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding and exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=itus_StockOptionsNotGrantedUnder2003SharePlanOr2010SharePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices067Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices067Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices258To556Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=itus_RangeOfExercisePrices258To556Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6911824176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2017 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Oct. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRentCurrentAndNoncurrent', window );">Accrued Rent</a></td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Operating Leases, Future Minimum Payments Due, Next Twelve Months</a></td>
<td class="nump">182,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Operating Leases, Future Minimum Payments, Due in Two Years</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="nump">$ 229,000<span></span>
</td>
<td class="nump">$ 188,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInSanJoseCaliforniaMember', window );">Office Space In San Jose California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of Land (in Square Feet) | ft&#178;</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">Sep. 30,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Operating Leases, Rent Expense, Minimum Rentals</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_LeaseBaseRentAnnualIncrease', window );">Lease Base Rent Annual Increase</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInLosAngelesCaliforniaMember', window );">Office Space In Los Angeles California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems', window );"><strong>COMMITMENTS AND CONTINGENCIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of Land (in Square Feet) | ft&#178;</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Operating Leases, Rent Expense, Minimum Rentals</a></td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_LeaseBaseRentAnnualIncrease', window );">Lease Base Rent Annual Increase</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_COMMITMENTSANDCONTINGENCIESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_LeaseBaseRentAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage annual increase of base rent of lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_LeaseBaseRentAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77910348&amp;loc=d3e34039-112682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseMinimumRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInSanJoseCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInSanJoseCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInLosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=itus_OfficeSpaceInLosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747145840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percentage Use For Deferred Tax Assets and Liabilities</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=itus_FederalCorporateTaxableMember', window );">Federal Corporate Taxable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 83,579,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">1,257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=itus_NewYorkStateMember', window );">New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">72,483,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=itus_CaliforniaMember', window );">California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_INCOMETAXESDetailsLineItems', window );"><strong>INCOME TAXES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 9,656,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate used to value the deferred tax assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePercentageUseForDeferredTaxAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_INCOMETAXESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_INCOMETAXESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=itus_FederalCorporateTaxableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=itus_FederalCorporateTaxableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=itus_NewYorkStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=itus_NewYorkStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=itus_CaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=itus_CaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6916665184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - Income tax provision (benefit) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Federal:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(12,534,000)<span></span>
</td>
<td class="num">(1,631,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>State:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(4,351,000)<span></span>
</td>
<td class="num">(134,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Adjustment to valuation allowance related to net deferred tax assets</a></td>
<td class="nump">16,885,000<span></span>
</td>
<td class="nump">1,765,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Provision (Benefit)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747935312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract', window );"><strong>Long-term deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_FederalAndStateNOLAndTaxCreditCarryforwards', window );">Federal and state NOL and tax credit carryforwards</a></td>
<td class="nump">$ 18,961,000<span></span>
</td>
<td class="nump">$ 33,079,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Deferred compensation</a></td>
<td class="nump">3,718,000<span></span>
</td>
<td class="nump">6,232,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">543,000<span></span>
</td>
<td class="nump">713,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">205,000<span></span>
</td>
<td class="nump">289,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">23,427,000<span></span>
</td>
<td class="nump">40,313,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(23,427,000)<span></span>
</td>
<td class="num">(40,313,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_FederalAndStateNOLAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and tax carry forwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_FederalAndStateNOLAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetNoncurrentClassificationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747230160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract', window );"><strong>Reconciliation of income taxes at the Federal statutory tax rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at U.S. Federal statutory income Tax rate</a></td>
<td class="num">$ (1,703,000)<span></span>
</td>
<td class="num">$ (1,706,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at U.S. Federal statutory income Tax rate</a></td>
<td class="num">(34.00%)<span></span>
</td>
<td class="num">(34.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes</a></td>
<td class="num">$ (443,000)<span></span>
</td>
<td class="num">$ (411,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes</a></td>
<td class="num">(8.84%)<span></span>
</td>
<td class="num">(8.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="num">$ (10,000)<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther', window );">Expiring net operating losses, credits and other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Expiring net operating losses, credits and other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Rate Changes</a></td>
<td class="nump">$ 19,041,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Rate Changes</a></td>
<td class="nump">380.13%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">$ (16,885,000)<span></span>
</td>
<td class="nump">$ 1,765,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(337.09%)<span></span>
</td>
<td class="nump">35.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to expiring net operating losses, credits and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_IncomeTaxReconciliationExpiringNetOperatingLossesCreditsAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">itus_ReconciliationOfIncomeTaxesAtTheFederalStatutoryTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>itus_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32059-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M'WY781^MV[M_;'P15"W\N@OU!5!+ P04    " !$0"E,F5R<(Q &  "<)P
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M]>?M]/H\7?3->?YI(+G^/K'Y'U!+ P04    " !$0"E,G/K<4+P"   U"P
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M!S8Y$BH7S%MOFV'-!L=A.[X@-CWC_!]02P,$%     @ 1$ I3(O(.A6V 0
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M@,:%XXT_FVG,)L/I?OY!9/G&Y0=02P,$%     @ 1$ I3*5G#(:V 0  T@,
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M/-MIS";#FW[^06SYQN5?4$L#!!0    ( $1 *4P3,*9=MP$  -(#   9
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MF $1&?9!@B*)'1V94VP^@1Y.K/GD@X=33#"%!%-+,/U ,'.NB#!S+#*#(C-
ML'!$$&:)1>909 X(5HX(P*QB++* (@M 0!P1A/$$=0E%EH# 33N$\01^!456
M@, -/,)X D]B7$$QH'!##T&>V!-/I1) X48?@$R']NC <MT2"BC<!( @3P80
M7-=D BA&K0>!/$E </F3<6W3V$T#"/+E >X 9%S>-![E 0+Y\@ W 3*N<!J/
M\@" B"\/<!\@XR*G9)0'".3+ ]P*R+C.*1GE 0+Y\@!W S(N=4IFF(+B4J?Q
M_W^+**YB"@J4S)W;0M#"T8D>/O$EEQ<[W*C@**Z5G:P>3H<!:DOMB/ /WDU?
MWYF\Y)4*#D*;0<.. V<A-#>^Q$\F8S,S\ V;@I]UNUR8M>RFGFZC1=U/=-$P
M5J9_ 5!+ P04    " !$0"E,HEL.H- !  "<!   &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6QU5-MNW" 0_17$!P2;O21=V9:RB:)4:J15JK;/K#V^
M*& <P.OD[PO8Z[HN?5F8\;G,L S)(-6;K@$,^A"\U2FNC>D.A.B\!L'TC>R@
MM5]*J00S-E05T9T"5GB2X(1&T9X(UK0X2WSNI+)$]H8W+9P4TKT03'T>@<LA
MQ3&^)EZ;JC8N0;*D8Q5\!_.C.RD;D5FE: 2TNI$M4E"F^#X^'/<.[P$_&QCT
M8H]<)V<IWUSPM4AQY H"#KEQ"LPN%W@ SIV0+>-]TL2SI2,N]U?U)]^[[>7,
M-#Q(_JLI3)WB.XP**%G/S:L<GF'J9X?1U/PWN "W<%>)]<@EU_X7Y;TV4DPJ
MMA3!/L:U:?TZ3/I76IA )P)=$<AHY"M_9(9EB9(#4N/9=\S]Q?&!VK/)7=(?
MA?]FB]<V>\EH?)>0BQ.:,,<10Q>8>$80JSY;T)#%D?Y#IV'Z)ECAQM,W2_?=
M;5A@&Q38>H'M7RU^6;48P- H;+(+FNP" O'*)(3YSU'L@R;[@,!F91+";%<F
M9'$[!*C*SX5&N>Q;/Y.+[#QZ]]3?KC_P<6Y?F*J:5J.S-/:.^IM42FG EA+=
MV(9K^U3, 8?2N.VMW:MQ8,; R&YZ"\C\(&6_ 5!+ P04    " !$0"E,^G/V
M9+<!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6QM4]MNW" 0
M_17$!X1=UMF-5K:E;*HJE5IIE:CM,VN/+PH7!_ Z_?L,V''=U"_ #.><N3"D
M@[$OK@'PY$U)[3+:>-\=&7-% TJX&].!QIO*6"4\FK9FKK,@RDA2DO'-9L^4
M:#7-T^@[VSPUO9>MAK,EKE=*V#\GD&;(Z)9^.)[:NO'!P?*T$S4\@__9G2U:
M;%8I6P7:M483"U5&[[?'4Q+P$?"KA<$MSB14<C'F)1C?RHQN0D(@H?!!0>!V
MA0>0,@AA&J^3)IU#!N+R_*'^-=:.M5R$@P<C?[>E;S)Z1TD)E>BE?S+#(TSU
MW%(R%?\=KB 1'C+!&(61+JZDZ)TW:E+!5)1X&_=6QWT8;PY\HJT3^$3@,^$N
MQF%CH)CY%^%%GEHS$#OVOA/AB;='CKTI@C.V(MYA\@Z]UYSSVY1=@]"$.8T8
MOL!L9P1#]3D$7PMQXO_1^3I]MYKA+M)WR^C[9%T@615(HD#R3XG[3R6N80Z?
M@K!%3Q78.DZ3(X7I=9SDA7<>V/OXB.PO?)SV'\+6K7;D8CR^;.Q_98P'3&5S
M@R/4X >;#0F5#\<#GNTX9J/A33?](#9_X_P=4$L#!!0    ( $1 *4QOS-$Q
M'@(  !X'   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;(U5VXZ;,!#]
M%<0'K+$A5Q&D9*M5*[52M%6WSPZ9!+0&L[83MG]?VQ!*DXF4%VP/9\Z9&9AQ
MVDKUK@L $WQ6HM:KL#"F61*B\P(JKI]D [5]<Y"JXL8>U9'H1@'?>Z=*$!9%
M4U+QL@ZSU-NV*DOER8BRAJT*]*FJN/JS 2';54C#B^&U/!;&&4B6-OP(/\'\
M:K;*GLC LB\KJ'4IZT#!816NZ7)#$^?@$6\EM'JT#UPJ.RG?W>';?A5&+B(0
MD!M'P>URAF<0PC'9.#YZTG#0=([C_87]Q2=OD]EQ#<]2_"[WIEB%\S#8PX&?
MA'F5[5?H$YJ$09_]=SB#L' 7B=7(I=#^&>0G;635L]A0*O[9K67MU[;GO[CA
M#JQW8%<.I!/RD7_AAF>IDFV@NN(WW'UCNF2V-KDS^E+X=S9X;:WGC+%Y2LZ.
MJ,=L.@P;8>B ()9]D&"8Q(;=N#/</48CC+U[\E^$"YP@00D23Q"/">(()YB@
M!)/;"&)Z52,,<R?-*2HR10CB*Q$,D^ B,U1DAA!,<((Y2C!_O)8+E&#Q0"TQ
MS!07H1'^5T</5!,%S>[HW.D>BE#,[U"@W;&F[/&24KQ#*-(B-T5%07?ZB.*-
M1)-'JHJ DNM\R&@\5:".?C#K()>GVM\*(^LP_-?,C[=_\.[F^,'5L:QUL)/&
M#DD_R@Y2&K"Q1$^V*PM[60T' 0?CMC.[5]W$[@Y&-OUM1(8K,?L+4$L#!!0
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MA\JX[=[NU30PDV%D/[\%9'F0\C=02P,$%     @ 1$ I3 &&:S0X P  F@P
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MZC3X0IUJ571A?"M*639WI'&-!D2DN2O2X(LO==Y0 Y(?;79]<(4&1**Y*]&
M:#2*XP>;Q<'U&1"!YJY  Z*\_/:5<9L+EUY M)>[VCL835_-/*,Y4KMO2 G-
M?*AHTM'5HCW8YK<+MO+<*-,[36;'!ON1F([0F5^;QMMVBN]A^J[]>]$>RJ8+
MGJ72_:;M"O=2*J$YXWN];$?]H3 .*K%7YC;5]VW?+?<#)4_#ET T?HZL_@-0
M2P,$%     @ 1$ I3%(A-,Y] P  8!   !D   !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&ULE5CM;N,V$'P500]P$I>22 6V@23%H05:(+BB[6_%IFWA)-$G
MR?'U[4M]Q+7(X5V<'Y%(SRYGEYPUUZN+;K]V1Z7ZX'M=-=TZ//;]Z2&*NNU1
MU47W29]48S[9Z[8N>C-L#U%W:E6Q&XWJ*J(XSJ*Z*)MPLQKG7MK-2I_[JFS4
M2QMTY[HNVG^?5*4OZY"%[Q-?RL.Q'R:BS>I4'-2?JO_K]-*:473ULBMKU72E
M;H)6[=?A(WMXYNE@,"+^+M6ENWD/AE!>M?XZ#'[;K<-X8*0JM>T'%X5YO*EG
M556#)\/CV^PTO*XY&-Z^OWO_/ 9O@GDM.O6LJW_*77]<AS(,=FI?G*O^B[[\
MJN: TC"8H_]=O:G*P <F9HVMKKKQ?[ ]=[VN9R^&2EU\GYYE,SXOL_]W,VQ
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M(-^VNM%_YQ>>*7E=B>IC*[*J^6]MSY44>9=%E9(G;^TQ+9KCM<O_'H8#:!=
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MR%$(#49B-#'WN#+ORKA@<-1VFIFY[+MKO]"B'1X.,KY>Q3]02P,$%     @
M1$ I3+X <&4# @  >@4  !D   !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M?93MCIP@%(9OQ7@!BXHZZT1-=MTT;=(FDVW:_F;T.)I%L<",V[LO'ZYQU/:/
M<. ]+\\!)!T9?Q,-@'3>.]J+S&VD'(X(B;*!CH@'-D"O9FK&.R)5R"](#!Q(
M99(ZB@+/BU%'VM[-4S-VXGG*KI*V/9RX(ZY=1_B?9Z!LS%S?_1AX;2^-U ,H
M3P=R@>\@?PPGKB(TNU1M![UH6>]PJ#/WR3\6L=8;P<\61K'H.[J2,V-O.OA2
M9:ZG@8!"*;4#4<T-"J!4&RF,WY.G.R^I$Y?]#_=/IG95RYD(*!C]U5:RR=Q'
MUZF@)E<J7]GX&:9Z(M>9BO\*-Z!*KDG4&B6CPGR=\BHDZR87A=*1=]NVO6E'
M.Q,E4]I^0C E!'."'_XW 4\)>)6 +)DI]85(DJ><C0ZWAS40?2?\(U:;6>I!
MLW=F3E4KU.@MQ\$A13=M-&F>K298:()[1;%58&^6( 4P4P2[%(')QW<4C_L&
M>-< &X/PSB!9E6$UL='TM@Q\B&*\JF5K%8;[*.$N2KA%66R&1;&::($2^7&X
M)MFJPB3Q_'V8:!<FVH'Q5S#19AG?3Y+-OFQEH=J\?]#$NS3QAB99W[5X<TBA
ME_CQZBR+K2R)(ARL8-#B+]"OTC?"+VTOG#.3ZH<RU[YF3()R]!Y498UZ".>
M0BUU]Z#ZW#X'-I!LF%XZ-#^W^5]02P,$%     @ 1$ I3'&MH2DQ @  B@8
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MC\8(:H0@4QIKC*">@*#&".HQ"&J*X+E]7F,&]1@&@ZB?W,PB86XZ-',0,(9
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ME_/4S($6P_(@D/55*GX#4$L#!!0    ( $1 *4S \F^,]@(  ,D*   9
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MBT^/229U:(!M,A"(4IA*#%*)'2H,)1:5V)$<I\I)+,8[%Q9%R10VHY. =!*
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MTCO4[J.*<P5:T]UHT5J?+%-!H5)F&NNY&/ZOH5"\&X\./)U?^5]02P,$%
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MFP0G(30S.L,G4X_,?!QT&\Y.VBY3LY;-A&PV6E3M] ^Z3Y#5/U!+ P04
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ME5R3J!H'1H7Y]0X7(5DSNBB4!G\,8]V:L1_];VGN!#@FP"DAC)XFH#$!+1+
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MO.L6NXED;=\)!T,[OO@/4$L#!!0    ( $1 *4R @Q!G 5X  #V! 0 4
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M+1Z6#@ZQ[8=T/@-.1J0]_"/MZOJYM)I MW<Q+,4LR)GEKX !P%'9Q$!)K58
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MM$:,X* 9^&^\H#_BX<!!:V[A_=[:UB^RK<\5O+2&8DH6G#THIFSUV;U2S+%
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M2LA[KL)!U(ZLG$SL1K:^L^1 -@:4W_38Z&6<T1[  :<M]XDR<[ZEY685E"C
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M=Q'I^ 9!<N/14.B\#$<V2"<K^T/>9J)'O*<-G'RR$'@I!Z_,U90M(CXCQIP
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M'G)#;6\K#[PG9LX3*H"%:OJ6("Z!\\+4.:V7[5=H<#$S,4B,_6\*JY?5]>=
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M+2^L/2.P%:"QP2S9WD514)\IJ6)"S.&0E7>:I7;FU$XD[7C5NB2HJ<2!X+S
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MU,EK@(2+%BAG[EBGBQ7;PLNQV:0]H5K$I,=6*,&.)@;6;G%A>PX:(O7,#FJ
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ME9-D3BWO'ID^^5W'QF:B.:,C></PBC2S0/2(KG*.*5*@6@Z-JIPAC-M@<[,
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M_OC#>RWA4/GHUQ61)39]U!H[MO6O^IU%JM9D6%HZK9 AIJ'C#9 )',K<U!
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MC]_DYE"0END[NT073/!H?[3"H\4P:SE0)'BT/T%.6W[I"HYOSO0;4$L#!!0
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M+RYR96QS4$L! A0#%     @ 1$ I3&;S"V""    L0   !
M ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !$0"E,6AL=-NX
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 1$ I3)SZW%"\ @
M-0L  !@              ( !N \  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( $1 *4S]JZ^WC ,  ) .   8              "  :H2
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !$0"E,[>[P
MM_X!   S!0  &               @ %L%@  >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ 1$ I3 @AK6O$!   -!8  !@
M ( !H!@  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( $1
M*4Q[4.0[[@0  . 7   8              "  9H=  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " !$0"E,L/P$^K,!  #2 P  &
M        @ &^(@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    ( $1 *4P3,*9=MP$  -(#   9              "
M 5LL  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 1$ I
M3$&6D[.V 0  T@,  !D              ( !22X  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " !$0"E,GFK%?9$"  !B"@  &0
M        @ $V,   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( $1 *4RB6PZ@T $  )P$   9              "  ?XR  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ 1$ I3/IS]F2W 0  T@,
M !D              ( !!34  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " !$0"E,;\S1,1X"   >!P  &0              @ 'S-@
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( $1 *4SBC;Q7
MT@$  )P$   9              "  4@Y  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ 1$ I3 &&:S0X P  F@P  !D
M ( !43L  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !$
M0"E,4B$TSGT#  !@$   &0              @ ' /@  >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( $1 *4P;/D1L50,  &,1   9
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M970R-BYX;6Q02P$"% ,4    " !$0"E,?V4+J!,&   8)   &0
M    @ %Z3P  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M $1 *4PX<DQ,L@(  #\)   9              "  <15  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ 1$ I3(8.5 _? 0  H00  !D
M             ( !K5@  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " !$0"E,P/)OC/8"  #)"@  &0              @ '#6@  >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( $1 *4PD[*!2AP(
M !@)   9              "  ?!=  !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ 1$ I3-P.*6G> 0  RP0  !D              ( !
MKF   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !$0"E,
MP,J.(BL"  "C!@  &0              @ '#8@  >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( $1 *4R^TNG$HP(  / )   9
M      "  25E  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ 1$ I3-IEA_YU @  C@@  !D              ( !_V<  'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !$0"E,]9$K(5("  !L!P
M&0              @ &K:@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( $1 *4QKX9C#-P(  #@'   9              "  31M  !X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 1$ I3$0+N-;2
M @  F@L  !D              ( !HF\  'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    " !$0"E,@(,09P%>   ]@0$ %
M@ &K<@  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4    " !$0"E,R_#*
MDSL"  " "@  #0              @ '>T   >&PO<W1Y;&5S+GAM;%!+ 0(4
M Q0    ( $1 *4S,9NA/. ,  #\9   /              "  433  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " !$0"E,K:+'C9@!  "W%P  &@
M        @ &IU@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " !$0"E,R5/E^*(!   <&   $P              @ %YV   6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     +P O +L,  !,V@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>129</ContextCount>
  <ElementCount>240</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>41</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS` EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF SHAREHOLDERS` EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ConsolidatedCashFlow</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - BUSINESS AND FUNDING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/BUSINESSANDFUNDING</Role>
      <ShortName>BUSINESS AND FUNDING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ACCRUEDEXPENSES</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - PATENT ACQUISITION OBLIGATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATION</Role>
      <ShortName>PATENT ACQUISITION OBLIGATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITY</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ACCRUEDEXPENSESTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/ACCRUEDEXPENSES</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITY</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/INCOMETAXES</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - BUSINESS AND FUNDING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/BUSINESSANDFUNDINGDetails</Role>
      <ShortName>BUSINESS AND FUNDING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/BUSINESSANDFUNDING</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/HierarchyforourfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisTable</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Hierarchy for our financial assets and liabilities measured at fair value on a recurring basis</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Changes in the fair value of the Company's Level 3 financial liabilities measured at fair value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ChangesinthefairvalueoftheCompanysLevel3financialliabilitiesmeasuredatfairvalueTable</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Changes in the fair value of the Company's Level 3 financial liabilities measured at fair value</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/WeightedaverageassumptionsusedinestimatingthefairvalueofstockoptionsTable</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Weighted average assumptions used in estimating the fair value of stock options</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - ACCRUED EXPENSES (Details) - Accrued liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/AccruedliabilitiesTable</Role>
      <ShortName>ACCRUED EXPENSES (Details) - Accrued liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/ACCRUEDEXPENSESTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - PATENT ACQUISITION OBLIGATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATIONDetails</Role>
      <ShortName>PATENT ACQUISITION OBLIGATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/PATENTACQUISITIONOBLIGATION</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/Informationregardingthe2003SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2003 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under the 2003 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/Stockoptionsoutstandingandexercisableunderthe2003SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding and exercisable under the 2003 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding the 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/Informationregardingthe2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Information regarding the 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/Stockoptionsoutstandingunder2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding under 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/InformationregardingStockoptionsgrantednotunder2003SharePlanor2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Information regarding Stock options granted not under 2003 Share Plan or 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - SHAREHOLDERS' EQUITY (Details) - Stock options outstanding not under 2003 Share Plan and 2010 Share Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/Stockoptionsoutstandingnotunder2003SharePlanand2010SharePlanTable</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details) - Stock options outstanding not under 2003 Share Plan and 2010 Share Plan</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/SHAREHOLDERSEQUITYTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/INCOMETAXESTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - INCOME TAXES (Details) - Income tax provision (benefit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/IncometaxprovisionbenefitTable</Role>
      <ShortName>INCOME TAXES (Details) - Income tax provision (benefit)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/INCOMETAXESTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ThetaxeffectsoftemporarydifferencesofthedeferredtaxTable</Role>
      <ShortName>INCOME TAXES (Details) - The tax effects of temporary differences of the deferred tax</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/INCOMETAXESTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="itus-20171031.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ITUScorp.com/role/ReconciliationofincometaxesattheFederalstatutorytaxrateTable</Role>
      <ShortName>INCOME TAXES (Details) - Reconciliation of income taxes at the Federal statutory tax rate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ITUScorp.com/role/INCOMETAXESTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>itus-20171031.xml</File>
    <File>itus-20171031.xsd</File>
    <File>itus-20171031_cal.xml</File>
    <File>itus-20171031_def.xml</File>
    <File>itus-20171031_lab.xml</File>
    <File>itus-20171031_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/invest/2013-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>62
<FILENAME>0001513162-18-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001513162-18-000006-xbrl.zip
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MCWO=WFXPWH$J\>^9.[^QGYCGHSKP=D#; )5@)P8I:_@WRFX@K,?*:% ( AF
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MYMY@G%;C6R^CL(#Q[S\XKA!7;Z_"U1GWTF<4"P.69=1S\+)F4=5*E+Q/M15
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MH:HNOU']_(61->P.1DGN+C9Y9B/6+(_E@VF#6JW<U1OUQMU)?[/#E#']FWW
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MVAILZP)U MA:S6HI(-0N.*;PJN<SQP-)IH$L!A*UE#Z;B_C#4V#!/,2\()K
MFCZ35>+;51@3SXH5>L#H"QXI"JL#)+" E_ ^6YUG#DP9)<JSXUK&,XAR*0M^
MXLYQ<<\1U _$PW1D->;[TM;\FJM0?XDFR-46+$"3#H)DZQ>A >+^=/B@Y#,G
MS;DYGP>VT_9I'+#3;O#H<;5(%$T;ZGAFLAP +GQPT R)$V4I$RG,(]@5+"WQ
M<6:NQ^.!GL&[?<24,^EY4*T@0N1-1*S34ER^#]M^ !E%&Q+.!L-!=!*9%!B/
M@=^@^P'HZ84HS\OS+@5H7'/#F#"6;*['774$1EF? 7.YI@[K-1P=Q0[>P
M+28ROE!,A+W(RUTJ/WH!K%+ZXH'A)-HWDRQ7-"RLVWQD=CSH?5N'-22I>/6U
M?2]34!KW)]G(_<Y06]$$)C:O!2=J";R$>2S'S@H\-,5'#4,?T4X+713ILX>
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M(4#VG5!1;%>D4?5YWA/H^?F2/+RLI&Y]Z5F-SG^A"O_'WK#5'8Q^.IK";]S
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MHZYB<\=E_(02S(N-$^1SK&!C-7ZT7%A&Y *T/'1&-NJ0Y">J\<V$%@XY,.S
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M!BEG!CP#T2-:2E3ZPE,56MSQ).8Y :6U#P7U/C*07QEFND'H;H OL...Z]B
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M1U9TQ="B(J# 8"L1'*,> 3<_>(S\VU#23$_V;3\*,H1W2>+F7-Q#4.@ ="7
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M^#'<,7.=[S0D]=V$,1&V)],( ,6ZYKI+7+$VYV,9N&2']\O$:\O;=&VYK?F
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MX8Q\ <1'8<"%"E\*N0#7/_2Z@UCYAQ^V!25I+0JH^ T*9U6-WD21Z:W[SO1
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MO6ESVTBR+OS]_15X'>X(=QR(QD( I+I'$;0D]ZBO;?G:<B]SXT8'1((2IDF
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MO00]*V!V/@YSZX +N#N[#4+J6*B%M/.RVRPG2A --7^;#X/=8ANA'DKNVTK
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MB7. Q\/ PO'*%7R?!E[O. $GMKW]0F(%G?W*ND=@?T J4VX9B#R8:'B[*/P
M2U_9ST3J'DT'-.&-+/S(+?07[LE>P78,I#RX'Z<'79!"=VWKJ"'<2(\:/E1
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M:M5%7I4U7AH7-79L)VB49$S#<,T!IS! G.@Z;EM7!T]7"T=*4]^:*2!30*:
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M 91=6:@9^\_$"&DD*44PL;#]^Y71%>"KHV;2,CA1:91D?EP.E[($AV)XGZU
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M'^B53F&O<.XWPM&SOQ,3@R;WI^W\C:EQ"5, 0V*9>I[IV6=K-(D?3^30UL0
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MHB>[( OK!#,T=<)=_C76^&0>S D!?Z%.;+;_H']$-O+8B3O^5O8?P5?!ZC,
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M^B;,<&<A&G&?]9$E36UH1R&SG^_$-N ,FMA9&L[2%T4"'H!KBB9,$,FE6K*
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M*@#"?ZS-Y<,T\3/?/-B),"&P!ZM3&(51MZJ'A>07)8[3!Q3R=_X'4$L#!!0
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MAV^B7_[T3+_(_/[[1?CKLT^?/KT+_[K[J6_G_9 ,>_;NZ^W-S%RAM?'6=OW
M<$U*P+=_\L,O;SS3"$+1EO)U4O@+^J^WR<_>TJ_>GIV_O3C[^[-O[5@DO[&"
M'9GT ._?17]\0^5U<O(S]APT18N3\!5_"K:/Z)<WOKU^="CGX7<KC!:_O+&#
MC4^HG7TX.XUH_1?]YG?\.T'6]QS;HB!=&@Y]Y]D*H>#-"1WZ?CK*O.UH?C\S
M/?Q(@7Y'?_"N\/EWL19 ,OG[G8&1&ZQ08)N&XU?E^7 XJ%<8D4FY1K. ?%X3
M>C)L'PY!6(5F4X&P2T94]1*S%1EWY3D6,87#?V_L8#LG@YQ[^(*7:<8(D5(H
M%W;?\%=7CO==1JR[9]^IL@J7][/1>#B;]<:#J_OQ8#2^YN4KY\E08FJ O;^]
M[4V_3:YFH^OQZ&K4[XWGO7Y_<C^>$T)WDYM1?S2<<8/,-YHZ]LG@T_OA8/CU
M;CB>\?-Y^)@RE.]Z\R%]Y7_>CV:C^6@RGES>C*Y[]!,O;ZPAE$WG7WO3X:^3
MF\%P.AL20O-OW @?/ZD.S?[D]G8TOR6O3Y6]/PFU9C@6T4#6$*JD-QH3*L-Y
M[RL_6^E'%)J[GFEZ&S<@WN@=L5RFC?S+;?AIRST3BD=0R">?79@;#P[B7@6%
MQE3I=QP8#S&N\Q]6*>JC"2HHUJ+G58HP-1W$N#M^4-6D_M4F6S-LKK8+#Y.M
MU\)VB1-K$U?6]U'@&Z[EV,:#[=@!F2)K9/@;C(BGL#!L_&0X&^2YQ+TQ-QB3
MF43V(;8?LL?[6C#$E:UJ_97A+I%O4\=R3W1!_D5WMH:[]6_0$W(N=GRSV142
M#0AME;K\!=G+%7$9#;*=-Y:$HK]9/])-K;_QD66[R _LM4$M;/8-_, S__2B
M7PI)1!U!A7Z8:>(-2JNIT"L5/:Z.P9%+IM8Z##9@M#2P%8F'1@O"G<D=V;,*
ML<P_H$KCGH+0VP0TH$+IDO]'SPB;MD\);LB_<*5WJTJF!MC.3A7#=C0@/&RA
M!.5?17!4A>^3)\0T-TMLN,1 N5X0,Y/2$*_"&RNGJVR%+, BEQ/R)^6@"Q!2
M]LY1Z"DPGA^Q]V33"/D#<M'"#@0Q98ZBC-OYBA)!BP4R Y_X#VC]Z!&?:VO9
MY"N,7!/YH5=A(?)/XC.0'PN]A_3X"N?E%)D>\8'(,DKUPR,N42Q;Y!L!H7U%
MJ&/#(4H3; (/;\E?Z&&%T'M6H@$831L0'FS^&&KQ .IL M<&59!OL4'KB&L)
MO@#'2"J]\^/MK*C "P=0M[TJCED),LLQ$M V7I#1G"<5.(T#S]S04Y">:PW=
MP ZV*8>!ES/F&'&P@6S5>9DL.+5,#AWI<>7[D'?+)E3I\O>6K!#&Q@G>G,1D
MTCSOQB#[X7?DD7?Q;]X=/UX/K][:L%UI5J.G]RL@!+,K,@0V-P_H[8ZP&+]Y
M Z1F$8B 0\&\7:/U \*"TLT\NIM4$%P:CB/&&WU@QQ'14]NUZ;2Z(;0S7*'G
M !%OUDKXH@_+'IK'Y A!QS,S5!R:?.#AA(AC/"#GES?$IBP-X_'WW9$JX0Z-
MR$<_5TKANRX,_R%\X?CA=]0JO4-.X"??A';J[>E9G);P7PPJ>]62YSGVZ #Y
MS?AS&31[.,LR 3_A)-8#/D6)GUE@;\V#2N 5R\'#Q"?]Y<TI^6VHPC\1%S8@
M2C9TPE^1:8"64=I \G?'\Y'URYL ;](O*89&=,H=YOP@/QCY_@99$TS_2[FZ
M#,^_>\\VB%YQT][97N48YMI=)J89K4WCR2_)8Z0/D02 DI(?Q MAW5"F:,-!
M>;S>Y^$HJN_\"*<%7(HP)+Z_G^I&&!C>Q/74A2\5<(SP&6,.5UL=^_1<;;((
M0VE0!KB86"LL+D-6'/#(H),F!&=,<ZAD_"T==K-4+]/ Y(F)8]%3! F,_2L
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MPV:E:1:'SV3C;_M !D*8B<9G"4K(E:<N2R7&D9W3#3*+BQ:DJLO(5FD%6-@
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M^4"J;O+>]25C]B4[9R0&:6HCT3?\U97C?7]38:O9U4-U]5!*ZJ%F)G(-8K/
MZZ RA(#L.D3Y4U9 4+4""95[UW]$IKVPR8("5OQ43*R6'@,\-5!Y:IF!IUA>
M0/7H101ABJ"8$#6A#$H:(-#.#V,4T-65^ &T,:9UN;WW:=NF77?\GAG83T1F
ML/=X27#1 N=*1K8@-3VOP^.55^42CUAU.\54$N6=8T!V=RB@I/-H2@U*12($
MLY-TRVJX)IHL0M(]U_IB8$R3YE)AI GN.X8-L[<08^ %3$1!B4-5M70WPBE'
MEO.*.%9EB' V1\\T,=H1#"\NF+B,A!]_[C%O?RE(\E! 1E\$KQJZRL1<6C6B
M(D\NY :CB+7H@DGIU,;<L30>8BK D5MBY1>7R=G= 7K$9!>47 &:-AD01I=%
MKOW>$E.88!<%T8N[J!\]<6>&0Y9Q\A*$[6!+';:P*<AC'*53CB8G9;T9(FJ@
MY15R:3&'+,+=K79@N/+=>E><B2#9Q!4CPT<#%/TWQ7A<_ L9!Q*@WGZK+")J
MY34@Q4S<8?1HV-8@;OP3NV5DV0@3F^#V/9*<:/2SQ.<*&WX^R4,=J!SS0YQY
M;T/VVW?&%NH$LIRH7F.N&N(CD0)=9)]+F8QHW=C&@^V$MJDV/ _IZMOA L!Y
M)%2E%]R'F[%CNE-O:SCA^N):T:6-2[HI0TO#N4(H?\(6[&>E!V\;BA5%J3@H
M)>Y*Z#UW>P'^EHBHRPLV%8(=79*J^["5Q45[#UN9LE5JJG<'B,8VZ9X41<QF
M*P\'<X37P#<;\Q%NX#SFT/_,"2V?@,$NIB'LFPA9X5W'4="E-H3Y*#<R_B$*
M,J>0H?(E#HAGPFK$4P -7XJ0?YE8,\1=C\VN%V]^ZB_0>I=CK?ZN2_Y7T>N
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M^+9/DU*03]?E\*N-3\RU[P^0;V+[,2FL/.)I3A"Y=(!"X; ,ZS6@Y<J4GF'
MT'$UR*IKPL[N;V][TV^3J]GH>CRZ&O5[XWFOWY_<C^=D\MY-;D;]T7#V6B?Q
MS%ZZ]L(V:2Y1O;.1DW*;IA6O,!LU/\A<F-X/!\.O=\/Q+)H(DJ<J4>F''UD'
MO#$<T+G (B??OB9;;Y:,G2E9VCLQH/-#EA6MAQ$<.I#I;",K;E['O:Y)=->;
M#^FR\L_[T6PT'TW&D\N;T76/?GHC=:!5V $F?TH5'F.5CR,>VB@;NF!:B/.8
M4>J:-5H4A]1A&H]@^%KEU>8C_=J;#G^=W R&T]F0Z/#\FZP_%.[=5IY#WLZG
MT>M@._8"T&!6"<6*URT=#5R3]><GKK.#/0_61SM[/I%RQF-K:Z\^N;T=S6^)
MD:<[__XDW#P,Q_'602X.N%[;45E.NI36K"\*+,1 A0@X#QW0R23(@;X9):43
MV9BGF*P;-LM&8S+/AO/>UV0?(MO,P5NCN?%<SSQBD:O2D.)P4- IPJ2GO:=(
M&9P'72<8DFN6WW4<);C<AI^V$NJ?-)0\&/$A'C'Y]]&Y65F#3N[Q),Y+.&GD
MW.@AS6_-=W?(HI)N$<HGG<KW?,C8J2LJ.W1C/]'LL6QCVLOMK?&'1QL.^S[4
MY1\BY &M6.FU(#)ZGC9J0F(&:L/.X&'/P=A8([A[1419@#L9Y;IL1&)R<(*>
M+W"E-6B27,#<5B(%/#CTK'M,ZL6>]\X3N;A^$%9I9%PTM9'\- &]SJ:DD<L6
M'V7D!62-XY/:@S4E7D] MPJ<E/7@6,7=$A4M2"^5*7I"[@9-D>DM(XG5 &DY
MT?:BR2%0D.+/*?(1>46:RCT@+#A>V*0C;E(:;_) H"PGJ^6(4 V6'#(%ZCQX
M9=@X3+V_108-*E#*M=E<?N*:3LHJ BL@7)["%87%2/#8\A'6D>2I EE.L?+<
MBR$92$VZG]4 93&QUII<AOPXJE<D:U<R?G?*)8=;-LN)MM<#XA HR'47H_4C
M,>OA%0QX8/N/GF\XD\6-YRY#VA$S=<Q*&3[::F_EA%YZ-T;EL[A:K&\!+0WE
M2FKF;9'LRJ^WD$IX61D8D<TOLOK>FKK4T8US2<HW88=H%5$BVGG0AS/%,FRT
MT^N5$GAYJVUI#SC%Q!0Y1D#Y\NOQ@3E)MW0F<TLV 5?U_1:[_=5D$9=E&<[(
M]<F@Z[T[#KIQ91)NZV++*=8$5;4!IJ&!7<(X[? 0&I(:IFD9R7::X5)!)OBI
M;ZQ[3]N2#?W 7A.; ')"?D"AI0;T4$X)(JPHD%P'HN\I3K'GDH\F2DWF&B:9
M, _MW9F*BSL!GA$HDBS*I[X6CE9HV_^SCY%E!_03C+M33*ZM:R%3A ELQ;&B
MQE6$AKDX_IN*E63M+0PU5\C:T,L%=DY.%#L@&Y-4=58<K[<FQ*\U-YBVR V/
M3T/IP59(*&509P\%P2)3M<# Y PEG'$P=.]Z#S["3Y2OD?NX">A)+?&D'9M5
M3*9X=Z*23XW-<<0T"08EH!L:]VJ_CYK$?2M[WPULI9N-TI>*BO1\?[..OJO3
M("GAL%6%[XK!*4W(T%@@G_(+7F^=_!YPGA+N.N>>!#]MJIBO)OBFE<T?UQU+
M>MWA!J9HM*-M"[."I'P4V3J7HI'YJUO8(]1;T\(M[5TE2\G[:ZE?H4<K-)T7
MJD E,S[8)H.O_H1+_S*9S!GA<'6MD08 KFCD@ *8>\Y5$I*G;WDBYR[I4"!T
MF)*-'+%K+<@0DSQO085$M>/YZ>E%=,Y *.955125-N8]J-=WR9V[^\K%W#=5
MW6@W(75V*BG4XP<;+M2<-U5=^Q.M%ZE=V]@+KK%!UF/KGOAX.(/L!,M*OQH%
M?7T:2C"J*+CRW:_"&$HZ-2'-=]RT=:LG;B+(E:9S9R$76"4(4*5^I;S1;_W>
M)EAYV/XK5ND4PV&BTN4VN>SG#MLFFAKN4K,"5>=:XQ$KC)(I )*G:DI#XYA=
M!.&UMH[98T\1]UQZFCY9[$C%U5*7R"4(!'6:=W%V-!ZE"':=J21TJ+LG]DP-
MXML."2MYAX5U:H$8*UI=<6D=$!2W\HWF,4?#Q0)19P+MWFEJ!.C@$*]&+9#@
MIYVJ("-XW@U 7:OKKS;"M.QVN_"PM\&+)-75"'7;<"UGK]OK^ #9"!:&C9_H
M\;+G$F<C/DQ^V.4@B#>:CMPAKN2= 0H,V_%5,RYXDM ,5D6#A/IY%S@0T<\F
MG%DJ.'=IAE8=Q3ST(U']!$GIC8= )TH,:D!A$,[3I08HP/%"S,(&YFQEBHA;
M8)NTQ">7=OZW<-V5*O%3RZD-X[BL?&H=M >I(/KFJ0/,P5Q5A=!XAE>?.H"<
M_QTE7EYN=Q]W%O&&-K8!ZY?)1UE[J\QF+B:\N$&%Y_.ZY/C'G #VWQ1B0/?B
M(3;-RMH1,00-%;\38@.H\:8HXCI;;M:#-]_2((/WK>>B[:V!_T3!U<:U )W"
M DHZJV!4^,UI3(N$"7;G:Q_A(+S]+4 ^#0$_>KX=P$'((O>2<&2*%=Y%"XM=
M_-!ZG,&!R2*G$TPICR/7LN;)$6PJYE$]KQ>]\Y>*WKF6N7=1+WH7+Q6]BP/T
MU">9Y=OW'2_[\[/Z@J-YQ'6EC#4N>B^!&]C,WS>;K$MA2BCJ:]O97$4I XG'
MLDAU5(B:5]:C%\7$.I4X5@D&-!S=N,%;#.QO8(4-J@JRTFD2PV<1A96S+7AM
M]X6N:+:L3X!9H;TH%N1?-#_0<+>Q.[:3)EN(^XP9X4R.F).1.U^A5+^Z^2$G
MNP9V.9+O!?M>(R+W3T/15MK$_XL=K([:6_C9#"T_JWD)F]MPK+KBKM49U6=Q
M@+6P+)BK &.UQ\.A4$9N@##QI9(++(IO#N=+.!,93V-%0PVZ("Y>M1']D/[P
MF?9/(=1683ON1<3 GBH7IJ6#:.L75Q>,Y6)4>G]/2#-N7C/W0G7!:.IM#2?8
M)AHU<B,FIO9R%?#-3;$17[2AEI$PYS:B+O?N"Z)\$1?MB?C&2_+:NU9&&\(5
M<7"C5J5$;[/^GT]+K+Q4TZ,W,H8EH=Z+J*<:*=W[]-ZZX8YZ%L1,::&('Z>4
MH&Q#PMQ"MA[&5%^I*EUN\YM/Q?3#*ERBUW<(VYYU\$;A'P=$XW;,0SAU=;^"
MIA@GA'J6M\T'U 0 UR^O"YK0E&0.H-&Y@P*?0VH@]S&&FO10KFP/A\J6[LZ9
M\$H]47HR/D=X?09F86"XU>>2\,R5(_L !!G0;:[2)HW%\F?/(</0+2PM.6O4
M@B; MJZ.]5):!PTA3-Z94M9IP^\KC%#BR;="]W*9UK:SUJIZ^?C!]:2!F#8#
M^\FVR)ZN%;J7R_3KU+U\_'CV_K4V!([ZK#H'!?U26_GCGJU"NP#&XS)AKWBX
M&:+.NVNB\)*J_@;CJ&B2FY_\ ?3>4U(BYGV#-:8,0-KE#]>/CK=%*+X:+,5E
MKNP5W>542K3Q> G(#ZHD9Q*L$#[F%A"W$HI:+QH6P*Q,<.4Q_9__\^W;D__Y
M<OOYA__]GZ_FX^;YF_O^D_77AZ?EMZU[/]A\O_Z /WWXQ_D?]_.M[WQX,O\Z
M=7X+_G;V^=\7?ZU6]\YB@.[>3?]Y_]?]O^SO7\_^]2.^__>OGW_[^K1P_UR9
M#];5Y\'EQ=>__L ?K[^=.?>?O^ OUMGMU>CS#^?><O#AIF\\7=^O__7#!-^<
M?[7^=H<NSO_Q<6,,K[_<__#X_/3CN][J]':+']Z?_N;^ZX^_?7RX/5UN!D_3
MF^=WO8OYC[W^Y&^3[<>'[>;Q\]?@8?CC;]-?I]^"N_.+[?WCYROCR_?AI_?S
MRV^KP?M/?_O?D_YL^O:MO)M5JXJV7SO+%;/8&ZFS[9F[\/ Z]+@P6A*G*CIP
MR#293#5;4=&R/$X*XJ%\E.@CV-M<BI1LK],JU*LT<!<F Q34YVWR7@5_1B=X
M<6DK:/91K7GVZVP9+SLMJO25[SK+=YWEN\[R76?YFCO+JSIOGFP"/S!<:B+'
M&Z@J-O5,-J:I=E67 Q!'N"-G-7P>G,9G^CDW7 N9K#>J'W<#]9.-.\=ACI3>
MTA2.D>^3C?-@0_.HHP2;J-=X.K\C8<<"44%Q+C06XL IDP08O <MZBV:7Z+:
M"9-%65OZ#9O:-WB1&EFS$O!4A&E9GZ\\O$!$V'C_)DU<B_/8[-9=7CQC[7M?
M=Z)8V23*8;9UME3T';0E4S38F KK0:S0/RI,@E;H\/9<*^:7!AWSMME%$7E@
M'E[22EX/:+&B?6B#HO&;SKK5[[481)WXQIKZ457 $?9=1FY ]H&^;>;4-]6M
MG0>\O"BWLEX48QW\U)3DR%FJPM';OP3Y?[1_B0V];JXP44&=7\QUS=WQ)7<%
MB0N0WF]E3F5CS6 7!1[G1#3]ML?==2ZUY%?4H[GU7 K99634D9%1[YRMEK#1
M96QT&1M=Q@:LXY(WA:%,( 2;.F\9T6=+00"O,0]!TC.!L^D0;$)N2+G6!D"S
MH$@9BR&&6:< 6(59[*#T4>-ZV5YM[+(MVY)M&9(*D9LL,FCZIS]^F'MG']Z_
M%Q RUT#U9SC6L+3N8..3)0B,2E\O.A>:+%(AT:1/4"8R6B&B#<V9SFLDX.-+
M.B'GL.URVGO4/TCR50H#^?$+'9PP31$%E/RX[[EA=>+&<&CKH7-^[6X<YQHZ
M^.A0_L;)77W3%O4S7?!E51VPZ^"V6P3J5 V.7.8F%&J?G1Z??TI-2N%C[!3E
M@O-.937,N:1J*]0^$C'X2[:B4)N%?X5"[6-I=\>"L*%LQ=.B*]3NCOVZ8S_H
MT&%J]HF%#H\?;'CH,.=-NT+MUUFH7>9R=(7:S:G!>8V%VAKT4T^A=D7^LQ<H
M7&//KS'GI!J;G3[RXLD70*F_@)%Y>X=^NZF0_195Z2C35)7HEQ> =UTNVJY/
M\ETN6)7979>+KLN%+@LGU^6"49:MR4GLNERT3#$K=+E@U&IW72ZZ+A?ZC*EL
MEPM&2;?F0!&KBKL9%K6865U7>377J#* Y2GLUJ&+)6U6FJ&#N7U8.M4KP3$)
MDM=2N2'%:>,6<46L=QYG%=P3O55^NT]^7B?'3:+';Y U[\VZ_+6<VQ>[4P<"
M-]%(QO5%VENRA$U8E&0@UI-EVM@:O9NN"4O7A*5KPO(ZLBWU-0[HFK (>A9=
M-F:7C=DU8>F:L'!O32L"WC5AZ9JP\)J%K@E+UX2E:\+255(TK)*"V3A$0?N5
M)@@:<$4M[;TB@)L:V,[//\R]#Z>G5;$[&.=U G@H3,7-1T#>K[B52N.770;K
M>L[+-$0+ZU*%<E56=WXFR?XQVW*]<R /V^I_M9=CB24.ZS1H$D]/G>9/E<PC
MEVAIN_1M+PTRG%GGX;2F]^LFC0:=XKE=M#'NTG&[H=:X2SFL=^Z28E4 *BU3
M.5]5M1ILH/FOV(OPM4R$!HB;J]BN^5,E\TCSW2/1]WG1#3H;(6&>,CW-[0C3
M68)+6F6-+-<+XB3!5/]OKS!G$+:7GR1_!6F$*MK^5>9([B[3&E@$ZI-8B1NX
ME5M!1T55RBG7>+$:R@HR!KM\087=&57,V4IY@UW68)<UV&4-EBW#J>8B8R^X
MCB;J_=$LG>#<@WN>I;42!7UWFY0D,E04G/*\YWHNM>?!&YB'EM1PJ7>EH+%5
MFO>I\SY[G4KZ EI;M$=S:^TZ"?LJK'X8=>MP3KN+3F\AP>8\4M1<:)LK3/(G
M%7&TKO2V*[WM2F^[TMO7$$KK2F^[(%H71'LA0;2N]+8KO>U*;QOG4'>EM]4A
M[DION]+;IFAC=P#6'8#QH-G5_+Z@FM_W'^?>^_<_5J[YS8[S.@$\%*;BFE_U
MUV875WEF8^D5CDJ@.>MN2H>"'$Q[ :K,>"Y]YZQA86EWXSA_T=GX#98[5VFO
M9N,N^+*J\CMT<-LM G6J!M]MC_75IY"/*#">'['W9-/]^0-R"86@2K5)-.C<
M>+Y+!KV,!NT]^*$EX)H@Y:-4"(9?(8*"X>QH#)^I5J"8 K58MKL)5W?RLVB!
MS^5=32"G C<:4U^X84Y'7JH(OG1?)Z,)_0W&R UBOHXX@H"[C*2^@$KU:9'&
MNE2T,/'; 5H@0MABOPP$L)R4]38)4(LQK[!Y0J-RE\0: 2++\ WY55/,>66>
M=%W?)671JR, TQ(KMCX9]NHT[R6$M7K=BB9-CK$O$[?J/IJ'=HCGU2!-/Q=]
MG8$' .C%9 ^202#R)M8?&S^@Z8&31<(Y>;#G^RBXL8T'V[&#+82**.=17YV1
MU$*A'B/%]1,EC-:H$ZW;UI7-]N)P1XW!COF*1CK08H',P/<6 5H_>MC 6\LF
M7Y'%RT3TVQ7Q9".-(S^6O:@KE"2A1R42T9LLY@F]P9X>^7:%TAHN$B&I,G[5
MS54R&_TQ"L:>:T:K?]\Q?-]>V&94AP+H8TOQH:VZ38$FY"VX8B H#9^$KQ5O
M^LB2'R[]X\D-^4B8ZA/>B&$W,-XN/$SKC?B:PHB,IW<3764:[*+20N(#RX4_
M>A7R(?DNMN:9XC+7BHT[2/IO!6[:K1$JX !JDW[$TK7G6=]MAVKNR T,=VF3
M53+Z4RTZP:*O<6\%I@),>4/U23[B8D)<(Y [R LHZ8R0@$$9"['\%%#-1,6>
M7].4#"DU"K*,OK+G5R0FV..('35:4ATICN-XWVG/YEH0RB&K+X  [1#GR1CJ
M""+/5M2UY=&;*RJ@VF7;%]ZLW;IB!5-D$G-O.W;X.AX9.DZ40,3O(H8E]MU]
MXKAOB&ILR5\P\>&KI$UD24X6NY@*\GO!?$=REI D?YG2@*M(R* JC0K[C!VI
M+ \%D:-><,C*_GG"$&@L3@F#VF(-BM0H-[JG!CJPK6RTGMA/*$,PR[0&Q5+!
MUDM2)R4P@=5)%RA[_N$6 O&N15EX2<HA+'[ER<0B:EJG5E3B1Y^KK\F E"I,
M20:N*KMQY6%D+]T,I\DN)[ -IT;[4<K*BU(2:3S*KYP!,R<ZE$4)7QK/JS79
M%VX]*KZ113ZQ/LL*<;]M;+M+LHV.4RC<Y8U'=M9^=))$B]-R@K=E>?>R1'1E
M+RI4!$72YKB+!,R4[,X1M?DB*0[JSVC7:1K2HH]5X(-J%2A0SOZ*5BB-W*%+
M^ \C;#5'2PH8> V>19'L8Q7XJ,&?J$\=*G#S^GR'$DWY!),:F\^#IN,I!5R]
MG$5%!41)/$Q/5%6S-JEF\06XL&#H)8JF.LOH=6==0UJ5H@H,1LA4G9W(2^^O
MSP3D4G])X7(1H2>X-R(9__)^-AH/9[/>>'!U/QZ,QM?QQ0GRK?E[INEMZ(LO
M[SS'-FT$6N7)H"9;BNXY#@&/: #M1G%EN\3@DN%!IDLA+8WYD^7X90H."Z4%
M=//>& 5]PU^%93%$UR^W]V30D;L+ O7H/"3R@CG]$:"N,PM/#$,1D8+4#18P
M,'*?D*\-TSSJK<<T5Z2E9[=2?>:C>V[\N=<S_[VQ,9JM/!S0UE,1#^$?(>#D
M(]P>)#D%R5/B)PXB]DR$+/^*\#\SHK;I-:'(1UEOM8D@D)S"+#_Y5 ,E^898
M^&!+&VP%M(<6T:['^,*6&O L)M]N4!EB+3V+5&-IZP66GWJ+;6XYJ,7'BPH]
MHIU_K<4CRJ/>'DQ%1%IZ7BB<-)"V$R/?W] HWF0QI3T*_0G-5R <<"4&< VD
MKW<9'R8"(BD_MZNZ&NYI][WUFN:L>>:?T&M@/M&VKGP%(BP]25,UCU)41^X4
M+6T_0!A9 V*YS4#!].(;O_%!F^H2+#_?JNR;IJZ+2)JV6M"S,9]H6V=C@0A5
M'QE%VA1[2K>&A2;N#)D;JC7H@7Q'/O%-.?806FOK1.95B22 SGL2LE<>GJ+'
M#397AA_.9[*EQ $M4;_#N\Y@4 N;* ^MFEG" BX_X9'LI4C=5V*(/>*VFA@1
M-@8H^B_(V40QM::[ESP"2T J#K/(0D3_1_>'3X9#]88VEJDI:"9 O3W[-A&1
M)J"R(RRUW8]^?WO;FWZ;7,U&U^/1U:C?&\][_?[D?CP?C:_O)C>C_F@XDSYP
MC7KJB]"XR;_HO.AN!+FAI=QZ(5HY=XVK>(7]A> U70FN ,#]W0H2 E1P@;=4
M@@#MI34G/X2ZO#9+0.>ULQ5U.VT&#Z0&U<$W_XZ.'L8T-RVTLI?;_6]BWRCD
M;<^@:\'?[ W"I][[P7/G1?E]F56Q <K3@&"VS@M<%:B2UCM<M6@3U_6K,MHT
M133+B'"!@^V<<.@39Y&&-RZWZ;] +2@"U,'\ZCK7&A%I W4[3!."6T5RJ&B_
M"EQ<U8N@X[;P:@""L<X%$&FTK*H!XKVS6@JEP_NWE4*S&QP*D5J-WEY48,U,
M0AIY]Q0K! 3X/G ^&\:Z]CTC!!C;M*< 9)2R@M9KCCAE#6EF>FY@6[:SH240
MX<E'F$<Q?#:=C84L>B9%?<Q-$%=<# U,KR3U[Q"./,QM_@!@ 0) =H'F7:VA
M!D@T87KNYE.$#4&4TJS#,K#B"?"3LEQK!",-(.##K %\\.N- 31+ _A6(*FB
MQ_6CXVT12F4^P'E9Q<3TIBIPFL!,W6*QW,#:@WXQ:(@I@,,G2T!SJH$$* <"
M @JP%.8OP %31E)C6H$$3*4"Y"RK:LAM[VJ.>)09%QF5OB5R7&_6< J<):#7
MLN2$$M+"/Y %D,"-9V"!9P@T6^!96:CU<\+-73*?:/I+E)?K83]/]@7)$*SG
M=:8#%8?Z=]D-S%=7[JF$)(EY]XEC7>"I%(CXZ"%]5IY#JL>O"!4?ZM.%,KRI
MA]XH,D"/GD\[U(>7JY$=!VUP Y/#R$-74P>KZHD_8M(%:]7>6WN$_E^[;BKP
M5Y&54-37YE =IF5"A;IO+-\YK"_M0E];('78%<E0:8E^R'-:2V*#/_?21/N>
MSW<E#=](+09'1%Y0O<>3#1'"3[:)\M5D[(4)S2C:;/ES+S"<0P['7O -!;2/
MU=*E;7= HUS*F=75UD_=! <$LKQ%0+-4+RJO"&MCPJ_H[\Y:I8_Y;_ 2?(BZ
M05?=:#VS2:$TXA:*0ENQ]'/MM3S%HN!I;2[O"3XPPH1QE/#A,$IX9=@XW',0
M7W6S3LI0'U'89!GA-8AY .3V)9@"2# Y.JO#9) SP]2?HSYGD:F"4SE5_+4^
M"*$6K?+.$4IS!;B/Q,D&8@/31TD-8^U=X10#Q-6(O<9:T+O>?$A%\L_[T6PT
M'TW&D\N;T76/?DH7@$KT7PCH1*)=JOR0V<F#8R]S;T0O:<)0/HZD!S=R:2L1
M/XA=%@8EOKI4D?$T]A(70"9UV9& J, R-*(N,&2]1]9@@W=F.9Q??HH;D-@N
M/W%-2Z8@KA)"55I!5<9S5>N@+R8H,\&8@@"+J>=#'[G5>J;3,6U]NQRU$RI'
MJAQ7C<H!>TW>RX]NG9N0'3GU8 G9%75MZ3G< XBC6$ZT/8N>@"#Y8O*UM?;X
MM3<=_CJY&0RGLR'QZ>;?*K;Q*!KOR%=F][LH'T:N/4?1N *M.-A#U-YV@UO@
M^Q8;)4+0U$ZC*XWFK(WATN&*9="JNRAT9=!=&30+HJX,NFLYI,36Y;<74@Y$
MUUY(FT'MV@MU[86Z]D+YVD1[2P;;)/H:!14F..R.3>SEY19RZ>"F#8<YU*+"
M+U:0*ZC8Y"EQN 6$FW8M,YFQ+(BJ/C^^:0&#^-Z\Y&'LN@C"&@UU'?A"NN[T
M&M9PO>@[AN]/%F'8%\H6%Q-KG_%E" [DKK@T&3B[FD-%>ZBB5$4SQ3HY8H)J
MC'%,"\84%H"BT>I5A 2N4\7K:,@F'FH]:K[&.NCIFJ]US=>ZYFL'YBMN&S+!
MX0UJ4":FF%C[/"2&X$K+<)0!!>XJY9+3W)JL5&5+80(.+S)H@KI0Q6!I-7.J
M\ (+X"5Q0BBSEQF_=0?96>EPE&E5@0#.H#7J."5/X_)DSF^HJ@L=QC0U[>A!
M3/*\GI=X4E1LX+[8P2JY9?$.V_0RS4_G[P6:QO",H[6S((??LDN2XA**VKE0
M0O?LXN,'-7"D1]+9,$D-'AFYJ-Z;E-$^/3U5 \E^('VMEA3AD9()1R:Z0C3>
MGUXH 6,_S@LP5RFAP+2LGB%,>^G6U7R31:X!QBSGV"!SF,$2EN(]8-0IAHCQ
M-,Q/H.Z$P/3(?5#K?"CNU,EX4]5'$M'.)74Q]=@+KNG40]:]2TB=GYY>[)B8
M8%GI5Z.@;PDIP:BBX&#\WUZ&M-@4.7ZPX5,DYTVARL6Z9N8OL$=QJ$?3R+FP
MXIDL,&7RGWRY/:19X@)K9$E>9>VYX$W0#XGH]+Y$4^2R#="/Q 56DMZU]NY:
M>^L3.'AK[]?<;%IYUE/2(!Q.=P\H:&BZPR?X(HF K:#,)A?1]U<>COL1UM\^
MY)@#76VWA*J/9:4+L^U[$0T9Q:N_6<T7F5M ^8D4^;W42<Z5L\()<TQ)7Z=G
M^:F1(R^03&?I5G?C#7WIR2)N^K,)5AZ&ZM^LGLEVV4KU&($EIJKB]8E(A6[;
MR"(01@B;K%9'O&IL6J-7PXY1*^\!7JN6Q>&7D#E_Y$9.QS7V?!@'#H#-UZ-;
M+*S*\[YTJ-5D$_AD5V@1=S::&$U4JF,F7\=B6(P1;-MQ-;Q^0?3D'UF])X2-
M)<H<\#=<RYBLOSISQHUI>2OR>AN1FR9R")]!]LGC2WET-R1G\-F.+3HL5!S=
MR*62=S/9+&"7X.61:1>JN8+B[?!=$98ILE!T[P&][@"FN(!)L,U0'0DO 4UY
M$=Q!Y^P;SUU2DE!-6%GD6A8Z8THNP8L1X50YQ>"N5RBAJ/&.%Z73[/#Z _4]
MCZE>C%R?#!.6U\=WC,(!QZ37.D^8+;T$-=47#\99SO3VY# 9.NU00V#&I-<Z
MS-C22S!3?6-?G][+AFDU5-*](E22Z&OBI8)<:51.M'7H<<@Q@5!U160!Z>BD
MMD[\$HIM6^7*!)@ ISX*15=4M*9A^>Q*.["?; NY%E O[3*BK9M]''),0&3=
M'Z>LA']W]K*[6:IO. ZR+K>)E8]_6%_S# &66@=_90P2Y5 =>LEE[* "[) ;
M&(LMQ<C+4(1R>2?Y-<I*N\*[;LF6E_Z'>N )3;+YM7$8\1L8 2,*YR/S[TOO
MZ5TT$(7Y(OY, ;Y( <Q+JB71 F[))9 Q^WO4=4U+?W)[.YK?#L?S66\\Z$_"
MVPB'X]1=A'*W[I6/>R1$=FZ<P'C2>7NE-/@O<^$="RIVF7^GBP0J^_0^7NE4
MON5%+E[F/9+=RG:V>?@#F<'<F^!TWLCDD9Y<D.WH#3)\N!XXPDSH[4(HJ/#9
M\)JPO*&RV858 >R](\&&UBZ(TE-&6@] >UU+< +4#4A.$?1V#-*D"Q!='T/3
M-EDLB,L\>S1,-')GAOL;&9)LHNR%AUW;$*@AXAI(8UF\O/';K>Q\L@*H]LT0
MOO'\GKM$3KC9K8@38RR-I4C*L6*)#*R"J8>1,5G<&"Y(4GYJ='VQ6$DW.4]"
M'##(@!"J2'9C"1)\R:736F#RI::XE51"+#N=_2G9\<0)!'%Y,OW&<$ V(MRT
M6PLEOW0Y[C867KA"HC1#CE+IN>[&<$:NB>FW7(L5ZWEMX:XJP0&F0,K+@J36
M(=,DCUN48'^#<4C7&GNN&?T#9'$J(:DIY;WJ<E4FR/)J&R46\FH3;' R?>/,
M4W^P07TX0 4Y:">^HF+FZ'X,"??(G7_WOB$#U[$R<C"A*[NT'M33TBZO6)%V
M56EF4+@@ ]9IYQ-JYYPM$%IY]<9)G8='HS%YS>&\]S5S6"3L31T/(W8VQ'I>
MSK\['I'_Y*?H6< 3Z?S#'@ZQ[ORWPA>N?)@CN5@0[]%;H[GQ'->79^_)5INH
MGDM)\Q4&)1J834_/%Q5(E/V8&-R)2B$MO?<:L%63C0SL70=%]&#..9CP:#W-
MJ(X0W)T(5XB,:CA]LI!ZM)B.T*836R#2S1Y!8WR[S#;L5IL2&4!TJQZC[]\\
M_&=XZZ& K',>T]N(CUO&>2\,T9=/YJRF0>=GW/(L/&%1W]IJOW7S?#^L@"&$
M:0DN\([XB)JFO1.GX\HC+J#C%Z(O?8PL.TB3@ZOP8I'3%BX61(DI,M6-PD,&
MAXL%,@/[">WF^)38PBDB.QC3=NRH[CV(UR)J)S=DH&WFQW?$4Z<[\"6Z]^D1
M[2#.T*?VPO=16/%T8QL/9#B:I<UE_#2PI2N$);(#U8&6XJ.A1-45O J$%5'!
M5ENLC1((>-K9J=./ON>216Q#UK%X0?-<D/5>@'J[T<X7*.=A5ETAU(%GAH7.
MQ#0-";NTTSQ9&]<AMZ+!5 O9OR?CI88I"*;F%6V0$:@B_4 _4/WY(:4_I:,+
MVTLZ8O324[2T_8!62]#+#JKSF3NJAE60%Q&JS,724+P?IH3FV*#%V;/M^L%S
MJLL[.YP.LR$JZ0,!*+UR-\T+O2!"W;P+1ZM_5R8JW.S+*]\G4Q+Q:?65[9N&
M0\\OAZ[%5YA6)NO"D?4$?D1E7RP8M9?T[<U5ZI:3J&$K5^\,,5/.I-$.8'B$
MI393:D_U;O/@V.:5XQF,^(08(NDAFV^1<L3 XP@*B[M'&+(H4U>.H4#YL\.U
M85T]$$!I+I&T@ ?(-[$=MG12*.?TJ"WP%_.EP=%Y5M+2$TJ89G9:Z/D?:*O,
MN!\,JR4I6=*<'TJ$,T-'1OC1PCY%CQZFT>XP:J%@3\<<O0TFARV>TLZD<FA\
M]IR-&QAX>V4[B)6J* ;#X; MF@I'$N%J/RHI_I!&G[BU2P\KLT/90=OD51Z(
M@Z>'J)S<OR#'^8?K?7=GR/ ]%UEAIRE&1WHQ!(J&;Q,6A2+BZ!0J'6:(KC%0
MM@?.'[85QJA (NK;?::)[7?;5^0;A8'6PX';L!X7"H6C>6<U "+,02!(#]V"
MC0%#+CSM.!DG(#^_HX0>#!]1*?Q_4$L#!!0    ( $1 *4R'_^;4R&   /H(
M!0 5    :71U<RTR,#$W,3 S,5]L86(N>&UL[7UK<^2VL?;W\ROP.JG4NB*M
M):WW8CLYIV9U<91H-3J2UHZ/*Y6B9C 2;8J<D!SMCG_]BP9X'0(@ !( =Y,/
MB5<2@6Z@'S0:C4;WG_[GXV.$GG":A4G\YR\.GQ]\@7"\2)9A?/_G+][?[,]N
MCL_/O_B?_T;HO_[T__;WT?<XQFF0XR6ZVZ+P^%G^^"7:1\?)X_IF$:+S."=_
M7>3A$R:_BTF_Y&?R]X<\7W_[U5<?/GQXOB"?9HLPQ5FR21<X@U^@_7U" )4T
MCE,,%+Y%[Y(8_36(T<$;=/3BVZ-7W[YXC4YO;M'1P>$;UN:__A2%\:]W0881
M&4B<_?F+!JF/=VGT/$GOOSHZ.'CQ5?GA%^S+;S_"+UK??WA!OS[\YIMOOJ)_
MK3[-0MZ'I-O#K_[^[N)F\8 ?@_TPSO(@7@"!+/PVH[^\2!9!3J>VER\D_ )^
MVB\_VX=?[1\>[;\X?/XQ6WY!)^Z_$/I3FD3X&J\0Y?S;?+O&?_XB"Q_7$3!$
M?_>0XA6?D2A-OX+V7\7X'J8>B'P#1 Y? 9'?%;^^)3C!%\$=CKY \/G[ZW/A
MP+YI==AH^95+CHV8W>4S@I\O"#\M3O''',=+O"QYA1XD8J8$**C*?J'G9-'J
M,P*X)&G9)27\YR\VV?Y]$*S_>9,3[AYQG,]79V%,H!8&T562A0"PV5V6P\KC
MSASE9!5D=Y2=HCO"UN'KKW"49^5O]N$W^P>'!;1^IT673%<Q)F"Z-:IRK6O-
M%!.<\3S\,[J+Z/(EC4&5X7C__<T7_UTU1<D*58U1V1K]7+;_QY\8"_]=RPI^
MG*5M@07IHF22_+-G8,477RT2HB76^7YKC*LT>303=9X83,U7QB@\#K*'6;R$
M_YS^:Q,^!1$AE\WRXR!-MV3;^"&(-OP%/!"&:H2_VI&8520JL22 (C1"0;Q$
M"_@'KIO7R/, /"WI-I&G/A4C:XHU3L-D28"?YA=CB.I 1U8HR-$=O@_CF'0!
M.F6+@[2A.CY3&1[093:^%$_CY2@R/-25(=G)N]+[+$5WV!2=GOGQD*0Y,>0>
MSXEAG^6PRV16S T>G=9^9=_"X+ @LBC@TS_\[LW1X>%WY+#SB,*Z"?DW6I S
M4+@*R<3B#""VQ&O8CWWK")DP6P:%:"9,4725XG40+D\_KG&<80+9>?Z TUF6
MX3P[WJ0I(6 #5"IDW6),@2,!Y(J6"+.F&=5J";1&"]80!;2;"F0> *8AYR;>
M5&?%%'[6@<:#U*B8RI,\B&2[I J$;J$3$5J\**1>9/ QH 6",-]D_R3GHC#'
M%^$37EX1I4STV27>00)\1^5[>%!(5]+2P<%73%VD(=@'>RC&]*0;+!:;QTU$
M_7;!(]'HX6_4+05_^_WAWM$W!WLO7KRB>N3WW[QZN7?P]<$>(MRO,?7E1=OF
M=N40'/T" X3T3(\V3$K$-;H\CW,RO^%=A!D,9_6$SAKS:4.A&'#A=B/39[ /
MM4*X/B,&U4D214&:?>ES<S-'1E.C&4Z<N>65D%-6OKTBDYZ3G17."6LPZ#KZ
M;RR32T+/PL8H-[;$O BM+-:$:D5<?L]5J<2F3_$BK%7JBY=[KX]>,GWZ]:N]
M;UY*U*D?XZP?"FVKK&?ZC'5L ^@GC5DD_XXP=5K&K04@9,2**3<6;TY]DF-Q
MK;DLA.N!J[/]F)@C8ZUEG8XYZ[5):7"VL7>H&=O453S)2(\PTSFZB,\L R]<
M"+22#;&+KH)M0 P$FV=7/B77ZHO#@P #Y<=HS;[VKE\D@MK1%J)!FJ[]Q2+=
MX.5%&-R%49B'V*J/0TC,[<E#R(<8+O!]Y3CS>83H%=@.7B0#'?LNIE\OR]CA
MW9]17?UYS/:!N:WK9G$*5Z5;C"@ORK8K,JJ;^57F:E"1K$A]SR3S?\P6Q!9D
M$1OSNRB\YSB6!/Y)67LG>W@?%U*_#SE!5$U04K5!SRZ3'*.OO_1R+ZLJE\H-
MV3=Z&TNQ$96G+0Z>MB[DT6B#ZD8^/<$C"N+ U-!JK'C+VMOY<:M!6ZJKIZBC
M>Y3ST)BWY/$Q9)??$&21Q'D8W^-X80D$,G)NX]O$C(BBVNH6+-BFV8;I\@RQ
MFZ;7?E2ZADQ; 38]4V&H3JX(;# Q')8W>;+XU5KL)(_,V,>&GF"'7?KBX ;V
M)<K@TSURM$_1$S1 OS\\.$!KG*+L(4CQ=^CPF[TWKP[83P1MF_PA2</?\/([
M%"?E;\,L@Q-?DJ)DDT-\/KQLH/"[P2E <@80A8<*</F"UAK4O^:0WD/[!_NT
M^\:?"QYHE$:3B1S-%WER1[I\<;@'CQI>TV_(/UY-[;I "-*=V VND%W:/#V\
M<,V=2N8W3.;TZSUTSL0V'?_U,#$86SS@F\ZW]&D/SG(V*_,4_@N^J[?;6]+'
M[&-H92=4INW6\:3*ED#'L>:H;(_@<_0S-/B'URU15])-U&E-R8#@P0:TW^%'
MHCSM;Y<%'>?A@1T6>K=,^BWZF7W]#T]'-15AB?558Z3CH.0J2.<I?1>SI+KP
M"J<WL"_;QXV0LO/@!Q6NU.RQAD'4V!AKN\AK6(Z>X,48E$Z1L?NW38-VF,TJ
MR]$^'#L4?2JT76943P,=BWM22DXD5#'4N/,PCN)C7;.=V!6Z"FH.'X.*N="$
M%#NE34=]\<37AZ/&P,V=7=4;TN,HR++YBO9OR\ 7$W/\XD?$A\C/!9]!K%]A
M<K6-=Y\OAD52XSX3YH[6^($8]:C,7!GI,G).O:021D2/QDK?DXKI[@5-_:)L
MX:EG!@P]#^!S36*[GM$.#8=[URYMB4\]B3D>R><'ATV/Y-'7>P<'!_ _GD_T
M\-7>JX.CO=<OOZ%>QC?D7T=[+]Z\MN&E].3.YV%EUX??F>]AMT)%=RX/F2ID
MW6Z>"API0%O]:.E)*6K(6X"ZWH/E0!BZ.%3*R#F_G!0PHJ1(94=)O^A2.4;V
MC7[XEFO[_"@BY=@[)F!#!T([1T?_ZJGO["@;L[%_J]/IO#8CG."G2<\WB!J\
MZ""I87E-#DX<<4HQM3L%YF_$EDL:P15$5T&X/(^/@W68!Y$-3(E(.8:3@ U1
M6'OU-8+<"?N0=80U\.P<[1%<*^9:,F)CX%SC/ ACO#P-4LC/E+4>::W"16@E
M %N!JLO0FWYVQ*\E&B_ZZ)=^+21U<3:1I3C^]@K7=)@2G?>01$N<9NP:W(ZG
MM$/%1UQ_EPUIK"C=UXK/:9:DU]_15Z.Y]Z FL=3:GE+N<$<_Z"AFL>.SPXMJ
M>CN[F%T>GWJ-)QDRQ0<6?!A*2>;X[/ RRG6F^-,#\N$ ]U<CO'H6+]THP5Z:
MHR],G:AY+DNJH?34JSI==:DJ;4$ OGAJ#!T5Y_$B><3519;-_,<B4HX/!0(V
M!/AB7Z,ZX3$WM;$7*/6(KHD@V9@'' N><+RQ\W2CZMLQ.$JZ C04?_8M^=V9
M;]OIC1&8RS;9!E&^+?('6I%PFX+3HUR+M'#ADWDD$X12^G6YLU0/<7(4X7NR
M]:RP[^=;?%FU,-$=L,$YC;X'O"#;$'O^1[:BBW!!.B334?2\HPH$[VM[NG!S
MYZ; B0 8=2,*B*ALUDV'X%@[:,BG>MZI, .FF30::7KFJ]W$;%:<CG**CG-J
M2)D1N8IV<DJN628_S^E8E 39<D+VCWWT7!M]#YGZ>>*=_G<%4K=#L]V,29^+
M; 9DYKC&&2;<0P;U$V*&1 G-Q673B) 2=.L>EG BM"99&[J/+.M6=4;J9V&\
MB#8T@"A.XGV:<I\%>21KBDDH T4^90"MFD'NQ*,W;_8.W[ @H]\?O?QF[YL7
M.]D3_;X;5L)*V[#MF^$!ON>= U)9;\I6N*Z,G-/@#PDCJ@?BLDWGY=T4#L4\
M04H.QIWQ&QH_4JS:"^55(>O6#%+@2$4Y-MJBHG$WQG=J2DP<YZLZ*\;9^2/Z
M=[RD$01O@PPOCQL;A<4-69&RZS@ ):X$0+PL-]Z;WHW7:VHV+9FW3$+UV3&V
M#&]P1'Y]S\I>1I#%=?D8QB&X(<$8L8A(1<J.$:G&E0"1[X+T5PQ>J#UTSSJ@
M2C)H=3'0B*0VY#<OOMY[^:9(P/WJ\,7>*XA=%]B0?MY7Z,"J_=1"60!#04\Z
MKR1FW03HI>GX28^<&^&['MJ,XJYJ*-[X/9F:JN+EP$X^(<8QQQE-JL1WQHX5
M++I#PW5RM5T&I-?"D!P\H-A90#.6:]VSE[9/6NU84,Y@S2,-YN5TL%//19)9
MP0B/C//<NAPF1/Y\\B<$LBGADL2^W7H2037A(1KC #_(]T$89] 1SN;$\H/.
M-V'VP$KAGN [*X$!_40=6V>]# F@!.T0M:&:36I/_B1SLVJ+O@E!M9D:S^80
MED,?($B>X]]0DCX/@/;D9R.&L/?"1HDS7C@A%=TS:/DE2/"T(T%H_'D*:D@8
M8IERS.)1?)?$B*AJZP49KG:8$'JYBYQRY7&X2+GZ-;4A7W[IW<O-%5;;L]T=
MIZD_L2Y:RRR-LF\[(!'0<GF;)V*B#RTA_=H[..32:J-$,M#!]VF@K\X(;RS-
M[X;HK'EE8K_%JR3%[+O;X"/.WH5QDC9R'Y)S3[L7%NSZ#N</R=)R[6R7[+L/
MM78X.MF9ZXX2*=8,RH&,SVW9 V2[-Y'NA#(H7IR0+_:5MSC&*SL/ $6DO,2+
M=]@0U_5[(N<"8G@28;6P79SR7GMVF?<(L M)_LA]:2TN-[P37!&G0+Y'M4R>
M%8W\VV]C",'&N>P)IW>)_&0FX8AW'CNOU@!:EX+PK^>'SOV0HQ;!(^G%EONU
MT;N%8WO?*JVIBZ[3<8XB\F??.>!W1;!3I[<Y"+<5'IJD>8H-)O"B/8%3G\$#
M"]M%?^6")@<\Q<1!XM0G\M#\,OHD? J7.%YF[>R"-C20B-28AINZPT? C4 ]
MG6#\"(D:BD8H3W:+F;"GEX4UY]T3U"/6)I1D$V$,*[*([-XFM@GX2-70XJ!G
M5T-!GJ?AW2:':@T GD4C/5'Q:-?K+0]77DV4=$=KC(TR54B9GN]MD(4+B'D,
MHTUN)QE:'TF'64E[6!$ B7[%'@2P[R98'T!1KJVR)@J386Y0_XC#^P?2S8R<
M7H)[?+F!4)KYBE)JI,]R@#]#3IP_AS+C4PNS+'N99V_',&0T$3Q@Q@;E1"I>
M)A3)Q5MY'VPF:U C[#:84(4E441A]5RES#5?9@<)UDGV'2I*27&2._C,0:\B
M=&X^^MX9,O3^VLYEVDU@ZB,Y5'_ZTB)E$5_/^4!,3Z)27G92]QFA=IB0I-OB
M3NPG,*\'YD]VEK]LBNN9VT20Q9'_/H.N]#F-Y,^N,8M*PC<X?0H7D!B;R.4:
M+Y+[..P60!\KV:<;UITG#W4R+.&&)7J@00Z5^'$=)5M<IR3)-A&Q/W*_1TO'
M$&ZG/74G*_/G($"*Z8J334IL1=8_S6#?9./T(TX7869IA]5FPJ7W6YL[E7H(
M146.S9K&<[*&8 8VWT#Y=@(;8Z.3FU![]H9F;.T29+NB;TC+N/ 0SZK/Y6C8
MGHZ9:HP7!9CWS>1H>DS]ZL&,4YY=7'R'J@_WF$#_;<4YYI6BYJ,",X9Y-Y B
MJ7J^'/<IUP$WG++MC_WZ+$D+T\Y2$48=!EP79M3@36/GH5=<G//'E( K1X"J
M!<6?)>,BC[+5X1.M(@[&?N@[2,N.A]A/PS8: E[9C$U"!TD8Y)E"S#/"/D>L
M'\0Z*G?/O?*O$();=O=O)]P#"R<[J@AG]=-'Y]MHB_8DT-MA2T\5T7>D*9Y&
MJD]=J:MNG9WI<7[?K<.=KM*AG>RA9C?_'F(<D"E4JLX\*1@.\4D9/:,IF<G<
MKNF"0'E#Y"H<[UL%GS=3&Z?9SZ=AQ8XJ4B/SAN8\USKDW2;']6&!QO6D>$$Z
M5DMU/Q(IA^[J$=DV/Y.Q4+*B&Z_I],?%2I5V?\0)UHSDD9$7'"8L+ !-2L[,
MQ?%X'@G\OK?J\>'2MP8,IMD\<)CR<(V7]-''/#T.HHBS(JW9H/V47:<E5>)*
MF+%YB1_79:D$ JHGG.:T5L+."YHI>(F5A=XQ4-2F9]C)2$:#+1 OF"Q(^SF]
M]S,V%)?3LJ+5,: %T<94F1K0C1+E3$_?)M=X'6ROZ/&R8:C/J\1H'#TJL!B,
M.W?PM&<0@WH600I=3B_9W"CRKTR 05.IK6%-2?(4[GC@;>A4AS:N,:.CHUCP
M5NA3 '57"X\PMS:\&M?P="F;K\AF1_XPV'.QTYV31T":3&G E,"O42X8I;0?
M8BFPCGQ"4E^D2@X&SDR-##H&Y_%0Q^W/QE-P<[^ )?AY-TE-Q:QVS!= <>P;
MZTO\@?[%^75U3=CQ2TD%EO0PFN+[,(,T<Z5SJJLAIW/=P!>ZZC5G>X9,7TK*
M8.\#C[N47:I//=;& N8$+$LS-"C?B760.K[JG.</E@K5]!+UX?N4,:2%R_T@
MWR>-T",M\\(S)Z<#PZZ@555E/2]V(D%<HZ])=2HQ2@V>QD"@[QLE?;DKJ\,=
M- [,N,&R)L!;T22&J!E;M6#E!-V^OI1P(L!>D3BC_K9;!M9G!@V9$+F9,X1#
M'P"IAD/(7N&W+A&G1XX.>;FN8@%.G$IN7BIQ"<33+L7%&Y_AX4#P0MT>..0$
M7>H8*2<"S-1M$#3:)QM8T8Q;"]!+Z@,%@;83%O1-PP!]<XWS((SQLDRZ9K/@
M-)>24\W#YT%X%\P^1N77$]%!<I&U:T<+AVOLJJBR1AT'V<-9E'S('*46Z])S
M?N@3\Z*22@P:(=J*ESO,<_(PH30%.</X,S#L9,?>^%Z1&;19XYE/R7W2:3XC
M=E+\^#JS"27:.:?Q)\)A"E8Q%^*@^R1%[^,P1ZP9@G95Y>%&*M9)>!0'BL(\
M6QF<P /"8Y%G<!8O?PS2%.#9"-F<I\=1$#[:*="DQ8#;UQ]:O(T?).^CI(8)
M'%J%-K2G3!>Y]"YRMEBDF$9>K,J:2?-8$I:1W2;2LHB"6^P1R(RE)/MSU8S$
ML>CH5G8,QE)8ELDC/TIC@C+ >KA3@M'K.Y#QD%-=C(\TYZ.%P<W8(T'&P059
M<*IP5^W+A9M!AZ$A;RA1Q/J84@RF3("RX#3AW)B_JSC!:[(QA12W1)G/'I,T
M#W\+;&4@E9%SZHN0,"*L-U*WH%MZT&A#ZTVG4)8^W](_0H+*-1S6O!XQ%:3;
MJCO2,RF&;@NHB PU*N;Q31 1R^&JF"@P<JD;GTZ4#;@I4O93[D:-.5E=3H*[
M99BMDRR()@I /='OEM%6G!UCO\=Y3#;V(,,GF/WW/+Z"..AP>5*\-BFV;[(6
MZ(WE+,NPM3*V)IQ8RI38FUC/C%UA(4[:M+0>V7DI@69HL2&=@?%)VWM%\C"L
M[-0J-)V\876>=Z@2LS;9D(/;5;"%&DAN8+U+U$=P6R]7XB,2_8I8EO0S_Z5)
MU20J!Q]O["-J5#@\$>/U(@SNPH@<E.R$4BK1=9TC1H4IR6D<CC.E3IR8ZA,+
MM1=KO/'K'U_H":G;_W6R#2+HENA.5IC['DY*9%>+SC#F:SK!6=FX<U>O&TT9
M%-VWEHW+:XRB.8J@/5K!!<>NWG-]E!XJ\.IL/6CNAE1@A(L[6N1ZB9=OM^\S
MO#R/B[KQ\?ULD8=/UE2D!G7W)</5F9.4=5S %>\F8]'F2=D4!55;SQNVOOQW
MRCWJ3)'#RSL]SD25DND%?=D'NMNB9^^9*+]$54]H]N\H2_/;/Z*VRE(KS'5X
M\Y"D.3G>/9['3[BHPV)#V:@1MI487J9IE#@3N0##[&Y#C#[Z3=/5G$$?^\0@
M?"1XK7H!-;2 #!:KD @)PUM!M,3K) MSO[> 6K!HU;A6GCR'ZD>9*9[F*1N#
M-(OFZ*:69J,'7[=:[H0V0,^DR0+C979&.&;N.F>*1HVRXV U-:Z$_C#6&('\
MT6.0;U*Z%=!J,0,4C1_4:B&C!5OU.70?/J;.'%?IM"0,[6FQTSZU\YF*[V#
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MH*8)DMXE,=Z^H]&<9YMX:;&^G8"24\.2SX, /_1CQ+Y&]/.IE$B4"ZV)&\F
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ML@KL]1E:X<)W(G>[EG%9UV^V*,$!$<-5AP4-<$/]&.8/[^/D+L/I$Y2Y8EJ
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MHWE4:6HBY2@VA:$;'C5+0+<H>-!P2O3'CB#H19X.=ZKZSJ?"TY$R3^TIS\.
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M3H00WD68_<D)J&7T70:BZS F=/V7GWE3M4/$+(5GWVP,.$=V:,V)<64E+:V
MDM/[1SX/HJ<(\+=)."3XPI%"IA[80)=7#4);%6$$E,;WH"9Y$*GXL=J,B,+-
M-G>TP^DI&U%5"\GPQL+(#Z7W8E8Z+YP AD-V1%?1-PP^,<U2*<V1J\"8 $T7
M.,N^Y3E_IJ5_Q/*5 DTP#:.=%"ZQ5:][BXZ%V$)MO43XZ+/=*]_@'O@,_?H'
M9?*2XJ8<IUG *0;6PBBDR)NO*@\BSF;Y[0,NSK5PJ-V0+K;D+]?@M]?QU0VE
MX=+I,9!740!KJU=PSH55# [.4)!39UWI+LG*SBD^4_";\$.YW,>WCH.6.O9U
MA-D>'%W89D+@0I_EN[S4[0E'5B^&1F'03P3C&*SW1[$5H6NPCMX_OWG.64AA
M'2 )Z\FKO6 %>-Q;H-%FW]#R9:[Y\ FW>FQSY6%AC<'6>,NI;3C?]H41C,"\
MU07E94F-"+3F0AIKKAW&:H[$,J]N9M4U:H2;0P/4[GX/8%,BIB*QVV@/"H\L
M=L*I_H.=KB!&MF_X83?8BL]*EX4IV"@BYH3O*6$!-*UYWW@VE+N" 2&=&HLF
M@DO(#N+'X8O*,?@U@?1$%;0.N@=/V<@:^2Q)<7@?M[@I0UCR,(@<:N9>5CS%
M%NIQ*< UL3<>@Q@B"!N!4CZ?#@S$@X+&5IHI4SBKK",?V!Z%+PL^QU%TN17L
M3U>OFZR%T:;1-)$0=RF>?ER'*222P'D1A!O?7R19AC,6(@:/J3E1!7T/44V)
M.(N!'<JI -!E>QKKG90]H(AVL5?$%K('^4D[0L%'9I]Q$-%][#ID3LW?,*HL
ML-LR]-&;E=[@P%6B.#/V/FV$#P.%KM[>F35S# N6T/$#9&,YCT_C8)'3.U;'
MMSL"!B9A=_-Y$^;L(8=(UL)OB7 C22O8UI+9L&E1NT/H &ZF:CV/@.#I:E=U
M1 ^<*N/([IZ5Y"E0;@2N'%[P#.=6]+J=]H#"6!Y@-RFGM@%R-#2[3H0>F94_
M_;_]??3SC^]^^/H?/_]]L=Y\_"E^^<WRM]=/]S]MX_<GFP_?OTZ_>?VWHU_>
MWVZSZ/73XK>#Z*_Y'P]_^->+WQX>WD>K$WSUU?7_OO_M_?^%'_Y^^'^OTO?_
M^LL/?_W[TRK^]6%QMSS[X>3MB[__]DOZYON?#J/W/_R8_K@\?'=V_L/71\G]
MR>N+X^#I^_>/__?U/+TX^OORCU?XQ='?WFR"T^]_?/_U^N/3JZ]F#P?OMNG=
MRX._QO_WRQ_?W+T[N-^</%U??/QJ]N+VU>QX_L?Y]LW==K/^X>_YW>FKOU[_
MY?JG_.J'7WY]]\=M]K^S[^^V/^'3Z/7?UMGF'^CXYGI_WSRB7D<%>=(+8[/H
M/./ R ,8J#<FOFL:JA ;<SS@H0J?'=[[;W<KADO=Z56O.E\:&=.\'FKTY=P/
M6N%\3,-](F)O6*A*)PCE,Q>F>3P)4UDV$W#N4'#YM+)-6I2#Y.;F]/;&MRG,
MET,3$9S!#-A26&]%\BC[XM\EY/!HQ65 G@NLR"SSK<]K9*F NKC@C<_<CUJF
MB@EQ1G,?)(M?'Y)H253\Z;\V8;ZU"1AEVFZ]IZILB1ZYG<_>GE^<WYZ?WJ#9
MY0FZ^<OL^O0O\XN3T^N;/_SNS='AZ^_0Z?^^/[_]R>NFI2OX)A"U9LATOVH0
M<:"\)-0<:C Q%SUJ+*H;>M5E_4(3X&A<K>96C\DUE[,RA[J*BI:]*!J4B@G3
MAM_Z/?;K*2,%]6,&HJNTRG1(*+ 2@HV*(C:0U$?2(9QZ6!'%*96M4 ;-]EB1
MRE:A&I_J25&D37BIS(,YQJHXC^,DH_$=Q=LNJ^>T?J*.DSOU,B0LHUI&52R@
M(8VEP$73;[U:5\IR;4)-;1J,;^].@Q2*(F=7.*4PM@DQ(2V73@$1$P(T7>*<
M1N?4Q74][X-] FMYD61C'> ]V"EX>[F!>D;S54</V@23-@^.U9<N?P+\5?6?
M@Z+^\R)Y?$QBSA;JU<0W1403K48S9JSXR,(^#K('6EEDB9=OM^\SO#R/*W4[
M _<K.\U:1+$!%V[]'OH,B@ZEI!>TBI(/&0+H-((?@ZH+O]NS.2*:*#:<L '/
MCU(<9/@$L_\V*!T'ZS /(LO5M52INWX&JLA7[_UW Z?4TTKM2:YGQ5\4C28"
M=J)E=&;*\$&H8%&<QT\X\ZYL95Q,0ME*&%14MF'9P]25K0(B%)1MWX29*EL!
MN;,P#N*%;QC+N)@$C"4,*L)X5?8P=1@K($(!QGT39@KCF\UZ'6&H$A%$0/>,
MS'"CB+A5K[@B:9<> 46>A,E0Z]9H40*6:-RJ@V\]/^+1%'?+C:XQ-0/\"677
MEV0PY)^U^HZ7G#7@J,+Q4)Y<0G@HLRK87M8U:),5BI-XGZ%=JI-]E%(;"4RM
M*FMCS.^ !3)/[X,X_(T%GB9QED3ADO[P-LC";+ZZ(H "*=%?;;(PQEEV@K-%
M&JZ++/ZSQ2+9T*K.5Z0QU'6^Q1_SMX3LKU9N$ZPR[/HFPN9@1+<8#9I[J$5U
M#U&ZL J;E,FO"]JH09P>5VORJ*2/?@8.$&7!3^4@I]ANW:A8%Z>Q4_(FO(_#
M5;@(XMSQ@E6D['CEJ7$EVKWJQM-> 7I2;]EGZO-CCLG% UYN(CQ?G05A"J\;
MBOH;D$FI]H.]PP'L>,MY?(T7FQ0>N=/U=!O<1=@N=$=ET*F?<E361<N@H '[
M!5!!E,P>FM7NS 8I5-)"9.^HJ!4[SL^4(.*N&T]G&QO@;*VPT25DZ$*MR"M0
M?1\G=QE.GX#X>;S>Y#OY%FRN1BM\NCQ+V1B J)1>8SDJKL$]U*2)*-&=]R\]
MR]3#*K6)W>9BM2:Z 4>W6H'0BVQ"&R^O@BT<JF=0.9!&D,VI9=EX.IAEFT?V
M.Y?[YR@<NC811^5>80^E9/;O@ XJ""%*:0]16J@@MH<J<JA!3[HZO>Z@8^*3
MOX6.)B&S)&Z\SK5JGD@[<%G01,:( ,(U&(.ZC9_+$V5A5+G1>L=K_/Z1G9HR
M@D= &3O;IQO<M.UJ=YY5-6S*BMN[/4,N18\OB]Y0T5WIK8(.6Q91W:7@V.[G
MU>8P]+2>\0V85^-[P$HQJU!W:8@8\.-V&0QA5<'&4%X7$F/"JRUA#BB^Y6 X
MRT;5TZZ"'$R3Q;\V81;"5C._B\)[V<E98"XH=>3@]8XR,Z+W.[0I:K1%=6.A
M/G9N4>C(K;(LE*?%W'_:>8IVF4!>8B=&A3IQKX\2!4P):QG4[?\0K)/L.\2Z
M0="/BJTPC0>,/3B0OV>43=F -[*<LUJS'GSSK%9<>&_]>"@TN7()[\'<RM[F
M%IZ'9H<=QT/9Z_0\@>/AJ\_#8##C%I<-?<,RV^0/21K^AI?O8[*0&UQ=$3EG
M;[>G'W&Z"#-\E88+? T1Z'Z7U7"N)^ ,''=$F@["G67*'FW5]-$&&&@M7T1Y
MV$-W6U2R@2@?B#+R*;@/[2!?:\&/(V=CFX_P\ACFX.&$>T*6MNL>QPMWWB1-
M#AQNCWJ<B2+#ZT[HV;C5S42]16:@:(4AZD_=",GT'2%62L_Q/B+C19Y-$G(2
M]L+/9ZYE1:CUSL (\42@L1.H7Y0UBH2WZQB[/%OHL^/TE8(YGPHV2]TG_-3
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M/ONX?(SL>S_IG_[*;R,>I_G. M?7\U6Q5\W3:ZAP9\L^%Q-S>_<DY$.TE="
MAF2%2A.$: C:9@KW ;T2;&T@TI$;):,I^OHQS!]:KU7GJV^.7FKH$95^QH>)
M7+$H\-1CK'X@37>?21,@_?Z;YT<O)^ JUA!>I854)\7D[DC<]^&+-Z_'@5.S
M)\?W24I,&2+J\,5STH7_BR8M$2J :G=F3"T<"86#@X-QD%5WY-3^4>'(%%4'
MSP\.)F$BZ<A/!5;MF3'+URKN_N7!BU$@5?<SG;VOXLD04R^?'[R8]-[7$9X"
MGMJ38AC7?Y5",==\>[.Y^X6<[&Z3>3I["L((XJ//DK0J?'H!A5!M6>GZ3+@\
MQVMS)PHW+?I!14<H3\"LK_I"*_)3U1NBW75C$WT$IIIBI!6\:C2+IEOO?+4B
M:^1F'2SP>7P3Q']-,GP<1"&9XC@,-/2D4D=.MUX5CD0%M&A31-NB\QB1U@B:
MH[K]!+2DCNPJ-:D\*V;;;JO[BR2;Q?<XPMEP2$GZ&EO':<!*S)4BLD@'J.A!
M#BZ_Z.J7)!]@/?,S0H*A(D^7O?!9 277)>DY//0G$ZH^YX3N^\PCQ!4:-X-0
M=\ FOHLBA<5QDJX3LGM"Q["=:N@B>0]N-9"4%WE:$E0U0D4K[W'ZZ@*J5$S_
M!.@K%MKQ)?[P4Y+^2O- :("#T\S");T<%%T>!$@@'R+X<@(&C'BZ*U$+AF7D
M#C<R0OS:L(I6Q:3,TEX+81QSL[YXC^!U!-$'D*RSJJALYY9,1,MIO6X!$\)@
MB^;GJ/[>>T9+N=S:P162(0^L'7^%TS!9$H,CA0/U"6;_M8(>,367(3M"+H3*
M)7O80ZP)*MN@9V6K+_WZ7/I%N%N+73)X\_,(= S_@_SZ3T%49%F](;9K?HO3
M1U;TG29?M84L1>I.SRWJ?$FQ!_^/&GWLT1=<M!N6O:;1D=\+?VT4[()38[8,
M'=G'$*5&,][@#!(\K9,LS&?Y<9"F6Z)3:0E,*QA5H>M2#RKP(T)EHRE+%D8;
M$UCFJ&S/2K-ZUHT:HFX!475J!A0]X*9>MX$[ 26WI;JY/&A6ZO":A$@JKE9Z
M(?%033PWLT>B_<+?:"?%,^C;I-GS<9*IU=]4Z\D)+-3Y$3T*:;1%Y3/XVZ0%
M%P3MO3IUM&17G0[5YV6 X5_E><#I$WBKN:"]3.B.BY<TH4AVF^3@<VHS<IGD
M/V%:_OD^AK.)#0UFCUF7QU9KH^C-2L((2DJK5%19+69B7W86$E0'0UO,RJ4S
MNC[UL77\<I.B6)'<%%<Q.R*>)6GQ*_CN\)-:VOP1>,HCY&1POM1 Y1J!J)0&
M0Y^E>I N#"<Z0RQ[LSN!(M\&=%,D^E:[%N"T<[&;BHCW)#^A "X^]19^+)GK
M3OZ3W:&Y#K$4\'&@.,?H61BC$_!:I]F77HWP 9-^,"B7/7?%SR!&\QZ#$^OM
MMO[D*MC"KZ@:H/_W U$+87S/%KN5G7=4_EP6"!V1;TT'!&I0@92RS>\*2FSG
MW&/_006U8H/TZPNS@<=^O\< N9C[U@9F2B '\$UL);?^.(RY/+2.PK%F9H^R
M=P0 1HW^:1+S@@*L*;8 R6*C5.B6PVI7>MMQK"!PQ"0@#7GXV-HN-Q#N4-0=
M;508G=3^)F3R4]CD1,S;V^D8Q:IT;[- K^]5: VGH^Q[4E&-?;&DST_CR<7W
M\*YHRFNTPZOKRMF6QN%RU;8>%U'JT[MO&P_%-E8P5WKFU?^,[>G% D?P1JK=
MLGM/Z/L<*>'3:95 "P.PM7!1@R;'.<MWNGQ*RU<!O.,<.GMD-\ Z;F>_NL9+
M_$ASXD (DZ5'L3*";A_ 2C@1/G9MY3_;0W4S1-MY!;*2,-NO5_NF8 "TSN,<
M$YGEA8\2JM=!OR?XSHIJEY%S_/Q+R(CP#1AK4?JC]U!=Z@^:34=5*LBT_3!,
M/A7&K_OYL+7G"^NAZ/:F5LZ,@>9JN*0F@3(U^:HHLAT7DE$R1P+6\SC+TPWL
MQV54I3VH2>DY/BK*>.DM4@J-]\CA+,FRZ4!+19KM@J0],V!\9"HRH$#0.$T>
ME\TW>98'\9+T;P-74GI^LA1S>9'GPF'E8%@CU&@U'82IR)63W5@\%P.3'6?4
MMT[U(H/M>99ML)UKVAZ*CI-32IF1)CO.BON;8JLL]D?6<CI(4Y-O-^VQ=$K,
MJZ8M,7X,.@F53\*G<(GCI:5B:7U$'2NV7H:$R73+=IT4VU73Z0!/6=;M@FDJ
M4S-N_MW*YUE=/AX'4827;[>EUBT^=)>E5X,EQ]@=R*YNRM^66[^^3V?=@U^Q
MVO'+%M[?0(\#L=XTPIIS/NZ2V<G&MTO1CME@Q,@4ED<?D_J+HIOFL;L.FCL!
M6I,EE(';^,LI+@]5./4N"J69UL^"1D.:_UD_UBW[/?VX#E/J93\)<LD+VPPO
MGM\G3U^QC@#R+XI_ ]A?-,"N2LK-FS8U9H3^RK)9#<ZZ(8*67L*6]81) VHU
MYF% B%^*@_GJ@ISIK,3IU;V[/6#5A$4Q<^0#T&#P"0MX^]>&*"ITAG'N6UMU
M9=**7&L/S?101+-^MJ%D90/ETG$+!AX+(A<A34DR 86A(J8F*H1C-,5'.SUL
M=DT44'%54A2>A-\$D973B3)MMSA294N4L;.=:#B#>XZX<;%6%B M>O%ZC-:5
M?A.*6M-D]-:*=@RA"-#3+(XW051FX6G#4?#F2M;>W;M]"1=2[01-&'18HRJ5
MDM?G00HRJ9X)]8U\P,W^;+%(-W@)'1]OTI3VO[PDO+,?K!@Y/21=5A65LR*R
MA5@KBBF_;VL4I=<RAQ2&;&X>[^BRLTV^24LU5H1!92<;?&P/79H<. 2;'F?*
MFR+KI]H-RYX0Z6H/7>*/.;K]@*,G\D42YP^93^/,#!V2O5)E#JV#^3R^_9#\
MA(/4A6VGP(3+P#MM[H;">@]PC<CYDW2(:(]^-; Q1@Q0O3.+ W9]5L(B7C++
MDOO\?L33;(>00Z7+9<#HP.']5"N25^=8RQWN&&HPR3(:-K-*4IHWPJZ^ZU#S
MLE?O<M&/'0B2:C7Q[![KEQ]?%W%';@ZCV^#C<8J78=[LU%[LG8R<TQAB"2,"
M+$$!"=:DA:,R>,7OAJ<@QB:<^D9ODIKP=+7""WB(7!6KN YR#&EIXD48A>PI
M1E[4*H $]AO2T;;U\14F$B8J\AZ_S^#=U$D1Q@"%+[(,TQ"NBS"X(]W!I:V2
ME\0#6\X2W[@?FRBK5,D(:E1;@>Y1FQF:$K:LO5$QM-N(II JN$*$+43X0B5C
MK) +98U&*C:8\^HY\@?_RB'E"0[FF\_;( NS^6JV6(#F@80?210NMNS_;\DA
M^2UI_ZN-?4B1LN,("#6N!&N0-H;+P+HY64BT*?JY^"_T@6@GWNK;F,F^N7EI
MS))QY,XU?L+Q!C>2JCD 93]1Y\&6/0P)@RUINV;ZORE#45G8[6A+E;D9 , ,
MDR$\$'U[0BA%R?JQOH%BE.Q L)^LV^M*!8Z$*&0MJ9G0:%O?54X9DLKB;X-2
M;;),K]//@C"EZ>[?X2#;I/1-M;,]6YVX0Y>$,E.B0G2D/:N-@!H]*$'3 RRU
MY=\$I]Y4#:L]0Q; 3ND0!P!5(^R\XDPO2Y)B,U1W=NO-3%=Q:@E_M]J,VDP9
MOJFN0R =0%%,S.WN+>2C-_!5$61>GNCW"++]0%\V :;[\#DYHL?WX5V$V:G\
M+"0F*+X@1_^E/=NPGZCCXTDO0^)L$$6[PI&TAUC3?=I6#7E^<D.H27TG0X3"
M)!F?4\X?UV1;!WS/TY,P6R=9$,U7\$:=DF T72@\$S[<9BTQX% $X*HK>+)2
M=D8#P2$Y .VO@O9DU>@ Y+0 ;CJOQOMXX2]ULHT+:+F,)A$QT5MO?<**5"Y"
M;NEU\2%EQ(1^<Y94)89ZG 31!,!79'(S>YNZ"1O>,]]*V=-,MK>'6&_TI%/U
MAVB'$S[G#(!/?\:\_OD=<#IOT"GJF4&:/2?G<T72;JM7*_$D3*;1R/E8%KZC
M[:>[[VL"H)U=0WVR!JCFRE$U7Q6UM2&ROTQ19%$9JQ%V:K4JL=3OVR2F:=4<
M-=I/V96D!0.NH[-WS@Q-T-T\_@YT9Q])AS9!#RNB$!5.I8B)FJ>*XFW5%U.8
M$_,]^WU&H'R:Y>$CE$"V :\="BYWX#9I 7H@"@G*C92?37=[Y<NJB17.@ =L
MEI?X0R,2(TUB\L\%;B@Z!\I)FP?'CDI=_@0@)-TT@GM0NZ,I[Z2F&&FBUF@.
MAV3V@Y,/>X9^'6:_LG!9^)>=DXF8G-O[0C$CXGQ^=0L$'^Z58=+LAVG>9"L(
M>">OGW1>3 VY?VW"?%LF<699 N<I_!?2N-V2'DZ2QR",K5ATJK0=5\E59$MD
MYM'FJ$KX7:243%)4=K&'H!/T,^OF'YZ?@>@BH&7TZ4R5Z55CD2N*91*T!D8.
M%3_9QQH<]*468]DC.SCREQB,(R-.UJ_=$9I?_5'/.,21TVWX CZ&I"W60"(G
MZ/Y*1,")_%ZD:H3*5CQ5Y.U2I$><W9L1V20,J65/=1LX_)*8=&Y[&]PEY-*=
MP6- OKM5'T]"^TA%U=VO>",U=TTTPAEV(QW>!;\D*55ZE\&C14-*EP6W_EL]
MYD2>W$9X#.*$S]"N$-L9H;.I6%>&Z&@Y<PTFT.3YY,YSEA!G=]O&P9;\? M6
M71O @C>/JGTY>ZBHR) XLT_E\R@^WX/\Q<6)\EGYRR_1S[0;;_X.$T%6K_=T
MYDA?7RJ2N AC?$[V<[6WM3K].3+G=?D:#CGH"M&^?&D[4]EJ0*\]7Z9G28@B
ML+L7[U!P6NVN15I4)(K\)-HA?=2!X@JD5?>I.RH#JYZB[.8OL^O3O\PO3DZO
M;T[_]_WY[4]4H6GL:_(>G.UF4C9$X4>--G\(UDGV'6)-T3/6F+=YN=8A2A*J
MM$;_-!AN4Z*.]3:G_EY<;DF]W S #7<'F@IVQ+N.VI28E\O)\C1<0(@0]V4/
M_[?O,%2&L+$S#>+'^9-;8U9UWY)-Y:0X!EQV7N(.F\,QG^AFU2__$N(4'@AO
M+;I#M!APBVPMWOJCVJH&4T&QD?#[WNC*)\@H]?7-^W?O9M<_S<]NSK^_/#\[
M/YY=WLZ.C^?O+V_/+[^_FE^<'Y^?WIS@/ BCK**Z2E*"AE494A=0)PQ1*E&=
MD.:1L;T,\A5A^@F83N(@A3H_*3G>W$'J$ U[TS^;;M;'1$8KLH$88VA^AAJL
MH9HW5#*'GA7L?8GV&ZN3\(@(DZCB$@5U JD&HZCD%-)4 :_HB46OQBA %;^(
M,LSS-3FWN;Q+K&O4>6?)V /KE77-L\TT6'5WXI[$>#\M]<3W2_Y;J2C)V7,2
M;(WK)"FX/8\)FX_T*C[%]T$*98[S!PQ28Z'A!+Q#7&[:9!S<I8_$JKX/IK&>
M&U101081.@@(L2<']%GA)&ZIQH./Q)]C-/_Z)08'$Q_J6#0BY=*R'X5C5ZMC
M(A=JXR)JG%72V3G&>WE.?YO--OE#DH:_X>7[>(E3&BO(7@/3%\"M&J'7! 46
MK_)LL.DXIM3"$+1?MS-JJ":'-D"OB%XMWKY3DIW2N)3L-"XJ+6*V_SG\<($9
MQ]C>+![P<A/A^6H :V^W7>8X%N!(R]8NQRYO].T.1;22"Z(TPGR457VW%2SL
M73/4Q[IV@N_6$K<OU-&SPA@J((%9.\'MN645?Y*[<Z^5;'&#]F\PNX&OM9W:
MDT/F\,")0Z9#9KH.F5U6K1TY#P\^?8>,"#X#CIK<^7?ED&D0M^V0X9*:M$.&
MQ[&KU>%_?[& J'%6R2"'C#YYNI4E="O+[M,@SO$R3G)J+[3\1$GJ8G<9Q,U4
M5]N005E8D,P*+/A!!4.(<%18B;O>TR3MW=TFO6['0+C9TAXL^*FN?HN;Z6".
M/,;L6QS61/6 8!__+!7"2/O]*$@P?]W,/^7.TA1.K30V\^VV_J8H2CVCQ3SA
M_R %R"Q>VG]V985/IZY>"P.0O^&G[;AQP]-QW(P#M'ZWS0CS/,#G6F22O0K2
MW&)8/(>*\VI^NQP("Z>Q1,+TR\E 5"RF]KL+[B#-Z_ !,"V^"FIT[]#UW2 K
MPH#@[M>3[+M2: E]9SCF&^XLSL-E&&T@Y_D-!.W1H#Z[FV<O3:<)0_JX$3V8
M;S1#=;L]<3H0'SA2%6\37$H38CW>W-*CE6D_,AG]48C/*^^!,C<+77;X(D+3
MS6#6]31?'/0>_(VPRCNN3QJODC.W^6P.J#3"\AW^&,#I(I^GU^']@\5$<C)R
M;G/XBAGI2VE9M 'O$6TUB?QR"G+DI+D4#G]4-^T(-RO3N0X9>H<QZ6MTS1L"
M2V[]D7SQ4W*@C^'UGOP5LX$[>:QM["I-UCC-MS>;NU_P(K]-YNGLB1  @)XE
MZ9S\,8#471<XR&QFUC)@PZ%'PX ]48JNHB=4=(7R!/;#JC?Z7+/J#]$.IQ$D
M/P IK91?AE-I&#=W/'_W[OSVW>GE[<WL\N1X3DW"TTNCLZ]J7\ZTIB)#(KNL
M;HU(<]1J+]UX72M.32%6VE-G?JSA2V]3UNG/988Q#;Z&PHV[6T\/<N)-6W>N
MS.NT%\5CBY!DFQ=,0EI>:@7O,-%;*QA5#2:5#E\L.FZ-8-ZH3=-EGE\2E)[>
MSOYNL ^*VKK41P(>1$B@7R/Z^<2.E#V"J)2*;,!&6;*Z'>KM5++V3CQ2?5QH
M8F$BAT0%L4@PP3L6CBJ(9;*@=49I9 5/(+/%(L6TS/.JK!TTCZ^"'"(M%O_:
MA%E(_W@7A?>TC^PV*;\[_0@Q&Q32![Q+P+)G\"6&90DF\N.:]HZ"NGN4U/W#
M":OZ&C,2SST:L\,GJ(.#L>9\?#>A$EPV>'F#G\BYCTP<K;A\O$E3TD@$A.,@
M3;=P.F8)B@+J7(:W!7=!!'V@[ 'C'"W)!,!?FE@(8TB5 SF.XB7!S;8Z<N/'
M=91L,6E;<O+<G_$IFQ2N\.4S.+HV[I?J8Y+FX6_-4MJW23,F"Y@4KO-'2!</
MD@L:W:"TB!LBRWG1+$R^(%T]][J%*XVV*S?U.1K9T]4K/L+%8Q+3Z%16]^TV
MH7HDQ4RI7(0+J:*N!+B@':&,AA>'K%C><I.6;X'6. V395.R]+=,G4>,B,<C
MH-HL=(]_.K/G8XOF,'B-B3*4[!CLZ:M(X)<;"(X"@6?LN3'\2R[S]2;--G 9
M2(3>W;^SAM+VJ(>-)TH%$SI3/@$%T,<N3>$K @A+:+R+BB8&4NA>;LE]6D"@
M0QX#!XV)]6"?'9/%N(G8WQNVXJ%8[2\(;N_+?;IN7)K>U-JJ%<%SGV<MSN X
M$A-,@ _-?;I:X06$"E8^H6L"G&L, PVCD(6[YV=X24S!"&HG;LCA?]OZ^ JG
M4&LXN,?O,[AP.<$K#!8Q^)=HQLE9O+RH,TZ*5G3=#2SK)>D_R\,%6C'29)T7
MM%$>?$0I6.*;C(&"&>V @&5!FG[#3TKJ%1[N9[N#/E\"]P+NCW#O1Q3@ WPV
M7S&=6"M"$13;[0".Q3;"W3H\P*AG7%VA*TV$:YN@ !E!"RW*>CF_(/\D(&*U
MRNF9G*AV>$<C5!K%#G&'R8?DW!Y%98U:(C-0"^P'^/T'.,E2.[*K)%"0YVEX
MM\GIX9UHE"5>;L@B@9^2ZN8\2C*F3:#= KA#)7M^3XL:\]A!AK8,W!_]&Q4M
M&6ZS2RP\ZI,_,=F Q *&CF"5D[-$L"!T-NQ<V'(#R+P]'BU$[K"[\A-/C@?;
MKMXF6OL)L7)".*X1UNIH#+*:<,9@!AO&G @@[3__TUT^)'M8BD%2=SC_@#&X
M<M9$HD2R(;NA@R5:FH?/[G",5V'^)5V\\-M%[Y?@#]K 5W=;%*S7T;8\;$KL
MDD:'8)Y0-_$ZQ?!S\:=GH$*^1"!DL&3)-&R@WT+%P"%U5Q'A8N903 #95D7P
M6&7!IH\.+($)].F&'BK\[F7$*&CR87@0SE,:;839?\_CZV0;1& -01$E*OI[
M<-S@^R ZPSB[8HYC$?YO"?+"HD_T;%GT^F73"\)6 /Q4^$/"F/X^N+^'U^'$
M7 ZJ1=3,T5_YK^$4E99<,JL9N"- ;QK-'D!E-),\, T0B1==VKI/D5V^B,[/
MYSN75%!T(4F77/=9>8@.S.[$/&Z4&A/%087F)+LW?VC8(CPOOP;6XG@31"66
M9>IB71^G ]JH5B!$L)#8$:7%X2:"W_I;XI(!=N35.QFNSS 7!"8,(/30"WYX
MLK *. F/+76KPCU1M"L7JN<#A7Q07:$HS,'805V]@I$L99&ZK+]H7B!U]9[7
ML[]D7!W!],Z!Z]4B8>@6?\S?DN/[KS*E1AJ'*1P L@4Q@3<I%MST];K[)R6W
M:N@Z MR9+P\&2I'MI+J+9/;4MMQ2SXMX$?J>3:@)0:H+J+&:;/)5E'Q@AR,J
M2L+P0[%=,;MT6]DC8+:6LDYI_RC,F/E2WQ1#KPU,;#*<0H &^R[Y$+/[Q?H+
M?SN@UDQR0*(M!P_:F/*8O0N6>![3M 1X>8+)>3LG_Q(IY"XXB)$:H*J=YP4M
M&Y)(2M(9<"^6-%E@O,S.R+#@]A"\7_-5\THQOL;W809(6IX0;"WR.?A>R/;>
M<V=7+L PIH(+LBQ9A%13?PCSA^+$6O9,%#IT31JQOG<#/?Q:0P,FJ8N"H1/N
MPYO!9YKIDSXX5$M8 H1"9Y/!8O!CLBV@4.LE)*8(@?8,*,J:-VT>-N_>Q&:B
MO&8L,7TVW^193LXN9 S$Z"]2U(._A&P[9&!9N*BB#"1:XFZ+/CR$"P:#!8LP
M;%6*9/LSS5_(?+ LW -_I#-+_XC+&@-K6F, PC.+K)-)S6/A^JVX].DG=33U
M'3PZ%;E[/XFUX;%8-!&2ZT@U!=CM@1,FVM _W25$_3T1 ZV('8Z3>+_XL>CI
MLP0IFR]WX&Q*S[E]96U4/V+81O!R!B':][A5(D2$U+(-"EBC0F&N"7IID"54
MZ:VU<1%W";^7 +K(YDL;-#+^HC6A[.\\Y67:W4&Z7_BN_3JC5K=A*W:^:HR_
MF)'V-,A<"O%N_##Y'TZ?BFNNL+#&4/%ON.?=Y#0[=6E-+&%=Y$$8TVL2YER2
MK8.LE>]:^H"$'F*CJ+E4LO*V;K$A'3W2JDH4)M!-V\#Q>=/B1<R*Z\H)V#[I
M=274)\6 ^]2*:*U]X.\KTC50;34L23E9H(MD$RV9XS;%':N?+6)Z8B3_6!=I
M3N@J4EZ4C"!L:$:+[=->;4.$;W<%#H>EEU5YYV?XU_B1;4H0L9 &BWP31+<X
M?3P2K=".U9>6/= 0I*(+E),^Z"%&=3G!40:Q_%A7\4_QN_CD-OX+^4^9,XO5
M)MAC3R$_!H]K./T4WQ_^]/+=X8N3XLL4KV%WCO.L$<@".W5 78(HB3':XB E
M?4&RWD?"]0,A3R,Q'T+R*8Z)4MEZOC.=)"CX*W=J7/J+TVH\FSFA$3%7-!B&
MS0?[_5F2WA#+$3:#\N%&3$/,F'<V2=7?L!6F)EDW48@WE8L<5DA6D&!K$B(
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M8I"?IE(!\"TCB"J*J"))E?QB9Z_UL?Y'GDJ>BK B+8<[PR7.&>=0O%-6S[=
MR;,+6CUUME,B]2J8@&W5&@M/6)S!FIU02^OW+,S(CL V^3/RNVRX_A9W[<)E
M).6@[_S"&I06'FWB"1%*,MH]RO#'.\2%45CQUV556+ CQL"(M'=G6[Z,"[F7
MHVB#JD:(M?*U7ZA*K.W_D(R\;3)HJY5;\MUXFH3VYLC=U:39IR[@&]\^CN9,
M[^J#:@R#'%M,J_R$@]3*!E%W[&S="QA0W!W@^^[>X'=SZ$B'OS6TA^KX6##
MU.>8[7L\N]W'8M08GNR$KF)2NY-5;61"V3%6UGQ#BQK@E(4@O<6K)*W/##A[
M%\9)&M9Q+;-XV>Z%71Z^P_D#^).@1A&M9"B2>=M<I\7<:CY0S0BZHYP4]ZV(
M]8\:!/8:YT.XEKHDLH1LH4D404\EO[Z/>@ZGG(=#YQ)W>7]<&#HM+YBRV["T
M]7:]AA-T%RJ-D^O[59\@EW+C1#GR507[#'7B0[VL8V&PIW183O7[3G!66;Z&
M1GHU(KK>!EFXH.$X$616[BT.4737R#'/0IE1H\\]1'NE"ZGHU[/7Q6PR>((=
M,JT.76;?!R'D&\OF\4T0X?GJ*DV@3-46'K3GH+37CY+K2&A=;LO$^#H)LW52
M%DE?H;(OFB<@1U5O?A6CVHAY(M69*[?7G&=!F-)HNG<X@"+VP >\_7P?)W>0
M%YW5U%P3V+6=N? C4?<%#K,R\F4KK;0*Q%BB]CW4H,=J*34I(D9RQP=/S*Z*
M*EW_Y!<58=:O9R5@939Y@+(H-J-C?K'UUP?$T4)8A#T[.GC*>!"<]4M;KWG4
M[T2S.#_K]XFH/.Q+!^O2;I.^:VIF6BFCPI?2-P'[M-00:@:HHT:$.A1\:'Y7
M1*DC&J:^5R:ZV:N>^M,RB8PCGPX#_4GBJ1/3J79J;DJ9G.</?;F*6%/$VA:B
MVRML2R)@Z&"RDJ3<:4NN,2D.#<.ACT$TGG]PA3W^8F?ELCL'E';6#\^FAZ-9
MYV+0I<#=FL?\=PO</:;Q95%,L' F]@4)^-(UO4\X1(,?=!>,H=Y>=!XO\<>_
MX>UP^Y#?K;L09R[]GGM?]C&B7R/RN:_K/ZE(=FYY.0,TB/*;D;6_I%=)47 _
M7/CM[IQ=_;7("F1=?8/@(W]F/W?&2]EV!^+X.F_$K8/YR9Q;!8RL7VT^]B1:
MWN2;DC(,$6%*Z1K?AY!&*LXO@\<1? W<7EW%F_&(R_>1^EL$'_O3,3)IM+<1
MSO#<&G0J@:KDE\<I7H;B:V7UJ&'X ^N,%PX\T6#@>@)XFL!D"AUO*[LO3<[C
MJQ2O@W!9!DH4EV:S>$G/R"QH0A)$L/M(ASI_6)?5]2W<1='>BN"2"<0"&$R"
MX%K?>#H=.AYT@M!/XV"1TX"9Z\*W.=;K@*+GZM/NNI_HJN=/C:D&D$VTXS-\
M([6=,/]&X05D7_FWY@IVA898:S@NG?)%)$]\W_]<HOJT_6C"[_;'X9\WR<)A
M?D)^U+,D7>$PWP!:8N86=G$Z:I"=R!7)^/-HXX D%)>W-!T*^3G\+N8&(SR)
M=(8RZ+#9R)E9W*[4L3BCN3%E-!Q>>/=ST^/AI"U9MIP]3OB6Q_=0ZL+<<8#V
M38;35$:[\=Z7N/_!>C/L'9XR)BMI]+O7I^K-@?&6MG@"C,)7F(A_2*)-G ?I
M]BR,<#K: [7=;EW?3>S0EZ_<ZF/$OO;_%DT@E?;JY(W1X'J"=4;[.":GE?LD
M'>V&JMVI<UW>(B^' /T4E=_ZO9OBBJ(M^N[(7&IBN>>HXPCREFJ'IT1WW#1^
M'720OIB<:!7,3X$[KN@ \:W3:3C@NH-4<[>))F<*4DLVD. GV,+-CK[(:&M4
M-/>[4'I'IRRK[I0,"9GX$4?1W^+D0WQ#""0Q7E+?3SK6QB3JWOD6)6!$OEE!
MH_U?H14JFS$G7NK[.JQ';.U-3#9VKP>+[U.)AX][M* M/&M>_C"4#A*- 3M]
M7)AD-&=Q<9,BG'+Z'4L-7'SI^YIIEW/>+/-'-\&,4F=)BL/[N/7%20C5,S!9
MIT$T_**HH-#YKDGED[DRZILNT\LC-3%X" 4515I?X@_T3\)UJQ*"3CIA7WA?
MTVICY7K!-69I>I$?_ R'8JFJ+WMQMDB<?5*)XD139+K4Y5/N_H')-5YB_(B7
M\_0XB"(>BN5+O&R/$O"A0 _\Y>[]J4G_0(7K6W6.A@0(G^!LD8;K9@G#$>*$
MF[VZ"NSC$>\-&FY\ZRT!NDP6G0CBW<'IGWAKB!&-0#-/-0_=7>&O@NR.CJEH
M" AX_16.\JS\#:T;VX""@(+;1XU-T@(85!^AG^EG7BH(R\71U@F=,1G<M'9Z
MNPAC?$[^*;F(&0$"-177H>\=#OK1 )\B^JVW<L#]8N)"HSU([4NZ3G\WQ%X*
MR'XS^QC:Q4>+D,OH'QX#(H04GZ"?X:-I: N>@+C(Z(ROVCF*<1#H_%K G/R&
M_ #Q1Z"R_S]02P,$%     @ 1$ I3+-M%^W=.@  HP($ !4   !I='5S+3(P
M,3<Q,#,Q7W!R92YX;6SM?6MSVT:RZ/?S*W1\OMQ;6UY+<AS'J>2>HDA*898B
MM23EQYXZE8+ (8D$!+@ *(O^]7<&#Q)OS*,' ]#XL!N9$J=[NGMZ^CV__/?+
MUKQX1HYKV-:OKZ[^?OGJ EFZO32L]:^O'N>O>_/^:/3JO__?Q<5__/*?KU]?
MW"$+.9J'EA=/APNC_W^\[?^]>'W1M[>[N6Y<C"P/_U;WC&>$/[/PNOC?^/<;
MS]O]_.;-UZ]?_Z[C/W5UPT&NO7=TY)(/+EZ_Q@ N(AA]!Q$(/U_<V];%[YIU
M<?G3Q?7;GZ]__/GM^XOA?'%Q?7GU4_"=__C%-*R_GC077>"-6.ZOKV*@7IX<
M\^^VLWYS?7GY]DWTAZ^"O_SYA7R0^/NO;_V_OOKPX<,;_[?'/W6-O#_$RUZ]
M^7P_GNL;M-5>&Y;K:99. +C&SZ[_X=C6-<\G;25>%X5_0?[U.OJSU^2CUU?7
MK]]>_?W%7;[R"?<?%Q>_.+:)9FAUX6/^LW?8H5]?N<9V9Q*$_,\V#EK]^LKP
M]BY>Y.K]U66PQ'^13_YP_L ,<VW36!+:WV@FV<I\@Y#WZH(L_3@;)38Q6CS.
M==O9$?Z](7_PIO#[;T+FRD3RCP?-09:W09ZA:Z8KBG-Z.5E;&.&SMD5S#_^\
MQ?!XT$XO@5&5C28 L2M6A-K$?(/7W=CF$FNXX;_WAG=8X$6N;><M+=(E*[R1
M<_;ZFKNY->VO/&0]?I?@!H+9S>-\-!G.Y[W)X/9Q,AA-[FCQROFF3S$8QC[>
MW_=F7Z:W\]'=9'0[ZO<FBUZ_/WV<+#"@A^EXU!\-Y]1,IEL-#GV\^.QQ.!A^
M?AA.YO1XIK\&QN6'WF)(MOS/Q]%\M!A-)].;\>BN1WZBQ:UL";#C_%MO-OQM
M.AX,9_,A!K3X0LWA[#?AN-F?WM^/%O=X^T38^U-?:H83%@DL6P**>J,)AC)<
M]#[3HQ7_"J"ZZ^FZO;<\;&0^8,VE&\B].?@_':A/0O$*@'C2Z86%]F0BZEN0
M:4U(NR.E/-BPSO\R)*DS!Y21K$7?AR1A[#BP89?](M2A_LW 'I>C;PXKV\$>
MU<JPL!%K8%/6=9'G:M;2-+0GPS0\?$2V2'/W#L*6PDHSG&?-W"/;PN:-OG<<
M?)*P>V&X/GJTVY(#'.Q6ZV\T:XU<@QB6)Z K_"_BL&K6P1VC9V2^/>)=CBX3
M::3 AI3E3\A8;[#)J&$O75MCB.Y^NR.^JKMW$?;_D>L96XUHV.0.7,_6_[*#
MOV2B"!Q 0#M,UYT]BHLITY:*O@Z'X,C"1VOKQQ <M-:<94 >$@3P/9,'[+,R
MH4R_(*1RC['0WGLD3D+@XO]'+\C1#9< W.-_.4)[$P53 ]NN+H'9EEE0/MM\
M"O)OA7%5P/WD$3&.S=K1+*R@+-L+D8E)B"VP8W"X8#=D 2]R,<&_ F<Z R"P
M/0>A)T][V3GVLT$"WT_(0BO#8^1IZ2I@V"XV! A:K9#NN=A^0-N=C6VNP]+
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M/,88DP*+(!D+Z\K3\CQHM-!6YZ(VP)M? K4C1RQGR"238OJV6X_=3@FZC7J
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M@PR>EL)K%T_+21?Q5,%#-\'CDBX9OQCVT/ER%KXYB>3,[*\&VB[N4A Q8C%
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MXI/F(O*O_P]02P$"% ,4    " !$0"E,0\C].TC<  "3D0T $0
M    @ $     :71U<RTR,#$W,3 S,2YX;6Q02P$"% ,4    " !$0"E,IQD0
M(5,1  "LK0  $0              @ %WW   :71U<RTR,#$W,3 S,2YX<V10
M2P$"% ,4    " !$0"E,OMGXXQX,  !VB0  %0              @ 'Y[0
M:71U<RTR,#$W,3 S,5]C86PN>&UL4$L! A0#%     @ 1$ I3,C1\ &].0
M@^\# !4              ( !2OH  &ET=7,M,C Q-S$P,S%?9&5F+GAM;%!+
M 0(4 Q0    ( $1 *4R'_^;4R&   /H(!0 5              "  3HT 0!I
M='5S+3(P,3<Q,#,Q7VQA8BYX;6Q02P$"% ,4    " !$0"E,LVT7[=TZ  "C
M @0 %0              @ $UE0$ :71U<RTR,#$W,3 S,5]P<F4N>&UL4$L%
3!@     &  8 B@$  $70 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
